NO165959B - ANALOGY PROCEDURE FOR THE PREPARATION OF 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES. - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES. Download PDFInfo
- Publication number
- NO165959B NO165959B NO870984A NO870984A NO165959B NO 165959 B NO165959 B NO 165959B NO 870984 A NO870984 A NO 870984A NO 870984 A NO870984 A NO 870984A NO 165959 B NO165959 B NO 165959B
- Authority
- NO
- Norway
- Prior art keywords
- methylene chloride
- dihydroxy
- hydroxy
- ether
- group
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 41
- 238000002360 preparation method Methods 0.000 title claims description 5
- -1 hydroxy, amino Chemical group 0.000 claims description 154
- 150000001875 compounds Chemical class 0.000 claims description 64
- 125000000217 alkyl group Chemical group 0.000 claims description 47
- 125000003118 aryl group Chemical group 0.000 claims description 27
- 229920006395 saturated elastomer Polymers 0.000 claims description 25
- 125000000623 heterocyclic group Chemical group 0.000 claims description 22
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 21
- 239000001257 hydrogen Substances 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 125000001589 carboacyl group Chemical group 0.000 claims description 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 11
- 150000002367 halogens Chemical class 0.000 claims description 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 150000002170 ethers Chemical class 0.000 claims description 10
- 230000004962 physiological condition Effects 0.000 claims description 10
- 125000003282 alkyl amino group Chemical group 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 150000001721 carbon Chemical group 0.000 claims description 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000002837 carbocyclic group Chemical group 0.000 claims description 6
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 239000007858 starting material Substances 0.000 claims description 6
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 6
- RQPAUNZYTYHKHA-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-(2-fluorophenyl)methanone Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2C(=CC=CC=2)F)=C1 RQPAUNZYTYHKHA-UHFFFAOYSA-N 0.000 claims description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 5
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 5
- FSKSXFIUMKDGCE-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-pyridin-4-ylmethanone Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2C=CN=CC=2)=C1 FSKSXFIUMKDGCE-UHFFFAOYSA-N 0.000 claims description 4
- 150000000179 1,2-aminoalcohols Chemical class 0.000 claims description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000005277 alkyl imino group Chemical group 0.000 claims description 4
- 150000001409 amidines Chemical class 0.000 claims description 4
- 150000001411 amidrazones Chemical class 0.000 claims description 4
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- MCOIDMKILOXTJS-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1 MCOIDMKILOXTJS-UHFFFAOYSA-N 0.000 claims description 3
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical group FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 3
- 125000004525 thiadiazinyl group Chemical group S1NN=C(C=C1)* 0.000 claims description 3
- 125000000335 thiazolyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000004306 triazinyl group Chemical group 0.000 claims description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 2
- 125000005011 alkyl ether group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 2
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 229910052701 rubidium Inorganic materials 0.000 claims description 2
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 7
- HDFRDWFLWVCOGP-UHFFFAOYSA-N carbonothioic O,S-acid Chemical compound OC(S)=O HDFRDWFLWVCOGP-UHFFFAOYSA-N 0.000 claims 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims 1
- MIQPIUSUKVNLNT-UHFFFAOYSA-N tolcapone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 MIQPIUSUKVNLNT-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 663
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 289
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 216
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 200
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 173
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 171
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 162
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 156
- 239000000243 solution Substances 0.000 description 150
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 147
- 239000013078 crystal Substances 0.000 description 110
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 99
- 229910052938 sodium sulfate Inorganic materials 0.000 description 96
- 235000011152 sodium sulphate Nutrition 0.000 description 96
- 239000011541 reaction mixture Substances 0.000 description 88
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 84
- 238000003756 stirring Methods 0.000 description 84
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 68
- 229960000583 acetic acid Drugs 0.000 description 63
- 238000010992 reflux Methods 0.000 description 62
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 60
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 60
- 239000000203 mixture Substances 0.000 description 56
- 235000019439 ethyl acetate Nutrition 0.000 description 51
- 239000012074 organic phase Substances 0.000 description 50
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 49
- 238000001816 cooling Methods 0.000 description 47
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 46
- 239000000741 silica gel Substances 0.000 description 45
- 229910002027 silica gel Inorganic materials 0.000 description 45
- 239000002904 solvent Substances 0.000 description 45
- 238000009835 boiling Methods 0.000 description 44
- 239000005457 ice water Substances 0.000 description 44
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 41
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 38
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 38
- 238000001953 recrystallisation Methods 0.000 description 36
- 239000002244 precipitate Substances 0.000 description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- 239000003921 oil Substances 0.000 description 32
- 235000019198 oils Nutrition 0.000 description 32
- 239000012071 phase Substances 0.000 description 32
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 31
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 30
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 29
- 239000012362 glacial acetic acid Substances 0.000 description 28
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 27
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 26
- 239000003208 petroleum Substances 0.000 description 24
- 239000000052 vinegar Substances 0.000 description 23
- 235000021419 vinegar Nutrition 0.000 description 23
- 239000000725 suspension Substances 0.000 description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- UTGFDKXCQRIQLP-UHFFFAOYSA-N hexyl 2-(3,4-dihydroxy-5-nitrophenyl)-2-oxoacetate Chemical compound CCCCCCOC(=O)C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 UTGFDKXCQRIQLP-UHFFFAOYSA-N 0.000 description 20
- GANOKOPJCWEJLV-UHFFFAOYSA-N 2-bromo-1-(3,4-dihydroxy-5-nitrophenyl)ethanone Chemical compound OC1=CC(C(=O)CBr)=CC([N+]([O-])=O)=C1O GANOKOPJCWEJLV-UHFFFAOYSA-N 0.000 description 19
- 239000000284 extract Substances 0.000 description 19
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000002253 acid Substances 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- JSHLOPGSDZTEGQ-UHFFFAOYSA-N 3-methoxy-4-phenylmethoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 JSHLOPGSDZTEGQ-UHFFFAOYSA-N 0.000 description 14
- 238000000354 decomposition reaction Methods 0.000 description 14
- 150000002430 hydrocarbons Chemical group 0.000 description 14
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 13
- 235000011121 sodium hydroxide Nutrition 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 12
- 229910017604 nitric acid Inorganic materials 0.000 description 12
- IJVYFNLZNWULEZ-UHFFFAOYSA-N 2-bromo-1-(4-hydroxy-3-methoxy-5-nitrophenyl)ethanone Chemical compound COC1=CC(C(=O)CBr)=CC([N+]([O-])=O)=C1O IJVYFNLZNWULEZ-UHFFFAOYSA-N 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 10
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- PNDFTWPJERLXHE-UHFFFAOYSA-N 3,4-dimethoxy-5-nitrobenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC([N+]([O-])=O)=C1OC PNDFTWPJERLXHE-UHFFFAOYSA-N 0.000 description 9
- 102000006378 Catechol O-methyltransferase Human genes 0.000 description 9
- 108020002739 Catechol O-methyltransferase Proteins 0.000 description 9
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 8
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 8
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- 239000012876 carrier material Substances 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 6
- 239000001632 sodium acetate Substances 0.000 description 6
- 235000017281 sodium acetate Nutrition 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000001072 heteroaryl group Chemical group 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 4
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 4
- WASZYBLMIRDXNA-UHFFFAOYSA-N 2-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-oxoacetic acid Chemical compound COC1=CC(C(=O)C(O)=O)=CC([N+]([O-])=O)=C1O WASZYBLMIRDXNA-UHFFFAOYSA-N 0.000 description 4
- HDPSONAKHMNQPA-UHFFFAOYSA-N 3,4-dihydroxy-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 HDPSONAKHMNQPA-UHFFFAOYSA-N 0.000 description 4
- NOUWQZZKSKEHCI-UHFFFAOYSA-N 3,4-dimethoxy-5-nitrobenzaldehyde Chemical compound COC1=CC(C=O)=CC([N+]([O-])=O)=C1OC NOUWQZZKSKEHCI-UHFFFAOYSA-N 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 125000004423 acyloxy group Chemical group 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 125000005530 alkylenedioxy group Chemical group 0.000 description 4
- DQPBABKTKYNPMH-UHFFFAOYSA-N amino hydrogen sulfate Chemical compound NOS(O)(=O)=O DQPBABKTKYNPMH-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 150000008064 anhydrides Chemical class 0.000 description 4
- 239000012300 argon atmosphere Substances 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- 150000004292 cyclic ethers Chemical class 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- JDAWJIRVXGDDQC-UHFFFAOYSA-N diethyl 2-(3,4-dimethoxy-5-nitrobenzoyl)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)C(=O)C1=CC(OC)=C(OC)C([N+]([O-])=O)=C1 JDAWJIRVXGDDQC-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- QONPVNYXLRVYKT-UHFFFAOYSA-N ethyl 3-(3,4-dimethoxy-5-nitrophenyl)-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(OC)=C(OC)C([N+]([O-])=O)=C1 QONPVNYXLRVYKT-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 229910052703 rhodium Inorganic materials 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- XRJGGLYXJTZFPK-UHFFFAOYSA-N (2-acetylphenyl) 3,4-dimethoxy-5-nitrobenzoate Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)OC=2C(=CC=CC=2)C(C)=O)=C1 XRJGGLYXJTZFPK-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- FNVILAFBAWUBRW-UHFFFAOYSA-N 1-(3,4-dimethoxy-5-nitrophenyl)ethanone Chemical compound COC1=CC(C(C)=O)=CC([N+]([O-])=O)=C1OC FNVILAFBAWUBRW-UHFFFAOYSA-N 0.000 description 3
- BBFJODMCHICIAA-UHFFFAOYSA-N 3,4-dihydroxy-5-nitrobenzaldehyde Chemical compound OC1=CC(C=O)=CC([N+]([O-])=O)=C1O BBFJODMCHICIAA-UHFFFAOYSA-N 0.000 description 3
- SJLUBPYBSAERDO-UHFFFAOYSA-N 3,4-dimethoxy-5-nitroaniline Chemical compound COC1=CC(N)=CC([N+]([O-])=O)=C1OC SJLUBPYBSAERDO-UHFFFAOYSA-N 0.000 description 3
- ICZSHZGGYMYYKG-UHFFFAOYSA-N 3-(3,4-dihydroxy-5-nitrophenyl)-6-methyl-1,4-benzoxazin-2-one Chemical compound N=1C2=CC(C)=CC=C2OC(=O)C=1C1=CC(O)=C(O)C([N+]([O-])=O)=C1 ICZSHZGGYMYYKG-UHFFFAOYSA-N 0.000 description 3
- HWFJLOCDSNDWGJ-UHFFFAOYSA-N 5-(2-bromoacetyl)-2,3-dimethoxybenzonitrile Chemical compound COC1=CC(C(=O)CBr)=CC(C#N)=C1OC HWFJLOCDSNDWGJ-UHFFFAOYSA-N 0.000 description 3
- KYMXIFPGMCNFSS-UHFFFAOYSA-N 5-acetyl-2,3-dimethoxybenzonitrile Chemical compound COC1=CC(C(C)=O)=CC(C#N)=C1OC KYMXIFPGMCNFSS-UHFFFAOYSA-N 0.000 description 3
- ZEHYRTJBFMZHCY-UHFFFAOYSA-N 5-nitrovanillin Chemical compound COC1=CC(C=O)=CC([N+]([O-])=O)=C1O ZEHYRTJBFMZHCY-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000005909 Kieselgur Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 125000005236 alkanoylamino group Chemical group 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000002178 crystalline material Substances 0.000 description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 description 3
- 239000012954 diazonium Substances 0.000 description 3
- 150000001989 diazonium salts Chemical class 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- RZPZYXLZCDAIRQ-UHFFFAOYSA-N ethyl 3-(3,4-dihydroxy-5-nitrophenyl)-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 RZPZYXLZCDAIRQ-UHFFFAOYSA-N 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- JBTCHCWUNMZNEO-UHFFFAOYSA-N n-phenylhexanamide Chemical compound CCCCCC(=O)NC1=CC=CC=C1 JBTCHCWUNMZNEO-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 229910052760 oxygen Chemical group 0.000 description 3
- 239000001301 oxygen Chemical group 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229910052702 rhenium Inorganic materials 0.000 description 3
- 229910021481 rutherfordium Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- QFOBUXGTMVOBKZ-UHFFFAOYSA-N (2-chloro-3-cyano-6-methoxyphenyl) acetate Chemical compound COC1=CC=C(C#N)C(Cl)=C1OC(C)=O QFOBUXGTMVOBKZ-UHFFFAOYSA-N 0.000 description 2
- AYJHPRPTJFVQSF-UHFFFAOYSA-N (2-chloro-3-formyl-6-methoxy-5-nitrophenyl) acetate Chemical compound COC1=C(OC(C)=O)C(Cl)=C(C=O)C=C1[N+]([O-])=O AYJHPRPTJFVQSF-UHFFFAOYSA-N 0.000 description 2
- HIMMACGPRADPJO-UHFFFAOYSA-N (2-chloro-3-formyl-6-methoxyphenyl) acetate Chemical compound COC1=CC=C(C=O)C(Cl)=C1OC(C)=O HIMMACGPRADPJO-UHFFFAOYSA-N 0.000 description 2
- KENAPLUXUWNTDX-UHFFFAOYSA-N (2-fluoro-3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C(F)=C1OC KENAPLUXUWNTDX-UHFFFAOYSA-N 0.000 description 2
- BMFNHOFJYSZLON-UHFFFAOYSA-N (2-fluoro-3,4-dimethoxyphenyl)methyl acetate Chemical compound COC1=CC=C(COC(C)=O)C(F)=C1OC BMFNHOFJYSZLON-UHFFFAOYSA-N 0.000 description 2
- CQWJHXNPWOOAHJ-UHFFFAOYSA-N (2-fluorophenyl)-(3-methoxy-4-phenylmethoxyphenyl)methanone Chemical compound COC1=CC(C(=O)C=2C(=CC=CC=2)F)=CC=C1OCC1=CC=CC=C1 CQWJHXNPWOOAHJ-UHFFFAOYSA-N 0.000 description 2
- RSMBYASOUAJGMV-UHFFFAOYSA-N (2-fluorophenyl)-(4-hydroxy-3-methoxy-5-nitrophenyl)methanone Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C(=O)C=2C(=CC=CC=2)F)=C1 RSMBYASOUAJGMV-UHFFFAOYSA-N 0.000 description 2
- KLFLITGABCRRNN-UHFFFAOYSA-N (2-fluorophenyl)-(4-hydroxy-3-methoxyphenyl)methanone Chemical compound C1=C(O)C(OC)=CC(C(=O)C=2C(=CC=CC=2)F)=C1 KLFLITGABCRRNN-UHFFFAOYSA-N 0.000 description 2
- ILQVWQFEMVOKQE-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 ILQVWQFEMVOKQE-UHFFFAOYSA-N 0.000 description 2
- GCRUTJCNHREIPR-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-imidazol-1-ylmethanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)N2C=NC=C2)=C1 GCRUTJCNHREIPR-UHFFFAOYSA-N 0.000 description 2
- XBWROAKUHKPHML-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)C=2C=CC=CC=2)=C1 XBWROAKUHKPHML-UHFFFAOYSA-N 0.000 description 2
- BKQWDYBKLLIQIB-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-pyridin-2-ylmethanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)C=2N=CC=CC=2)=C1 BKQWDYBKLLIQIB-UHFFFAOYSA-N 0.000 description 2
- WQEODNAKDYYKHM-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-thiophen-2-ylmethanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)C=2SC=CC=2)=C1 WQEODNAKDYYKHM-UHFFFAOYSA-N 0.000 description 2
- ASUFGWJUSOTVHQ-UHFFFAOYSA-N (3-amino-4,5-dimethoxyphenyl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound NC1=C(OC)C(OC)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 ASUFGWJUSOTVHQ-UHFFFAOYSA-N 0.000 description 2
- ICKPCWLYICVBQE-UHFFFAOYSA-N (3-cyano-2-fluoro-6-methoxyphenyl) acetate Chemical compound COC1=CC=C(C#N)C(F)=C1OC(C)=O ICKPCWLYICVBQE-UHFFFAOYSA-N 0.000 description 2
- WTKCNEXBXFEQHQ-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-[4-(trifluoromethyl)phenyl]methanol Chemical compound COC1=CC(C(O)C=2C=CC(=CC=2)C(F)(F)F)=CC=C1OCC1=CC=CC=C1 WTKCNEXBXFEQHQ-UHFFFAOYSA-N 0.000 description 2
- ZHSOCEKRPWKSIP-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound COC1=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=CC=C1OCC1=CC=CC=C1 ZHSOCEKRPWKSIP-UHFFFAOYSA-N 0.000 description 2
- TTXIIDNWJQGNAA-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-pyridin-3-ylmethanol Chemical compound COC1=CC(C(O)C=2C=NC=CC=2)=CC=C1OCC1=CC=CC=C1 TTXIIDNWJQGNAA-UHFFFAOYSA-N 0.000 description 2
- DGLYFAKHQSCYHC-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-pyridin-3-ylmethanone Chemical compound COC1=CC(C(=O)C=2C=NC=CC=2)=CC=C1OCC1=CC=CC=C1 DGLYFAKHQSCYHC-UHFFFAOYSA-N 0.000 description 2
- NSZAKAAYJWNFIS-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-pyridin-4-ylmethanone Chemical compound COC1=CC(C(=O)C=2C=CN=CC=2)=CC=C1OCC1=CC=CC=C1 NSZAKAAYJWNFIS-UHFFFAOYSA-N 0.000 description 2
- XECBSJWCGVYLHB-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-quinolin-3-ylmethanol Chemical compound COC1=CC(C(O)C=2C=C3C=CC=CC3=NC=2)=CC=C1OCC1=CC=CC=C1 XECBSJWCGVYLHB-UHFFFAOYSA-N 0.000 description 2
- XZPLDUBGMDHIRQ-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-quinolin-4-ylmethanone Chemical compound COC1=CC(C(=O)C=2C3=CC=CC=C3N=CC=2)=CC=C1OCC1=CC=CC=C1 XZPLDUBGMDHIRQ-UHFFFAOYSA-N 0.000 description 2
- GUPMWKILKXMIHE-UHFFFAOYSA-N (4-hydroxy-3-methoxy-5-nitrophenyl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 GUPMWKILKXMIHE-UHFFFAOYSA-N 0.000 description 2
- UPGHSZOOHJXNFM-UHFFFAOYSA-N (4-hydroxy-3-methoxy-5-nitrophenyl)-quinolin-4-ylmethanone Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C(=O)C=2C3=CC=CC=C3N=CC=2)=C1 UPGHSZOOHJXNFM-UHFFFAOYSA-N 0.000 description 2
- ODVHWTMXCUMUTD-UHFFFAOYSA-N (4-hydroxy-3-methoxyphenyl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(O)C(OC)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 ODVHWTMXCUMUTD-UHFFFAOYSA-N 0.000 description 2
- BLBOUPJTYKRRRN-UHFFFAOYSA-N (4-hydroxy-3-methoxyphenyl)-pyridin-3-ylmethanone Chemical compound C1=C(O)C(OC)=CC(C(=O)C=2C=NC=CC=2)=C1 BLBOUPJTYKRRRN-UHFFFAOYSA-N 0.000 description 2
- FGOVJXTYYNEESV-UHFFFAOYSA-N (4-hydroxy-3-methoxyphenyl)-quinolin-4-ylmethanone Chemical compound C1=C(O)C(OC)=CC(C(=O)C=2C3=CC=CC=C3N=CC=2)=C1 FGOVJXTYYNEESV-UHFFFAOYSA-N 0.000 description 2
- KNHVUQNJSRWZHF-UHFFFAOYSA-N (5-acetyl-2-acetyloxy-3-cyanophenyl) acetate Chemical compound CC(=O)OC1=CC(C(C)=O)=CC(C#N)=C1OC(C)=O KNHVUQNJSRWZHF-UHFFFAOYSA-N 0.000 description 2
- MQGVUJIACAETGG-UHFFFAOYSA-N (6-acetyloxy-3-carbonochloridoyl-6-nitrocyclohexa-2,4-dien-1-yl) acetate Chemical compound CC(=O)OC1C=C(C(Cl)=O)C=CC1(OC(C)=O)[N+]([O-])=O MQGVUJIACAETGG-UHFFFAOYSA-N 0.000 description 2
- AZHYWNKGSJUVRH-UHFFFAOYSA-N 1-(3,4-dimethoxy-5-nitrophenyl)-3,4-dihydroisoquinoline Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C=2C3=CC=CC=C3CCN=2)=C1 AZHYWNKGSJUVRH-UHFFFAOYSA-N 0.000 description 2
- MLMKZSIHWKRZJQ-UHFFFAOYSA-N 1-(3,4-dimethoxy-5-nitrophenyl)-3-(2-hydroxyphenyl)propane-1,3-dione Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)CC(=O)C=2C(=CC=CC=2)O)=C1 MLMKZSIHWKRZJQ-UHFFFAOYSA-N 0.000 description 2
- KUCAVFQKKTZISS-UHFFFAOYSA-N 1-(3-amino-4,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(C(C)=O)=CC(N)=C1OC KUCAVFQKKTZISS-UHFFFAOYSA-N 0.000 description 2
- FMHSTDHUPHGHNF-UHFFFAOYSA-N 1-(3-methoxy-4-phenylmethoxyphenyl)-4-phenylbutan-1-one Chemical compound COC1=CC(C(=O)CCCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=C1 FMHSTDHUPHGHNF-UHFFFAOYSA-N 0.000 description 2
- HDVWXVSTQCEOJJ-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-methylpropan-1-one Chemical compound COC1=CC(C(=O)C(C)C)=CC([N+]([O-])=O)=C1O HDVWXVSTQCEOJJ-UHFFFAOYSA-N 0.000 description 2
- GGXKLSWBMOPTQV-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxy-5-nitrophenyl)butan-1-one Chemical compound CCCC(=O)C1=CC(OC)=C(O)C([N+]([O-])=O)=C1 GGXKLSWBMOPTQV-UHFFFAOYSA-N 0.000 description 2
- RXEAFAIZLAXHLY-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxyphenyl)-2-methylpropan-1-one Chemical compound COC1=CC(C(=O)C(C)C)=CC=C1O RXEAFAIZLAXHLY-UHFFFAOYSA-N 0.000 description 2
- AOLSHZAGFYJNKF-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxyphenyl)-4-phenylbutan-1-one Chemical compound C1=C(O)C(OC)=CC(C(=O)CCCC=2C=CC=CC=2)=C1 AOLSHZAGFYJNKF-UHFFFAOYSA-N 0.000 description 2
- ATFSJFVUBBVFDB-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxyphenyl)butan-1-one Chemical compound CCCC(=O)C1=CC=C(O)C(OC)=C1 ATFSJFVUBBVFDB-UHFFFAOYSA-N 0.000 description 2
- AZBGHCITBXXXSK-UHFFFAOYSA-N 1h-benzimidazol-2-yl-(3,4-dimethoxy-5-nitrophenyl)methanol Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(O)C=2NC3=CC=CC=C3N=2)=C1 AZBGHCITBXXXSK-UHFFFAOYSA-N 0.000 description 2
- SCSROOBIOOCHHI-UHFFFAOYSA-N 2,3-dihydroxy-5-nitrobenzaldehyde Chemical compound OC1=CC([N+]([O-])=O)=CC(C=O)=C1O SCSROOBIOOCHHI-UHFFFAOYSA-N 0.000 description 2
- NKBHDAWHDOTGJC-UHFFFAOYSA-N 2,3-dimethoxy-5-[4-(trifluoromethyl)benzoyl]benzonitrile Chemical compound N#CC1=C(OC)C(OC)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 NKBHDAWHDOTGJC-UHFFFAOYSA-N 0.000 description 2
- DQOHADHUZGMXLU-UHFFFAOYSA-N 2-(3,4-dimethoxy-5-nitrophenyl)pyridine Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C=2N=CC=CC=2)=C1 DQOHADHUZGMXLU-UHFFFAOYSA-N 0.000 description 2
- HEQOJEGTZCTHCF-UHFFFAOYSA-N 2-amino-1-phenylethanone Chemical compound NCC(=O)C1=CC=CC=C1 HEQOJEGTZCTHCF-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- PPMWHRFQUVXEBO-UHFFFAOYSA-N 2-chloro-3-(hydroxyiminomethyl)-6-methoxyphenol Chemical compound COC1=CC=C(C=NO)C(Cl)=C1O PPMWHRFQUVXEBO-UHFFFAOYSA-N 0.000 description 2
- RZPFQWJODMMQTJ-UHFFFAOYSA-N 2-chloro-3-hydroxy-4-methoxy-5-nitrobenzaldehyde Chemical compound COC1=C(O)C(Cl)=C(C=O)C=C1[N+]([O-])=O RZPFQWJODMMQTJ-UHFFFAOYSA-N 0.000 description 2
- ZZOWFQRYHWXNIS-UHFFFAOYSA-N 2-chloro-3-hydroxy-4-methoxy-5-nitrobenzonitrile Chemical compound COC1=C(O)C(Cl)=C(C#N)C=C1[N+]([O-])=O ZZOWFQRYHWXNIS-UHFFFAOYSA-N 0.000 description 2
- DTMJGFBJQBQOIA-UHFFFAOYSA-N 2-chloro-3-hydroxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(Cl)=C1O DTMJGFBJQBQOIA-UHFFFAOYSA-N 0.000 description 2
- UDBUQQVUWKHCAR-UHFFFAOYSA-N 2-fluoro-3,4-dimethoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(F)=C1OC UDBUQQVUWKHCAR-UHFFFAOYSA-N 0.000 description 2
- WQKRKQDDAUESPS-UHFFFAOYSA-N 2-fluoro-3,4-dimethoxybenzonitrile Chemical compound COC1=CC=C(C#N)C(F)=C1OC WQKRKQDDAUESPS-UHFFFAOYSA-N 0.000 description 2
- POSJALLNKFCQJS-UHFFFAOYSA-N 2-fluoro-3-hydroxy-4-methoxy-5-nitrobenzonitrile Chemical compound COC1=C(O)C(F)=C(C#N)C=C1[N+]([O-])=O POSJALLNKFCQJS-UHFFFAOYSA-N 0.000 description 2
- FKBZHXRWRUFAQA-UHFFFAOYSA-N 2-fluoro-3-hydroxy-4-methoxybenzonitrile Chemical compound COC1=CC=C(C#N)C(F)=C1O FKBZHXRWRUFAQA-UHFFFAOYSA-N 0.000 description 2
- NOFJIFYZDAAYQQ-UHFFFAOYSA-N 3,4-diacetyloxy-5-nitrobenzoic acid Chemical compound CC(=O)OC1=CC(C(O)=O)=CC([N+]([O-])=O)=C1OC(C)=O NOFJIFYZDAAYQQ-UHFFFAOYSA-N 0.000 description 2
- JRBDMOJXCREXNN-UHFFFAOYSA-N 3,4-dihydroxy-5-nitrobenzonitrile Chemical compound OC1=CC(C#N)=CC([N+]([O-])=O)=C1O JRBDMOJXCREXNN-UHFFFAOYSA-N 0.000 description 2
- YFSXWSANVLPQJZ-UHFFFAOYSA-N 3,4-dimethoxy-5-nitro-n-(2-phenylethyl)benzamide Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)NCCC=2C=CC=CC=2)=C1 YFSXWSANVLPQJZ-UHFFFAOYSA-N 0.000 description 2
- PBAWBCCUXJMEOI-UHFFFAOYSA-N 3,4-dimethoxy-5-nitrobenzamide Chemical compound COC1=CC(C(N)=O)=CC([N+]([O-])=O)=C1OC PBAWBCCUXJMEOI-UHFFFAOYSA-N 0.000 description 2
- GQNSKXYALDGGGN-UHFFFAOYSA-N 3,4-dimethoxy-5-nitrobenzoic acid Chemical compound COC1=CC(C(O)=O)=CC([N+]([O-])=O)=C1OC GQNSKXYALDGGGN-UHFFFAOYSA-N 0.000 description 2
- VDCDWNDTNSWDFJ-UHFFFAOYSA-N 3,5-dinitrocatechol Chemical compound OC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O VDCDWNDTNSWDFJ-UHFFFAOYSA-N 0.000 description 2
- YBLPKZOSNMBROT-UHFFFAOYSA-N 3-(3,4-dihydroxy-5-nitrophenyl)-1H-quinoxalin-2-one Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2C(NC3=CC=CC=C3N=2)=O)=C1 YBLPKZOSNMBROT-UHFFFAOYSA-N 0.000 description 2
- WIGNVYQMAXKHTQ-UHFFFAOYSA-N 3-(3,4-dihydroxy-5-nitrophenyl)prop-2-enoic acid Chemical compound OC(=O)C=CC1=CC(O)=C(O)C([N+]([O-])=O)=C1 WIGNVYQMAXKHTQ-UHFFFAOYSA-N 0.000 description 2
- ZKASBMPOXOFPFC-UHFFFAOYSA-N 4-(1H-benzimidazol-2-yl)-2-methoxy-6-nitrophenol Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C=2NC3=CC=CC=C3N=2)=C1 ZKASBMPOXOFPFC-UHFFFAOYSA-N 0.000 description 2
- BDBOJIKRGRYQAW-UHFFFAOYSA-N 4-(2-amino-1,3-thiazol-4-yl)-2-methoxy-6-nitrophenol Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C=2N=C(N)SC=2)=C1 BDBOJIKRGRYQAW-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 description 2
- AEGJXXCGTFMRGY-UHFFFAOYSA-N 4-bromo-2-methoxy-1-phenylmethoxybenzene Chemical compound COC1=CC(Br)=CC=C1OCC1=CC=CC=C1 AEGJXXCGTFMRGY-UHFFFAOYSA-N 0.000 description 2
- AEDVAGWYAKIOIM-UHFFFAOYSA-N 4-hydroxy-3-methoxy-5-nitrobenzoic acid Chemical compound COC1=CC(C(O)=O)=CC([N+]([O-])=O)=C1O AEDVAGWYAKIOIM-UHFFFAOYSA-N 0.000 description 2
- YVNRFQCFZVYDRO-UHFFFAOYSA-N 4-hydroxy-5-methoxybenzene-1,3-dicarbaldehyde Chemical compound COC1=CC(C=O)=CC(C=O)=C1O YVNRFQCFZVYDRO-UHFFFAOYSA-N 0.000 description 2
- SYFAPMRHLKMQEP-UHFFFAOYSA-N 5-(2-bromoacetyl)-2,3-dihydroxybenzonitrile Chemical compound OC1=CC(C(=O)CBr)=CC(C#N)=C1O SYFAPMRHLKMQEP-UHFFFAOYSA-N 0.000 description 2
- NPEMVHXILGPCKS-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-3-yl-3-nitrobenzene-1,2-diol Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2N3C=CC=CC3=NC=2)=C1 NPEMVHXILGPCKS-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RGYIJRYFFVNZDS-UHFFFAOYSA-N Cl.CCOC(=N)C(O)C1=CC(OC)=C(OC)C([N+]([O-])=O)=C1 Chemical compound Cl.CCOC(=N)C(O)C1=CC(OC)=C(OC)C([N+]([O-])=O)=C1 RGYIJRYFFVNZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 208000030713 Parkinson disease and parkinsonism Diseases 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- FANCNISIGMSCAT-UHFFFAOYSA-N [(e)-1-aminoethylideneamino] 3,4-dimethoxy-5-nitrobenzoate Chemical compound COC1=CC(C(=O)ON=C(C)N)=CC([N+]([O-])=O)=C1OC FANCNISIGMSCAT-UHFFFAOYSA-N 0.000 description 2
- JKFQCNFHRNCZDN-UHFFFAOYSA-N [2-(3,4-dihydroxy-5-nitrophenyl)-2-oxoethyl] acetate Chemical compound CC(=O)OCC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 JKFQCNFHRNCZDN-UHFFFAOYSA-N 0.000 description 2
- LRGXHQWQNRGUFT-UHFFFAOYSA-N [O-][N+](=O)C1=C(OC)C(OC)=CC(C2=NN(C)C(O)=C2)=C1 Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C2=NN(C)C(O)=C2)=C1 LRGXHQWQNRGUFT-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical class C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004622 benzoxazinyl group Chemical group O1NC(=CC2=C1C=CC=C2)* 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- FSBCENNZJFNCPO-UHFFFAOYSA-N bis[2-(4-hydroxy-3-methoxy-5-nitrophenyl)quinolin-3-yl]methanone Chemical compound OC1=C(C=C(C=C1[N+](=O)[O-])C1=NC2=CC=CC=C2C=C1C(=O)C=1C(=NC2=CC=CC=C2C=1)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)OC FSBCENNZJFNCPO-UHFFFAOYSA-N 0.000 description 2
- FHQZNMDMQAKBLY-UHFFFAOYSA-N bis[2-(4-hydroxy-3-methoxyphenyl)quinolin-3-yl]methanone Chemical compound OC1=C(C=C(C=C1)C1=NC2=CC=CC=C2C=C1C(=O)C=1C(=NC2=CC=CC=C2C1)C1=CC(=C(C=C1)O)OC)OC FHQZNMDMQAKBLY-UHFFFAOYSA-N 0.000 description 2
- QYIFZOPMWTZLSG-UHFFFAOYSA-N bis[4-(3,4-dimethoxy-5-nitrophenyl)-1-methylimidazol-2-yl]methanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C=2N=C(N(C)C=2)C(=O)C=2N(C=C(N=2)C=2C=C(C(OC)=C(OC)C=2)[N+]([O-])=O)C)=C1 QYIFZOPMWTZLSG-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000005661 deetherification reaction Methods 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- ACPFYBYFZMSBCK-UHFFFAOYSA-N ethyl 2-(3,4-dihydroxy-5-nitrophenyl)-2-oxoacetate Chemical compound CCOC(=O)C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 ACPFYBYFZMSBCK-UHFFFAOYSA-N 0.000 description 2
- SCIHGMXLYVKLOT-UHFFFAOYSA-N ethyl 2-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-oxoacetate Chemical compound CCOC(=O)C(=O)C1=CC(OC)=C(O)C([N+]([O-])=O)=C1 SCIHGMXLYVKLOT-UHFFFAOYSA-N 0.000 description 2
- OXSDUDGOCITNQQ-UHFFFAOYSA-N ethyl 5-(3,4-dimethoxy-5-nitrophenyl)-1,3-oxazole-4-carboxylate Chemical compound N1=COC(C=2C=C(C(OC)=C(OC)C=2)[N+]([O-])=O)=C1C(=O)OCC OXSDUDGOCITNQQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- JRJZZYNGMCKYBK-UHFFFAOYSA-N hexyl 2-(3-cyano-4,5-dimethoxyphenyl)-2-oxoacetate Chemical compound CCCCCCOC(=O)C(=O)C1=CC(OC)=C(OC)C(C#N)=C1 JRJZZYNGMCKYBK-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000005945 imidazopyridyl group Chemical group 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
- JQHIEQIQQYSKDA-UHFFFAOYSA-N methyl 2-(3-cyano-4,5-dihydroxyphenyl)-2-oxoacetate Chemical compound COC(=O)C(=O)C1=CC(O)=C(O)C(C#N)=C1 JQHIEQIQQYSKDA-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- JMSDPEIHYBNNHK-UHFFFAOYSA-N n-(6-aminohexyl)-4-hydroxy-3-methoxy-5-nitrobenzamide;hydrobromide Chemical compound Br.COC1=CC(C(=O)NCCCCCCN)=CC([N+]([O-])=O)=C1O JMSDPEIHYBNNHK-UHFFFAOYSA-N 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- MGCGJBXTNWUHQE-UHFFFAOYSA-N quinoline-4-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CC=NC2=C1 MGCGJBXTNWUHQE-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- 239000005049 silicon tetrachloride Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- NQRSSBQISFJNKO-UHFFFAOYSA-N (1-benzylimidazol-2-yl)-(3,4-dimethoxy-5-nitrophenyl)methanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)C=2N(C=CN=2)CC=2C=CC=CC=2)=C1 NQRSSBQISFJNKO-UHFFFAOYSA-N 0.000 description 1
- ODXXHKAHKLJTGC-UHFFFAOYSA-N (2-fluorophenyl)-(3-methoxy-4-phenylmethoxyphenyl)methanol Chemical compound COC1=CC(C(O)C=2C(=CC=CC=2)F)=CC=C1OCC1=CC=CC=C1 ODXXHKAHKLJTGC-UHFFFAOYSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- PAXXKYROBMLGPL-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-(1H-imidazol-2-yl)methanone dihydrobromide Chemical compound Br.Br.[O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2NC=CN=2)=C1 PAXXKYROBMLGPL-UHFFFAOYSA-N 0.000 description 1
- CEOUCHPFRTUNGX-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-(3-methyl-1h-indol-2-yl)methanone Chemical compound N1C2=CC=CC=C2C(C)=C1C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 CEOUCHPFRTUNGX-UHFFFAOYSA-N 0.000 description 1
- AHKGETRIYCXKAE-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-(3-phenyl-1h-indol-2-yl)methanone Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C2=C(C3=CC=CC=C3N2)C=2C=CC=CC=2)=C1 AHKGETRIYCXKAE-UHFFFAOYSA-N 0.000 description 1
- YJJRYGOORZESBE-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 YJJRYGOORZESBE-UHFFFAOYSA-N 0.000 description 1
- YRMOUOBNCPNOPP-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-pyridin-3-ylmethanone;hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2C=NC=CC=2)=C1 YRMOUOBNCPNOPP-UHFFFAOYSA-N 0.000 description 1
- HCXACNXSARTLLE-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-quinolin-4-ylmethanone hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2C3=CC=CC=C3N=CC=2)=C1 HCXACNXSARTLLE-UHFFFAOYSA-N 0.000 description 1
- JWIHLMWZQUIAJZ-UHFFFAOYSA-N (3,4-dihydroxy-5-nitrophenyl)-thiophen-2-ylmethanone Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)C=2SC=CC=2)=C1 JWIHLMWZQUIAJZ-UHFFFAOYSA-N 0.000 description 1
- SRVJLPGZCCRAED-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-[1-(phenylmethoxymethyl)imidazol-2-yl]methanone Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(=O)C=2N(C=CN=2)COCC=2C=CC=CC=2)=C1 SRVJLPGZCCRAED-UHFFFAOYSA-N 0.000 description 1
- MOSJYSFSEXAXEM-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-pyridin-2-ylmethanol Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(O)C=2N=CC=CC=2)=C1 MOSJYSFSEXAXEM-UHFFFAOYSA-N 0.000 description 1
- UAYLQVWJRXIBPD-UHFFFAOYSA-N (3,4-dimethoxy-5-nitrophenyl)-thiophen-2-ylmethanol Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C(O)C=2SC=CC=2)=C1 UAYLQVWJRXIBPD-UHFFFAOYSA-N 0.000 description 1
- OXGOWGGJQJJUAJ-UHFFFAOYSA-N (3,5-dinitro-2-propanoyloxyphenyl) propanoate Chemical compound CCC(=O)OC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)CC OXGOWGGJQJJUAJ-UHFFFAOYSA-N 0.000 description 1
- BJNUKUFILBOFNC-UHFFFAOYSA-N (3-amino-4,5-dimethoxyphenyl)-(2-fluorophenyl)methanone Chemical compound NC1=C(OC)C(OC)=CC(C(=O)C=2C(=CC=CC=2)F)=C1 BJNUKUFILBOFNC-UHFFFAOYSA-N 0.000 description 1
- ZJWXVJLONCPRIV-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-pyridin-4-ylmethanol Chemical compound COC1=CC(C(O)C=2C=CN=CC=2)=CC=C1OCC1=CC=CC=C1 ZJWXVJLONCPRIV-UHFFFAOYSA-N 0.000 description 1
- SMMKESHQJJRJBO-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxyphenyl)-quinolin-4-ylmethanol Chemical compound COC1=CC(C(O)C=2C3=CC=CC=C3N=CC=2)=CC=C1OCC1=CC=CC=C1 SMMKESHQJJRJBO-UHFFFAOYSA-N 0.000 description 1
- HUTXSWJRQUSTHM-UHFFFAOYSA-N (4-fluorophenyl)-(3-methoxy-4-phenylmethoxyphenyl)methanol Chemical compound COC1=CC(C(O)C=2C=CC(F)=CC=2)=CC=C1OCC1=CC=CC=C1 HUTXSWJRQUSTHM-UHFFFAOYSA-N 0.000 description 1
- FXEHQENXVMBFFY-UHFFFAOYSA-N (4-hydroxy-3-methoxy-5-nitrophenyl)-(3-methyl-1h-indol-2-yl)methanone Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C(=O)C2=C(C3=CC=CC=C3N2)C)=C1 FXEHQENXVMBFFY-UHFFFAOYSA-N 0.000 description 1
- IZILGYZBFREXNE-UHFFFAOYSA-N (4-hydroxy-3-methoxy-5-nitrophenyl)-pyridin-3-ylmethanone Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C(=O)C=2C=NC=CC=2)=C1 IZILGYZBFREXNE-UHFFFAOYSA-N 0.000 description 1
- SLDTWXKORBOKML-UHFFFAOYSA-N (4-hydroxy-3-methoxyphenyl)-pyridin-4-ylmethanone Chemical compound C1=C(O)C(OC)=CC(C(=O)C=2C=CN=CC=2)=C1 SLDTWXKORBOKML-UHFFFAOYSA-N 0.000 description 1
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- QUKGLNCXGVWCJX-UHFFFAOYSA-N 1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=CS1 QUKGLNCXGVWCJX-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- WGIGIUKFANLRQM-UHFFFAOYSA-N 1-(3,4-dihydroxy-5-nitrophenyl)-2-hydroxyethanone Chemical compound OCC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 WGIGIUKFANLRQM-UHFFFAOYSA-N 0.000 description 1
- CXRSAKIJUPDQCH-UHFFFAOYSA-N 1-(3,4-dihydroxy-5-nitrophenyl)-2-methylpropan-1-one Chemical compound CC(C)C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 CXRSAKIJUPDQCH-UHFFFAOYSA-N 0.000 description 1
- JZRSYJOJGYVKCS-UHFFFAOYSA-N 1-(3,4-dihydroxy-5-nitrophenyl)-3-(2-hydroxyphenyl)propane-1,3-dione Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C(=O)CC(=O)C=2C(=CC=CC=2)O)=C1 JZRSYJOJGYVKCS-UHFFFAOYSA-N 0.000 description 1
- MZMSHBJJBHLEHX-UHFFFAOYSA-N 1-(3,4-dihydroxy-5-nitrophenyl)butan-1-one Chemical compound CCCC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 MZMSHBJJBHLEHX-UHFFFAOYSA-N 0.000 description 1
- RZTRFWLYXYIRAX-UHFFFAOYSA-N 1-(3,4-dihydroxy-5-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 RZTRFWLYXYIRAX-UHFFFAOYSA-N 0.000 description 1
- YAMORMXVKVDTFD-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxy-5-nitrophenyl)-4-phenylbutan-1-one Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C(=O)CCCC=2C=CC=CC=2)=C1 YAMORMXVKVDTFD-UHFFFAOYSA-N 0.000 description 1
- RASIHJHGNLXRPH-UHFFFAOYSA-N 1-(chloromethyl)-2-fluoro-3,4-dimethoxybenzene Chemical compound COC1=CC=C(CCl)C(F)=C1OC RASIHJHGNLXRPH-UHFFFAOYSA-N 0.000 description 1
- HPMFKOBTJATLDZ-UHFFFAOYSA-N 1-(phenylmethoxymethyl)imidazole Chemical compound C=1C=CC=CC=1COCN1C=CN=C1 HPMFKOBTJATLDZ-UHFFFAOYSA-N 0.000 description 1
- LRWQENBAFMBIJR-UHFFFAOYSA-N 1-adamantylthiourea Chemical compound C1C(C2)CC3CC2CC1(NC(=S)N)C3 LRWQENBAFMBIJR-UHFFFAOYSA-N 0.000 description 1
- KKKDZZRICRFGSD-UHFFFAOYSA-N 1-benzylimidazole Chemical compound C1=CN=CN1CC1=CC=CC=C1 KKKDZZRICRFGSD-UHFFFAOYSA-N 0.000 description 1
- IPWBFGUBXWMIPR-UHFFFAOYSA-N 1-bromo-2-fluorobenzene Chemical compound FC1=CC=CC=C1Br IPWBFGUBXWMIPR-UHFFFAOYSA-N 0.000 description 1
- XLQSXGGDTHANLN-UHFFFAOYSA-N 1-bromo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(Br)C=C1 XLQSXGGDTHANLN-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- HVUFKLUSBBBCAG-UHFFFAOYSA-N 1-n,1-n'-diethylethane-1,1,2-triamine Chemical compound CCNC(CN)NCC HVUFKLUSBBBCAG-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- ZROMRLNHWDKKNB-UHFFFAOYSA-N 2,3-dihydroxy-5-(6-methyl-2-oxo-1,4-benzoxazin-3-yl)benzonitrile Chemical compound N=1C2=CC(C)=CC=C2OC(=O)C=1C1=CC(O)=C(O)C(C#N)=C1 ZROMRLNHWDKKNB-UHFFFAOYSA-N 0.000 description 1
- LDISPOFKOIMMLB-UHFFFAOYSA-N 2,3-dihydroxy-5-[4-(trifluoromethyl)benzoyl]benzonitrile Chemical compound N#CC1=C(O)C(O)=CC(C(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 LDISPOFKOIMMLB-UHFFFAOYSA-N 0.000 description 1
- NNQAESZIAYMADQ-UHFFFAOYSA-N 2,3-dihydroxy-5-nitrobenzonitrile Chemical compound OC1=CC([N+]([O-])=O)=CC(C#N)=C1O NNQAESZIAYMADQ-UHFFFAOYSA-N 0.000 description 1
- KYKNZENWQXJPCA-UHFFFAOYSA-N 2,3-dimethoxy-5-nitrobenzaldehyde Chemical compound COC1=CC([N+]([O-])=O)=CC(C=O)=C1OC KYKNZENWQXJPCA-UHFFFAOYSA-N 0.000 description 1
- LXFQSRIDYRFTJW-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonic acid Chemical compound CC1=CC(C)=C(S(O)(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- MDDNBIYFEMASMO-UHFFFAOYSA-N 2-(3,4-dihydroxy-5-nitrophenyl)-2-oxoacetic acid Chemical compound OC(=O)C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 MDDNBIYFEMASMO-UHFFFAOYSA-N 0.000 description 1
- QWCQLSYQCRNDFS-UHFFFAOYSA-N 2-(3,4-dihydroxy-5-nitrophenyl)chromen-4-one Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2OC3=CC=CC=C3C(=O)C=2)=C1 QWCQLSYQCRNDFS-UHFFFAOYSA-N 0.000 description 1
- YQTQHILMYWETPA-UHFFFAOYSA-N 2-(3,4-dimethoxy-5-nitrophenyl)chromen-4-one Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C=2OC3=CC=CC=C3C(=O)C=2)=C1 YQTQHILMYWETPA-UHFFFAOYSA-N 0.000 description 1
- SFIAWXDEIAXFOS-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-2-hydroxyacetonitrile Chemical compound COC1=CC=C(C(O)C#N)C=C1OC SFIAWXDEIAXFOS-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- RRCSFROTQGXYKJ-UHFFFAOYSA-N 2-[3-carbonochloridoyl-6-(carboxymethyl)-6-nitrocyclohexa-2,4-dien-1-yl]acetic acid Chemical compound OC(=O)CC1C=C(C(Cl)=O)C=CC1(CC(O)=O)[N+]([O-])=O RRCSFROTQGXYKJ-UHFFFAOYSA-N 0.000 description 1
- IGEQVXWYDQVFOK-UHFFFAOYSA-N 2-[hydroxy-(3-methoxy-4-phenylmethoxyphenyl)methyl]benzonitrile Chemical compound COC1=CC(C(O)C=2C(=CC=CC=2)C#N)=CC=C1OCC1=CC=CC=C1 IGEQVXWYDQVFOK-UHFFFAOYSA-N 0.000 description 1
- DETJLNXWXKDZOR-UHFFFAOYSA-N 2-amino-1-(3,4-dihydroxy-5-nitrophenyl)ethanone;hydrobromide Chemical compound Br.NCC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 DETJLNXWXKDZOR-UHFFFAOYSA-N 0.000 description 1
- WASQBNCGNUTVNI-UHFFFAOYSA-N 2-amino-4,6-dichlorophenol Chemical compound NC1=CC(Cl)=CC(Cl)=C1O WASQBNCGNUTVNI-UHFFFAOYSA-N 0.000 description 1
- ZMXYNJXDULEQCK-UHFFFAOYSA-N 2-amino-p-cresol Chemical compound CC1=CC=C(O)C(N)=C1 ZMXYNJXDULEQCK-UHFFFAOYSA-N 0.000 description 1
- UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
- VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 description 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- SDTPFVAZAREICN-UHFFFAOYSA-N 2-bromo-1-(4-hydroxy-3-methoxyphenyl)ethanone Chemical compound COC1=CC(C(=O)CBr)=CC=C1O SDTPFVAZAREICN-UHFFFAOYSA-N 0.000 description 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- CSLHJKBTWPZQQO-UHFFFAOYSA-N 2-chloro-3,4-dihydroxy-5-nitrobenzaldehyde Chemical compound OC1=C(O)C([N+]([O-])=O)=CC(C=O)=C1Cl CSLHJKBTWPZQQO-UHFFFAOYSA-N 0.000 description 1
- FCCMPPPCJVQGBC-UHFFFAOYSA-N 2-chloro-3,4-dihydroxy-5-nitrobenzonitrile Chemical compound OC1=C(O)C([N+]([O-])=O)=CC(C#N)=C1Cl FCCMPPPCJVQGBC-UHFFFAOYSA-N 0.000 description 1
- HKHVCYVMGKWFMY-UHFFFAOYSA-N 2-fluoro-3,4-dihydroxy-5-nitrobenzonitrile Chemical compound OC1=C(O)C([N+]([O-])=O)=CC(C#N)=C1F HKHVCYVMGKWFMY-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical compound OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- LLGWEMLOSOXAFB-UHFFFAOYSA-N 2-methoxy-6-nitro-4-(2H-tetrazol-5-yl)phenol Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C=2NN=NN=2)=C1 LLGWEMLOSOXAFB-UHFFFAOYSA-N 0.000 description 1
- WGKZNIWUIVCEEM-UHFFFAOYSA-N 2-methoxy-6-nitro-4-quinoxalin-2-ylphenol Chemical compound [O-][N+](=O)C1=C(O)C(OC)=CC(C=2N=C3C=CC=CC3=NC=2)=C1 WGKZNIWUIVCEEM-UHFFFAOYSA-N 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- RRXRZVYGVKJPRR-UHFFFAOYSA-N 2-n-hexylbenzene-1,2-diamine Chemical compound CCCCCCNC1=CC=CC=C1N RRXRZVYGVKJPRR-UHFFFAOYSA-N 0.000 description 1
- RPKCLSMBVQLWIN-UHFFFAOYSA-N 2-n-methylbenzene-1,2-diamine Chemical compound CNC1=CC=CC=C1N RPKCLSMBVQLWIN-UHFFFAOYSA-N 0.000 description 1
- WHVUPKSFLNXRHY-UHFFFAOYSA-N 2-n-propylbenzene-1,2-diamine Chemical compound CCCNC1=CC=CC=C1N WHVUPKSFLNXRHY-UHFFFAOYSA-N 0.000 description 1
- OFVGPHQYOCKLLM-UHFFFAOYSA-N 2-phenylethylthiourea Chemical compound NC(=S)NCCC1=CC=CC=C1 OFVGPHQYOCKLLM-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- WXSDVLIPNRUETJ-UHFFFAOYSA-N 3,4-dihydroxy-5-nitrobenzamide Chemical compound NC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 WXSDVLIPNRUETJ-UHFFFAOYSA-N 0.000 description 1
- BCYDBQTTWGWRRF-UHFFFAOYSA-N 3,4-dimethoxy-5-nitrobenzonitrile Chemical compound COC1=CC(C#N)=CC([N+]([O-])=O)=C1OC BCYDBQTTWGWRRF-UHFFFAOYSA-N 0.000 description 1
- KJWQBLYMGWGEBN-UHFFFAOYSA-N 3-(3,4-dihydroxy-5-nitrophenyl)-1,4-benzoxazin-2-one Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2C(OC3=CC=CC=C3N=2)=O)=C1 KJWQBLYMGWGEBN-UHFFFAOYSA-N 0.000 description 1
- BFCCKGQJHMPJSX-UHFFFAOYSA-N 3-[2-(2-carboxyethyl)-5-(6-chloro-2-oxo-1,4-benzoxazin-3-yl)-3-nitrophenyl]propanoic acid Chemical compound [O-][N+](=O)C1=C(CCC(O)=O)C(CCC(=O)O)=CC(C=2C(OC3=CC=C(Cl)C=C3N=2)=O)=C1 BFCCKGQJHMPJSX-UHFFFAOYSA-N 0.000 description 1
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 1
- ZGIKWINFUGEQEO-UHFFFAOYSA-N 3-bromoquinoline Chemical compound C1=CC=CC2=CC(Br)=CN=C21 ZGIKWINFUGEQEO-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- NVNLHLRVSHJKBN-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)benzene-1,2-diamine Chemical compound NC1=CC(C(F)(F)F)=CC(Cl)=C1N NVNLHLRVSHJKBN-UHFFFAOYSA-N 0.000 description 1
- QRNYSLHHIBTSIG-UHFFFAOYSA-N 3-nitro-5-(2-pyridin-3-yl-1,3-thiazol-4-yl)benzene-1,2-diol Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C(SC=2)C=2C=NC=CC=2)=C1 QRNYSLHHIBTSIG-UHFFFAOYSA-N 0.000 description 1
- AUZISIWDFDKLQB-UHFFFAOYSA-N 3-nitro-5-(2H-tetrazol-5-yl)benzene-1,2-diol Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2NN=NN=2)=C1 AUZISIWDFDKLQB-UHFFFAOYSA-N 0.000 description 1
- AFLNPIPDMBYHJD-UHFFFAOYSA-N 3-nitro-5-[2-(2-phenylethylamino)-1,3-thiazol-4-yl]benzene-1,2-diol;hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C(NCCC=3C=CC=CC=3)SC=2)=C1 AFLNPIPDMBYHJD-UHFFFAOYSA-N 0.000 description 1
- KCDOJBCOAYCTSD-UHFFFAOYSA-N 3-nitro-5-[2-(pyridin-3-ylamino)-1,3-thiazol-4-yl]benzene-1,2-diol;hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C(NC=3C=NC=CC=3)SC=2)=C1 KCDOJBCOAYCTSD-UHFFFAOYSA-N 0.000 description 1
- VVAVMCIMLBGOHL-UHFFFAOYSA-N 3-nitro-5-[2-(quinolin-3-ylamino)-1,3-thiazol-4-yl]benzene-1,2-diol;hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C(NC=3C=C4C=CC=CC4=NC=3)SC=2)=C1 VVAVMCIMLBGOHL-UHFFFAOYSA-N 0.000 description 1
- GNJXAMISRMWYDF-UHFFFAOYSA-N 3-nitro-5-pyridin-2-ylbenzene-1,2-diol hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C=2N=CC=CC=2)=C1 GNJXAMISRMWYDF-UHFFFAOYSA-N 0.000 description 1
- YZJVWIUMDDXVEA-UHFFFAOYSA-N 4,5-dihydroxybenzene-1,3-dicarbaldehyde Chemical compound OC1=CC(C=O)=CC(C=O)=C1O YZJVWIUMDDXVEA-UHFFFAOYSA-N 0.000 description 1
- SWLXKQKTIPGUAW-UHFFFAOYSA-N 4,5-dihydroxybenzene-1,3-dicarbonitrile Chemical compound OC1=CC(C#N)=CC(C#N)=C1O SWLXKQKTIPGUAW-UHFFFAOYSA-N 0.000 description 1
- AGAHETWGCFCMDK-UHFFFAOYSA-N 4-methoxybenzene-1,2-diamine Chemical compound COC1=CC=C(N)C(N)=C1 AGAHETWGCFCMDK-UHFFFAOYSA-N 0.000 description 1
- RAUWPNXIALNKQM-UHFFFAOYSA-N 4-nitro-1,2-phenylenediamine Chemical compound NC1=CC=C([N+]([O-])=O)C=C1N RAUWPNXIALNKQM-UHFFFAOYSA-N 0.000 description 1
- UJKJHLTWPSYAKJ-UHFFFAOYSA-N 5-(1H-benzimidazol-2-yl)-3-nitrobenzene-1,2-diol Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2NC3=CC=CC=C3N=2)=C1 UJKJHLTWPSYAKJ-UHFFFAOYSA-N 0.000 description 1
- QDSGPDIHYXSHBN-UHFFFAOYSA-N 5-(2-amino-1,3-thiazol-4-yl)-3-nitrobenzene-1,2-diol;hydrobromide Chemical compound Br.S1C(N)=NC(C=2C=C(C(O)=C(O)C=2)[N+]([O-])=O)=C1 QDSGPDIHYXSHBN-UHFFFAOYSA-N 0.000 description 1
- DWLHXRGZKXJKST-UHFFFAOYSA-N 5-(2-amino-6H-1,3,4-thiadiazin-5-yl)-3-nitrobenzene-1,2-diol hydrobromide Chemical compound Br.C1SC(N)=NN=C1C1=CC(O)=C(O)C([N+]([O-])=O)=C1 DWLHXRGZKXJKST-UHFFFAOYSA-N 0.000 description 1
- ZNNJEQWXFKFAIL-UHFFFAOYSA-N 5-(2-anilino-1,3-thiazol-4-yl)-2,3-dihydroxybenzonitrile;hydrochloride Chemical compound Cl.N#CC1=C(O)C(O)=CC(C=2N=C(NC=3C=CC=CC=3)SC=2)=C1 ZNNJEQWXFKFAIL-UHFFFAOYSA-N 0.000 description 1
- PLJPXHRIHDBGAY-UHFFFAOYSA-N 5-(2-methyl-1,3-thiazol-4-yl)-3-nitrobenzene-1,2-diol;hydrobromide Chemical compound Br.S1C(C)=NC(C=2C=C(C(O)=C(O)C=2)[N+]([O-])=O)=C1 PLJPXHRIHDBGAY-UHFFFAOYSA-N 0.000 description 1
- QZQNXRBHNWEMDP-UHFFFAOYSA-N 5-(3,4-dihydroxy-5-nitrophenyl)-1,2-dihydropyrazol-3-one Chemical compound N1C(O)=CC(C=2C=C(C(O)=C(O)C=2)[N+]([O-])=O)=N1 QZQNXRBHNWEMDP-UHFFFAOYSA-N 0.000 description 1
- KKGNXGHRCIANCL-UHFFFAOYSA-N 5-(3,4-dihydroxy-5-nitrophenyl)-6-oxo-1H-pyrazine-2,3-dicarbonitrile Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2C(=NC(=C(C#N)N=2)C#N)O)=C1 KKGNXGHRCIANCL-UHFFFAOYSA-N 0.000 description 1
- MTUVCFBLTXHOMC-UHFFFAOYSA-N 5-(3,4-dimethoxy-5-nitrophenyl)-2-phenyl-4h-pyrazol-3-one Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C=2CC(=O)N(N=2)C=2C=CC=CC=2)=C1 MTUVCFBLTXHOMC-UHFFFAOYSA-N 0.000 description 1
- UFTUMWCJFYXZIT-UHFFFAOYSA-N 5-(3,4-dimethoxy-5-nitrophenyl)-5-methyl-2h-1,2,4-oxadiazole Chemical compound [O-][N+](=O)C1=C(OC)C(OC)=CC(C2(C)N=CNO2)=C1 UFTUMWCJFYXZIT-UHFFFAOYSA-N 0.000 description 1
- CZXDBEIXVCIBLX-UHFFFAOYSA-N 5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-nitrobenzene-1,2-diol Chemical compound CC1=NOC(C=2C=C(C(O)=C(O)C=2)[N+]([O-])=O)=N1 CZXDBEIXVCIBLX-UHFFFAOYSA-N 0.000 description 1
- OVUYYPBVWXIGNJ-UHFFFAOYSA-N 5-[2-(1-adamantylamino)-1,3-thiazol-5-yl]-3-nitrobenzene-1,2-diol;hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C=2SC(NC34CC5CC(CC(C5)C3)C4)=NC=2)=C1 OVUYYPBVWXIGNJ-UHFFFAOYSA-N 0.000 description 1
- INRKWHTYBZFBPL-UHFFFAOYSA-N 5-acetyl-2,3-dihydroxybenzonitrile Chemical compound CC(=O)C1=CC(O)=C(O)C(C#N)=C1 INRKWHTYBZFBPL-UHFFFAOYSA-N 0.000 description 1
- ZZLRKLDKYQMSQM-UHFFFAOYSA-N 5-imidazo[2,1-b][1,3,4]thiadiazol-6-yl-3-nitrobenzene-1,2-diol Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C3SC=NN3C=2)=C1 ZZLRKLDKYQMSQM-UHFFFAOYSA-N 0.000 description 1
- WPJNKFIEWBZUDG-UHFFFAOYSA-N 5-imidazo[2,1-b][1,3]benzothiazol-2-yl-3-nitrobenzene-1,2-diol Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C3N(C4=CC=CC=C4S3)C=2)=C1 WPJNKFIEWBZUDG-UHFFFAOYSA-N 0.000 description 1
- OEKIDYQVHDYWEH-UHFFFAOYSA-N 5-imidazo[2,1-b][1,3]thiazol-6-yl-3-nitrobenzene-1,2-diol;hydrobromide Chemical compound Br.[O-][N+](=O)C1=C(O)C(O)=CC(C=2N=C3SC=CN3C=2)=C1 OEKIDYQVHDYWEH-UHFFFAOYSA-N 0.000 description 1
- UHAUUSRSUAFCQA-UHFFFAOYSA-N 6-(3,4-dihydroxy-5-nitrophenyl)-3-sulfanylidene-2H-1,2,4-triazin-5-one Chemical compound [O-][N+](=O)C1=C(O)C(O)=CC(C=2C(NC(S)=NN=2)=O)=C1 UHAUUSRSUAFCQA-UHFFFAOYSA-N 0.000 description 1
- LUNQKJOETZSRDV-UHFFFAOYSA-N 6-[(4-hydroxy-3-methoxy-5-nitrobenzoyl)amino]hexyl N-tert-butylcarbamate Chemical compound OC1=C(C=C(C(=O)NCCCCCCOC(NC(C)(C)C)=O)C=C1[N+](=O)[O-])OC LUNQKJOETZSRDV-UHFFFAOYSA-N 0.000 description 1
- SPGNVLDSOGAMEK-UHFFFAOYSA-N 6-aminohexyl n-tert-butylcarbamate Chemical compound CC(C)(C)NC(=O)OCCCCCCN SPGNVLDSOGAMEK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- TXZUWXQGHZIWHU-UHFFFAOYSA-N Br.OC1=CC(=NN1C1=CC=CC=C1)C1=CC(=C(C(O)=C1)O)[N+](=O)[O-].B(Br)(Br)Br Chemical compound Br.OC1=CC(=NN1C1=CC=CC=C1)C1=CC(=C(C(O)=C1)O)[N+](=O)[O-].B(Br)(Br)Br TXZUWXQGHZIWHU-UHFFFAOYSA-N 0.000 description 1
- IHVVZSPWQJWRDV-UHFFFAOYSA-N Butyl ethyl malonate Chemical compound CCCCOC(=O)CC(=O)OCC IHVVZSPWQJWRDV-UHFFFAOYSA-N 0.000 description 1
- OEOAIPVHBHEZBL-UHFFFAOYSA-N C(#N)C1=C(C=CC=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.C(#N)C1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O Chemical compound C(#N)C1=C(C=CC=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.C(#N)C1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O OEOAIPVHBHEZBL-UHFFFAOYSA-N 0.000 description 1
- TYOHPXZLYYQXSD-UHFFFAOYSA-N C(#N)C1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)C#N)C=C1)OC Chemical compound C(#N)C1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)C#N)C=C1)OC TYOHPXZLYYQXSD-UHFFFAOYSA-N 0.000 description 1
- IXAZIDHMZALXOG-UHFFFAOYSA-N C(C(C)(C)C)(=O)OC=1C=C(C(=O)C2=CC=CC=C2)C=C(C1OC(C(C)(C)C)=O)[N+](=O)[O-].OC=1C=C(C(=O)C2=CC=CC=C2)C=C(C1O)[N+](=O)[O-] Chemical compound C(C(C)(C)C)(=O)OC=1C=C(C(=O)C2=CC=CC=C2)C=C(C1OC(C(C)(C)C)=O)[N+](=O)[O-].OC=1C=C(C(=O)C2=CC=CC=C2)C=C(C1O)[N+](=O)[O-] IXAZIDHMZALXOG-UHFFFAOYSA-N 0.000 description 1
- LEGPTFTZDLWKAG-UHFFFAOYSA-N C(C(C)C)(=O)OC1=C(C(=CC(=C1)C=1N=C2SC3=C(N2C1)C=CC=C3)[N+](=O)[O-])OC(C(C)C)=O.N=3C(=CN1C3SC3=C1C=CC=C3)C3=CC(=C(C(O)=C3)O)[N+](=O)[O-] Chemical compound C(C(C)C)(=O)OC1=C(C(=CC(=C1)C=1N=C2SC3=C(N2C1)C=CC=C3)[N+](=O)[O-])OC(C(C)C)=O.N=3C(=CN1C3SC3=C1C=CC=C3)C3=CC(=C(C(O)=C3)O)[N+](=O)[O-] LEGPTFTZDLWKAG-UHFFFAOYSA-N 0.000 description 1
- PQHMDSJWHGQKIO-UHFFFAOYSA-N C(C(C)C)(=O)OC=1C=C(C=C(C1OC(C(C)C)=O)[N+](=O)[O-])C1=NC2=CC=CC=C2N=C1.OC=1C=C(C=C(C1O)[N+](=O)[O-])C1=NC2=CC=CC=C2N=C1 Chemical compound C(C(C)C)(=O)OC=1C=C(C=C(C1OC(C(C)C)=O)[N+](=O)[O-])C1=NC2=CC=CC=C2N=C1.OC=1C=C(C=C(C1O)[N+](=O)[O-])C1=NC2=CC=CC=C2N=C1 PQHMDSJWHGQKIO-UHFFFAOYSA-N 0.000 description 1
- HJECITMMGHPJSY-UHFFFAOYSA-N C(C)(=O)OC=1C=C(C=C(C1OC(C)=O)[N+](=O)[O-])C1=NC=CC(=C1)C(=O)C1=CC(=NC=C1)C1=CC(=C(C(=C1)[N+](=O)[O-])OC(C)=O)OC(C)=O.OC=1C=C(C=C(C1O)[N+](=O)[O-])C1=NC=CC(=C1)C(=O)C1=CC(=NC=C1)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O Chemical compound C(C)(=O)OC=1C=C(C=C(C1OC(C)=O)[N+](=O)[O-])C1=NC=CC(=C1)C(=O)C1=CC(=NC=C1)C1=CC(=C(C(=C1)[N+](=O)[O-])OC(C)=O)OC(C)=O.OC=1C=C(C=C(C1O)[N+](=O)[O-])C1=NC=CC(=C1)C(=O)C1=CC(=NC=C1)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O HJECITMMGHPJSY-UHFFFAOYSA-N 0.000 description 1
- KKOVYGZRXBNEGZ-UHFFFAOYSA-N C(C)(=O)OC=1C=C(C=C(C1OC(C)=O)[N+](=O)[O-])C=1C(OC2=C(N1)C=CC=C2)=O.OC=2C=C(C=C(C2O)[N+](=O)[O-])C=2C(OC1=C(N2)C=CC=C1)=O Chemical compound C(C)(=O)OC=1C=C(C=C(C1OC(C)=O)[N+](=O)[O-])C=1C(OC2=C(N1)C=CC=C2)=O.OC=2C=C(C=C(C2O)[N+](=O)[O-])C=2C(OC1=C(N2)C=CC=C1)=O KKOVYGZRXBNEGZ-UHFFFAOYSA-N 0.000 description 1
- DHLYWDNVOJSTKV-UHFFFAOYSA-N C(C)(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.C(C)(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O Chemical compound C(C)(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.C(C)(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O DHLYWDNVOJSTKV-UHFFFAOYSA-N 0.000 description 1
- ANEOQCAQYQOTMK-UHFFFAOYSA-N C(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.C(C)O Chemical compound C(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.C(C)O ANEOQCAQYQOTMK-UHFFFAOYSA-N 0.000 description 1
- YXSDPNNGDYNTGL-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)Cl)C=C1)OC.C(C1=CC=CC=C1)OC1=C(C=C(C(C2=C(C=CC=C2)Cl)O)C=C1)OC Chemical compound C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)Cl)C=C1)OC.C(C1=CC=CC=C1)OC1=C(C=C(C(C2=C(C=CC=C2)Cl)O)C=C1)OC YXSDPNNGDYNTGL-UHFFFAOYSA-N 0.000 description 1
- RFLVEMCBKPFPSC-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2F)F)C=C1)OC.C(C1=CC=CC=C1)OC1=C(C=C(C(C2=C(C=CC=C2F)F)O)C=C1)OC Chemical compound C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2F)F)C=C1)OC.C(C1=CC=CC=C1)OC1=C(C=C(C(C2=C(C=CC=C2F)F)O)C=C1)OC RFLVEMCBKPFPSC-UHFFFAOYSA-N 0.000 description 1
- DPWXWWASVGWCCF-UHFFFAOYSA-N C(CC)(=O)OC1=C(C(=CC(=C1)C1=NC2=CC=CC=C2N=C1)[N+](=O)[O-])OC(CC)=O.[N+](=O)([O-])C1=C(C(O)=CC(=C1)C1=NC2=CC=CC=C2N=C1)O Chemical compound C(CC)(=O)OC1=C(C(=CC(=C1)C1=NC2=CC=CC=C2N=C1)[N+](=O)[O-])OC(CC)=O.[N+](=O)([O-])C1=C(C(O)=CC(=C1)C1=NC2=CC=CC=C2N=C1)O DPWXWWASVGWCCF-UHFFFAOYSA-N 0.000 description 1
- URTALGAQWVWYTC-UHFFFAOYSA-N C(CC)(=O)OC=1C=C(C=C(C1OC(CC)=O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)C(=O)O)=O.OC=2C=C(C=C(C2O)[N+](=O)[O-])C=2C(OC1=C(N2)C=C(C=C1)C(=O)O)=O Chemical compound C(CC)(=O)OC=1C=C(C=C(C1OC(CC)=O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)C(=O)O)=O.OC=2C=C(C=C(C2O)[N+](=O)[O-])C=2C(OC1=C(N2)C=C(C=C1)C(=O)O)=O URTALGAQWVWYTC-UHFFFAOYSA-N 0.000 description 1
- WEJZMQVFMDBNEU-UHFFFAOYSA-N C(CCC)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.C(CCC)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O Chemical compound C(CCC)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.C(CCC)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O WEJZMQVFMDBNEU-UHFFFAOYSA-N 0.000 description 1
- YOKZNRURFHGCTR-UHFFFAOYSA-N C(CCC)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.C(CCC)O Chemical compound C(CCC)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.C(CCC)O YOKZNRURFHGCTR-UHFFFAOYSA-N 0.000 description 1
- MSZVYFVJNPRBGV-UHFFFAOYSA-N CC=1C=C2N=CC(=NC2=CC1C)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O.CC=1C=C2N=CC(=NC2=CC1C)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC Chemical compound CC=1C=C2N=CC(=NC2=CC1C)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O.CC=1C=C2N=CC(=NC2=CC1C)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC MSZVYFVJNPRBGV-UHFFFAOYSA-N 0.000 description 1
- OJTZVWWVLYKNGP-UHFFFAOYSA-N CC=1C=C2N=CC(=NC2=CC1C)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC.CC1=CC(=C(C=C1C)N)N Chemical compound CC=1C=C2N=CC(=NC2=CC1C)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC.CC1=CC(=C(C=C1C)N)N OJTZVWWVLYKNGP-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VIUNPNPLHOJIKW-UHFFFAOYSA-N ClC1=C(C=CC=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.ClC1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O Chemical compound ClC1=C(C=CC=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.ClC1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O VIUNPNPLHOJIKW-UHFFFAOYSA-N 0.000 description 1
- ILNXEMWUJKOIKB-UHFFFAOYSA-N ClC1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)Cl)C=C1)OC Chemical compound ClC1=C(C=CC=C1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)Cl)C=C1)OC ILNXEMWUJKOIKB-UHFFFAOYSA-N 0.000 description 1
- NUJGIBOYRGZMEO-UHFFFAOYSA-N ClC1=CC2=C(N=C(N2)C2=CC(=C(C(O)=C2)O)[N+](=O)[O-])C=C1Cl.ClC1=CC2=C(N=C(N2)C2=CC(=C(C(=C2)[N+](=O)[O-])O)OC)C=C1Cl Chemical compound ClC1=CC2=C(N=C(N2)C2=CC(=C(C(O)=C2)O)[N+](=O)[O-])C=C1Cl.ClC1=CC2=C(N=C(N2)C2=CC(=C(C(=C2)[N+](=O)[O-])O)OC)C=C1Cl NUJGIBOYRGZMEO-UHFFFAOYSA-N 0.000 description 1
- MMSHGEFITAGEME-UHFFFAOYSA-N ClC1=CC=C(C=C1)C(C1=CC(=C(C=C1)O)O)=O.ClC1=CC=C(C=C1)C(C1=CC(=C(C=C1)O)OC)=O Chemical compound ClC1=CC=C(C=C1)C(C1=CC(=C(C=C1)O)O)=O.ClC1=CC=C(C=C1)C(C1=CC(=C(C=C1)O)OC)=O MMSHGEFITAGEME-UHFFFAOYSA-N 0.000 description 1
- WATJPWSRSVNXDX-UHFFFAOYSA-N ClC=1C=C(C=CC1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.ClC=1C=C(C=CC1)C(C1=CC(=C(C=C1)O)OC)=O Chemical compound ClC=1C=C(C=CC1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.ClC=1C=C(C=CC1)C(C1=CC(=C(C=C1)O)OC)=O WATJPWSRSVNXDX-UHFFFAOYSA-N 0.000 description 1
- AIZZVMWBJFWEMH-UHFFFAOYSA-N ClC=1C=C(C=CC1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=CC(=CC=C2)Cl)C=C1)OC Chemical compound ClC=1C=C(C=CC1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=CC(=CC=C2)Cl)C=C1)OC AIZZVMWBJFWEMH-UHFFFAOYSA-N 0.000 description 1
- VJTWCSCNUPJZNG-UHFFFAOYSA-N ClC=1C=C2N=C(C(NC2=CC1Cl)=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O.ClC1=CC(=C(C=C1Cl)N)N Chemical compound ClC=1C=C2N=C(C(NC2=CC1Cl)=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)O.ClC1=CC(=C(C=C1Cl)N)N VJTWCSCNUPJZNG-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- KFEKPMXXHCTETF-UHFFFAOYSA-N FC1=C(C(=CC=C1)F)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.FC1=C(C(=CC=C1)F)C(C1=CC(=C(C=C1)O)OC)=O Chemical compound FC1=C(C(=CC=C1)F)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O.FC1=C(C(=CC=C1)F)C(C1=CC(=C(C=C1)O)OC)=O KFEKPMXXHCTETF-UHFFFAOYSA-N 0.000 description 1
- SMDIUMTXZUAKHG-UHFFFAOYSA-N FC1=C(C(=CC=C1)F)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2F)F)C=C1)OC Chemical compound FC1=C(C(=CC=C1)F)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2F)F)C=C1)OC SMDIUMTXZUAKHG-UHFFFAOYSA-N 0.000 description 1
- JMDLIMSCNFSDHF-UHFFFAOYSA-N FC1=CC=C(C=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.FC1=CC=C(C=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O Chemical compound FC1=CC=C(C=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.FC1=CC=C(C=C1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O JMDLIMSCNFSDHF-UHFFFAOYSA-N 0.000 description 1
- NYXLEQPTJAVNIJ-UHFFFAOYSA-N FC1=CC=C(C=C1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=CC=C(C=C2)F)C=C1)OC Chemical compound FC1=CC=C(C=C1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=CC=C(C=C2)F)C=C1)OC NYXLEQPTJAVNIJ-UHFFFAOYSA-N 0.000 description 1
- CSEDDJQZDPZQTP-UHFFFAOYSA-N FC=1C=C(C=CC1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.FC=1C=C(C=CC1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O Chemical compound FC=1C=C(C=CC1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)O)=O.FC=1C=C(C=CC1)C(C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)=O CSEDDJQZDPZQTP-UHFFFAOYSA-N 0.000 description 1
- BXBFXRPOWAHGBI-UHFFFAOYSA-N FC=1C=C(C=CC1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=CC(=CC=C2)F)C=C1)OC Chemical compound FC=1C=C(C=CC1)C(C1=CC(=C(C=C1)O)OC)=O.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=CC(=CC=C2)F)C=C1)OC BXBFXRPOWAHGBI-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- BEACFPXAECSYNN-UHFFFAOYSA-N N(C1=CC=CC=C1)C=1SC=C(N1)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC.C1(=CC=CC=C1)NC(=S)N Chemical compound N(C1=CC=CC=C1)C=1SC=C(N1)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC.C1(=CC=CC=C1)NC(=S)N BEACFPXAECSYNN-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- NBIFDFFAVSHQLW-UHFFFAOYSA-N NC=1C(=C(C=C(C(=O)C2=C(C=CC=C2)F)C1)OC)OC.COC=1C=C(C(=O)C2=C(C=CC=C2)F)C=C(C1OC)[N+](=O)[O-] Chemical compound NC=1C(=C(C=C(C(=O)C2=C(C=CC=C2)F)C1)OC)OC.COC=1C=C(C(=O)C2=C(C=CC=C2)F)C=C(C1OC)[N+](=O)[O-] NBIFDFFAVSHQLW-UHFFFAOYSA-N 0.000 description 1
- LNCVLXUCGBBXSE-UHFFFAOYSA-N NC=1C(=C(C=C(C(=O)C2=CC=CC=C2)C1)OC)OC.COC=1C=C(C(=O)C2=CC=CC=C2)C=C(C1OC)[N+](=O)[O-] Chemical compound NC=1C(=C(C=C(C(=O)C2=CC=CC=C2)C1)OC)OC.COC=1C=C(C(=O)C2=CC=CC=C2)C=C(C1OC)[N+](=O)[O-] LNCVLXUCGBBXSE-UHFFFAOYSA-N 0.000 description 1
- YRKLBSPUMIVUIL-UHFFFAOYSA-N OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1)OC.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1)OC Chemical compound OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1)OC.C(C1=CC=CC=C1)OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1)OC YRKLBSPUMIVUIL-UHFFFAOYSA-N 0.000 description 1
- MDQGACCUFKYOTG-UHFFFAOYSA-N OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1[N+](=O)[O-])OC.OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1)OC Chemical compound OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1[N+](=O)[O-])OC.OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1)OC MDQGACCUFKYOTG-UHFFFAOYSA-N 0.000 description 1
- CEDNIRUDSSHQHY-UHFFFAOYSA-N OC1=C(C=C(C(=O)C2=CC(=C(C=C2)OC)OC)C=C1[N+](=O)[O-])OC.OC1=C(C=C(C(=O)C2=CC(=C(C=C2)OC)OC)C=C1)OC Chemical compound OC1=C(C=C(C(=O)C2=CC(=C(C=C2)OC)OC)C=C1[N+](=O)[O-])OC.OC1=C(C=C(C(=O)C2=CC(=C(C=C2)OC)OC)C=C1)OC CEDNIRUDSSHQHY-UHFFFAOYSA-N 0.000 description 1
- YZACBSRSQQJUAG-UHFFFAOYSA-N OC=1C=C(C(=O)C2=C(C=CC=C2)C)C=C(C1O)[N+](=O)[O-].OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1[N+](=O)[O-])OC Chemical compound OC=1C=C(C(=O)C2=C(C=CC=C2)C)C=C(C1O)[N+](=O)[O-].OC1=C(C=C(C(=O)C2=C(C=CC=C2)C)C=C1[N+](=O)[O-])OC YZACBSRSQQJUAG-UHFFFAOYSA-N 0.000 description 1
- GXUDRVDRQNBQLI-UHFFFAOYSA-N OC=1C=C(C(=O)C2=CC=C(C=C2)C)C=C(C1O)[N+](=O)[O-].OC1=C(C=C(C(=O)C2=CC=C(C=C2)C)C=C1[N+](=O)[O-])OC Chemical compound OC=1C=C(C(=O)C2=CC=C(C=C2)C)C=C(C1O)[N+](=O)[O-].OC1=C(C=C(C(=O)C2=CC=C(C=C2)C)C=C1[N+](=O)[O-])OC GXUDRVDRQNBQLI-UHFFFAOYSA-N 0.000 description 1
- LSBPVCRWSSPPTP-UHFFFAOYSA-N OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(NC2=CC(=C(C=C2N1)C)C)=O.CC1=CC(=C(C=C1C)N)N Chemical compound OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(NC2=CC(=C(C=C2N1)C)C)=O.CC1=CC(=C(C=C1C)N)N LSBPVCRWSSPPTP-UHFFFAOYSA-N 0.000 description 1
- XJVMVPBWGRUCRW-UHFFFAOYSA-N OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)C(=O)O)=O.NC=2C=C(C(=O)O)C=CC2O Chemical compound OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)C(=O)O)=O.NC=2C=C(C(=O)O)C=CC2O XJVMVPBWGRUCRW-UHFFFAOYSA-N 0.000 description 1
- HYVFHJDZUVECIX-UHFFFAOYSA-N OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)C)=O.NC2=CC(=CC=C2O)C Chemical compound OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)C)=O.NC2=CC(=CC=C2O)C HYVFHJDZUVECIX-UHFFFAOYSA-N 0.000 description 1
- LDVRZIOJEXWMGS-UHFFFAOYSA-N OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)CCC)=O.NC2=C(C=CC(=C2)CCC)O Chemical compound OC=1C=C(C=C(C1O)[N+](=O)[O-])C=1C(OC2=C(N1)C=C(C=C2)CCC)=O.NC2=C(C=CC(=C2)CCC)O LDVRZIOJEXWMGS-UHFFFAOYSA-N 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- QGODWYFIZGLLBC-UHFFFAOYSA-N [2-(2,2-dimethylpropanoyloxy)-5-(2-ethoxy-2-oxoacetyl)-3-nitrophenyl] 2,2-dimethylpropanoate Chemical compound C(C)OC(C(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])OC(C(C)(C)C)=O)OC(C(C)(C)C)=O)=O QGODWYFIZGLLBC-UHFFFAOYSA-N 0.000 description 1
- XRGBTNNKCRQNNV-UHFFFAOYSA-N [2-(2,2-dimethylpropanoyloxy)-5-(6-methyl-2-oxo-1,4-benzoxazin-3-yl)-3-nitrophenyl] 2,2-dimethylpropanoate Chemical compound N=1C2=CC(C)=CC=C2OC(=O)C=1C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C([N+]([O-])=O)=C1 XRGBTNNKCRQNNV-UHFFFAOYSA-N 0.000 description 1
- VXVZAHFAHINETI-UHFFFAOYSA-N [2-heptanoyloxy-3-nitro-5-(3-oxo-4h-quinoxalin-2-yl)phenyl] heptanoate Chemical compound [O-][N+](=O)C1=C(OC(=O)CCCCCC)C(OC(=O)CCCCCC)=CC(C=2C(NC3=CC=CC=C3N=2)=O)=C1 VXVZAHFAHINETI-UHFFFAOYSA-N 0.000 description 1
- VYTPFPWQGFFMAV-UHFFFAOYSA-N [3-nitro-5-(7-nitro-2-oxo-1,4-benzoxazin-3-yl)-2-propanoyloxyphenyl] propanoate Chemical compound [O-][N+](=O)C1=C(OC(=O)CC)C(OC(=O)CC)=CC(C=2C(OC3=CC(=CC=C3N=2)[N+]([O-])=O)=O)=C1 VYTPFPWQGFFMAV-UHFFFAOYSA-N 0.000 description 1
- SXGXGIKXODBGLK-UHFFFAOYSA-N [5-(2-ethoxy-2-oxoacetyl)-2-(2-methylpropanoyloxy)-3-nitrophenyl] 2-methylpropanoate Chemical compound CCOC(=O)C(=O)C1=CC(OC(=O)C(C)C)=C(OC(=O)C(C)C)C([N+]([O-])=O)=C1 SXGXGIKXODBGLK-UHFFFAOYSA-N 0.000 description 1
- JEGOUFCDDGCPHL-UHFFFAOYSA-N [5-(6-methyl-2-oxo-1,4-benzoxazin-3-yl)-2-(2-methylpropanoyloxy)-3-nitrophenyl] 2-methylpropanoate Chemical compound [O-][N+](=O)C1=C(OC(=O)C(C)C)C(OC(=O)C(C)C)=CC(C=2C(OC3=CC=C(C)C=C3N=2)=O)=C1 JEGOUFCDDGCPHL-UHFFFAOYSA-N 0.000 description 1
- ZBRYGHQUBQPIMY-UHFFFAOYSA-N [5-(6-methyl-2-oxo-1,4-benzoxazin-3-yl)-3-nitro-2-propanoyloxyphenyl] propanoate Chemical compound [O-][N+](=O)C1=C(OC(=O)CC)C(OC(=O)CC)=CC(C=2C(OC3=CC=C(C)C=C3N=2)=O)=C1 ZBRYGHQUBQPIMY-UHFFFAOYSA-N 0.000 description 1
- QXSRIYKCJIBLNI-UHFFFAOYSA-N [5-imidazo[2,1-b][1,3,4]thiadiazol-6-yl-2-(2-methylpropanoyloxy)-3-nitrophenyl] 2-methylpropanoate Chemical compound [O-][N+](=O)C1=C(OC(=O)C(C)C)C(OC(=O)C(C)C)=CC(C=2N=C3SC=NN3C=2)=C1 QXSRIYKCJIBLNI-UHFFFAOYSA-N 0.000 description 1
- ZCWHOSMFYWUYSJ-UHFFFAOYSA-N [N+](=O)([O-])C=1C(=C(C=C(C(=O)C2=CC=C(C=C2)O)C1)O)O.OC1=C(C=C(C(=O)C2=CC=C(C=C2)OC)C=C1[N+](=O)[O-])OC Chemical compound [N+](=O)([O-])C=1C(=C(C=C(C(=O)C2=CC=C(C=C2)O)C1)O)O.OC1=C(C=C(C(=O)C2=CC=C(C=C2)OC)C=C1[N+](=O)[O-])OC ZCWHOSMFYWUYSJ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005100 aryl amino carbonyl group Chemical group 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000004658 aryl carbonyl amino group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- VINITGRJTKQFED-UHFFFAOYSA-N bis[2-(1H-benzimidazol-2-yl)-3,4-dihydroxy-5-nitrophenyl]methanone Chemical compound N1=C(NC2=C1C=CC=C2)C1=C(C=C(C(=C1O)O)[N+](=O)[O-])C(=O)C1=C(C(=C(C(=C1)[N+](=O)[O-])O)O)C=1NC2=C(N=1)C=CC=C2 VINITGRJTKQFED-UHFFFAOYSA-N 0.000 description 1
- NYYFIQUUOPUDJB-UHFFFAOYSA-N bis[2-(1h-benzimidazol-2-yl)-3,4-dimethoxy-5-nitrophenyl]methanone Chemical compound C1=CC=C2NC(C3=C(OC)C(OC)=C(C=C3C(=O)C3=C(C=4NC5=CC=CC=C5N=4)C(OC)=C(C(=C3)[N+]([O-])=O)OC)[N+]([O-])=O)=NC2=C1 NYYFIQUUOPUDJB-UHFFFAOYSA-N 0.000 description 1
- RQPUOHZYEQTGCE-UHFFFAOYSA-N bis[2-(3,4-dihydroxy-5-nitrophenyl)quinolin-3-yl]methanone hydrobromide Chemical compound Br.Oc1cc(cc(c1O)[N+]([O-])=O)-c1nc2ccccc2cc1C(=O)c1cc2ccccc2nc1-c1cc(O)c(O)c(c1)[N+]([O-])=O RQPUOHZYEQTGCE-UHFFFAOYSA-N 0.000 description 1
- LVRHPGGRVXTXPR-UHFFFAOYSA-N bis[2-(4-hydroxy-3-methoxy-5-nitrophenyl)pyridin-4-yl]methanone Chemical compound OC1=C(C=C(C=C1[N+](=O)[O-])C1=NC=CC(=C1)C(=O)C1=CC(=NC=C1)C1=CC(=C(C(=C1)[N+](=O)[O-])O)OC)OC LVRHPGGRVXTXPR-UHFFFAOYSA-N 0.000 description 1
- FMSQCPBQQKIDDK-UHFFFAOYSA-N bis[4-(3,4-dihydroxy-5-nitrophenyl)-1-methylimidazol-2-yl]methanone hydrobromide Chemical compound Br.Cn1cc(nc1C(=O)c1nc(cn1C)-c1cc(O)c(O)c(c1)[N+]([O-])=O)-c1cc(O)c(O)c(c1)[N+]([O-])=O FMSQCPBQQKIDDK-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- LMSNZLCSZWZZGU-UHFFFAOYSA-N butan-1-ol;hydrochloride Chemical compound Cl.CCCCO LMSNZLCSZWZZGU-UHFFFAOYSA-N 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- CQCMPUPIHNURLC-UHFFFAOYSA-N butyl 3,4-dihydroxy-5-nitrobenzoate Chemical compound CCCCOC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 CQCMPUPIHNURLC-UHFFFAOYSA-N 0.000 description 1
- YNLUGAJWARBAOC-UHFFFAOYSA-N butyl 3-(3,4-dihydroxy-5-nitrophenyl)prop-2-enoate Chemical compound CCCCOC(=O)C=CC1=CC(O)=C(O)C([N+]([O-])=O)=C1 YNLUGAJWARBAOC-UHFFFAOYSA-N 0.000 description 1
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003543 catechol methyltransferase inhibitor Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical group C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- WNVHAIOQCHJCIV-UHFFFAOYSA-N ethyl 2-(3,4-diacetyloxy-5-nitrophenyl)-2-oxoacetate Chemical compound CCOC(=O)C(=O)C1=CC(OC(C)=O)=C(OC(C)=O)C([N+]([O-])=O)=C1 WNVHAIOQCHJCIV-UHFFFAOYSA-N 0.000 description 1
- FPULFENIJDPZBX-UHFFFAOYSA-N ethyl 2-isocyanoacetate Chemical compound CCOC(=O)C[N+]#[C-] FPULFENIJDPZBX-UHFFFAOYSA-N 0.000 description 1
- ABVGKYXWLWSHTJ-UHFFFAOYSA-N ethyl 3,4-dihydroxy-5-nitrobenzoate Chemical compound CCOC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 ABVGKYXWLWSHTJ-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005241 heteroarylamino group Chemical group 0.000 description 1
- URFRZKNWEKIZGD-UHFFFAOYSA-N hexyl 2-(3,4-dihydroxy-2-nitrophenyl)-2-oxoacetate Chemical compound CCCCCCOC(=O)C(=O)C1=CC=C(O)C(O)=C1[N+]([O-])=O URFRZKNWEKIZGD-UHFFFAOYSA-N 0.000 description 1
- WDSPFUFORNQGDK-UHFFFAOYSA-N hexyl 3,4-dihydroxy-5-nitrobenzoate Chemical compound CCCCCCOC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 WDSPFUFORNQGDK-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000003077 lignite Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- SPUACDWLOLSOQO-UHFFFAOYSA-M methoxyazanium;chloride Chemical compound [Cl-].CO[NH3+] SPUACDWLOLSOQO-UHFFFAOYSA-M 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- MZAKWJNGZOTSDL-UHFFFAOYSA-N methyl 2-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-oxoacetate Chemical compound COC(=O)C(=O)C1=CC(OC)=C(O)C([N+]([O-])=O)=C1 MZAKWJNGZOTSDL-UHFFFAOYSA-N 0.000 description 1
- NJDBUIWQZVNVNW-UHFFFAOYSA-N methyl 3,4-dihydroxy-5-nitrobenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 NJDBUIWQZVNVNW-UHFFFAOYSA-N 0.000 description 1
- JJYHPXONDJSWCK-UHFFFAOYSA-N methyl 3-(3,4-dihydroxy-5-nitrophenyl)prop-2-enoate Chemical compound COC(=O)C=CC1=CC(O)=C(O)C([N+]([O-])=O)=C1 JJYHPXONDJSWCK-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- AEXITZJSLGALNH-UHFFFAOYSA-N n'-hydroxyethanimidamide Chemical compound CC(N)=NO AEXITZJSLGALNH-UHFFFAOYSA-N 0.000 description 1
- IXJBJCXFEHLLMT-UHFFFAOYSA-N n,n-diethyl-3,4-dihydroxy-5-nitrobenzamide Chemical compound CCN(CC)C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 IXJBJCXFEHLLMT-UHFFFAOYSA-N 0.000 description 1
- BSZXLTZSSNESLT-UHFFFAOYSA-N n-(6-aminohexyl)-3,4-dihydroxy-5-nitrobenzamide;hydrobromide Chemical compound Br.NCCCCCCNC(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 BSZXLTZSSNESLT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XTBLDMQMUSHDEN-UHFFFAOYSA-N naphthalene-2,3-diamine Chemical compound C1=CC=C2C=C(N)C(N)=CC2=C1 XTBLDMQMUSHDEN-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- PGKVPHVPNDBJTO-UHFFFAOYSA-N nitroapocynin Chemical compound COC1=CC(C(C)=O)=CC([N+]([O-])=O)=C1O PGKVPHVPNDBJTO-UHFFFAOYSA-N 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- CFOJQUGXHMGMOT-UHFFFAOYSA-N pyridin-3-ylthiourea Chemical compound NC(=S)NC1=CC=CN=C1 CFOJQUGXHMGMOT-UHFFFAOYSA-N 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- XQWBMZWDJAZPPX-UHFFFAOYSA-N pyridine-3-carbothioamide Chemical compound NC(=S)C1=CC=CN=C1 XQWBMZWDJAZPPX-UHFFFAOYSA-N 0.000 description 1
- BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 1
- FWHWMBUEPKVKDX-UHFFFAOYSA-N quinolin-3-ylthiourea Chemical compound C1=CC=CC2=CC(NC(=S)N)=CN=C21 FWHWMBUEPKVKDX-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- UHLVUIOFQZVWIP-UHFFFAOYSA-M sodium;2-hydroxy-6-nitro-4-oxalophenolate Chemical compound [Na+].OC1=CC(C(=O)C([O-])=O)=CC([N+]([O-])=O)=C1O UHLVUIOFQZVWIP-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- KNRQKQMCUXJVDY-UHFFFAOYSA-K trimethyl(phenyl)azanium;tribromide Chemical compound [Br-].[Br-].[Br-].C[N+](C)(C)C1=CC=CC=C1.C[N+](C)(C)C1=CC=CC=C1.C[N+](C)(C)C1=CC=CC=C1 KNRQKQMCUXJVDY-UHFFFAOYSA-K 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
- C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
- C07C47/565—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Description
Foreliggende oppfinnelse vedrører en analogifremgangsmåte The present invention relates to an analog method
ved fremstilling av terapeutisk aktive forbindelser med den generelle formel in the preparation of therapeutically active compounds of the general formula
hvori Ra betyr nitro eller cyano, Rb hydrogen eller halogen, where Ra means nitro or cyano, Rb hydrogen or halogen,
Rc' nitro, cyano eller gruppen -(A)n-(Q)^-R<11> eller Rc' nitro, cyano or the group -(A)n-(Q)^-R<11> or
-(A)n-Q-R<21>, A eventuelt med lavere alkyl-substituert vinylen, n tallet 0 eller 1, m tallet 0 eller 1, R<11>-(A)n-Q-R<21>, A optionally with lower alkyl-substituted vinylene, n the number 0 or 1, m the number 0 or 1, R<11>
gruppen -COR<31>, en karbocyklisk, aromatisk gruppe eller en gjennom et karbonatom bundet, aromatisk eller delvis umettet heterocyklisk gruppe, R<21> en eventuelt substituert, the group -COR<31>, a carbocyclic, aromatic group or an aromatic or partially unsaturated heterocyclic group bound through a carbon atom, R<21> an optionally substituted,
mettet eller delvis umettet lavere hydrokarbonrest, R<31>saturated or partially unsaturated lower hydrocarbon residue, R<31>
hydroksy, amino, en gjennom et oksygenatom eller en imino- hydroxy, amino, one through an oxygen atom or an imino-
eller lavere alkyliminogruppe bundet eventuelt substituert, or lower alkylimino group attached optionally substituted,
mettet eller delvis umettet lavere hydrokarbonrest, eller en gjennom et ringnitrogenatom bundet, mettet N-holdig heterocyklisk gruppe, Q-gruppen -CO eller >C=N-(Z)p-R<4>, Z saturated or partially unsaturated lower hydrocarbon residue, or a saturated N-containing heterocyclic group bonded through a ring nitrogen atom, the Q group -CO or >C=N-(Z)p-R<4>, Z
et oksygenatom eller en iminogruppe, p tallet 0 eller 1, an oxygen atom or an imino group, p number 0 or 1,
og R<4> hydrogen eller en eventuelt sustituert og eventuelt gjennom en karbonylgruppe bundet, mettet eller delvis umettet, lavere hydrokarbonrest, hvorunder Ra betyr cyano, and R<4> hydrogen or an optionally substituted and optionally bound through a carbonyl group, saturated or partially unsaturated, lower hydrocarbon residue, where Ra means cyano,
når Rc' betyr cyano eller nitro, og R<31> har en forskjellig when Rc' means cyano or nitro, and R<31> has a different
betydning fra hydroksy når m betyr tallet 0, meaning from hydroxy when m means the number 0,
og hvorunder de eventuelt substituerte hydrokarbonrester er usubstituerte eller substituert med lavere alkoksykarbonyl, and wherein the optionally substituted hydrocarbon residues are unsubstituted or substituted with lower alkoxycarbonyl,
halogen, amino, lavere alkylamino, di(lavere alkyl)-amino, halogen, amino, lower alkylamino, di(lower alkyl)-amino,
fenyl, hydroksyfenylkarbonyl eller trifluormetylfenylamino- phenyl, hydroxyphenylcarbonyl or trifluoromethylphenylamino-
karbonyl, og den karbocykliske aromatiske gruppen betyr en eventuelt med halogen, trifluormetyl, lavere alkyl, hydroksy eller cyano mono- eller disubstituert fenyl- eller natfylgruppe, carbonyl, and the carbocyclic aromatic group means an optionally halogenated, trifluoromethyl, lower alkyl, hydroxy or cyano mono- or disubstituted phenyl or natyl group,
og den aromatiske eller partielt umettede heterocykliske gruppe and the aromatic or partially unsaturated heterocyclic group
en eventuelt med halogen, trifluormetyl, nitro, karboksy, an optionally with halogen, trifluoromethyl, nitro, carboxy,
amino, anilino, lavere alkyl, lavere alkoksy, hydroksy, okso, mercapto, 1-adamantylamino, 2-ekso-bornylamino, cyano, fenyl, fenyl-lavere alkyl, fenyl-lavere alkylamino, pyridyl, pyridylamino, chinolinylamino eller med trifluormetylfenylaminokarbonyl-lavere alkylamino mono-, di- eller trisubstituert pyridyl-, pyrazinyl-, triazinyl-, tiadiazinyl-, tiazolyl-, oksazolyl-, oksadiazolyl-, pyrazolyl-, tetrazolyl-, imidazolyl-, tienyl-, chinolinyl-, isochinolinyl-, dihydroisochinolinyl-, benzoksazinyl-, chinoksazinyl-, benzopyranyl-, benzimidazolyl-, indolyl-, imidazotiazolyl-, imidazotiadiazolyl-, imidazopyridyl-, benzotiazinyl-, benzochinoksalinyl- eller imidazobenzotiazolylgruppe, amino, anilino, lower alkyl, lower alkoxy, hydroxy, oxo, mercapto, 1-adamantylamino, 2-exo-bornylamino, cyano, phenyl, phenyl-lower alkyl, phenyl-lower alkylamino, pyridyl, pyridylamino, quinolinylamino or with trifluoromethylphenylaminocarbonyl-lower alkylamino mono-, di- or trisubstituted pyridyl-, pyrazinyl-, triazinyl-, thiadiazinyl-, thiazolyl-, oxazolyl-, oxadiazolyl-, pyrazolyl-, tetrazolyl-, imidazolyl-, thienyl-, quinolinyl-, isoquinolinyl-, dihydroisoquinolinyl-, benzoxazinyl, quinoxazinyl, benzopyranyl, benzimidazolyl, indolyl, imidazothiazolyl, imidazothiadiazolyl, imidazopyridyl, benzothiazinyl, benzoquinoxalinyl or imidazobenzothiazolyl group,
av under fysiologiske betingelser hydrolyserbare ester- og eterderivater og av farmasøytisk akseptable salter derav. of ester and ether derivatives hydrolyzable under physiological conditions and of pharmaceutically acceptable salts thereof.
Disse forbindelser hemmer spesielt enzymet katekol-O-metyl-transferase (COMT), et løselig, magnesium-avhengig enzym, som katalyserer overføringen av metylgruppen fra S-adenosylmetionin til et katekolsubstrat, hvorunder den tilsvarende metyleter dannes. Egnede substrater som O-metyleres med COMT og dermed deaktiveres er f.eks. ekstraneuronale katekolaminer og eksogent administrerte terapeutiske virkestoffer med katekolstruktur. These compounds specifically inhibit the enzyme catechol-O-methyl-transferase (COMT), a soluble, magnesium-dependent enzyme, which catalyzes the transfer of the methyl group from S-adenosylmethionine to a catechol substrate, during which the corresponding methyl ether is formed. Suitable substrates that are O-methylated with COMT and thus deactivated are e.g. extraneuronal catecholamines and exogenously administered therapeutic agents with a catechol structure.
De ovennevnte forbindelser med formel Ib kan følgelig anvendes ved forebyggelse eller bekjempelse av sykdommer, ved hvilke deaktiveringen av ekstraneuronale katekolaminer med COMT spiller en rolle, f.eks. ved forebyggelse eller bekjempelse av depresjoner. I dette tilfellet kan forbindelsene med ovennevnte formel Ib anvendes som enkeltforbindelser eller i kombinasjon med andre terapeutiske virkestoffer som påvirker sykdomsforløpet gunstig. Forbindelsene med formel Ib kan imidlertid også anvendes som komedikasjon til andre terapeutiske virkestoffer. The above-mentioned compounds of formula Ib can consequently be used in the prevention or combating of diseases in which the deactivation of extraneuronal catecholamines by COMT plays a role, e.g. when preventing or combating depression. In this case, the compounds of the above-mentioned formula Ib can be used as single compounds or in combination with other therapeutic agents that favorably influence the course of the disease. However, the compounds of formula Ib can also be used as comedication to other therapeutic agents.
Forbindelsene med formel Ib kan imidlertid også anvendes for forebyggelse eller bekjempelse av sykdommer med terapeutiske virkestoffer som har en katekolstruktur. Som eksempel nevnes behandlingen av Parkinson-sykdom og av Parkinsonisme med L-dopa, et terapeutisk virkestoff med katekolstruktur. I slike tilfeller kan forbindelsene med formel Ib anvendes i form av en komedikasjon eller som kombinasjonspreparater. However, the compounds of formula Ib can also be used for the prevention or combating of diseases with therapeutic active substances that have a catechol structure. An example is the treatment of Parkinson's disease and Parkinsonism with L-dopa, a therapeutic agent with a catechol structure. In such cases, the compounds of formula Ib can be used in the form of a comedication or as combination preparations.
En videre mulighet for anvendelse av de ovennevnte forbindelser med formel Ib ligger på området diagnostikk. Etter administrering av [<18>F]-6-fluor-L-dopa kan [18F]-dopamin synlig-gjøres i hjernen ved hjelp av positron-emisjonstomografi. Ved tilsetning av en forbindelse med den ovennevnte formel Ib hemmes COMT og dermed forhindres dannelsen av [<18>F]-3-0-metyldopa. Uten en COMT-hemmer ville det dannede [<18>F]-3-0-metyldopa trenge inn i hjernen og føre til en sterk øket bakgrunn, hvilket ville vanskeliggjøre diagnostikken sterkt. A further possibility for the use of the above-mentioned compounds of formula Ib lies in the area of diagnostics. After administration of [<18>F]-6-fluoro-L-dopa, [18F]-dopamine can be made visible in the brain using positron emission tomography. By adding a compound of the above formula Ib, COMT is inhibited and thus the formation of [<18>F]-3-0-methyldopa is prevented. Without a COMT inhibitor, the formed [<18>F]-3-0-methyldopa would penetrate the brain and lead to a strongly increased background, which would greatly complicate diagnostics.
Uttrykket "lavere" angir rester og forbindelser med maksimalt 7, fortrinnsvis maksimalt 4 karbonatomer. Uttrykket "alkyl" tatt alene eller i sammensetninger såsom "alkylgrupper", "alkoksy", "alkyltio" og "alkylimino" angir rettkjedede eller forgrenede mettede hydrokarbonrester, såsom metyl, etyl, propyl, isopropyl, n-butyl, s-butyl, i-butyl og t-butyl . Uttrykket "mettet eller delvis umettet, lavere hydrokarbonrest" betyr åpenkjedede og sykliske grupper og kombinasjoner derav. Eksempler på mettede og delvis umettede lavere hydrokarbonrester er: Lavere alkylgrupper slik de er definert ovenfor; lavere alkenylgrupper, såsom 2-propenyl, 2-butenyl, 3-butenyl og 2-metyl-2-propenyl; eventuelt med lavere alkylgrupper substituerte C3_7-cykloalkyl- og C8_10-bicykloalkylgrupper, såsom cyklopropyl, cyklopentyl, 2-metylcyklopenetyl, cykloheksyl og 3-metylcyklo-heksyl; eventuelt med lavere alkylgrupper substituerte lavere cykloalkenylgrupper, såsom 3-cyklopentenyl, l-metyl-3-cyklopentenyl og 3-cykloheksenyl; med lavere cykloalkyl- eller cykloalkenylgrupper substituerte lavere alkyl- eller alkenylgrupper, såsom cyklopropylmetyl, cyklopropyletyl, cyklopentylmetyl, cykloheksyl-metyl, 2-cykloheksenylmetyl og 3-cyklopropyl-2-propenyl. De lavere alkenylgrupper inneholder fortrinnsvis 2-4 karbonatomer; cykloalkyl- og cykloalkenylgruppene inneholder fortrinnsvis 3-6 karbonatomer. The term "lower" denotes residues and compounds with a maximum of 7, preferably a maximum of 4 carbon atoms. The term "alkyl" taken alone or in combinations such as "alkyl groups", "alkoxy", "alkylthio" and "alkylimino" denotes straight chain or branched saturated hydrocarbon radicals, such as methyl, ethyl, propyl, isopropyl, n-butyl, s-butyl, i -butyl and t-butyl. The term "saturated or partially unsaturated, lower hydrocarbon residue" means open-chain and cyclic groups and combinations thereof. Examples of saturated and partially unsaturated lower hydrocarbon residues are: Lower alkyl groups as defined above; lower alkenyl groups such as 2-propenyl, 2-butenyl, 3-butenyl and 2-methyl-2-propenyl; optionally with lower alkyl groups substituted C3-7-cycloalkyl and C8-10-bicycloalkyl groups, such as cyclopropyl, cyclopentyl, 2-methylcyclopentyl, cyclohexyl and 3-methylcyclohexyl; optionally with lower alkyl groups substituted lower cycloalkenyl groups, such as 3-cyclopentenyl, 1-methyl-3-cyclopentenyl and 3-cyclohexenyl; with lower cycloalkyl or cycloalkenyl groups substituted lower alkyl or alkenyl groups, such as cyclopropylmethyl, cyclopropylethyl, cyclopentylmethyl, cyclohexylmethyl, 2-cyclohexenylmethyl and 3-cyclopropyl-2-propenyl. The lower alkenyl groups preferably contain 2-4 carbon atoms; the cycloalkyl and cycloalkenyl groups preferably contain 3-6 carbon atoms.
Som substituenter for de ovenfornevnte lavere hydrokarbonrester kommer de følgende på tale: hydroksy, cyano, nitro, halogen, amino, lavere alkylamino, di(lavere alkyl)amino, lavere alkoksy, lavere alkoksykarbonyl, aryl, arylaminokarbonyl, arylkarbonyl, arylkarbonylamino, lavere alkanoyloksy, lavere alkanoyl, karbamoyl, mono- eller di(lavere alkyl)karbamoyl, lavere alkylendioksy, trifluormetyl, karboksy, lavere alkanoylamino, lavere alkoksykarbonylamino og lavere alkyltio. De mettede eller delvis umettede lavere hydrokarbonrester er fortrinnsvis usubstituerte eller mono- eller disubstituerte. Substituents for the above-mentioned lower hydrocarbon residues include the following: hydroxy, cyano, nitro, halogen, amino, lower alkylamino, di(lower alkyl)amino, lower alkoxy, lower alkoxycarbonyl, aryl, arylaminocarbonyl, arylcarbonyl, arylcarbonylamino, lower alkanoyloxy, lower alkanoyl, carbamoyl, mono- or di(lower alkyl)carbamoyl, lower alkylenedioxy, trifluoromethyl, carboxy, lower alkanoylamino, lower alkoxycarbonylamino and lower alkylthio. The saturated or partially unsaturated lower hydrocarbon residues are preferably unsubstituted or mono- or disubstituted.
Uttrykket "aryl" betyr karbocykliske aromatiske grupper og fortrinnsvis mono- eller bicykliske grupper. Spesielt foretrukne karbocykliske aromatiske grupper er fenyl- og naftylgruppene, spesielt fenylgruppene. Disse grupper er eventuelt substituert med: halogen, trifluormetyl, nitro, amino, mono- eller di(lavere alkyl)amino, lavere alkyl, lavere alkoksy, lavere alkyltio, lavere alkanoyl, lavere alkoksykarbonyl, karboksy, hydroksy, cyano, lavere alkanoyloksy, karbamoyl, mono- eller di(lavere alkyl)karbamoyl, lavere alkylendioksy, lavere alkanoylamino eller lavere alkoksykarbonylamino. De karbocykliske aromatiske grupper er fortrinnsvis usubstituerte eller mono- eller disubstituerte. The term "aryl" means carbocyclic aromatic groups and preferably mono- or bicyclic groups. Particularly preferred carbocyclic aromatic groups are the phenyl and naphthyl groups, especially the phenyl groups. These groups are optionally substituted with: halogen, trifluoromethyl, nitro, amino, mono- or di(lower alkyl)amino, lower alkyl, lower alkoxy, lower alkylthio, lower alkanoyl, lower alkoxycarbonyl, carboxy, hydroxy, cyano, lower alkanoyloxy, carbamoyl , mono- or di(lower alkyl)carbamoyl, lower alkylenedioxy, lower alkanoylamino or lower alkoxycarbonylamino. The carbocyclic aromatic groups are preferably unsubstituted or mono- or disubstituted.
Uttrykket "aromatisk eller delvis umettet, heterocyklisk gruppe" angir fortrinnsvis en mono-, di- eller tricyklisk, aromatisk eller delvis umettet, heterocyklisk gruppe med opptil 5 heteroatomer fra gruppen bestående av nitrogen, svovel og oksygen. Disse heterocykliske grupper inneholder fortrinnsvis 1-4 nitrogenatomer og/eller et oksygen- eller svovelatom. De er fortrinnsvis mono- eller bicykliske. Heteroatomene er fortrinnsvis fordelt på én eller to ringer, hvorunder nitrogenatomene samtidig også kan være bestanddel av to ringer. De heterocykliske grupper er fortrinnsvis aromatiske. De kan være substituert, hvorunder de i disse tilfelle fortrinnsvis er mono-, di-eller trisubstituerte. Som substituenter kommer på tale: Halogen, trifluormetyl, nitro, karboksy, amino, arylamino, lavere alkyl, lavere alkoksy, hydroksy, lavere alkoksykarbonyl, lavere alkanoyl, lavere alkanoyloksy, okso, lavere alkylendioksy, merkapto, lavere alkyltio, lavere alkylamino, di(lavere alkyl)-amino, <C>3_7-cykloalkylamino, C8_10-bicykloalkylamino, lavere alkanoylamino, lavere alkoksykarbonylamino, karbamoyl, mono-eller di(lavere alkyl)karbamoyl, cyano, aryl, arvl-lavere alkyl, aryl-lavere alkylamino, heteroaryl, heteroaryl-lavere alkyl, heteroarylamino og C3_7-cykloalkyl. De monocykliske heterocykliske grupper er fortrinnsvis 5- eller 6-leddet og inneholder maksimalt fire heterogenatomer. De bisykliske heterocykliske grupper er fortrinnsvis 8- til 10-leddet, hvorunder de enkelte ringer fortrinnsvis er 5- eller 6-leddede. The term "aromatic or partially unsaturated, heterocyclic group" preferably denotes a mono-, di- or tricyclic, aromatic or partially unsaturated, heterocyclic group with up to 5 heteroatoms from the group consisting of nitrogen, sulfur and oxygen. These heterocyclic groups preferably contain 1-4 nitrogen atoms and/or an oxygen or sulfur atom. They are preferably mono- or bicyclic. The heteroatoms are preferably distributed over one or two rings, under which the nitrogen atoms can also be part of two rings at the same time. The heterocyclic groups are preferably aromatic. They can be substituted, whereby in these cases they are preferably mono-, di- or tri-substituted. Examples of substituents include: Halogen, trifluoromethyl, nitro, carboxy, amino, arylamino, lower alkyl, lower alkoxy, hydroxy, lower alkoxycarbonyl, lower alkanoyl, lower alkanoyloxy, oxo, lower alkylenedioxy, mercapto, lower alkylthio, lower alkylamino, di( lower alkyl)-amino, <C>3_7-cycloalkylamino, C8_10-bicycloalkylamino, lower alkanoylamino, lower alkoxycarbonylamino, carbamoyl, mono-or di(lower alkyl)carbamoyl, cyano, aryl, arvl-lower alkyl, aryl-lower alkylamino, heteroaryl , heteroaryl-lower alkyl, heteroarylamino and C3-7-cycloalkyl. The monocyclic heterocyclic groups are preferably 5- or 6-membered and contain a maximum of four heteroatoms. The bicyclic heterocyclic groups are preferably 8- to 10-membered, under which the individual rings are preferably 5- or 6-membered.
Som eksempel på slike heterocykliske grupper nevnes de følgende: pyridyl, pyrazinyl, triazinyl, tiadiazinyl, tiazolyl, oksazolyl, oksadiazolyl, pyrazolyl, tetrazolyl, imidazolyl, tienyl, kinolinyl, isokinolinyl, dihydroisokinolinyl, benzoksazinyl, kinoksalinyl, benzopyranyl, benzimidazolyl, indolyl, imidazotiazolyl, imidazotiadiazolyl, imidazopyridyl, benzotiazinyl, benzokinoksalinyl og imidazobenzotiazolyl. Examples of such heterocyclic groups include the following: pyridyl, pyrazinyl, triazinyl, thiadiazinyl, thiazolyl, oxazolyl, oxadiazolyl, pyrazolyl, tetrazolyl, imidazolyl, thienyl, quinolinyl, isoquinolinyl, dihydroisoquinolinyl, benzoxazinyl, quinoxalinyl, benzopyranyl, benzimidazolyl, indolyl, imidazothiazolyl, imidazothiadiazolyl, imidazopyridyl, benzothiazinyl, benzoquinoxalinyl and imidazobenzothiazolyl.
Uttrykket "heteroaryl" betyr aromatiske heterocykliske grupper slik de er definert ovenfor. The term "heteroaryl" means aromatic heterocyclic groups as defined above.
Uttrykket "en gjennom et ringnitrogenatom bundet, mettet, N-holdig heterocyklisk gruppe" angir fortrinnsvis en 3- til 7-leddet, fortrinnsvis 4- til 6-leddet, mettet N-heterocyklus, som ved siden av det nevnte nitrogenatomet også kan inneholde et oksygen-, svovel- eller nitrogenatom som andre heterogenatom. Disse mettede N-heterocykler kan også være mono- eller disubstituerte; lavere alkyl, hydroksy, lavere alkoksy, lavere alkanoyloksy, lavere hydroksyalkyl, lavere alkoksyalkyl, lavere alkanoyl-oksyalkyl, lavere alkoksykarbonyl, lavere alkanoyl, karbamoyl, mono- eller di(lavere alkyl)karbamoyl, okso og/eller lavere alkylendioksy. The expression "a saturated, N-containing heterocyclic group bound through a ring nitrogen atom" preferably denotes a 3- to 7-membered, preferably 4- to 6-membered, saturated N-heterocycle, which next to the mentioned nitrogen atom can also contain a oxygen, sulfur or nitrogen atom as second heteroatom. These saturated N-heterocycles may also be mono- or disubstituted; lower alkyl, hydroxy, lower alkoxy, lower alkanoyloxy, lower hydroxyalkyl, lower alkoxyalkyl, lower alkanoyloxyalkyl, lower alkoxycarbonyl, lower alkanoyl, carbamoyl, mono- or di(lower alkyl)carbamoyl, oxo and/or lower alkylenedioxy.
Som eksempler på slike N-holdige heterocykliske grupper nevnes de følgende: 4-morfolinyl, 1-pyrrolidinyl og 1-azetidinyl. The following are mentioned as examples of such N-containing heterocyclic groups: 4-morpholinyl, 1-pyrrolidinyl and 1-azetidinyl.
Ved de under fysiologiske betingelser hydrolyserbare If they are hydrolyzable under physiological conditions
ester- og eterderivater dreier det seg fortrinnsvis om forbindelser med formel Ib, hvori minst én av de to fenoliske hydroksygrupper er acylert med en lavere fettsyre eller er foretret med en lavere 1-alkoksykarbonyloksy-l-alkyl-, lavere 1-alkanoyloksy-1-alkyl- eller med en lavere 2-okso-l-alkylgruppe. ester and ether derivatives are preferably compounds of formula Ib, in which at least one of the two phenolic hydroxy groups is acylated with a lower fatty acid or is etherified with a lower 1-Alkoxycarbonyloxy-1-alkyl-, lower 1-Alkanoyloxy-1- alkyl or with a lower 2-oxo-1-alkyl group.
Substituenten Ra betyr fortrinnsvis nitro. Substituenten Rb befinner seg fortrinnsvis i p-stilling til substituenten Ra og betyr fortrinnsvis hydrogen, klor eller fluor, hvorunder betydningsmuligheten hydrogen er spesielt foretrukket. Substituenten Rc' betyr fortrinnsvis gruppen -CO-R<11>, hvorunder R<11> betyr en aromatisk, enkjernet, karbosyklisk gruppe eller en gjennom et karbonatom bundet, aromatisk, enkjernet heterocyklisk gruppe med 1-3 nitrogenatomer som heterogenringelementer. I en spesielt foretrukket utførelsesform betyr R<11> en eventuelt med halogen, trifluormetyl, cyano, hydroksy eller lavere alkyl mono- eller disubstituert fenylgruppe eller en pyridylgruppe. The substituent Ra preferably means nitro. The substituent Rb is preferably in the p-position to the substituent Ra and preferably means hydrogen, chlorine or fluorine, under which the possibility of meaning hydrogen is particularly preferred. The substituent Rc' preferably means the group -CO-R<11>, where R<11> means an aromatic, mononuclear carbocyclic group or an aromatic, mononuclear heterocyclic group bound through a carbon atom with 1-3 nitrogen atoms as heterogeneous ring elements. In a particularly preferred embodiment, R<11> means a phenyl group optionally substituted with halogen, trifluoromethyl, cyano, hydroxy or lower alkyl or a pyridyl group.
Innenfor rammen av foreliggende oppfinnelse særlig foretrukne forbindelser er: 3,4-dihydroksy-5-nitrobenzofenon, Within the scope of the present invention, particularly preferred compounds are: 3,4-dihydroxy-5-nitrobenzophenone,
2'-fluor-3,4-dihydroksy-5-nitrobenzofenon og 3,4-dihydroksy-5-nitrofenyl-4-pyridylketon. 2'-fluoro-3,4-dihydroxy-5-nitrobenzophenone and 3,4-dihydroxy-5-nitrophenyl-4-pyridyl ketone.
Forbindelsene med formel Ib, de hydrolyserbare ester- og eterderivater under fysiologiske betingelser og de farmasøytiske akseptable salter derav, kan fremstilles ifølge oppfinnelsen ved at man The compounds of formula Ib, the hydrolyzable ester and ether derivatives under physiological conditions and the pharmaceutically acceptable salts thereof, can be prepared according to the invention by
a) i en forbindelse med den generelle formel a) in connection with the general formula
hvori ett av symbolene R og R' betyr lavere alkyl og det wherein one of the symbols R and R' means lower alkyl and that
andre hydrogen eller lavere alkyl, og Ra, Rb og Rc' har others are hydrogen or lower alkyl, and Ra, Rb and Rc' have
ovennevnte betydning, above meaning,
spalter de(n) lavere alkyletergruppe(r), eller cleaves the lower alkyl ether group(s), or
b) omsetter en forbindelse med den generelle formel b) reacts a compound with the general formula
hvori X betyr en avspaltbar gruppe, og Ra, Rb, A og n har wherein X means a leaving group, and Ra, Rb, A and n have
ovenfornevnte betydning, above meaning,
med et tioamid, tiourinstoff, tiokarbonsyrehydrazid, tiosemikarbazid, amidin, guanidin, amidrazon, aminoguanidin, syklisk amidin, 1,2-diamin, 1,2-aminotiol eller en 1,2-aminoalkohol, og om ønsket dehydrogenerer det erholdte cyklokondensasjonsprodukt, eller with a thioamide, thiourea, thiocarbonic hydrazide, thiosemicarbazide, amidine, guanidine, amidrazone, aminoguanidine, cyclic amidine, 1,2-diamine, 1,2-aminothiol or a 1,2-amino alcohol, and if desired dehydrogenates the resulting cyclocondensation product, or
c) omsetter en forbindelse med den generelle formel c) reacts a compound with the general formula
hvori R" betyr lavere alkyl, og Ra, Rb, A og n har ovenfornevnte betydning, med et 1,2-diamin, 1,2-aminotiol, 1,2-aminoalkohol, semikarbazid, tiosemikarbazid, amidrazon eller et aminoguanidin, og om ønsket dehydrogenerer det erholdte cyklokondensasjonsprodukt, eller d) omsetter en forbindelse med den ovenfornevnte formel Ib<1> med en e-aminokarbonylforbindelse, eller wherein R" means lower alkyl, and Ra, Rb, A and n have the above meaning, with a 1,2-diamine, 1,2-aminothiol, 1,2-aminoalcohol, semicarbazide, thiosemicarbazide, amidrazone or an aminoguanidine, and if dehydrogenates the resulting cyclocondensation product as desired, or d) reacts a compound of the above-mentioned formula Ib<1> with an ε-aminocarbonyl compound, or
e) i en forbindelse med den generelle formel e) in connection with the general formula
hvori Rc'" betyr nitro, cyano eller gruppen -(A)n-R<12> og R<12 >gruppen -COR<31> en karbosyklisk, aromatisk gruppe eller en gjennom et karbonatom bundet, aromatisk eller delvis umettet, heterocyklisk gruppe, og Ra, Rb, A, n og R<31> har wherein Rc'" means nitro, cyano or the group -(A)n-R<12> and R<12 >the group -COR<31> a carbocyclic aromatic group or an aromatic or partially unsaturated heterocyclic group bonded through a carbon atom, and Ra, Rb, A, n and R<31> have
ovenfornevnte betydning, above meaning,
eller i et di-O-lavere alkanoylderivat derav overfører karboksal-dehydgruppen(e) i cyanogruppen(e), eller or in a di-O-lower alkanoyl derivative thereof transfers the carboxaldehyde group(s) into the cyano group(s), or
f) omsetter et di-O-lavere alkanoylderivat av en karboksylsyre med den generelle formel f) reacts a di-O-lower alkanoyl derivative of a carboxylic acid of the general formula
hvori Ra, Rb, A og n har ovenfornevnte betydning i nærvær av et kondensasjonsmiddel eller et reaktivt derivat av et di-O-lavere alkanoylderivat av en karboksylsyre med formel Ib<3> eller Ib<3> med en forbindelse med den generelle formel wherein Ra, Rb, A and n have the above meaning in the presence of a condensing agent or a reactive derivative of a di-O-lower alkanoyl derivative of a carboxylic acid of formula Ib<3> or Ib<3> with a compound of the general formula
hvori R<5> betyr en eventuelt substituert, mettet eller delvis umettet, lavere hydrokarbonrest, R<6> hydrogen eller lavere alkyl og R<7> hydrogen eller en eventuelt substituert, mettet in which R<5> means an optionally substituted, saturated or partially unsaturated, lower hydrocarbon residue, R<6> hydrogen or lower alkyl and R<7> hydrogen or an optionally substituted, saturated
eller delvis umettet, lavere hydrokarbonrest eller R<6> og R<7 >betyr sammen med nitrogenatomet en mettet N-holdig heterocyklisk gruppe, or partially unsaturated, lower hydrocarbon residue or R<6> and R<7> together with the nitrogen atom mean a saturated N-containing heterocyclic group,
eller or
l g) hydrolyserer en forbindelse med den ovennevnte formel Ib<2>1 g) hydrolyzes a compound of the above formula Ib<2>
eller den generelle formel or the general formula
hvori R<8> betyr lavere alkanoyl og Ra, Rb og Rc' har ovennevnte betydning, in which R<8> means lower alkanoyl and Ra, Rb and Rc' have the above meaning,
eller or
h) omsetter en forbindelse med den generelle formel h) reacts a compound with the general formula
hvori Ra og Rb har ovennevnte betydning og R"' betyr wherein Ra and Rb have the above meaning and R"' means
hydrogen eller lavere alkyl, hydrogen or lower alkyl,
eller et di-O-lavere alkanoylderivat derav i nærvær av et sekundært amin med en forbindelse med den generelle formel or a di-O-lower alkanoyl derivative thereof in the presence of a secondary amine with a compound of the general formula
hvori R<23> betyr en eventuelt substituert, mettet eller delvis umettet, lavere hydrokarbonrest, in which R<23> means an optionally substituted, saturated or partially unsaturated, lower hydrocarbon residue,
eller or
i) omsetter en forbindelse med den generelle formel i) reacts a compound with the general formula
hvori Ra, Rb, A, n og R" har ovennevnte betydning, med et hydrazin eller med et amidin, eller in which Ra, Rb, A, n and R" have the above meaning, with a hydrazine or with an amidine, or
j) omsetter en forbindelse med ovennevnte formel Ib, hvori m betyr tallet 1 og Q gruppen -CO-, j) reacts a compound with the above-mentioned formula Ib, in which m means the number 1 and Q the group -CO-,
med en forbindelse med den generelle formel with a compound of the general formula
hvori Z, p og R<4> har ovennevnte betydning, wherein Z, p and R<4> have the above meaning,
og, om ønsket, and, if desired,
k) overfører en forbindelse med ovennevnte formel Ib i et under fysiologiske betingelser hydrolyserbart ester- eller eterderivat, eller i et farmasøytisk akseptabelt salt derav. k) transfers a compound of the above-mentioned formula Ib in an ester or ether derivative hydrolyzable under physiological conditions, or in a pharmaceutically acceptable salt thereof.
Ifølge fremgangsmåtevariant a) kan forbindelsene med formel Ib fremstilles ved at man i en forbindelse med formel II spalter etergruppen(e). Denne eterspaltningen kan utføres etter i og for seg kjente og for enhver fagmann vanlige metoder. Eterspaltningen kan f.eks. oppnås ved behandling med hydrogenbromid i et egnet løsningsmiddel. Egnede løsningsmidler er f.eks. vann, eddiksyre og blandinger derav. Man arbeider fortrinnsvis ved høyere temperatur, f.eks. i et temperaturområde fra ca. 100°C til reaksjonsblandingens koketemperatur. Fortrinnsvis anvender man 48%-ig hydrogenbromid eller blandinger derav med eddiksyre. According to method variant a), the compounds of formula Ib can be prepared by cleaving the ether group(s) in a compound of formula II. This ether splitting can be carried out according to methods known per se and common to any person skilled in the art. The ether cleavage can e.g. obtained by treatment with hydrogen bromide in a suitable solvent. Suitable solvents are e.g. water, acetic acid and mixtures thereof. One preferably works at a higher temperature, e.g. in a temperature range from approx. 100°C to the boiling temperature of the reaction mixture. Preferably, 48% hydrogen bromide or mixtures thereof with acetic acid are used.
Eterspaltningen kan også utføres ved behandling med bortribromid i et egnet løsningsmiddel ved temperaturer fra ca. -60°C til ca. romtemperatur. Egnede løsningsmidler er spesielt halogenerte lavere hydrokarboner såsom metylenklorid, kloroform o.l.. Andre egnede metoder er: Behandling med pyridiniumhydro-klorid ved temperaturer fra ca. 150°C til ca. 250°C og behandling med natriumjodid/silisiumtetraklorid i et inert organisk løs-ningsmiddel ved høyere temperatur, f.eks. ved reaksjonsblandingens tilbakeløpstemperatur. Egnede løsningsmidler for den siste fremgangsmåten er f.eks. acetonitril, aromatiske hydrokarboner såsom benzen eller toluen, blandinger derav o.l.. The ether cleavage can also be carried out by treatment with boron tribromide in a suitable solvent at temperatures from approx. -60°C to approx. room temperature. Suitable solvents are particularly halogenated lower hydrocarbons such as methylene chloride, chloroform etc. Other suitable methods are: Treatment with pyridinium hydrochloride at temperatures from approx. 150°C to approx. 250°C and treatment with sodium iodide/silicon tetrachloride in an inert organic solvent at a higher temperature, e.g. at the reflux temperature of the reaction mixture. Suitable solvents for the last method are e.g. acetonitrile, aromatic hydrocarbons such as benzene or toluene, mixtures thereof etc.
Ifølge fremgangsmåtevariant b) kan forbindelser med den generelle formel According to method variant b), compounds with the general formula can
fremstilles, hvor Ra, Rb, A og n har ovennevnte betydning, og Q<1> er en gruppe med formlene is produced, where Ra, Rb, A and n have the above meaning, and Q<1> is a group with the formulas
Re er hydrogen, lavere alkyl, C3_7-cykloalkyl, aryl, heteroaryl, aryl-lavere alkyl eller heteroaryl-lavere alkyl, Rf hydrogen, aryl, aryl-lavere alkyl, lavere alkyl, lavere alkoksykarbonyl, heteroaryl, heteroaryl-lavere alkyl, C8_ 10-bicykloalkyl eller <C>3_7-cykloalkyl, Rg og Rh hver hydrogen, cyano, lavere alkyl, C3_7-cykloalkyl, aryl, aryl-lavere alkyl, heteroaryl eller heteroaryl-lavere alkyl, eller Rg og Rh danner sammen med de to hydrogenatomer som de er bundet til en karboksyklisk aromatisk gruppe eller en aromatisk eller delvis umettet heterocyklisk gruppe, den prikkede linje har en fakultativ binding og Q<4> betyr sammen med karbon- og nitrogenatomet en aromatisk eller delvis umettet heterocyklisk gruppe, som minst inneholder et nitrogenatom som heteroringelement. Re is hydrogen, lower alkyl, C3_7-cycloalkyl, aryl, heteroaryl, aryl-lower alkyl or heteroaryl-lower alkyl, Rf hydrogen, aryl, aryl-lower alkyl, lower alkyl, lower alkoxycarbonyl, heteroaryl, heteroaryl-lower alkyl, C8_ 10 -bicycloalkyl or <C>3_7-cycloalkyl, Rg and Rh each hydrogen, cyano, lower alkyl, C3_7-cycloalkyl, aryl, aryl-lower alkyl, heteroaryl or heteroaryl-lower alkyl, or Rg and Rh together with the two hydrogen atoms form they are attached to a carboxycyclic aromatic group or an aromatic or partially unsaturated heterocyclic group, the dotted line has a facultative bond and Q<4> together with the carbon and nitrogen atom means an aromatic or partially unsaturated heterocyclic group, containing at least one nitrogen atom which heteroring element.
Egnede løsningsmidler for dette fremgangsmåteaspekt er lavere alkoholer, såsom etanol, n-butanol, n-heksanol og etylenglykol, åpenkjedede og sykliske etere som også kan inneholde frie hydroksygrupper, såsom tetrahydrofuran, dioksan, t-butylmetyleter, etylenglykoldimetyleter, dietylenglykoldimetyleter, etylenglykolmonometyleter og dietylenglykolmonometyleter, acetonitril, dimetylformamid, dimetylacetamid og dimetylsulfok-syd. Den ønskede reaksjonen kan også utføres uten løsningsmiddel ved tørr oppvarming av reaksjonspartnerne. Reaksjonen utføres fortrinnsvis ved høyere temperatur, f.eks. i et område fra ca. 50°C til 150°C, hvorunder man fortrinnsvis arbeider ved løsnings-midlets koketemperatur, såfremt man arbeider i nærvær av et løsningsmiddel og kokepunktet ligger i det forannevnte området. Suitable solvents for this process aspect are lower alcohols, such as ethanol, n-butanol, n-hexanol and ethylene glycol, open-chain and cyclic ethers which may also contain free hydroxy groups, such as tetrahydrofuran, dioxane, t-butyl methyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, ethylene glycol monomethyl ether and diethylene glycol monomethyl ether, acetonitrile, dimethylformamide, dimethylacetamide and dimethylsulfox-syd. The desired reaction can also be carried out without solvent by dry heating the reaction partners. The reaction is preferably carried out at a higher temperature, e.g. in an area from approx. 50°C to 150°C, below which one preferably works at the solvent's boiling temperature, provided one works in the presence of a solvent and the boiling point is in the aforementioned range.
Ifølge fremgangsmåtevariant c) kan forbindelser med den generelle formel According to method variant c), compounds with the general formula can
fremstilles, hvori Ra, Rb, A og n har ovennevnte betydning og Q<2> betyr en gruppe med formel is prepared, wherein Ra, Rb, A and n have the above meaning and Q<2> means a group of formula
hvorunder Re, Rf, Rg, Rh og den prikkede linje har den ovenfornevnte betydning. under which Re, Rf, Rg, Rh and the dotted line have the above meaning.
Omsetningen ifølge fremgangsmåtevariant c) kan utføres under de samme reaksjonsbetingelser som fremgangsmåtevariant b). The reaction according to process variant c) can be carried out under the same reaction conditions as process variant b).
Ifølge fremgangsmåtevariant d) kan forbindelser med den generelle formel According to method variant d), compounds with the general formula can
fremstilles hvori Q<3> betyr gruppen med formel is prepared in which Q<3> means the group of formula
og Ra, Rb, Re, Rf, Rg, Rh, A, n og den prikkede linjen har ovennevnte betydning. and Ra, Rb, Re, Rf, Rg, Rh, A, n and the dotted line have the above meaning.
Også fremgangsmåtevariant d) kan utfores under de samme reaksjonsbetingelser som fremgangsmåtevariant b). Process variant d) can also be carried out under the same reaction conditions as process variant b).
Ifølge fremgangsmåtevariant e) kan forbindelser med formel Ib fremstilles, hvori Ra betyr cyano, Rc' nitro, cyano eller gruppen -(A)n-R<12> og R<12> gruppen -COR<31> en karbosyklisk, aromatisk gruppe, eller en gjennom et karbonatom bundet, aromatisk eller delvis umettet, heterocyklisk gruppe, og Rb, A, n og R<31 >har ovennevnte betydning. Overføringen av karboksaldehydgrup-pen(e) i cyanogruppen(e) kan skje etter i og for seg kjente og for enhver fagmann vanlige metoder. Man kan f.eks. behandle en forbindelse med formel Ib<2>, III eller IV med hydroksylamin-O-sulfonsyre ved høyere temepratur, hvorunder man fortrinnsvis anvender vann som løsningsmiddel. Reaksjonen kan utføres i et temperaturområde fra ca. 50°C til ca. 100°C. According to method variant e) compounds of formula Ib can be prepared, in which Ra means cyano, Rc' nitro, cyano or the group -(A)n-R<12> and R<12> the group -COR<31> a carbocyclic, aromatic group, or a through a carbon atom bonded, aromatic or partially unsaturated, heterocyclic group, and Rb, A, n and R<31 >have the above meaning. The transfer of the carboxaldehyde group(s) into the cyano group(s) can take place according to methods known per se and common to any person skilled in the art. One can e.g. treat a compound of formula Ib<2>, III or IV with hydroxylamine-O-sulfonic acid at a higher temperature, preferably using water as solvent. The reaction can be carried out in a temperature range from approx. 50°C to approx. 100°C.
Ifølge fremgangsmåtevariant f) kan di-O-lavere alkanoylderivater av forbindelser med formel Ib fremstilles, hvori Rc' betyr gruppen -(A)n-(CO)m-COR<32> og R3<2>amino, en gjennom et oksygenatom eller en imino- eller lavere alkyliminogruppe bundet, eventuelt substituert, mettet eller delvis umettet, lavere hydrokarbonrest, eller en gjennom et ringnitrogenatom bundet, mettet, N-holdig heterocyklisk gruppe, og A, n og m har ovennevnte betydning. Også denne reaksjonen kan utføres etter i og for seg kjente og for enhver fagmann vanlige metoder. Lavere alkylestere kan f.eks. fremstilles, idet man behandler karboksylsyren i nærvær av en syre med den tilsvarende lavere alkohol, hvorunder man som. løsningsmiddel fortrinnsvis anvender den tilsvarende lavere alkohol. Egnede syrer er f.eks. mineralsyrer såsom hydrogenklo-rid og organiske sulfonsyrer såsom p-toluensulfonsyre. Reak-sjonstemperaturen ligger fortrinnsvis i et område fra romtemperatur opp til det valgte løsningsmidlets koketemperatur. According to process variant f) di-O-lower alkanoyl derivatives of compounds of formula Ib can be prepared, in which Rc' means the group -(A)n-(CO)m-COR<32> and R3<2>amino, either through an oxygen atom or an imino or lower alkylimino group attached, optionally substituted, saturated or partially unsaturated, lower hydrocarbon residue, or a saturated, N-containing heterocyclic group attached through a ring nitrogen atom, and A, n and m have the above meaning. This reaction can also be carried out according to methods known per se and common to any person skilled in the art. Lower alkyl esters can e.g. is produced by treating the carboxylic acid in the presence of an acid with the corresponding lower alcohol, during which one as solvent preferably uses the corresponding lower alcohol. Suitable acids are e.g. mineral acids such as hydrogen chloride and organic sulphonic acids such as p-toluenesulphonic acid. The reaction temperature is preferably in a range from room temperature up to the boiling temperature of the chosen solvent.
De øvrige estere og amidene fremstilles fortrinnsvis ut fra reaktive karboksylsyrederivater. Egnede reaktive karboksylsyrederivater er f.eks. de tilsvarende karboksylsyrehalogenider, spesielt karboksylsyrekloridene, tilsvarende karboksylsyreanhyd-rider og blandede anhydrider (f.eks. med trifluoreddiksyre og organiske sulfonsyrer, såsom mesitylensulfonsyre og p-toluensulfonsyre), tilsvarende karboksylsyreimidazolider o.l.. Man arbeider hensiktsmessig i nærvær av et syrebindende middel og et inert organisk løsningsmiddel. Egnede syrebindende midler er f.eks. tertiære aminer såsom trietylamin og pyridin. Ved fremstillingen av amider kan som syrebindende middel også overskudd amin ved formel VI anvendes. Egnede løsningsmidler er f.eks. åpenkjedede og sykliske etere såsom tetrahydrofuran, dietyleter, t-butylmetyleter, dioksan, etylenglykol, dimetyleter e.l., halogenerte hydrokarboner såsom metylenklorid, kloroform og 1,2-dikloretan, acetonitril og dimetylformamid. The other esters and amides are preferably prepared from reactive carboxylic acid derivatives. Suitable reactive carboxylic acid derivatives are e.g. the corresponding carboxylic acid halides, in particular the carboxylic acid chlorides, corresponding carboxylic acid anhydrides and mixed anhydrides (e.g. with trifluoroacetic acid and organic sulphonic acids, such as mesitylenesulphonic acid and p-toluenesulphonic acid), corresponding carboxylic acid imidazolides etc. One works expediently in the presence of an acid binding agent and an inert organic solvent. Suitable acid binding agents are e.g. tertiary amines such as triethylamine and pyridine. In the production of amides, excess amine from formula VI can also be used as an acid-binding agent. Suitable solvents are e.g. open chain and cyclic ethers such as tetrahydrofuran, diethyl ether, t-butyl methyl ether, dioxane, ethylene glycol, dimethyl ether etc., halogenated hydrocarbons such as methylene chloride, chloroform and 1,2-dichloroethane, acetonitrile and dimethylformamide.
Også hydrolysene av forbindelser med formel Ib<4> til de tilsvarende katekolderivater ifølge fremgangsmåtevariant g) kan utføres etter i og for seg kjente og for enhver fagmann vanlige metoder. Hydrolysen kan f.eks. utføres ved behandling med et alkalimetallhydroksyd, såsom natrium- eller kaliumhydroksyd i et egnet løsningsmiddel. Egnede løsningsmidler er f.eks. lavere alkoholer såsom metanol og vann eller blandinger derav. Hydroly-sen kan f.eks. utføres i et temperaturområde fra ca. 0°C til løsningsmidlets koketemperatur, hvorunder man imidlertid fortrinnsvis arbeider ved romtemperatur. The hydrolyses of compounds of formula Ib<4> to the corresponding catechol derivatives according to method variant g) can also be carried out according to methods known per se and common to any person skilled in the art. The hydrolysis can e.g. is carried out by treatment with an alkali metal hydroxide such as sodium or potassium hydroxide in a suitable solvent. Suitable solvents are e.g. lower alcohols such as methanol and water or mixtures thereof. The hydrolysis can e.g. performed in a temperature range from approx. 0°C to the solvent's boiling temperature, below which, however, one preferably works at room temperature.
Ifølge fremgangsmåtevariant h) kan forbindelser med den generelle formel According to process variant h), compounds with the general formula can
hvori Ra, Rb, R<1>" og R<23> har ovennevnte betydning, wherein Ra, Rb, R<1>" and R<23> have the above meaning,
og de tilsvarende di-O-lavere alkanoylderivater derav fremstilles. Som sekundært amin anvender man fortrinnsvis sykliske aminer såsom pyrrolidin, piperidin, morfolin og tiomorfolin. Egnede løsningsmidler for denne fremgangsmåten er f.eks. åpenkjedede og sykliske etere, såsom; tetrahydrofuran, dietyleter, t-butylmetyleter, dioksan, etylenglykol og dimetyleter, halogenerte hydrokarboner, såsom metylenklorid, kloroform og 1,2-dikloretan, acetonitril og dimetylformamid. Reaksjonstemperturen ligger hensiktsmessig i et område fra ca. 0°C til det valgte løsnings-midlets koketemperatur, hvorunder man fortrinnsvis arbeider ved romtemperatur. I en spesielt foretrukket utførelsesform utføres reaksjonen i nærvær av en syre, fortrinnsvis en karboksylsyre såsom eddiksyre. and the corresponding di-O-lower alkanoyl derivatives thereof are prepared. Cyclic amines such as pyrrolidine, piperidine, morpholine and thiomorpholine are preferably used as secondary amines. Suitable solvents for this method are e.g. open-chain and cyclic ethers, such as; tetrahydrofuran, diethyl ether, t-butyl methyl ether, dioxane, ethylene glycol and dimethyl ether, halogenated hydrocarbons such as methylene chloride, chloroform and 1,2-dichloroethane, acetonitrile and dimethylformamide. The reaction temperature is suitably in a range from approx. 0°C to the boiling temperature of the chosen solvent, below which one preferably works at room temperature. In a particularly preferred embodiment, the reaction is carried out in the presence of an acid, preferably a carboxylic acid such as acetic acid.
Ifølge fremgangsmåtevariant i) kan forbindelser med den generelle formel According to method variant i), compounds with the general formula can
fremstilles, hvori Q<5> betyr gruppen is produced, in which Q<5> means the group
og Ra, Rb, Re, Rf, A og n har ovennevnte betydning. and Ra, Rb, Re, Rf, A and n have the above meanings.
Egnede løsningsmidler for denne fremgangsmåten er f.eks. lavere alkoholer, såsom metanol og etanol, åpenkjedede og sykliske etere såsom tetrahydrofuran, dietyleter, t-butylmetyleter, dioksan, etylenglykol og dimetyleter, acetonitril og dimetylformamid. Man arbeider fortrinnsvis ved høyere temperatur, f.eks. i et ormåde fra ca. 50°C til det valgte løsnings-midlets koketemperatur, hvorunder man fortrinnsvis arbeider ved det valgte løsningsmidlets koketemperatur. Suitable solvents for this method are e.g. lower alcohols such as methanol and ethanol, open chain and cyclic ethers such as tetrahydrofuran, diethyl ether, t-butyl methyl ether, dioxane, ethylene glycol and dimethyl ether, acetonitrile and dimethylformamide. One preferably works at a higher temperature, e.g. in a worm way from approx. 50°C to the boiling temperature of the chosen solvent, below which one preferably works at the boiling temperature of the chosen solvent.
Ifølge fremgangsmåtevariant j) kan forbindelser med den generelle formel According to method variant j), compounds with the general formula can
fremstilles, hvori Ri betyr gruppen -COR<31>, en karbosyklisk, aromatisk gruppe eller en gjennom et karbonatom bundet, aromatisk eller delvis umettet, heterocyklisk gruppe eller en eventuelt substituert, mettet eller delvis umettet, lavere hydrokarbonrest, og Ra, Rb, R<31>, R<4>, A, Z, n og p har ovennevnte betydning. is prepared, in which Ri means the group -COR<31>, a carbocyclic, aromatic group or an aromatic or partially unsaturated, heterocyclic group bound through a carbon atom or an optionally substituted, saturated or partially unsaturated, lower hydrocarbon residue, and Ra, Rb, R <31>, R<4>, A, Z, n and p have the above meaning.
Også denne fremgangsmåten kan utføres etter i og for seg This procedure can also be carried out independently
kjente og for enhver fagmann vanlige metoder. Egnede løsingsmid-ler er f.eks. lavere alkoholer såsom metanol og etanol, dimetylformamid og vann. Reaksjonen utføres hensiktsmessig ved romtemperatur. methods known and common to any professional. Suitable solvents are e.g. lower alcohols such as methanol and ethanol, dimethylformamide and water. The reaction is conveniently carried out at room temperature.
Forbindelsene med formel Ib kan overføres i under fysiologiske betingelser hydrolyserbare ester- og eterderivater. Egnede under fysiologiske betingelser hydrolyserbare esterderivater er spesielt forbindelsene med formel Ib, hvori minst en av de to fenoliske hydroksygrupper er acylert med en lavere fettsyre. The compounds of formula Ib can be converted into ester and ether derivatives hydrolyzable under physiological conditions. Suitable under physiological conditions hydrolysable ester derivatives are especially the compounds of formula Ib, in which at least one of the two phenolic hydroxy groups is acylated with a lower fatty acid.
Disse kan fremstilles etter i og for seg kjente og for enhver fagmann vanlige metoder. I en foretrukket utførelsesform utføres acyleringen med det tilsvarende lavere fettsyreanhydrid i nærvær av en katalytisk mengde av en sterk syre, hvorunder man som løsningsmiddel fortrinnsvis anvender overskudd av fettsyreanhydrid. Egnede syrer er f.eks. svovelsyre og organiske sulfonsyrer, såsom p-toluensulfonsyre. These can be produced according to methods known in and of themselves and common to any expert. In a preferred embodiment, the acylation is carried out with the corresponding lower fatty acid anhydride in the presence of a catalytic amount of a strong acid, during which an excess of fatty acid anhydride is preferably used as solvent. Suitable acids are e.g. sulfuric acid and organic sulphonic acids, such as p-toluenesulphonic acid.
Egnede under fysiologiske betingelser hydrolyserbare eterderivater er f.eks. forbindelser med formel Ib, hvori minst en av de to fenoliske hydroksygrupper er foretret med en lavere 1-alkoksykarbonyloksy-l-alkyl-, lavere 1-alkanoyloksy-l-alkyl-eller med en lavere 2-okso-l-alkylgruppe. Foretringen kan utføres etter i og for seg kjente og for enhver fagmann vanlige metoder. Man kan f.eks. omsette en forbindelse med formel Ib med et lavere 1-alkoksykarbonyloksy-l-alkyl-, et lavere 1-alkanoyloksy-l-alkyl- eller et lavere 2-okso-l-alkylhalogenid, hvorunder denne foretringen hensiktsmessig utføres i nærvær av en base. Hydrolyzable ether derivatives suitable under physiological conditions are e.g. compounds of formula Ib, in which at least one of the two phenolic hydroxy groups is etherified with a lower 1-alkoxycarbonyloxy-1-alkyl-, lower 1-alkanoyloxy-1-alkyl- or with a lower 2-oxo-1-alkyl group. The business can be carried out according to methods known in and of themselves and common to any person skilled in the art. One can e.g. reacting a compound of formula Ib with a lower 1-alkoxycarbonyloxy-1-alkyl-, a lower 1-alkanoyloxy-1-alkyl- or a lower 2-oxo-1-alkyl halide, wherein this etherification is conveniently carried out in the presence of a base.
Som halogenider kommer spesielt jodidene på tale. Egnede baser As halides, the iodides in particular come into question. Suitable bases
er f.eks. alkalimetallhydroksyder og alkalimetallkarbonater, is e.g. alkali metal hydroxides and alkali metal carbonates,
såsom natriumhydroksyd og natriumkarbonat. such as sodium hydroxide and sodium carbonate.
Ifølge sistnevnte fremgangsmåtevariant, kan forbindelser med den ovennevnte formel Ib også overføres i farmasøytisk antagelige salter. Som salter kommer spesielt salter med de farmasøytiske akseptable baser i betraktning. Som eksempler på slike salter nevnes alkalimetallsalter, såsom natrium- og kaliumsaltene. According to the latter method variant, compounds of the above-mentioned formula Ib can also be transferred in pharmaceutically acceptable salts. As salts, especially salts with the pharmaceutically acceptable bases come into consideration. Examples of such salts include alkali metal salts, such as the sodium and potassium salts.
Disse salter kan fremstilles etter i og for seg kjente og for enhver fagmann vanlige metoder. These salts can be produced according to methods known per se and common to any person skilled in the art.
De forskjellige forbindelser som anvendes som utgangsmaterialer er kjente eller kan fremstilles etter i og for seg kjente metoder. De etterfølgende eksempler inneholder detaljerte opplysninger vedrørende fremstillingen av disse utgangsstoffer. Som allerede innledningsvis nevnt hemmer forbindelsene med formel Ib enzymet COMT. Denne virkningen kan måles kvantitativt som følger: Man inkuberer rottelever-homogenisat i nærvær av et egnet substrat såsom beskrevet i J. Neurochem. 38, 191-195 (1982) og måler COMT-aktiviteten. I en andre forsøksrekke utføres inkubasjonen i nærvær av en forbindelse med formel Ib. Fra forskjellen til de målte COMT-aktiviteter kan man så beregne IC50. IC50 angis i nMol/1 og er den konsentrasjonen i inkube-ringsblandingen som er nødvendig for å nedsette COMT-aktiviteten med 50%. I den etterfølgende tabell er IC50-verdiene for noen forbindelser med formel Ib angitt. Denne tabell inneholder dertil angivelser over den akutte toksisiteten til disse forbindelsene (DL50 i mg/kg ved engangs oral administrering til mus). The various compounds used as starting materials are known or can be prepared according to methods known per se. The following examples contain detailed information regarding the production of these starting materials. As already mentioned at the outset, the compounds of formula Ib inhibit the enzyme COMT. This effect can be measured quantitatively as follows: Rat liver homogenate is incubated in the presence of a suitable substrate as described in J. Neurochem. 38, 191-195 (1982) and measures COMT activity. In a second series of experiments, the incubation is carried out in the presence of a compound of formula Ib. From the difference to the measured COMT activities, the IC50 can then be calculated. The IC50 is stated in nMol/1 and is the concentration in the incubation mixture that is necessary to reduce the COMT activity by 50%. In the following table, the IC50 values for some compounds of formula Ib are indicated. This table also contains information on the acute toxicity of these compounds (DL50 in mg/kg upon single oral administration to mice).
De beskrevne stoffer kan finne anvendelse som legemidler, f.eks. i form av farmasøytiske preparater for enteral eller parenteral applikasjon. Forbindelsene med formel Ib kan f.eks. gis peroralt, f.eks. i form av tabletter, lakktabletter, drageer, hård- og mykgelatinkapsler, løsninger, emulsjoner eller suspen-sjoner, rektalt, f.eks. i form av suppositorier, eller parente-ralt, f.eks. i form av injeksjonsløsninger. The substances described can be used as pharmaceuticals, e.g. in the form of pharmaceutical preparations for enteral or parenteral application. The compounds of formula Ib can e.g. given orally, e.g. in the form of tablets, varnish tablets, dragees, hard and soft gelatin capsules, solutions, emulsions or suspensions, rectally, e.g. in the form of suppositories, or parenterally, e.g. in the form of injection solutions.
Fremstillingen av de farmasøytiske preparater kan skje på vanlig måte for enhver fagmann ved at man bringer forbindelsene med formel Ib, eventuelt i kombinasjon med andre terapeutisk verdifulle stoffer, sammen med egnede, ikke-toksiske, inerte, terapeutisk fordragelige faste eller flytende bærematerialer og eventuelt de vanlige farmasøytiske hjelpestoffer i en galenisk administreringsform. The preparation of the pharmaceutical preparations can be carried out in the usual way for any person skilled in the art by bringing the compounds of formula Ib, possibly in combination with other therapeutically valuable substances, together with suitable, non-toxic, inert, therapeutically tolerable solid or liquid carrier materials and possibly the common pharmaceutical excipients in a galenic administration form.
Som bærematerialer egner seg både uorganiske og organiske bærematerialer. Således kan man for tabletter, lakktabletter, drageer og hårdgelatinkapsler f.eks. anvende laktose, mais-stivelse eller derivater derav, talkum, stearinsyre eller deres salter som bærematerialer. For mykgelatinkapsler egner seg som bærer f.eks. planteoljer, vokser, fett og halvfaste og flytende polyoler (avhengig av virkestoffets beskaffenhet er imidlertid bærere unødvendige ved mykgelatinkapsler). For fremstilling av løsninger og sirups er egnede bærematerialer f.eks. vann, polyoler, sakkarose, invertsukker og glukose. Egnet for injek-sjonsløsninger som bærematerialer er f.eks. vann, alkoholer, polyoler, glyserol og planteoljer. Egnet for suppositorier som bærematerialer er f.eks. naturlige eller herdede oljer, vokser, fett og halvt flytende eller flytende polyoler. As carrier materials, both inorganic and organic carrier materials are suitable. Thus, for tablets, varnish tablets, dragees and hard gelatin capsules, e.g. use lactose, corn starch or derivatives thereof, talc, stearic acid or their salts as carrier materials. For soft gelatin capsules suitable as a carrier e.g. vegetable oils, waxes, fats and semi-solid and liquid polyols (depending on the nature of the active ingredient, however, carriers are unnecessary for soft gelatin capsules). For the production of solutions and syrups, suitable carrier materials are e.g. water, polyols, sucrose, invert sugar and glucose. Suitable for injection solutions as carrier materials are e.g. water, alcohols, polyols, glycerol and vegetable oils. Suitable for suppositories as carrier materials are e.g. natural or hardened oils, waxes, fats and semi-liquid or liquid polyols.
Som farmasøytiske hjelpestoffer kommer de vanlige konserve-ringsmidler, løsningsformidlere, stabiliseringsmidler, fuktemid-ler, emulgeringsmidler, midler for smaksforbedring såsom søt-ningsmidler og aromatiseringsmidler, fargemidler, salter for endring av det osmotiske trykk, buffere, overtrekksmidler og antioksydanter på tale. Pharmaceutical excipients include the usual preservatives, solvents, stabilizers, wetting agents, emulsifiers, flavor enhancers such as sweeteners and flavoring agents, coloring agents, salts for changing the osmotic pressure, buffers, coating agents and antioxidants.
Doseringen av de beskrevne stoffer kan, avhengig av sykdommen som skal behandles, variere innenfor vide grenser med alderen og den individuelle tilstanden til pasienten og av applikasjons-måten, og må naturligvis i hvert enkelt tilfelle tilpasses de individuelle omstendigheter. Ved forbedringen av behandlingen av Parkinson-sykdommen og av parkinsonismus med L-dopa kommer en daglig dose på tale for voksne pasienter på ca. 25 mg til ca. 1000 mg, spesielt ca. 100 mg til ca. 300 mg. Avhengig av doseringen er det derunder hensiktsmessig å gi dagsdosen i flere doseringsenheter. The dosage of the described substances can, depending on the disease to be treated, vary within wide limits with the age and the individual condition of the patient and the method of application, and must of course be adapted to the individual circumstances in each individual case. In improving the treatment of Parkinson's disease and parkinsonism with L-dopa, a daily dose for adult patients of approx. 25 mg to approx. 1000 mg, especially approx. 100 mg to approx. 300 mg. Depending on the dosage, it is appropriate to give the daily dose in several dosage units.
De farmasøytiske preparater inneholder hensiktsmessig ca. The pharmaceutical preparations appropriately contain approx.
25 mg til ca. 300 mg, fortrinnsvis ca. 50 mg til ca. 150 mg av en forbindelse med formel Ib eller et under fysiologiske betingelser hydrolyserbart ester- eller eterderivat eller et farmasøytisk akseptabelt salt derav. 25 mg to approx. 300 mg, preferably approx. 50 mg to approx. 150 mg of a compound of formula Ib or an ester or ether derivative hydrolysable under physiological conditions or a pharmaceutically acceptable salt thereof.
De etterfølgende eksempler skal belyse den foreliggende oppfinnelse nærmere, men uten på noen måte å begrense dens omfang. Samtlige temperaturer er angitt i celsiusgrader. The following examples shall illustrate the present invention in more detail, but without in any way limiting its scope. All temperatures are given in degrees Celsius.
Eksempel 1 Example 1
a) 17,1 g (86,7 mmol) 4-hydroksy-3-metoksy-5-nitrobenzaldehyd blandes med 170 ml konstantkokende hydrogenbromid og oppvarmes i a) 17.1 g (86.7 mmol) of 4-hydroxy-3-methoxy-5-nitrobenzaldehyde are mixed with 170 ml of constant-boiling hydrogen bromide and heated in
3,5 timer under tilbakeløp. Etter avkjøling frafiltreres den utfelte felling, vaskes to ganger med isvann og opptas i eddikester. Den organiske fase vaskes to ganger med 50 ml koksaltløs-ning hver gang, tørkes over magnesiumsulfat og inndampes i vannstrålevakuum. De erholdte krystaller opptas i metylenklorid, hvorpå man filtrerer gjennom den tidobbelte mengde kiselgel. Det erholdte materialet krystalliseres fra eddikester/isopropyleter. Man får 3,4-dihydroksy-5-nitrobenzaldehyd i form av gule krystaller med smp. 142-143°C. 3.5 hours during reflux. After cooling, the precipitate is filtered off, washed twice with ice water and taken up in vinegar. The organic phase is washed twice with 50 ml sodium chloride solution each time, dried over magnesium sulphate and evaporated in a water jet vacuum. The crystals obtained are taken up in methylene chloride, after which it is filtered through a tenfold amount of silica gel. The material obtained is crystallized from ethyl acetate/isopropyl ether. 3,4-Dihydroxy-5-nitrobenzaldehyde is obtained in the form of yellow crystals with m.p. 142-143°C.
b) Man tilsetter en løsning av 1,83 g (10 mMol) 3,4-dihydroksy-5-nitrobenzaldehyd i 25 ml vann en løsning av 1,7 g (15 mmol) b) A solution of 1.83 g (10 mmol) 3,4-dihydroxy-5-nitrobenzaldehyde in 25 ml of water is added to a solution of 1.7 g (15 mmol)
hydroksylamin-O-sulfonsyre i 6 ml vann, rører deretter i 3,5 timer ved 65°C, avkjøler, frafiltrerer den utfelte felling og opptar denne i eddikester. Den organiske fasen tørkes over natriumsulfat og inndampes i vannstrålevakuum. De erholdte krystaller omkrystalliseres fra eddikester/n-heksan. Man får 3,4-dihydroksky-5-nitrobenzonitril i form av gule krystaller med smeltepunkt 194-195°C. hydroxylamine-O-sulfonic acid in 6 ml of water, then stirs for 3.5 hours at 65°C, cools, filters off the precipitate and absorbs this in acetic acid. The organic phase is dried over sodium sulfate and evaporated in a water jet vacuum. The crystals obtained are recrystallized from ethyl acetate/n-hexane. 3,4-dihydroxy-5-nitrobenzonitrile is obtained in the form of yellow crystals with a melting point of 194-195°C.
Eksempel 2 Example 2
aa) Til 4,1 g 4-(benzyloksy)-3-metoksy-brombenzen oppløst i 40 ml tetrahydrofuran dryppes ved -70°C i løpet av 10 min. 10 ml tert. butyllitiumløsning (1,4 M i heksan). Etter 2 timer røring ved -70°C tilsettes 1 ml pyridin-3-karbaldehyd i løpet av 5 min.. Reaksjonsblandingen røres 1 time ved -70°C og 2 timer ved 0°C og helles på 100 ml lN-saltsyre. Det ekstraheres tre ganger med hver gang 50 ml eter. De sammenslåtte eterfaser vaskes med 100 ml 1 N-saltsyre og 20 ml vann. De sammenslåtte vannfaser gjøres alkalisk med vandig ammoniakkløsning og ekstraheres tre ganger med hver gang 100 ml metylenklorid. De sammenslåtte metylenkloridfaser tørkes over natriumsulfat og inndampes. Man får alfa-[4-(benzyloksy)-3-metoksyfenyl]-3-pyridinmetanol som en olje. aa) To 4.1 g of 4-(benzyloxy)-3-methoxy-bromobenzene dissolved in 40 ml of tetrahydrofuran is added dropwise at -70°C during 10 min. 10 ml tart. butyl lithium solution (1.4 M in hexane). After 2 hours of stirring at -70°C, 1 ml of pyridine-3-carbaldehyde is added over 5 minutes. The reaction mixture is stirred for 1 hour at -70°C and 2 hours at 0°C and poured onto 100 ml of 1N hydrochloric acid. It is extracted three times with 50 ml of ether each time. The combined ether phases are washed with 100 ml of 1 N hydrochloric acid and 20 ml of water. The combined aqueous phases are made alkaline with aqueous ammonia solution and extracted three times with 100 ml of methylene chloride each time. The combined methylene chloride phases are dried over sodium sulfate and evaporated. Alpha-[4-(benzyloxy)-3-methoxyphenyl]-3-pyridinemethanol is obtained as an oil.
ab) På analog måte får man ved anvendelse av pyridin-4-karbalde-hyd alfa-[4-(benzyloksy)-3-metoksyfenyl]-4-pyridinmetanol som en olje. ab) In an analogous way, by using pyridine-4-carbaldehyde, alpha-[4-(benzyloxy)-3-methoxyphenyl]-4-pyridinemethanol is obtained as an oil.
ba) 3,2 g alfa-[4-(benzyloksy)-5-metoksyfenyl]-3-pyridinmetanol oppslemmet i 50 ml vann blandes med 2,5 g kaliumpermanganat, hvorpå man rører i 30 min. ved 90°C. Etter tilsetning av ytterligere 1,0 g kaliumpermanganat og røring i ytterligere 30 min. ved 9 0°C avkjøles til romtemperatur og ekstraheres to ganger med 150 ml eddikester hver gang. De sammenslåtte eddik-esterfaser vaskes med koksaltløsning, tørkes over natriumsulfat og inndampes. Den således oppnådde rest kromatograferes på 50 g kiselgel med eddikester. Man får etter omkrystallisering fra metylenklorid/heksan 4-(benzyloklsy)-3-metoksyfenyl-3-pyridylketon med smp. 7 6°C. ba) 3.2 g of alpha-[4-(benzyloxy)-5-methoxyphenyl]-3-pyridinemethanol suspended in 50 ml of water is mixed with 2.5 g of potassium permanganate, after which it is stirred for 30 min. at 90°C. After adding a further 1.0 g of potassium permanganate and stirring for a further 30 min. at 90°C, cool to room temperature and extract twice with 150 ml of acetic acid each time. The combined acetic ester phases are washed with sodium chloride solution, dried over sodium sulphate and evaporated. The residue thus obtained is chromatographed on 50 g of silica gel with acetic acid. After recrystallization from methylene chloride/hexane, 4-(benzyloxy)-3-methoxyphenyl-3-pyridyl ketone with m.p. 7 6°C.
bb) På analog måte får man ut fra alfa-[4-(benzyloksy)-3-metoksyfenyl)-4-pyridinmetanol 4-(benzyloksy)-3-metoksyfenyl 4-pyridylketon med smp. 85-87°C (metylenklolrid/heksan). bb) In an analogous manner, one obtains from alpha-[4-(benzyloxy)-3-methoxyphenyl)-4-pyridinemethanol 4-(benzyloxy)-3-methoxyphenyl 4-pyridyl ketone with m.p. 85-87°C (methylene chloride/hexane).
ca) Til 20 g 4-(benzyloksy)-3-metoksyfenyl 3-pyridylketon oppløst i 200 ml metylenklorid dryppes ved 10°C 50 ml 33% hydrogenbromid i eddiksyre i løpet av 15 min.. Etter 3 timer røring ved 2 0°C helles reaksjonsblandingen på en blanding av 100 ml kons. vandig ammoniakk og is. pH-et innstilles på 6 ved tilsetning av eddiksyre. Metylenkloridfasen fraskilles, den vandige fasen ekstraheres enda to ganger med 100 ml metylenklorid hver gang. De sammenslåtte metylenkloridfaser tørkes over natriumsuflat og inndampes. Resten omkrystalliseres fra metylenklorid/heksan. Man får 4-hydroksy-3-metoksyfenyl 3-pyridylketon med smp. 150-151°C. approx) To 20 g of 4-(benzyloxy)-3-methoxyphenyl 3-pyridyl ketone dissolved in 200 ml of methylene chloride, 50 ml of 33% hydrogen bromide in acetic acid is added dropwise at 10°C over the course of 15 min. After 3 hours of stirring at 20°C the reaction mixture is poured onto a mixture of 100 ml conc. aqueous ammonia and ice. The pH is set to 6 by adding acetic acid. The methylene chloride phase is separated, the aqueous phase is extracted twice more with 100 ml of methylene chloride each time. The combined methylene chloride phases are dried over sodium sulfate and evaporated. The residue is recrystallized from methylene chloride/hexane. 4-Hydroxy-3-methoxyphenyl 3-pyridyl ketone is obtained with m.p. 150-151°C.
cb) På analog måte får man fra 4-(benzyloksy)-3-metoksyfenyl 4-pyridylketon 4-hydroksy-3-metoksyfenyl 4-pyridylketon med smp. 215-218°C (acetonitril). cb) In an analogous manner, 4-(benzyloxy)-3-methoxyphenyl 4-pyridyl ketone is obtained from 4-hydroxy-3-methoxyphenyl 4-pyridyl ketone with m.p. 215-218°C (acetonitrile).
da) Til 1,15 g 4-hydroksy-3-metoksyfenyl-3-pyridylketon oppløst i 15 ml eddiksyre dryppes 0,38 ml 65% salpetersyre ved romtempe- da) To 1.15 g of 4-hydroxy-3-methoxyphenyl-3-pyridyl ketone dissolved in 15 ml of acetic acid, add 0.38 ml of 65% nitric acid at room temperature
råtur. Etter 2 timers røring helles reaksjonsblandingen på raw ride. After 2 hours of stirring, the reaction mixture is poured on
120 ml isvann, hvorpå man innstiller pH på 5 med kons. ammoniakk og frafiltrerer den dannede felling. Den derved oppnådde rest oppvarmes i 20 ml acetonitril under tilbakeløp, hvorpå man filtrerer fra på nytt. Man får 4-hydroksy-3-metoksy-5-nitrofe-nyl-3-pyridylketon som brune krystaller med smp. 193°C. 120 ml of ice water, after which the pH is adjusted to 5 with conc. ammonia and filters off the formed precipitate. The resulting residue is heated in 20 ml of acetonitrile under reflux, after which it is filtered off again. 4-hydroxy-3-methoxy-5-nitro-nyl-3-pyridyl ketone is obtained as brown crystals with m.p. 193°C.
db) På analog måte får man fra 4-hydroksy-3-metoksyfenyl-4-pyridylketon 4-hydroksy-3-metoksy-5-nitrofenyl-4-pyridylketon med smp. 240°C. db) In an analogous manner, 4-hydroxy-3-methoxy-4-pyridyl ketone is obtained from 4-hydroxy-3-methoxy-5-nitrophenyl-4-pyridyl ketone with m.p. 240°C.
e) 3,5 g 4-hydroksy-3-metoksy-5-nitrofenyl-3-pyridylketon oppløst i 70 ml 48% vandig hydrogenbromid røres i 18 timer ved e) 3.5 g of 4-hydroxy-3-methoxy-5-nitrophenyl-3-pyridyl ketone dissolved in 70 ml of 48% aqueous hydrogen bromide is stirred for 18 hours at
100°C. Så inndampes reaksjonsblandingen under redusert trykk. Resten omkrystalliseres fra vann. Man får 3,4-dihydroksy-5-nitrofenyl-3-pyridylketon-hydrobromid med smp. 265°C. 100°C. The reaction mixture is then evaporated under reduced pressure. The remainder is recrystallized from water. This gives 3,4-dihydroxy-5-nitrophenyl-3-pyridyl ketone hydrobromide with m.p. 265°C.
f) På analog måte får man fra 4-hydroksy-3-metoksy-5-nitrofe-nyl-4-pyridylketon 3,4-dihydroksy-5-nitrofenyl-4-pyridylketon med f) In an analogous way, 3,4-dihydroxy-5-nitrophenyl-4-pyridyl ketone is obtained from 4-hydroxy-3-methoxy-5-nitro-nyl-4-pyridyl ketone with
smp. 246°C (fra vann). m.p. 246°C (from water).
g) 13,2 g 3,4-dihydroksy-5-nitrofenyl-4-pyridylketon oppslemmes i 500 ml metanol og blandes under røring med 4,88 g metansulfon-syre. Suspensjonen oppvarmes 60 min. under tilbakeløp. Så avkjøles til 10°C, krystallene frafiltreres og vaskes to ganger med 30 ml metanol hver gang. Man får 3,4-dihydroksy-5-nitrofe-nyl-4-pyridylketon-metansulfonat med smp. 260-261°C (spaltning). g) 13.2 g of 3,4-dihydroxy-5-nitrophenyl-4-pyridyl ketone are suspended in 500 ml of methanol and mixed with stirring with 4.88 g of methanesulfonic acid. The suspension is heated for 60 min. during reflux. It is then cooled to 10°C, the crystals are filtered off and washed twice with 30 ml of methanol each time. This gives 3,4-dihydroxy-5-nitro-nyl-4-pyridyl ketone methanesulfonate with m.p. 260-261°C (decomposition).
Eksempel 3 Example 3
a) En løsning av 2,6 g (12,2 mmol) 4-hydroksy-3-metoksy-5-nitrobenzosyre i 26 ml konstantkokende hydrogenbromid oppvarmes 2 a) A solution of 2.6 g (12.2 mmol) of 4-hydroxy-3-methoxy-5-nitrobenzoic acid in 26 ml of constant-boiling hydrogen bromide is heated 2
timer under tilbakeløp. Etter avkjøling avdestilleres løsnings-midlet i vannstrålevakuum. Den krystallinske resten omkrystalliseres fra 50 ml vann på kokepunktet. Man får 3,4-dihydroksy-5-nitrobenzosyre i form av gule krystaller med smp. 224-226°C. hours during reflux. After cooling, the solvent is distilled off in a water jet vacuum. The crystalline residue is recrystallized from 50 ml water at the boiling point. 3,4-dihydroxy-5-nitrobenzoic acid is obtained in the form of yellow crystals with m.p. 224-226°C.
b) Man blander 1,0 g (5 mmol) 3,4-dihydroksy-5-nitrobenzosyre med 20 ml metanolisk saltsyreløsning, rører i 3 timer ved 45°C og opptar resten etter fjerning av løsningsmidlet i metylenklorid. Den organiske fasen vaskes med koksaltløsning, tørkes over natriumsulfat og inndampes. Det erholdte krystallinske produkt opptas i metylenklorid og filtreres gjennom den tidobbelte mengde kiselgel. Det erholdte materialet omkrystalliseres fra eddikester/n-heksan. Man får 3,4-dihydroksy-5-nitrobenzosyremetyl-ester i form av gule krystaller med smp. 144-145°C. b) 1.0 g (5 mmol) of 3,4-dihydroxy-5-nitrobenzoic acid is mixed with 20 ml of methanolic hydrochloric acid solution, stirred for 3 hours at 45°C and the residue taken up after removal of the solvent in methylene chloride. The organic phase is washed with sodium chloride solution, dried over sodium sulphate and evaporated. The crystalline product obtained is taken up in methylene chloride and filtered through a tenfold amount of silica gel. The material obtained is recrystallized from ethyl acetate/n-hexane. 3,4-dihydroxy-5-nitrobenzoic acid methyl ester is obtained in the form of yellow crystals with m.p. 144-145°C.
På analog måte får man ut fra 3,4-dihydroksy-5-nitrobenzo-syre de følgende estere: c) 3,4-dihydroksy-5-nitrobenzosyre-etylester med smp. 106-107°C (fra eddikester/n-heksan), d) 3,4-dihydroksy-5-nitrobenzosyre-n-butylester med smp. 73-74°C (fra metylenklorid) og e) 3,4-dihydroksy-5-nitrobenzosyre-n-heksylester med smp. 44-45°C (fra isopropyleter). In an analogous way, the following esters are obtained from 3,4-dihydroxy-5-nitrobenzoic acid: c) 3,4-dihydroxy-5-nitrobenzoic acid ethyl ester with m.p. 106-107°C (from acetic ester/n-hexane), d) 3,4-dihydroxy-5-nitrobenzoic acid n-butyl ester with m.p. 73-74°C (from methylene chloride) and e) 3,4-dihydroxy-5-nitrobenzoic acid n-hexyl ester with m.p. 44-45°C (from isopropyl ether).
Eksempel 4 Example 4
a) Til 10,0 g 3,4-dimetoksy-5-nitrobenzaldehyd oppløst i 150 ml tetrahydrofuran dryppes ved -2 0°C i løpet av 15 min. 25 ml 2 M-fenyllitiumløsning (i benzen/eter (7:3)), og reaksjonsblandingen røres 1 time ved 0°C og 2 timer ved 20°C. Så blandes med 150 ml 2 N-svovelsyre og ekstraheres tre ganger med 150 ml eter. De samlede eterfaser vaskes med koksaltløsning, tørkes over natrium-sulf at og inndampes. Den således erholdte rest kromatograferes på 180 g kiselgel med metylenklorid. Man får 3,4-dimetoksy-5-nitrobenzohydrol som amorft faststoff. b) 2,5 g 3,4-dimetoksy-5-nitrobenzohydrol oppløst i 50 ml metylenklorid blandes med 2,2 g pyridiniumklorkromat, hvorpå man a) To 10.0 g of 3,4-dimethoxy-5-nitrobenzaldehyde dissolved in 150 ml of tetrahydrofuran is added dropwise at -20°C during 15 min. 25 ml of 2 M-phenyllithium solution (in benzene/ether (7:3)), and the reaction mixture is stirred for 1 hour at 0°C and 2 hours at 20°C. Then mix with 150 ml of 2 N sulfuric acid and extract three times with 150 ml of ether. The combined ether phases are washed with sodium chloride solution, dried over sodium sulphate and evaporated. The residue thus obtained is chromatographed on 180 g of silica gel with methylene chloride. 3,4-dimethoxy-5-nitrobenzohydrol is obtained as an amorphous solid. b) 2.5 g of 3,4-dimethoxy-5-nitrobenzohydrol dissolved in 50 ml of methylene chloride are mixed with 2.2 g of pyridinium chlorochromate, after which
rører 2 timer ved romtemperatur. Så frafiltreres de uløste bestanddeler. Filtratet inndampes og resten kromatograferes på 60 g kiselgel med metylenklorid. Derved får man etter krystallisering fra metylenklorid/heksan 3,4-dimetoksy-5-nitrobenzofenon med smp. 78-80°C. stir for 2 hours at room temperature. The undissolved components are then filtered off. The filtrate is evaporated and the residue is chromatographed on 60 g of silica gel with methylene chloride. This gives, after crystallization from methylene chloride/hexane, 3,4-dimethoxy-5-nitrobenzophenone with m.p. 78-80°C.
c) 0,5 g 3,4-dimetoksy-5-nitrobenzofenon røres i en blanding av 4 ml eddiksyre og 4 ml 48%-ig vandig hydrogenbromid i 30 timer c) 0.5 g of 3,4-dimethoxy-5-nitrobenzophenone is stirred in a mixture of 4 ml of acetic acid and 4 ml of 48% aqueous hydrogen bromide for 30 hours
ved 110°C. Så inndampes reaksjonsblandingen til tørrhet. Resten at 110°C. The reaction mixture is then evaporated to dryness. The rest
tas opp i metylenklorid. Det vaskes med vann, tørkes over natriumsulfat og inndampes. Etter omkrystallisering fra metylenklorid/heksan får man 3,4-dihydrksy-5-nitrobenzofenon med smp. 132°C. taken up in methylene chloride. It is washed with water, dried over sodium sulphate and evaporated. After recrystallization from methylene chloride/hexane, 3,4-dihydroxy-5-nitrobenzophenone is obtained with m.p. 132°C.
Eksempel 5 Example 5
a) Man oppslemmer 4,9 g (0,2 mol) magnesium i 15 ml absolutt etanol og oppvarmer etter tilsetning av 1 ml karbontetraklorid a) 4.9 g (0.2 mol) magnesium is suspended in 15 ml of absolute ethanol and heated after adding 1 ml of carbon tetrachloride
til reaksjonen oppstarter. Så tildryppes en løsing av 31,8 g (0,2 mol) malonsyredietylester i 19,9 ml absolutt etanol og 80 ml absolutt toluen under røring slik at temperaturen ligger mellom 50°C og 60°C. Deretter røres videre ved denne temperatur i 1 time, hvorpå reaksjonsblandingen avkjøles til -5°C, og en løsning av 49,3 g (0,2 mol) 3,4-dimetoksy-5-nitrobenzoylklorid (smp. 82-85°C) i 300 ml absolutt toluen og 50 ml absolutt tetrahydrofuran dryppes slik til at temperaturen ikke overstiger -5°C. Så røres videre natten over ved romtemperatur. Etter avdestillering av løsningsmidlet oppløses resten i 500 ml eddikester. Under røring og iskjøling blandes med en iskald løsning av 12 ml konsentrert svovelsyre i 80 ml vann. Den organiske fasen vaskes med koksalt-løsning, tørkes over magnesiumsulfat og inndampes. Den erholdte olje kromatograferes på den tidobbelte mengde kiselgel med metylenklorid. Det erholdte krystallinske materialet omkrystalliseres fra isopropyleter. Man får 3,4-dimetoksy-5-nitrobenzoyl-malonsyredietylester i form av lys beige krystaller med smp. 70°C. until the reaction starts. A solution of 31.8 g (0.2 mol) of malonic acid diethyl ester in 19.9 ml of absolute ethanol and 80 ml of absolute toluene is then added dropwise with stirring so that the temperature is between 50°C and 60°C. Stirring is then continued at this temperature for 1 hour, after which the reaction mixture is cooled to -5°C, and a solution of 49.3 g (0.2 mol) 3,4-dimethoxy-5-nitrobenzoyl chloride (m.p. 82-85°C ) in 300 ml of absolute toluene and 50 ml of absolute tetrahydrofuran are added dropwise so that the temperature does not exceed -5°C. Then stir further overnight at room temperature. After distilling off the solvent, the residue is dissolved in 500 ml of vinegar. While stirring and cooling with ice, mix with an ice-cold solution of 12 ml of concentrated sulfuric acid in 80 ml of water. The organic phase is washed with sodium chloride solution, dried over magnesium sulphate and evaporated. The oil obtained is chromatographed on a tenfold amount of silica gel with methylene chloride. The crystalline material obtained is recrystallized from isopropyl ether. 3,4-dimethoxy-5-nitrobenzoyl-malonic acid diethyl ester is obtained in the form of light beige crystals with m.p. 70°C.
b) Man oppløser 19,0 g (51,4 mmol) 3,4-dimetoksy-5-nitroben-zoylmalonsyredietylester i 100 ml iseddik, tilsetter 5 dråper b) Dissolve 19.0 g (51.4 mmol) of 3,4-dimethoxy-5-nitrobenzoylmalonic acid diethyl ester in 100 ml of glacial acetic acid, add 5 drops
konsentrert svovelsyre og oppvarmer i 16 timer under tilbakeløp. Eddiksyren avdestilleres i vannstrålevakuum ved 60°C, og resten blandes tre ganger med 250 ml toluen hver gang, hvorunder det stadig inndampes. Den krystallinske rest ekstraheres med eddikester. Den organiske fasen vaskes med vann, tørkes over magnesiumsulfat og inndampes. De erholdte krystaller kromatograferes på den 30-dobbelte mengde kiselgel med toluen. Det erholdte krystallinske materialet omkrystalliseres fra isopropyl- concentrated sulfuric acid and heat for 16 hours under reflux. The acetic acid is distilled off in a water jet vacuum at 60°C, and the residue is mixed three times with 250 ml of toluene each time, during which it is constantly evaporated. The crystalline residue is extracted with vinegar. The organic phase is washed with water, dried over magnesium sulphate and evaporated. The crystals obtained are chromatographed on the 30-fold amount of silica gel with toluene. The crystalline material obtained is recrystallized from isopropyl
eter. Man får 3',4'-dimetoksy-5'-nitroacetofenon i form av gulaktige krystaller med smp. 86-87°C. ether. 3',4'-dimethoxy-5'-nitroacetophenone is obtained in the form of yellowish crystals with m.p. 86-87°C.
c) Man blander 2 g (8,9 mmol) 3',4'-dimetoksy-5'-nitroacetofe-non med 3 0 ml konstantkokende hydrogenbromid og rører i 2,5 timer c) 2 g (8.9 mmol) of 3',4'-dimethoxy-5'-nitroacetophenone are mixed with 30 ml of constant boiling hydrogen bromide and stirred for 2.5 hours
ved 140°C. Etter avkjølingen helles på 200 ml isvann og ekstraheres tre ganger med 100 ml eddikester hver gang. Den organiske fasen vaskes to ganger med 25 ml koksaltløsning hver gang, tørkes over natriumsulfat og inndampes. Det oppnådde produkt filtreres med eddikester over den 2 0-dobbelte mengde kiselgel. Etter omkrystallisering av det oppnådde materialet fra vann får man 3',4'-dihydroksy-5'-nitroacetofenon i form av gulaktige krystaller med smp. 159-160°C. at 140°C. After cooling, pour on 200 ml of ice water and extract three times with 100 ml of vinegar each time. The organic phase is washed twice with 25 ml sodium chloride solution each time, dried over sodium sulphate and evaporated. The product obtained is filtered with acetic acid over the 20-fold amount of silica gel. After recrystallization of the obtained material from water, 3',4'-dihydroxy-5'-nitroacetophenone is obtained in the form of yellowish crystals with m.p. 159-160°C.
Den samme forbindelse får man ut fra 4'-hydroksky-3'-metoksy-5'-nitroacetofenon ved behandling med hydrogenbromid ved kokepunktet. The same compound is obtained from 4'-hydroxy-3'-methoxy-5'-nitroacetophenone by treatment with hydrogen bromide at the boiling point.
Eksempel 6 Example 6
a) Man oppløser 100 g (0,8 mol) Guajacol i 136,4 g (0,86 mol) isosmørsyreanhydrid, blander med 120 g (0, 88 mol) vannfritt a) 100 g (0.8 mol) Guajacol is dissolved in 136.4 g (0.86 mol) isobutyric anhydride, mixed with 120 g (0.88 mol) anhydrous
sinkklorid (hvorunder alt går i løsning), oppvarmer reaksjonsblandingen til 155°C og avkjøler etter tre minutter. Resten underkastes først en vanndampdestillasjon for å fjerne de lett flyktige andeler, og ekstraheres så tre ganger med 500 ml eter hver gang. Den organiske fasen vaskes to ganger med 250 ml vann hver gang, én gang med 150 ml mettet bikarbonatløsning og igjen med 250 ml vann, tørkes over natriumsulfat og inndampes i vannstrålevakuum. Den oppnådde brune harpiks destilleres i høyvakuum. Destillatet med kokepnkt 105-120°C (6,67 Pa) oppløses i eter, hvorpå man blander med n-heksan til krystallisasjonen begynner. De oppnådde krystaller omkrystalliseres fra eter/heksan. Man får 4'-hydroksy-3'-metoksy-2-metylpropiofenon i form av fargeløse krystaller med smp. 86-87°C. zinc chloride (during which everything goes into solution), heat the reaction mixture to 155°C and cool after three minutes. The residue is first subjected to steam distillation to remove the easily volatile components, and then extracted three times with 500 ml of ether each time. The organic phase is washed twice with 250 ml of water each time, once with 150 ml of saturated bicarbonate solution and again with 250 ml of water, dried over sodium sulphate and evaporated in a water jet vacuum. The obtained brown resin is distilled in high vacuum. The distillate with a boiling point of 105-120°C (6.67 Pa) is dissolved in ether, after which it is mixed with n-hexane until crystallization begins. The crystals obtained are recrystallized from ether/hexane. 4'-Hydroxy-3'-methoxy-2-methylpropiophenone is obtained in the form of colorless crystals with m.p. 86-87°C.
b) Man oppløser 15,0 g (77,2 mmol) 4'-hydroksy-3'-metoksy-2-metyl-propiofenon i 300 ml iseddik og tildrypper under røring i b) 15.0 g (77.2 mmol) of 4'-hydroxy-3'-methoxy-2-methyl-propiophenone are dissolved in 300 ml of glacial acetic acid and added dropwise while stirring in
løpet av 15 min. 7,65 ml 50,5 % salpetersyre (11,2 N) i 40 ml iseddik. Etter 15 min. helles reaksjonsblandingen på isvann, og within 15 min. 7.65 ml of 50.5% nitric acid (11.2 N) in 40 ml of glacial acetic acid. After 15 min. the reaction mixture is poured onto ice water, and
de utfelte krystaller frafiltreres, vaskes med vann og oppløses i metylenklorid. Løsningen tørkes over natriumsulfat og inndampes. Det erholdte råprodukt opptas i metylenklorid og filtreres gjennom 100 g kiselgel. De således oppnådde krystaller omkrystalliseres fra metylenklorid/n-heksan. Man får 4'-hydroksy-3'-metoksy-2-metyl-5'-nitropropiofenon i form av gule krystaller med smp. 85-87°C. the precipitated crystals are filtered off, washed with water and dissolved in methylene chloride. The solution is dried over sodium sulfate and evaporated. The crude product obtained is taken up in methylene chloride and filtered through 100 g of silica gel. The crystals thus obtained are recrystallized from methylene chloride/n-hexane. 4'-hydroxy-3'-methoxy-2-methyl-5'-nitropropiophenone is obtained in the form of yellow crystals with m.p. 85-87°C.
c) Man blander 8,0 g (33,4 mmol) 4'-hydroksy-3'-metoksy-2-metyl-5'-nitropropiofenon med 64 g pyridinhydroklorid og rører i 45 min. ved 180°C. Etter avkjøling helles reaksjonsblandingen på 500 ml isvann, hvorpå man surgjør med 20 ml 3N-saltsyre og ekstraherer med metylenklorid. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes i vannstrålevakuum. Etter omrkystallisering fra metylenklorid/n-heksan får man 3',4'-dihydroksy-2-metyl-5'-nitropropiofenon i form av gule krystaller med smp. 98-99°C. c) 8.0 g (33.4 mmol) of 4'-hydroxy-3'-methoxy-2-methyl-5'-nitropropiophenone are mixed with 64 g of pyridine hydrochloride and stirred for 45 min. at 180°C. After cooling, the reaction mixture is poured into 500 ml of ice water, after which it is acidified with 20 ml of 3N hydrochloric acid and extracted with methylene chloride. The organic phase is washed with water, dried over sodium sulphate and evaporated in a water jet vacuum. After recrystallization from methylene chloride/n-hexane, 3',4'-dihydroxy-2-methyl-5'-nitropropiophenone is obtained in the form of yellow crystals with m.p. 98-99°C.
Eksempel 7 Example 7
a) Man oppløser 100 g (805,5 mmol) Guajacol i 136,4 g (86,2 mmol) smørsyreanhydrid, blander med 120 g (880 mmol) sinkklorid, oppvarmer som angitt i eksempel 6.a i 3 min. og opparbeider så som beskrevet deri. Råproduktet man får etter høyvakuumdestilla-sjon kromatograferes med toluen på 600 g kiselgel. Etter omkrystallisering fra eter/n-heksan får man 4'-hydroksy-3'-metoksybutyrofenon i form av fargeløse krystaller med smp. 40-41°C. b) Til en løsning av 12,7 g (65,4 mmol) 4'-hydroksy-3'-metoksy-butyrofenon i 250 ml iseddik dryppes under røring i løpet av 10 min. 6,5 ml 11,2 N salpetersyre. Man rører så i 15 min., heller reaksjonsblandingen på isvann, frafiltrerer den utfelte felling, vasker denne med isvann og opptar i metylenklorid. Metylenkloridløsningen filtreres så gjennom 50 g kiselgel. Det erholdte materialet omkrystalliseres fra metylenklorid/n-heksan. Man får 4'-hydroksy-3'-metoksy-5'-nitrobutyrofenon i form av gule krystaller med smp. 92-93°C. c) Man blander 10,2 g (42,6 mmol) 4'-hydroksy-3'-metoksy-5'-nitrobutyrofenon med 80 g pyridinhydroklorid og rører i 40 min. a) 100 g (805.5 mmol) Guajacol is dissolved in 136.4 g (86.2 mmol) butyric anhydride, mixed with 120 g (880 mmol) zinc chloride, heated as indicated in example 6.a for 3 min. and then processes as described therein. The crude product obtained after high vacuum distillation is chromatographed with toluene on 600 g of silica gel. After recrystallization from ether/n-hexane, 4'-hydroxy-3'-methoxybutyrophenone is obtained in the form of colorless crystals with m.p. 40-41°C. b) To a solution of 12.7 g (65.4 mmol) 4'-hydroxy-3'-methoxy-butyrophenone in 250 ml glacial acetic acid is added dropwise with stirring over the course of 10 min. 6.5 ml of 11.2 N nitric acid. The mixture is then stirred for 15 min., the reaction mixture is poured onto ice water, the precipitate that has formed is filtered off, this is washed with ice water and taken up in methylene chloride. The methylene chloride solution is then filtered through 50 g of silica gel. The material obtained is recrystallized from methylene chloride/n-hexane. 4'-hydroxy-3'-methoxy-5'-nitrobutyrophenone is obtained in the form of yellow crystals with m.p. 92-93°C. c) 10.2 g (42.6 mmol) of 4'-hydroxy-3'-methoxy-5'-nitrobutyrophenone are mixed with 80 g of pyridine hydrochloride and stirred for 40 min.
ved 200°C. Etter avkjøling helles reaksjonsblandingen på 500 ml isvann. Man blander med 3 0 ml 3 N saltsyre og ekstraherer med metylenklorid. Den organiske fasen tørkes over natriumsulfat og inndampes. Det erholdte råprodukt kromatograferes med metylenklorid på 150 g kiselgel. Det erholdte materialet omkrystalliseres fra metylenklorid/n-heksan. Man får 3',4'-dihydroksy-5'-nitrobutyrofenon i form av gule krystaller med smp. 88-90°C. at 200°C. After cooling, the reaction mixture is poured into 500 ml of ice water. It is mixed with 30 ml of 3 N hydrochloric acid and extracted with methylene chloride. The organic phase is dried over sodium sulfate and evaporated. The crude product obtained is chromatographed with methylene chloride on 150 g of silica gel. The material obtained is recrystallized from methylene chloride/n-hexane. 3',4'-dihydroxy-5'-nitrobutyrophenone is obtained in the form of yellow crystals with m.p. 88-90°C.
Eksempel 8 Example 8
a) Man oppløser 2,25 g (10 mmol) 3,4-dihydroksy-5-nitrokanel-syre i 50 ml metanol og innleder saltsyregass i denne løsningen i 10 min.. Etter 1 time tilsettes 50 ml isopropyleter og den utfelte felling frafiltreres og vaskes med isopropyleter. Etter omkrystallisering fra metanol/eter får man 3,4-dihydroksy-5-nitrokanelsyremetylester i form av gule krystaller med smp. 186-187°C. b) På analog måte får man ut fra 3,4-dihydroksy-5-nitrokanel-syre og butanolisk saltsyreløsning 3,4-dihydroksy-5-nitrokanel-syre-n-butylesteren i form av gule krystaller med smp. 129-130°C. a) 2.25 g (10 mmol) of 3,4-dihydroxy-5-nitrocinnamic acid are dissolved in 50 ml of methanol and hydrochloric acid gas is introduced into this solution for 10 min. After 1 hour, 50 ml of isopropyl ether is added and the precipitate that has formed is filtered off and washed with isopropyl ether. After recrystallization from methanol/ether, 3,4-dihydroxy-5-nitrocinnamic acid methyl ester is obtained in the form of yellow crystals with m.p. 186-187°C. b) In an analogous manner, from 3,4-dihydroxy-5-nitrocinnamic acid and butanol hydrochloric acid solution, the 3,4-dihydroxy-5-nitrocinnamic acid n-butyl ester is obtained in the form of yellow crystals with m.p. 129-130°C.
Eksempel 9 Example 9
Man oppløser 5,0 g (13,5 mmol) 3,4-dimetoksy-5-nitrobenzoyl-malonsyredietylester i 50 ml absolutt metylenklorid. Etter avkjøling til -20°C tildryppes under røring en løsning av 16,9 g (67,5 mmol) bortribromid i 30 ml metylenklorid slik at temperaturen ikke overstiger -2 0°C. Deretter røres natten over ved romtemperatur. Etter tilsening av 80 ml etanol røres i 30 min. ved romtemperatur, og deretter avdestilleres løsningsmidlet i vannstrålevakuum. Resten blandes med vann og ekstraheres med metylenklorid. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Det erholdte råprodukt filtreres over 50 g kiselgel med eddikester. Den erholdte krystallinske rest omkrystalliseres fra metylenklorid/n-heksan. Man får 3,4-dihydroksy-5-nitro-benzoyleddiksyreetylester i form av gule krystaller med smp. 141-142°C. 5.0 g (13.5 mmol) of 3,4-dimethoxy-5-nitrobenzoyl-malonic acid diethyl ester are dissolved in 50 ml of absolute methylene chloride. After cooling to -20°C, a solution of 16.9 g (67.5 mmol) of boron tribromide in 30 ml of methylene chloride is added dropwise while stirring so that the temperature does not exceed -2 0°C. Then stir overnight at room temperature. After adding 80 ml of ethanol, stir for 30 min. at room temperature, and then the solvent is distilled off in a water jet vacuum. The residue is mixed with water and extracted with methylene chloride. The organic phase is washed with water, dried over sodium sulphate and evaporated. The crude product obtained is filtered over 50 g of silica gel with vinegar. The crystalline residue obtained is recrystallized from methylene chloride/n-hexane. 3,4-dihydroxy-5-nitro-benzoylacetic acid ethyl ester is obtained in the form of yellow crystals with m.p. 141-142°C.
Eksempel 10 Example 10
a) En løsning av 1,49 g (12,3 mmol) 2-fenyletylamin i 100 ml metylenklorid blandes med 1,26 g trietylamin. Under røring a) A solution of 1.49 g (12.3 mmol) of 2-phenylethylamine in 100 ml of methylene chloride is mixed with 1.26 g of triethylamine. Under stirring
tildryppes en løsning av 3,0 g 3,4-dimetoksy-5-nitrobenzoylklorid i 100 ml metylenklorid, hvoretter man rører videre i 15 min.. Den organiske fasen ekstraheres så to ganger med 50 ml isvann hver gang, tørkes over natriumsulfat og inndampes i vannstrålevakuum. Etter omkrystallisering fra metylenklorid/n-heksan får man 3,4-dimetoksy-5-nitro-N-fenetylbenzamid i form av lys beige nåler med smp. 121-122°C. a solution of 3.0 g of 3,4-dimethoxy-5-nitrobenzoyl chloride in 100 ml of methylene chloride is added dropwise, after which the mixture is stirred for 15 min. The organic phase is then extracted twice with 50 ml of ice water each time, dried over sodium sulfate and evaporated in water jet vacuum. After recrystallization from methylene chloride/n-hexane, 3,4-dimethoxy-5-nitro-N-phenethylbenzamide is obtained in the form of light beige needles with m.p. 121-122°C.
b) 3,6 g (10,9 mmol) 3,4-dimetoksy-5-nitro-N-fenetylbenzamid oppvarmes med 36 ml fosforoksyklorid i en nitrogenatmosfære i 96 timer under tilbakeløp. Etter avdestillering av overskudd fosforoksyklorid i vannstrålevakuum ved 60°C blandes tre ganger med 100 ml toluen hver gang, hvorunder løsningsmidlet stadig avdestilleres. Resten opptas i metylenklorid. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes i vannstrålevakuum. Den erholdte røde harpiks kromatograferes med metylenklorid/eddikester (1:1) på 120 g kiselgel. Man får 1-(3,4-dimetoksy-5-nitrofenyl)-3,4-dihydroisokinolin i form av en gul harpiks. b) 3.6 g (10.9 mmol) of 3,4-dimethoxy-5-nitro-N-phenethylbenzamide are heated with 36 ml of phosphorus oxychloride in a nitrogen atmosphere for 96 hours under reflux. After distillation of excess phosphorus oxychloride in a water jet vacuum at 60°C, it is mixed three times with 100 ml of toluene each time, during which the solvent is constantly distilled off. The remainder is taken up in methylene chloride. The organic phase is washed with water, dried over sodium sulphate and evaporated in a water jet vacuum. The red resin obtained is chromatographed with methylene chloride/acetic ester (1:1) on 120 g of silica gel. 1-(3,4-dimethoxy-5-nitrophenyl)-3,4-dihydroisoquinoline is obtained in the form of a yellow resin.
c) Man blander 1,4 g (4,5 mmol) 1-(3,4-dimetoksy-5-nitrofenyl)-3,4-dihydroisokinolin med 15 ml konstantkokende hydrogenbromid og c) 1.4 g (4.5 mmol) of 1-(3,4-dimethoxy-5-nitrophenyl)-3,4-dihydroisoquinoline are mixed with 15 ml of constantly boiling hydrogen bromide and
oppvarmer under nitrogenatmosfære i 1,5 timer under tilbakeløp ved koking. Etter avdestillering av hydrogenbromidet i vannstrålevakuum omkrystalliseres den krystallinske resten fra aceton. Man får 5-(3,4-dihydro-l-isokinolinyl)-3-nitropyrokate-kol hydrobromid i form av gule krystaller med smp. >250°C (spaltning). heat under nitrogen atmosphere for 1.5 hours under reflux at boiling. After distilling off the hydrogen bromide in a water jet vacuum, the crystalline residue is recrystallized from acetone. 5-(3,4-dihydro-1-isoquinolinyl)-3-nitropyrocatecol hydrobromide is obtained in the form of yellow crystals with m.p. >250°C (decomposition).
Eksempel 11 Example 11
a) Man blander 5,0 g (27,7 mmol) 4-hydroksy-5-metoksy-isoftal-aldehyd med 50 ml konstantkokende hydrogenbromid og oppvarmer a) Mix 5.0 g (27.7 mmol) of 4-hydroxy-5-methoxy-isophthalaldehyde with 50 ml of constantly boiling hydrogen bromide and heat
under argonatmosfære i 3 timer ved tilbakeløp og røring ved kokepunktet. Etter avkjøling tilsettes 50 ml isvann, og den under an argon atmosphere for 3 hours at reflux and stirring at the boiling point. After cooling, 50 ml of ice water is added, and the
utfelte felling filtreres fra og vaskes med vann. Råproduktet opptas i eddikester og filtreres gjennom 50 g aluminiumoksyd (aktivitetstrinn II). Det erholdte krystallinske materialet omkrystalliseres fra eddikester/n-heksan. Man får 4,5-dihydrok-syisoftalaldehyd i form av svakt orangefargede krystaller med smp. 201-202°C. precipitate is filtered off and washed with water. The crude product is taken up in vinegar and filtered through 50 g of aluminum oxide (activity stage II). The crystalline material obtained is recrystallized from ethyl acetate/n-hexane. 4,5-Dihydroxy-sisophthalaldehyde is obtained in the form of slightly orange-coloured crystals with m.p. 201-202°C.
b) Til en løsning av 2,0 g (12,0 mmol) 4,5-dihydroksyisoftalal-dehyd i 20 ml vann dryppes under røring ved 30°C en løsning av b) To a solution of 2.0 g (12.0 mmol) 4,5-dihydroxyisophtalaldehyde in 20 ml of water, while stirring at 30°C, add drop by drop a solution of
3,27 g (28,9 mmol) hydroksylamin-O-sulfonsyre i 12 ml vann, hvorpå man holder temperaturen på 65°C i 10 timer. Etter avkjøling frafiltreres den utfelte felling, vaskes med vann og opptas i eddikester. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes i vannstrålevakuum. Etter omkrystallisering fra eddikester får man 4,5-dihydroksyisoftalo-nitril i form av gule krystaller som spaltes over 300°C. 3.27 g (28.9 mmol) of hydroxylamine-O-sulfonic acid in 12 ml of water, after which the temperature is maintained at 65°C for 10 hours. After cooling, the precipitate is filtered off, washed with water and taken up in vinegar. The organic phase is washed with water, dried over sodium sulphate and evaporated in a water jet vacuum. After recrystallization from acetic ester, 4,5-dihydroxyisophthalonitrile is obtained in the form of yellow crystals which decompose above 300°C.
Eksempel 12 Example 12
a) Til en løsning av 112,5 g 2-brom-4'-hydroksy-3'-metoksyace-tofenon i 560 ml iseddik drypper man under røring i løpet av 30 min. ved 20-25°C en løsning av 38 g rykende salpetersyre (96%) i 50 ml iseddik. Derved utskilles gulbrune krystaller. Etter 90 min. helles reaksjonsblandingen på 3 00 g is. Krystallene filtreres fra, vaskes med 1000 ml vann og oppløses i 1000 ml metylenklorid. Man vasker den organiske fasen med mettet koksaltløsning, tørker over natriumsulfat, filtrerer og inndamper filtratet ved 50°C i vannstrålevakuum til begynnende krystal-liser ing. Krystallisatet som er avkjølt til romtemperatur frafiltreres og vaskes med litt metylenklorid. Man får 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon med smp. 147-149°C. a) A solution of 112.5 g of 2-bromo-4'-hydroxy-3'-methoxyacetophenone in 560 ml of glacial acetic acid is added dropwise with stirring over the course of 30 min. at 20-25°C a solution of 38 g of fuming nitric acid (96%) in 50 ml of glacial acetic acid. Thereby, yellow-brown crystals are secreted. After 90 min. the reaction mixture is poured onto 300 g of ice. The crystals are filtered off, washed with 1000 ml of water and dissolved in 1000 ml of methylene chloride. The organic phase is washed with saturated sodium chloride solution, dried over sodium sulphate, filtered and the filtrate evaporated at 50°C in a water jet vacuum until crystallization begins. The crystallisate, which has cooled to room temperature, is filtered off and washed with a little methylene chloride. 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone is obtained with m.p. 147-149°C.
b) Metode A: b) Method A:
ba) Man blander en suspensjon av 580,1 mg 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon i 10 ml etanol med 443,8 mg selendioksyd og oppvarmer i 71 timer under tilbakeløp. Deretter filtreres reaksjonsblandingen fra selenet og inndampes. Man oppløser ba) A suspension of 580.1 mg of 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone in 10 ml of ethanol is mixed with 443.8 mg of selenium dioxide and heated for 71 hours under reflux. The reaction mixture is then filtered from the selenium and evaporated. One dissolves
resten i metylenklorid, vasker med mettet natriumkloridløsning, the residue in methylene chloride, washing with saturated sodium chloride solution,
tørker over natriumsulfat, filtrerer og inndamper. Man får 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyreetylester med smp. 165-167°C (fra etanol). dried over sodium sulfate, filtered and evaporated. 4-Hydroxy-3-methoxy-5-nitrophenylglyoxylic acid ethyl ester with m.p. 165-167°C (from ethanol).
På analog måte får man: Analogously, you get:
bb) Fra 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og n-butanol 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre-n-butyles-ter med smp. 105-107°C (fra etanol) og bb) From 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and n-butanol 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid n-butyl ester with m.p. 105-107°C (from ethanol) and
bc) fra 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og n-heksanol 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyreheksylester med smp. 103-105°C (fra n-heksanol/petroleumseter). bc) from 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and n-hexanol 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid hexyl ester with m.p. 103-105°C (from n-hexanol/petroleum ether).
c) Metode B: c) Method B:
ca) Man blander en suspensjon av 29,01 g 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon i 300 ml tert. butanol med 27,74 g selendioksyd og oppvarmer i 18 timer under tilbakeløp ved kokepunktet. Den varme reaksjonsblandingen filtreres under ettervasking med metylenklorid gjennom en filterhjelp av diatoméjord. Man inndamper filtratet og oppslemmer resten i 150 ml varmt metylenklorid. Den krystallinske felling filtreres fra og vaskes med litt metylenklorid. Man får 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre med smp. 169-171°C. ca) A suspension of 29.01 g of 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone is mixed in 300 ml of tert. butanol with 27.74 g of selenium dioxide and heating for 18 hours under reflux at the boiling point. The hot reaction mixture is filtered while washing with methylene chloride through a filter aid of diatomaceous earth. The filtrate is evaporated and the residue is suspended in 150 ml of hot methylene chloride. The crystalline precipitate is filtered off and washed with a little methylene chloride. 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid is obtained with m.p. 169-171°C.
Man oppløser 2,42 g 4-hydroksy-3-metoksy-5-nitrofenylglyok-sylsyre i 25 ml tørt N,N-dimetylformamid, blander ved romtemperatur med 50 mg 4-dimetylaminopyridin og 920 mg tørr metanol, avkjøles så med et isbad til 0°C og tilsetter 2,27 g N,N-dicyklo-heksylkarbodiimid. Etter 10 min. fjernes isbadet, og reaksjonsblandingen røres igjen 1 time ved romtemperatur. Deretter inndampes. Resten oppløses i eddikester, hvorpå man frafiltrerer uoppløst urea, vasker filtratet 4 ganger med vann, tørker over natriumsulfat, filtrerer og inndamper. Man får 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyremetylester med smp. 155-157°C (fra metylenklorid/eter). 2.42 g of 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid are dissolved in 25 ml of dry N,N-dimethylformamide, mixed at room temperature with 50 mg of 4-dimethylaminopyridine and 920 mg of dry methanol, then cooled in an ice bath for 0°C and adds 2.27 g of N,N-dicyclohexylcarbodiimide. After 10 min. the ice bath is removed, and the reaction mixture is stirred again for 1 hour at room temperature. Then evaporate. The residue is dissolved in acetic acid, after which undissolved urea is filtered off, the filtrate is washed 4 times with water, dried over sodium sulphate, filtered and evaporated. 4-Hydroxy-3-methoxy-5-nitrophenylglyoxylic acid methyl ester is obtained with m.p. 155-157°C (from methylene chloride/ether).
På analog måte får man: Analogously, you get:
cb) Fra 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre og etanol 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyreetylester med smp. 165-167°C (fra etaol) og cb) From 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid and ethanol 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid ethyl ester with m.p. 165-167°C (from ethanol) and
cc) fra 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre og isopropanol 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre-i-propylester med smp. 99-101°C (fra isopropanol). cc) from 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid and isopropanol 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid i-propyl ester with m.p. 99-101°C (from isopropanol).
d) Man blander en suspensjon av 17,2 g 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyreetylester i 100 ml torr acetonitril og d) A suspension of 17.2 g of 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid ethyl ester is mixed in 100 ml of dry acetonitrile and
100 ml tørr toluen med 10,53 g natriumjodid og 11,9 g silisium-tetraklorid og oppvarmer i 4 7 timer under tilbakeløp. Så inndamper man reaksjonsblandingen og destillerer resten 6 ganger med 2 00 ml toluen hver gang. Man fordeler den oppnådde rest mellom vann og eter og filtrerer gjennom en filtreringshjelp av diatoméjord. Man vasker eterfasen 4 ganger med mettet koksalt-løsning, tørker natriumsulfat, filtrerer og inndamper. Den oljeaktige resten behandles 3 ganger med eter og aktivt karbon. Man får 3,4-dihydroksy-5-nitrofenylglyoksylsyreetylester med smp. 77-79°C (fra eter/n heksan). 100 ml of dry toluene with 10.53 g of sodium iodide and 11.9 g of silicon tetrachloride and heat for 4 7 hours under reflux. The reaction mixture is then evaporated and the residue is distilled 6 times with 200 ml of toluene each time. The resulting residue is divided between water and ether and filtered through a filter aid of diatomaceous earth. The ether phase is washed 4 times with saturated sodium chloride solution, dried with sodium sulphate, filtered and evaporated. The oily residue is treated 3 times with ether and activated carbon. This gives 3,4-dihydroxy-5-nitrophenylglyoxylic acid ethyl ester with m.p. 77-79°C (from ether/n hexane).
På analog måte får man: Analogously, you get:
e) Fra 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyremetylester 3,4-dihydroksy-5-nitrofenylglyoksylsyremetylester som gult e) From 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid methyl ester 3,4-dihydroxy-5-nitrophenylglyoxylic acid methyl ester as yellow
destillat ved 145-150°C og 10,67 Pa, distillate at 145-150°C and 10.67 Pa,
f) fra 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyreisopropyl-ester 3,4-dihydroksy-5-nitrofenylglyoksylsyreisopropylester som f) from 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid isopropyl ester 3,4-dihydroxy-5-nitrophenylglyoxylic acid isopropyl ester which
gult destillat ved 155-160°C og 12,0 Pa, yellow distillate at 155-160°C and 12.0 Pa,
g) fra 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre-n-butyles-ter 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-butylester som gult g) from 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid n-butyl ester 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-butyl ester as yellow
destillat ved 160-165°C og 10,67 Pa og distillate at 160-165°C and 10.67 Pa and
h) fra 4-hydroksy-3-metoksy-5-nitrofenylglyoksylsyre-n-heksyl-ester 3,4-dihydroksy-5-nitrofenylglyoksylsyreheksylester som gult h) from 4-hydroxy-3-methoxy-5-nitrophenylglyoxylic acid n-hexyl ester 3,4-dihydroxy-5-nitrophenylglyoxylic acid hexyl ester as yellow
destillat ved 165-170°C og 12,0 Pa. distillate at 165-170°C and 12.0 Pa.
Eksempel 13 Example 13
Man oppløser 236,1 mg 3,4-dihydroksy-nitrofenylglyoksyl-syre-n-heksylester i 15 ml etanol og blander med 7,59 ml 0,1 N-natriumhydroksydløsning. Etter 1 time inndampes den rødgule løsning. Det erholdte natriumsalt av 3,4-dihydroksy-5-nitrofe-nylglyoksylsyre-n-heksylester krystalliseres fra vann og har et smp. på ~ 3 00°C. 236.1 mg of 3,4-dihydroxy-nitrophenylglyoxylic acid n-hexyl ester is dissolved in 15 ml of ethanol and mixed with 7.59 ml of 0.1 N sodium hydroxide solution. After 1 hour, the reddish-yellow solution is evaporated. The obtained sodium salt of 3,4-dihydroxy-5-nitro-nylglyoxylic acid-n-hexyl ester is crystallized from water and has a m.p. at ~ 300°C.
Eksempel 14 Example 14
En løsning av 3,18 g 3,4-dihydroksy-5-nitrofenylglyoksyl-syre-n-heksylester i 47,5 ml etanol blandes med 1,11 g 0-metyl-hydroksylamin-hydroklorid, 1,95 g natriumacetat og 2,5 ml vann og oppvarmes 5 timer under tilbakeløp ved koking. Etterpå inndampes reaksjonsblandingen og resten blandes med eter og vann. Den organiske fasen vaskes med mettet natriumkloridløsning, tørkes over natriumsulfat, filtreres og inndampes. Resten kromatograferes på kiselgel med metylenklorid. Man får en 7:3-blanding av E-og Z-3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester 0-metyloksim som en rødlig olje; 80 MHz-NMR-spektrum (CDC13): Signal for 0-metyl ved 3,96 og 4,05 ppm. A solution of 3.18 g of 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester in 47.5 ml of ethanol is mixed with 1.11 g of 0-methyl-hydroxylamine hydrochloride, 1.95 g of sodium acetate and 2, 5 ml of water and heated for 5 hours under reflux by boiling. The reaction mixture is then evaporated and the residue is mixed with ether and water. The organic phase is washed with saturated sodium chloride solution, dried over sodium sulphate, filtered and evaporated. The residue is chromatographed on silica gel with methylene chloride. A 7:3 mixture of E- and Z-3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester 0-methyloxime is obtained as a reddish oil; 80 MHz NMR spectrum (CDC 13 ): Signal for O-methyl at 3.96 and 4.05 ppm.
Eksempel 15 Example 15
Man blander en oppløsning av 5,1 g 3,4-dihydroksy-5-nitrofe-nylglyoksylsyreetylester i tørr metylenklorid ved -10°C i løpet av 15 min. dråpevis med 2 5 g bortribromid. Man rører så 1 time ved -10°C og deretter 17 timer ved romtemperatur. Så inndamper man reaksjonsblandingen, blander resten forsiktig med vann og rører ytterligere 30 min. ved 50°C. Etter avkjøling til romtemperatur frafiltrerer man den fnokkede felling. Man surgjør den vandige fase med 10 ml lN-saltsyre, ekstraherer 4 ganger med eter, vasker de samlede organiske ekstrakter 4 ganger med mettet natriumkloridløsning, tørker over natriumsulfat, filtrerer og inndamper. Råproduktet filtreres 3 ganger etter hverandre i eter gjennom et filterhjelpemiddel av diatoméjord. Man får 3,4-dihydroksy-5-nitrofenylglyoksylsyre med smp. 172-174°C (fra isopropyleter). A solution of 5.1 g of 3,4-dihydroxy-5-nitro-nylglyoxylic acid ethyl ester is mixed in dry methylene chloride at -10°C over the course of 15 minutes. dropwise with 2 5 g of boron tribromide. The mixture is then stirred for 1 hour at -10°C and then for 17 hours at room temperature. The reaction mixture is then evaporated, the residue is carefully mixed with water and stirred for a further 30 min. at 50°C. After cooling to room temperature, the fuzzed precipitate is filtered off. The aqueous phase is acidified with 10 ml of 1N hydrochloric acid, extracted 4 times with ether, the combined organic extracts are washed 4 times with saturated sodium chloride solution, dried over sodium sulfate, filtered and evaporated. The crude product is filtered 3 times in succession in ether through a filter aid of diatomaceous earth. This gives 3,4-dihydroxy-5-nitrophenylglyoxylic acid with m.p. 172-174°C (from isopropyl ether).
Eksempel 16 Example 16
a) En blanding av 3,93 g 3,4-dihydroksy-5-nitrofenylglyoksyl-syre-n-heksylester og 1,38 g 2-aminofenol bringes til smelting a) A mixture of 3.93 g of 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and 1.38 g of 2-aminophenol is brought to melting
under røring ved 120°C. Smeiten krystalliserer etter 5 min.. Etter 2 timer avkjøles og omkrystalliseres fra metanol. Man får 3-(3,4-dihydroksy-5-nitrofenyl)-2H-1,4-benzoksazin-2-on med smp. 202-204°C. with stirring at 120°C. The melt crystallizes after 5 min. After 2 hours, cool and recrystallize from methanol. This gives 3-(3,4-dihydroxy-5-nitrophenyl)-2H-1,4-benzoxazin-2-one with m.p. 202-204°C.
På analog måte får man: Analogously, you get:
b) Fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 2-amino-p-kresol 3-(3,4-dihydroksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksazin-2-on med smp. 233-235°C (fra metanol/metylenklorid). c) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 2- amino-4-propylfenol 3-(3,4-dihydroksy-5-nitrofenyl)-6-propyl-2H-1,4-benzoksazin-2-on med smp. 200-202°C (fra metanol), d) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 3- amino-4-hydroksybenzosyre 3-(3,4-dihydroksy-5-nitrofenyl)-2-okso-2H-l,4-benzoksazin-6-karbonsyre med smp. 286-287°C (fra aceton/petroleumseter), e) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 2-amino-4-klorfenol 6-klor-3-(3,4-dihydroksy-5-nitrofenyl)-2H-1,4-benzoksazin-2-on med smp. 241-243°C (fra metanol), f) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 2-amino-4,6-diklorfenol 6,8-diklor-3-(3,4-dihydroksy-5-nitrofe-nyl)-2H-1,4-benzoksazin-2-on med smp. 237-239°C (fra etanol/eter) og g) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 2-amino-5-nitrofenol 3-(3,4-dihydroksy-5-nitrofenyl)-7-nitro-2H-1,4-benzoksazin-2-on med smp. 253-255°C (fra acetonitril/etanol). b) From 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 2-amino-p-cresol 3-(3,4-dihydroxy-5-nitrophenyl)-6-methyl-2H-1,4-benzoxazine- 2-on with m.p. 233-235°C (from methanol/methylene chloride). c) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and 2-amino-4-propylphenol 3-(3,4-dihydroxy-5-nitrophenyl)-6-propyl-2H-1,4-benzoxazine- 2-on with m.p. 200-202°C (from methanol), d) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 3-amino-4-hydroxybenzoic acid 3-(3,4-dihydroxy-5-nitrophenyl)-2- oxo-2H-1,4-benzoxazine-6-carboxylic acid with m.p. 286-287°C (from acetone/petroleum ether), e) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 2-amino-4-chlorophenol 6-chloro-3-(3,4-dihydroxy-5 -nitrophenyl)-2H-1,4-benzoxazin-2-one with m.p. 241-243°C (from methanol), f) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 2-amino-4,6-dichlorophenol 6,8-dichloro-3-(3,4-dihydroxy -5-nitropho-nyl)-2H-1,4-benzoxazin-2-one with m.p. 237-239°C (from ethanol/ether) and g) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 2-amino-5-nitrophenol 3-(3,4-dihydroxy-5-nitrophenyl)- 7-nitro-2H-1,4-benzoxazin-2-one with m.p. 253-255°C (from acetonitrile/ethanol).
Eksempel 17 Example 17
a) Man oppvarmer en blanding av 396,0 mg 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 137,6 mg 1,2-fenylendiamin i 60 min. ved 120°C. Deretter oppslemmer man i metanol, frafiltrerer og omkrystalliserer fra N,N-dimetylformamid/vann. Man får 3-(3,4-dihydroksy-5-nitrofenyl)-2(1H)-kinoksalinon med smp. >300°C. a) A mixture of 396.0 mg of 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and 137.6 mg of 1,2-phenylenediamine is heated for 60 min. at 120°C. It is then suspended in methanol, filtered off and recrystallized from N,N-dimethylformamide/water. This gives 3-(3,4-dihydroxy-5-nitrophenyl)-2(1H)-quinoxalinone with m.p. >300°C.
På analog måte får man: Analogously, you get:
b) Fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og N-metyl-1, 2-fenylendiamin l-metyl-3-(3,4-dihydroksy-5-nitrofe-nyl)-2(1H)-kinoksalinon med smp. 271-273°C (fra metanol), c) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og N-propyl-1,2-fenylendiamin l-propyl-3-(3,4-dihydroksy-5-nitrofe-nyl)-2(1H)-kinoksalinon med smp. 183-185°C (fra metanol), d) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 4,5-dimetyl-l,2-fenylendiamin 3-(3,4-dihydroksy-5-nitrofenyl)-6,7-dimetyl-2(1H)-kinoksalinon med smp. >300°C (fra N,N-dimetylformamid/vann), e) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 4,5-diklor-l,2-fenylendiamin 6,7-diklor-3-(3,4-dihydroksy-5-nitrofenyl)-2(1H)-kinoksalinon med smp. >300°C (fra N,N-dimetylformamid/vann), f) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 3- klor-5-trifluormetyl-1,2-fenylendiamin en l:l-blanding av 8 (og 5)-klor-3-(3,4-dihydroksy-5-nitrofenyl)-6-(og 7)-trifluormety1-2-(1H)-kinoksalinon med smp. >300°C (fra N,N-dimetylformamid/vann), g) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 4- metoksy-l,2-fenylendiamin en l:l-blanding av 3-(3,4-dihydroksy-5- nitrofenyl)-6(og 7)-metoksy-2(1H)-kinoksalinon med smp. >300°C (fra etanol/eter), h) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 4-nitro-l,2-fenylendiamin en l:l-blanding av 3-(3,4-dihydroksy-5-nitrofenyl)-6(og 7)-nitro-2(1H)-kinoksalinon med smp. >300°C (fra N,N-dimetylformamid/vann) og b) From 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and N-methyl-1,2-phenylenediamine l-methyl-3-(3,4-dihydroxy-5-nitro-nyl)-2(1H) -quinoxalinone with m.p. 271-273°C (from methanol), c) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and N-propyl-1,2-phenylenediamine l-propyl-3-(3,4-dihydroxy-5 -nitro-nyl)-2(1H)-quinoxalinone with m.p. 183-185°C (from methanol), d) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 4,5-dimethyl-1,2-phenylenediamine 3-(3,4-dihydroxy-5-nitrophenyl )-6,7-dimethyl-2(1H)-quinoxalinone with m.p. >300°C (from N,N-dimethylformamide/water), e) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 4,5-dichloro-1,2-phenylenediamine 6,7-dichloro-3 -(3,4-dihydroxy-5-nitrophenyl)-2(1H)-quinoxalinone with m.p. >300°C (from N,N-dimethylformamide/water), f) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 3-chloro-5-trifluoromethyl-1,2-phenylenediamine a l:l- mixture of 8 (and 5)-chloro-3-(3,4-dihydroxy-5-nitrophenyl)-6-(and 7)-trifluoromethyl-2-(1H)-quinoxalinone with m.p. >300°C (from N,N-dimethylformamide/water), g) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 4-methoxy-1,2-phenylenediamine a 1:1 mixture of 3- (3,4-dihydroxy-5-nitrophenyl)-6(and 7)-methoxy-2(1H)-quinoxalinone with m.p. >300°C (from ethanol/ether), h) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and 4-nitro-1,2-phenylenediamine a 1:1 mixture of 3-(3,4 -dihydroxy-5-nitrophenyl)-6(and 7)-nitro-2(1H)-quinoxalinone with m.p. >300°C (from N,N-dimethylformamide/water) and
i) fra 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og N-heksyl-1,2-fenylendiamin l-heksyl-3-(3,4-dihydroksy-5-nitrofe-nyl)-2H-kinoksalinon med smp. 152-154°C (fra metanol). i) from 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and N-hexyl-1,2-phenylenediamine l-hexyl-3-(3,4-dihydroxy-5-nitro-nyl)-2H-quinoxalinone with m.p. 152-154°C (from methanol).
Eksempel 18 Example 18
En oppløsning av 1,07 g 3,4-dihydroksy-5-nitrofenylglyoksyl-syre-n-heksylester og 696,3 mg 2,3-diaminonaftalin i 3 ml 1-heksanol oppvarmes 3 timer under tilbakeløp til kokepunktet. Reakjsonsblandingen avkjøles deretter og fortynnes med metanol. Det rå produkt frafiltreres og omkrystalliseres fra N,N-dimetylformamid/vann. Man får 3-(3,4-dihydroksy-5-nitrofenyl)benzofg]-kinoksalin-2(1H)-on med smp. >300°C. A solution of 1.07 g of 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and 696.3 mg of 2,3-diaminonaphthalene in 3 ml of 1-hexanol is heated for 3 hours under reflux to the boiling point. The reaction mixture is then cooled and diluted with methanol. The crude product is filtered off and recrystallized from N,N-dimethylformamide/water. This gives 3-(3,4-dihydroxy-5-nitrophenyl)benzo[f]-quinoxalin-2(1H)-one with m.p. >300°C.
Eksempel 19 Example 19
En suspensjon av 2,05 g 3,4-dihydroksy-5-nitrofenylglyoksyl-syre-n-heksylester og 600,8 mg tiosemikarbazid røres kraftig 30 min. ved 90°C. Så avkjøles til 40°C og blandes med en løsning av 870,1 mg natriumhydroksyd i 15 ml vann. Deretter oppvarmer man løsningen i 30 min. til 90°C, avkjøler reaksjonsblandingen til romtemperatur og blander dråpevis med 2 ml kons. saltsyre. Det utkrystalliserte produkt frafiltreres og løses så i eddikester. Man vasker med mettet koksaltløsning, tørker over natriumsulfat, filtrerer og inndamper. Man får 6-(3,4-dihy-droksy-5-nitrofenyl)-3-merkapto-l,2,4-triazin-5(4H)-on med smp. 282-284°C (fra etanol). A suspension of 2.05 g of 3,4-dihydroxy-5-nitrophenylglyoxylic acid n-hexyl ester and 600.8 mg of thiosemicarbazide is stirred vigorously for 30 minutes. at 90°C. Then cool to 40°C and mix with a solution of 870.1 mg of sodium hydroxide in 15 ml of water. The solution is then heated for 30 min. to 90°C, cool the reaction mixture to room temperature and mix dropwise with 2 ml conc. hydrochloric acid. The crystallized product is filtered off and then dissolved in vinegar. Wash with saturated sodium chloride solution, dry over sodium sulphate, filter and evaporate. This gives 6-(3,4-dihydroxy-5-nitrophenyl)-3-mercapto-1,2,4-triazin-5(4H)-one with m.p. 282-284°C (from ethanol).
Eksempel 2 0 Example 2 0
aaa) Man blander en suspensjon av 2,9 g 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og 761,2 mg tiourea i 170 ml etanol ved 60°C med 820,3 mg natriumacetat og rører i 6 timer. Så inndamper man reaksjonsblandingen, blander resten med 170 ml vann og oppvarmer i 30 min. til 60°C. Etter avkjølingen frafiltrerer man produktet og vasker det med vann. Man får 4-(2-amino-4-tiazolyl)-2-metoksy-6-nitrofenol med smp. 248-250°C (fra etanol). aaa) A suspension of 2.9 g of 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and 761.2 mg of thiourea in 170 ml of ethanol is mixed at 60°C with 820.3 mg of sodium acetate and stirring for 6 hours. The reaction mixture is then evaporated, the residue is mixed with 170 ml of water and heated for 30 min. to 60°C. After cooling, the product is filtered off and washed with water. 4-(2-amino-4-thiazolyl)-2-methoxy-6-nitrophenol with m.p. 248-250°C (from ethanol).
På analog måte får man: Analogously, you get:
aab) Fra 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og N-fenyltiourea 4-(2-anilino-4-tiazolyl)-2-metoksy-6-nitrofenol med smp. 185-187°C (fra eter). aab) From 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and N-phenylthiourea 4-(2-anilino-4-thiazolyl)-2-methoxy-6-nitrophenol with m.p. 185-187°C (from ether).
aba) Til en løsning av 4,88 g 6-amino-4'-(trifluormetyl)-heksani-lid-hydroklorid i 70 ml vann setter man 50 ml 1,2-dikloretan og 3,56 g kalsiumkarbonat. Suspensjonen blander man i løpet av 60 min. under røring ved romtemperatur med en løsning av 2,6 g tiofosgen i 1,7 ml toluen. Etter 16 timer filtrerer man fellingen fra og vasker den organiske fasen med lN-saltsyre og vann. Etter tørking over natriumsulfat og filtrering inndamper man. Man får rått 4'-(trifluormetyl)heksanilid-6-isotiocyanat. aba) 50 ml of 1,2-dichloroethane and 3.56 g of calcium carbonate are added to a solution of 4.88 g of 6-amino-4'-(trifluoromethyl)-hexanilide hydrochloride in 70 ml of water. The suspension is mixed within 60 minutes. with stirring at room temperature with a solution of 2.6 g of thiophosgene in 1.7 ml of toluene. After 16 hours, the precipitate is filtered off and the organic phase is washed with 1N hydrochloric acid and water. After drying over sodium sulphate and filtration, it is evaporated. Crude 4'-(trifluoromethyl)hexanilide-6-isothiocyanate is obtained.
abb) Man blander en løsning av 5,2 g rått 4'-(trifluormetyl)hek-sanilid-6-isotiocyanat i 60 ml etanol med 100 ml kons. ammoniakk-løsning. Etter 30 min. inndamper man reaksjonsblandingen. Man løser resten i eddikester, vasker med vann, tørker over natriumsulfat, filtrerer og inndamper. Man får 1-[5-[(a,a,a-trifluor-p-tolyl)karbamoyl]pentyl]-2-tiourea med smp. 140-142°C (fra etanol). abb) A solution of 5.2 g of crude 4'-(trifluoromethyl)hexanilide-6-isothiocyanate in 60 ml of ethanol is mixed with 100 ml of conc. ammonia solution. After 30 min. the reaction mixture is evaporated. The residue is dissolved in vinegar, washed with water, dried over sodium sulphate, filtered and evaporated. 1-[5-[(α,α,α-trifluoro-p-tolyl)carbamoyl]pentyl]-2-thiourea with m.p. 140-142°C (from ethanol).
abc) Man blander en suspensjon av 666,7 mg 1-[ 5-[a ,a ,cx-trif luor-p-tolyl)karbamoyl]pentyl]-2-tiourea og 58 0,2 mg 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon i 50 ml etanol ved 60°C med 164,2 mg natriumacetat. Derved dannes en rødgul løsning. Etter 90 min. inndamper man reaksjonsblandingen, blander resten med vann, filtrerer fellingen fra og vasker 4 ganger med 10 ml vann hver gang. Man får 6-[[4-(4-hydroksy-3-metoksy-5-nitrofe-nyl)-2-tiazolyl]amino]-4'-(trifluormetyl)heksanilid med smp. 160-162°C (fra etanol). abc) A suspension of 666.7 mg of 1-[5-[a ,a ,cx-trifluoro-p-tolyl)carbamoyl]pentyl]-2-thiourea and 58 0.2 mg of 2-bromo-4' is mixed -hydroxy-3'-methoxy-5'-nitroacetophenone in 50 ml of ethanol at 60°C with 164.2 mg of sodium acetate. A reddish-yellow solution is thereby formed. After 90 min. the reaction mixture is evaporated, the residue is mixed with water, the precipitate is filtered off and washed 4 times with 10 ml of water each time. 6-[[4-(4-hydroxy-3-methoxy-5-nitro-nyl)-2-thiazolyl]amino]-4'-(trifluoromethyl)hexanilide with m.p. 160-162°C (from ethanol).
ac) En løsning av 29,0 g 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og 13,5 g 2-aminoacetofenon i 250 ml tørt N,N-dimetylformamid røres ved 90°C i 16 timer. Reaksjonsblandingen inndampes så til ca. 2/3 og helles på is. De utskilte krystaller frafiltreres og oppløses i metylenklorid. Man vasker med mettet koksaltløsning, tørker over natriumsulfat, filtrerer og inndamper. Man får 2-(4-hydroksy-3-metoksy-5-nitrobenzoyl)-3-metylin-dol med smp. 195-197°C (fra metylenklorid/metanol). ac) A solution of 29.0 g of 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and 13.5 g of 2-aminoacetophenone in 250 ml of dry N,N-dimethylformamide is stirred at 90°C in 16 hours. The reaction mixture is then evaporated to approx. 2/3 and pour over ice. The separated crystals are filtered off and dissolved in methylene chloride. Wash with saturated sodium chloride solution, dry over sodium sulphate, filter and evaporate. This gives 2-(4-hydroxy-3-methoxy-5-nitrobenzoyl)-3-methylindole with m.p. 195-197°C (from methylene chloride/methanol).
ada) Man blander en suspensjon av 14,5 g 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og 5,41 g 1,2-fenylendiamin i 350 ml metanol med 4,92 g natriumacetat og oppvarmer blandingen under tilbakeløp i 2 2 timer ved kokepunktet. Så inndamper man reak-sj onsblandingen , oppløser resten i metylenklorid, vasker denne løsningen 4 ganger med vann, tørker den over natriumsulfat, filtrerer og inndamper. Man får 2-(4-hydroksy-3-metoksy-5-nitrofenyl)kinoksalin med smp. 195-197°C (fra metylenklorid/metanol) . ada) A suspension of 14.5 g of 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and 5.41 g of 1,2-phenylenediamine in 350 ml of methanol is mixed with 4.92 g of sodium acetate and heating the mixture under reflux for 2 2 hours at the boiling point. The reaction mixture is then evaporated, the residue is dissolved in methylene chloride, this solution is washed 4 times with water, dried over sodium sulphate, filtered and evaporated. 2-(4-hydroxy-3-methoxy-5-nitrophenyl)quinoxaline is obtained with m.p. 195-197°C (from methylene chloride/methanol) .
På analog måte får man: Analogously, you get:
adb) Fra 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon og 4,5-dimetyl-1,2-fenylendiamin 6,7-dimetyl-2-(4-hydroksy-3-metoksy-5-nitrofenyl)kinoksalin med smp. 207-209°C (fra metylenklorid/metanol) . adb) From 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone and 4,5-dimethyl-1,2-phenylenediamine 6,7-dimethyl-2-(4-hydroxy-3-methoxy- 5-nitrophenyl)quinoxaline with m.p. 207-209°C (from methylene chloride/methanol).
b) Man blander en suspensjon av 267,3 mg 4-(2-amino-4-tiazolyl)-2-metoksy-6-nitrofenol i 10 ml tørt metylenklorid ved -20°Cb) A suspension of 267.3 mg of 4-(2-amino-4-thiazolyl)-2-methoxy-6-nitrophenol is mixed in 10 ml of dry methylene chloride at -20°C
med 1,25 g bortribromid. Man rører etter tilsetningen enda 1 time ved -2 0°C og uten kjøling ved romtemperatur i 18 timer. Så inndamper man reaksjonsblandingen, blander resten forsiktig med vann og rører i 30 min. ved 50°C. Etter avkjølingen til romtemperatur frafiltrerer man råproduktet og vasker det med litt vann. Man får 5-(2-amino-4-tiazolyl)-3-nitropyrokatekol-hydrobromid med smp. 244-246°C (fra metanol). with 1.25 g boron tribromide. After the addition, the mixture is stirred for another 1 hour at -2 0°C and without cooling at room temperature for 18 hours. The reaction mixture is then evaporated, the residue is carefully mixed with water and stirred for 30 min. at 50°C. After cooling to room temperature, the crude product is filtered off and washed with a little water. 5-(2-amino-4-thiazolyl)-3-nitropyrocatechol hydrobromide with m.p. 244-246°C (from methanol).
På analog måte får man: Analogously, you get:
c) Fra 4-(2-anilino-4-tiazolyl)-2-metoksy-6-nitrofenol 5-(2-anilino-4-tiazolyl)-3-nitropyrokatekol med smp. 202-204°C (fra c) From 4-(2-anilino-4-thiazolyl)-2-methoxy-6-nitrophenol 5-(2-anilino-4-thiazolyl)-3-nitropyrocatechol with m.p. 202-204°C (from
metanol) , methanol),
d) fra 6-[4-(4-hydroksy-3-metoksy-5-nitrofenyl)-2-tiazolyl)-amino]-4'-(trifluormetyl)heksanilid 6-[[4-(3,4-dihydroksy-S-nitrofenyl) -2-tiazolyl]amino]-4'-(trifluormetyl)heksanilid med smp. 214-216°C (fra metanol), e) fra 2-(4-hydroksy-3-metoksy-5-nitrobenzoyl)-3-metylindol 5-brom-2-(3,4-dihydroksy-5-nitrobenzoyl)-3-metylindol med smp. 265-267°C (fra metanol), f) fra 2-(4-hydroksy-3-metoksy-5-nitrofenyl)kinoksalin 2-(3,4-dihydroksy-5-nitrofenyl)kinoksalin med smp. 241-243°C (fra d) from 6-[4-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-thiazolyl)-amino]-4'-(trifluoromethyl)hexanilide 6-[[4-(3,4-dihydroxy- S-nitrophenyl)-2-thiazolyl]amino]-4'-(trifluoromethyl)hexanilide with m.p. 214-216°C (from methanol), e) from 2-(4-hydroxy-3-methoxy-5-nitrobenzoyl)-3-methylindole 5-bromo-2-(3,4-dihydroxy-5-nitrobenzoyl)- 3-methylindole with m.p. 265-267°C (from methanol), f) from 2-(4-hydroxy-3-methoxy-5-nitrophenyl)quinoxaline 2-(3,4-dihydroxy-5-nitrophenyl)quinoxaline with m.p. 241-243°C (from
metanol) og methanol) and
g) fra 6,7-dimetyl-2-(4-hydroksy-3-metoksy-5-nitrofenyl)-kinoksalin 6,7-dimetyl-2-(3,4-dihydroksy-5-nitrofenyl)kinoksalin g) from 6,7-dimethyl-2-(4-hydroxy-3-methoxy-5-nitrophenyl)-quinoxaline 6,7-dimethyl-2-(3,4-dihydroxy-5-nitrophenyl)quinoxaline
med smp. 274-276°C (fra metanol). with m.p. 274-276°C (from methanol).
Eksempel 21 Example 21
Man oppvarmer en blanding av 3,12 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon og 849,3 mg tioacetamid i 40 ml etanol i 18 timer under tilbakeløp ved kokepunktet. Etter avkjøling frafiltreres krystallene og omkrystalliseres fra metanol/isopropanol. Man får 5-(2-metyl-4-tiazolyl)-3-nitropyrokatekol-hydrobromid med smp. 280-282°C. A mixture of 3.12 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and 849.3 mg of thioacetamide in 40 ml of ethanol is heated under reflux at the boiling point for 18 hours. After cooling, the crystals are filtered off and recrystallized from methanol/isopropanol. 5-(2-methyl-4-thiazolyl)-3-nitropyrocatechol hydrobromide with m.p. 280-282°C.
Eksempel 22 Example 22
En løsning av 1,38 g 2-brom-3',4'-dihydroksy-5'-nitroaceto-fenon og 461 mg tiosemikarbazid i 20 ml n-butanol oppvarmes i 60 min. under tilbakeløp ved kokepunktet. Etter avkjøling til romtemperatur frafiltrerer man krystallene og omkrystalliserer dem fra n-butanol. Man får 5-(2-amino-6H-l,3,4-tiadiazin-5-yl)-3-nitropyrokatekol-hydrobromid med smp. 265-267°C. A solution of 1.38 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and 461 mg of thiosemicarbazide in 20 ml of n-butanol is heated for 60 min. under reflux at the boiling point. After cooling to room temperature, the crystals are filtered off and recrystallized from n-butanol. 5-(2-amino-6H-1,3,4-thiadiazin-5-yl)-3-nitropyrocatechol hydrobromide with m.p. 265-267°C.
Eksempel 2 3 Example 2 3
En løsning av 1,38 g 2-brom-3',4'-dihydroksy-5'-nitroaceto-fenon og 505,7 mg 2-amino-l,3,4-tiadiazol i 25 ml n-butanol oppvarmes i 7 timer under tilbakeløp ved kokepunktet. Så avkjøler man reaksjonsblandingen til romtemperatur og frafiltrerer de utskilte krystaller. Man får 5-(imidazo[2,1-b]-1,3 ,4-tiadiazol-6-yl)-3-nitropyrokatekol med smp. 278-280°C (fra metanol). A solution of 1.38 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and 505.7 mg of 2-amino-1,3,4-thiadiazole in 25 ml of n-butanol is heated for 7 hours under reflux at the boiling point. The reaction mixture is then cooled to room temperature and the separated crystals are filtered off. 5-(imidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-3-nitropyrocatechol with m.p. 278-280°C (from methanol).
Eksempel 24 Example 24
En blanding av 2,78 g 2-brom-3',4'-dihydroksy-5'-nitro-acetof enon, 1,01 g 2-aminotiazol og 40 ml etanol oppvarmes i 2 3 timer under tilbakeløp ved kokepunktet. Så avkjøler man reak-sj onsblandingen til romtemperatur og frafiltrerer krystallene. Man får 5-(imidazo[2,l-b]tiazol-6-yl)-3-nitropyrokatekol-hydrobromid med smp. 286-288°C (fra metanol). A mixture of 2.78 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone, 1.01 g of 2-aminothiazole and 40 ml of ethanol is heated for 23 hours under reflux at the boiling point. The reaction mixture is then cooled to room temperature and the crystals are filtered off. 5-(Imidazo[2,1-b]thiazol-6-yl)-3-nitropyrocatechol hydrobromide with m.p. 286-288°C (from methanol).
Eksempel 25 Example 25
En blanding av 1,95 g 2-brom-3',4'-dihydroksy-5'-nitroaceto-fenon, 1,06 g 2-aminobenzotiazol og 50 ml etanol oppvarmes 17 timer under tilbakeløp ved kokepunktet. Reaksjonsblandingen avkjøles så til romtemperatur, hvoretter man frafiltrerer krystallene. Man får 5-(imidazo[2,1-b]benzotiazol-2-yl)-3-nitropyrokatekol med smp. 303-305°C (fra N,N-dimetylformamid/metanol). A mixture of 1.95 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone, 1.06 g of 2-aminobenzothiazole and 50 ml of ethanol is heated under reflux at the boiling point for 17 hours. The reaction mixture is then cooled to room temperature, after which the crystals are filtered off. 5-(imidazo[2,1-b]benzothiazol-2-yl)-3-nitropyrocatechol with m.p. 303-305°C (from N,N-dimethylformamide/methanol).
Eksempel 26 Example 26
En blanding fra 2,78 g 2-brom-3',4'-dihydroksy-5'-nitroace-tof enon, 1,51 g 2-aminotiofenol og 50 ml etanol oppvarmes i 1 timeunder tilbakeløp til kokepunktet. Reaksjonsblandingen avkjøles så til romtemperatur, hvoretter man frafiltrerer krystallene. Man får 5-(2H,1,4-benzotiazin-3-yl)-3-nitropyroka-tekol med smp. 302-304°C (fra N,N-dimetylformamid/metanol). A mixture of 2.78 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone, 1.51 g of 2-aminothiophenol and 50 ml of ethanol is heated for 1 hour under reflux to the boiling point. The reaction mixture is then cooled to room temperature, after which the crystals are filtered off. 5-(2H,1,4-benzothiazin-3-yl)-3-nitropyrocatechol with m.p. 302-304°C (from N,N-dimethylformamide/methanol).
Eksempel 27 Example 27
En blanding av 987,5 mg 2-brom-3',4'-dihydroksy-5'-nitro-acetofenon og 1,01 g 2-aminopyridin smeltes ved 110°C. Etter 30 min. blander man med 15 ml etanol og oppvarmer i 3 timer under tilbakeløp ved kokepunktet. Så avkjøler man reaksjonsblandingen til romtemperatur og krystallene frafiltreres. Man får 5-(imidazo[1,2-a]pyridin-3-yl)-3-nitropyrokatekol med smp. 250-252°C (fra N,N-dimetylformamid/metanol). A mixture of 987.5 mg of 2-bromo-3',4'-dihydroxy-5'-nitro-acetophenone and 1.01 g of 2-aminopyridine is melted at 110°C. After 30 min. mix with 15 ml of ethanol and heat for 3 hours under reflux at the boiling point. The reaction mixture is then cooled to room temperature and the crystals are filtered off. 5-(imidazo[1,2-a]pyridin-3-yl)-3-nitropyrocatechol with m.p. 250-252°C (from N,N-dimethylformamide/methanol).
Eksempel 28 Example 28
a) Til en løsning av 10,7 g 4-hydroksy-3-metoksy-5-nitrobenzo-syre i 500 ml tørr tetrahydrofuran setter man 8,9 g l,l'-karbonyldiimidazol og oppvarmer så reaksjonsblandingen i 5 timer ved a) 8.9 g of 1,1'-carbonyldiimidazole is added to a solution of 10.7 g of 4-hydroxy-3-methoxy-5-nitrobenzoic acid in 500 ml of dry tetrahydrofuran and the reaction mixture is then heated for 5 hours at
65-70°C. Så avkjøler man den til romtemperatur og drypper i løpet av 15 min. til en løsning av 21,6 g 6-aminoheksyl-t-butylkarbamat i 50 ml tørr tetrahydrofuran. Man oppvarmer så reaksjonsblandingen i 18 timer til 65-70°C, inndamper, oppslemmer resten i eddikester, frafiltrerer og kromatograferer det frafil-trerte materialet med aceton/metylenklorid (3:1) på kiselgel. Man får [6-(4-hydroksy-5-nitro-m-anisamido)heksyl]-t-butylkarba-mat med smp. 145-147°C (fra isopropanol). 65-70°C. It is then cooled to room temperature and dripped over the course of 15 minutes. to a solution of 21.6 g of 6-aminohexyl-t-butyl carbamate in 50 ml of dry tetrahydrofuran. The reaction mixture is then heated for 18 hours to 65-70°C, evaporated, the residue is suspended in ethyl acetate, filtered off and the filtered material is chromatographed with acetone/methylene chloride (3:1) on silica gel. One obtains [6-(4-hydroxy-5-nitro-m-anisamido)hexyl]-t-butylcarbamate with m.p. 145-147°C (from isopropanol).
b) Til en løsning av 4,1 g [6-(4-hydroksy-5-nitro-m-anis-amido)heksyl]-t<->butylkarbamat i 80 ml iseddik setter man ved b) To a solution of 4.1 g of [6-(4-hydroxy-5-nitro-m-anis-amido)hexyl]-t<->butyl carbamate in 80 ml of glacial acetic acid, add
romtemperatur 5,8 ml hydrogenbromid i iseddik (£33%) . Man rører i 2 timer, frafiltrerer de utfelte krystaller og vasker dem med eter. Man får N-(6-aminoheksyl)-4-hydroksy-5-nitro-m-anisamid-hydrobromid med smp. 207-209°C (fra isopropanol). room temperature 5.8 ml hydrogen bromide in glacial acetic acid (£33%) . The mixture is stirred for 2 hours, the precipitated crystals are filtered off and washed with ether. N-(6-aminohexyl)-4-hydroxy-5-nitro-m-anisamide hydrobromide with m.p. 207-209°C (from isopropanol).
c) Til en suspensjon av 392,3 mg N-(6-aminoheksyl)-4-hydroksy-5-nitro-m-anisamidhydrobromid i 25 ml tørr metylenklorid setter c) To a suspension of 392.3 mg of N-(6-aminohexyl)-4-hydroxy-5-nitro-m-anisamide hydrobromide in 25 ml of dry methylene chloride put
man ved -20°C 1,25 g bortribromid. Etter tilsetning rører man i 1 time ved -20°C og så i 17 timer ved romtemperatur. Så inndamper man reaksjonsblandingen, blander resten med 10 ml vann og rører i 1 time ved romtemperatur. Etter fordampning av vannet kromatograferer man resten med toluen/etanol (1:1) på Sephadex LH 20. Man får N-6-aminoheksyl-3,4-dihydroksy-5-nitrobenzamid-hydrobromid med smp. 205-207°C. one at -20°C 1.25 g boron tribromide. After addition, the mixture is stirred for 1 hour at -20°C and then for 17 hours at room temperature. The reaction mixture is then evaporated, the residue is mixed with 10 ml of water and stirred for 1 hour at room temperature. After evaporation of the water, the residue is chromatographed with toluene/ethanol (1:1) on Sephadex LH 20. N-6-aminohexyl-3,4-dihydroxy-5-nitrobenzamide hydrobromide is obtained with m.p. 205-207°C.
Eksempel 29 Example 29
. aa) En løsning av 4,93 g 5-nitrovanillin og 2,7 g 1,2-fenylendiamin i 45 ml metanol og 15 ml nitrobenzen oppvarmes under tilbakeløp ved kokepunktet. Etter 15 min. begynner det å falle ut krystaller fra den røde løsningen. Etter 18 timer avkjøles reaksjonsblandingen til romtemperatur og fortynnes med 60 ml metanol. Krystallene frafiltreres og vaskes med metanol. Man får 4-(2-benzimidazolyl)-2-metoksy-6-nitrofenol med smp. 198-200°C (fra N,N-dimetylformamid/metanol). . aa) A solution of 4.93 g of 5-nitrovanillin and 2.7 g of 1,2-phenylenediamine in 45 ml of methanol and 15 ml of nitrobenzene is heated under reflux at the boiling point. After 15 min. crystals start to fall out of the red solution. After 18 hours, the reaction mixture is cooled to room temperature and diluted with 60 ml of methanol. The crystals are filtered off and washed with methanol. 4-(2-benzimidazolyl)-2-methoxy-6-nitrophenol with m.p. 198-200°C (from N,N-dimethylformamide/methanol).
På analog måte får man: Analogously, you get:
ab) Fra 5-nitrovanilin og 4,5-diklor-l,2-fenylendiamin 4-(5,6-diklor-2-benzimidazolyl)-2-metoksy-6-nitrofenol med smp. 258-260°C (fra N,N-dimetylformamid/eter). ab) From 5-nitrovanillin and 4,5-dichloro-1,2-phenylenediamine 4-(5,6-dichloro-2-benzimidazolyl)-2-methoxy-6-nitrophenol with m.p. 258-260°C (from N,N-dimethylformamide/ether).
b) En supspensjon av 860,1 mg 4-(2-benzimidazolyl)-2-metoksy-6-nitrofenol i 10 ml iseddik og 10 ml 48%-ig hydrogenbromid b) A suspension of 860.1 mg of 4-(2-benzimidazolyl)-2-methoxy-6-nitrophenol in 10 ml of glacial acetic acid and 10 ml of 48% hydrogen bromide
oppvarmes i 72 timer under tilbakeløp ved kokepunktet. Så inndampes, og resten blandes 4 ganger med 50 ml toluen hver gang, som man avdestillerer igjen. Man får 5-(2-benzimidazolyl)-3-nitropyrokatekol med smp. >300°C (fra aceton/vann). heated for 72 hours under reflux at the boiling point. It is then evaporated, and the residue is mixed 4 times with 50 ml of toluene each time, which is distilled off again. 5-(2-benzimidazolyl)-3-nitropyrocatechol with m.p. >300°C (from acetone/water).
På analog måte får man: Analogously, you get:
c) Fra 4-(5,6-diklor-2-benzimidazolyl)-2-metoksy-6-nitrofenol 5-(5,6-diklor-2-benzimidazolyl)-3-nitropyrokatekol med smp. 282-284°C (fra aceton/vann). c) From 4-(5,6-dichloro-2-benzimidazolyl)-2-methoxy-6-nitrophenol 5-(5,6-dichloro-2-benzimidazolyl)-3-nitropyrocatechol with m.p. 282-284°C (from acetone/water).
Eksempel 3 0 Example 3 0
Man blander en suspensjon av 29,0 g 2-brom-4'-hydroksy-3'-metoksy-5'-nitroacetofenon i 700 ml tørt metylenklorid ved -20°C i løpet av 30 min. med en løsning av 125,3 g bortribromid i 3 00 ml tørt metylenklorid. Man rører etter tilsetningen enda en time ved -20°C og 16 timer ved romtemperatur, inndamper så, blander resten under iskjøling forsiktig med vann og rører i 30 min. ved 50°C. Etter avkjølingen ekstraherer man med eter, vasker eterfasen med vann, tørker over natriumsulfat, filtrerer og inndamper. Man får 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med smp. 138-140°C (fra metylenklorid). A suspension of 29.0 g of 2-bromo-4'-hydroxy-3'-methoxy-5'-nitroacetophenone is mixed in 700 ml of dry methylene chloride at -20°C over the course of 30 minutes. with a solution of 125.3 g of boron tribromide in 300 ml of dry methylene chloride. After the addition, the mixture is stirred for another hour at -20°C and 16 hours at room temperature, then evaporated, the residue is carefully mixed with water under ice cooling and stirred for 30 min. at 50°C. After cooling, extract with ether, wash the ether phase with water, dry over sodium sulphate, filter and evaporate. 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is obtained with m.p. 138-140°C (from methylene chloride).
Eksempel 31 Example 31
a) Man oppvarmer en løsning av 3,6 g 3,4-dihydroksy-5-nitrofe-nylglyoksylsyreetylester i 30 ml eddiksyreanhydrid i nærvær av en a) A solution of 3.6 g of 3,4-dihydroxy-5-nitro-nylglyoxylic acid ethyl ester in 30 ml of acetic anhydride is heated in the presence of a
katalytisk mengde av kons. svovelsyre i 3 0 min. ved 110°C, avkjøler til romtemperatur, heller reaksjonsblandingen på 150 ml vann og rører 60 min .. Man ekstraherer med eter, vasker med mettet natriumkloridløsning, tørker de samlede organiske ekstrakter over natriumsulfat, filtrerer og inndamper. Man får 3,4-diacetoksy-5-nitrofenylglyoksylsyreetylester med smp. 87-89°C (fra eter/petroleumseter). catalytic amount of conc. sulfuric acid for 3 0 min. at 110°C, cool to room temperature, pour the reaction mixture into 150 ml of water and stir for 60 min. Extract with ether, wash with saturated sodium chloride solution, dry the combined organic extracts over sodium sulfate, filter and evaporate. This gives 3,4-diacetoxy-5-nitrophenylglyoxylic acid ethyl ester with m.p. 87-89°C (from ether/petroleum ether).
På analog måte får man: Analogously, you get:
b) Ut fra 3-(3,4-dihydroksy-5-nitrofenyl)-2H-1, 4-benzoksazin-2-on 3-(3,4-diacetoksy-5-nitrofenyl)-2H-1,4-benzoksazin-2-on med b) From 3-(3,4-dihydroxy-5-nitrophenyl)-2H-1,4-benzoxazin-2-one 3-(3,4-diacetoxy-5-nitrophenyl)-2H-1,4-benzoxazine -2-on with
smp. 186-188°C (fra metylenklorid/metanol), m.p. 186-188°C (from methylene chloride/methanol),
c) fra 3-(3,4-dihydroksy-5-nitrofenyl)-2(1H)-kinoksalinon 3-(3,4-diacetoksy-5-nitrofenyl)-2(1H)-kinoksalinon med smp. 241-243°C (fra metylenklorid/metanol), d) fra 3,4-dihydroksy-5-nitrobenzofenon 3,4-diacetoksy-5-nitrobenzofenon med smp. 141-143°C (fra metylenklorid/eter), e) fra 2'-fluor-3,4-dihydroksy-5-nitrobenzofenon 3,4-diace-toksy-2'-fluor-5-nitrobenzofenon med smp. 122-124°C (fra eter) og f) fra 3,4-dihydroksy-5-nitrofenyl-4-pyridylketon 3,4-diace-toksy-5-nitrofenyl-4-pyridylketon med smp. 148-150°C (fra c) from 3-(3,4-dihydroxy-5-nitrophenyl)-2(1H)-quinoxalinone 3-(3,4-diacetoxy-5-nitrophenyl)-2(1H)-quinoxalinone with m.p. 241-243°C (from methylene chloride/methanol), d) from 3,4-dihydroxy-5-nitrobenzophenone 3,4-diacetoxy-5-nitrobenzophenone with m.p. 141-143°C (from methylene chloride/ether), e) from 2'-fluoro-3,4-dihydroxy-5-nitrobenzophenone 3,4-diace-toxy-2'-fluoro-5-nitrobenzophenone with m.p. 122-124°C (from ether) and f) from 3,4-dihydroxy-5-nitrophenyl-4-pyridyl ketone 3,4-diacetoxy-5-nitrophenyl-4-pyridyl ketone with m.p. 148-150°C (from
metylenklorid/eter). methylene chloride/ether).
Eksempel 32 Example 32
a) Man oppvarmer en løsning av 2,0 g 3,5-dinitropyrokatekol i 25 ml propionsyreanhydrid i nærvær av en katalytisk mengde kons. a) A solution of 2.0 g of 3,5-dinitropyrocatechol in 25 ml of propionic anhydride is heated in the presence of a catalytic amount of conc.
svovelsyre i 18 timer ved 110°C, destillerer overskuddet anhydrid vekk ved 70°C i høyvakuum (1,33 Pa), oppløser resten i metylenklorid, vasker med vann, tørker over natriumsulfat, filtrerer og inndamper. Man får 1,2-dipropionyloksy-3,5-dinitrobenzen med smp. 74-76°C (fra metylenklorid/petroleumseter). sulfuric acid for 18 hours at 110°C, distills off the excess anhydride at 70°C in high vacuum (1.33 Pa), dissolves the residue in methylene chloride, washes with water, dries over sodium sulfate, filters and evaporates. 1,2-dipropionyloxy-3,5-dinitrobenzene is obtained with m.p. 74-76°C (from methylene chloride/petroleum ether).
På analog måte får man: Analogously, you get:
b) Fra 3-(3,4-dihydroksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksa-zin-2-on 3-(3,4-dipropionyloksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksazin-2-on med smp. 158-160°C (fra metylenklorid), c) fra 6-klor-3-(3,4-dihydroksy-5-nitrofenyl)-2H-1,4-benzoksa-zin-2-on 5-(6-klor-2-okso-2H-l,4-benzoksazin-3-yl)-3-nitro-o-fenylen-dipropionat med smp. 148-150°C (fra metylenklorid/eter), d) fra 3-(3,4-dihydroksy-5-nitrofenyl)-7-nitro-2H-l,4-benzoksa-zin-2-on 3-nitro-5-(7-nitro-2-okso-2H-l, 4-benzoksazin-3-yl)-o-fenylen-dipropionat med smp. 177-179°C (fra metanol), e) fra 3-(3,4-dihydroksy-5-nitrofenyl)-2-okso-2H-l,4-benzoksa-zin-6-karboksylsyre 3-[3,4-bis(propionyloksy)-5-nitrofenyl]-2-okso-2H-l,4-benzoksazin-6-karboksylsyre med smp. 192-194°C (fra metylenklorid), f) fra 3-nitro-5-(2-kinoksalinyl)pyrokatekol 3-nitro-5-(2-kinoksalinyl)-o-fenylen-dipropionat med smp. 152-154°C (fra b) From 3-(3,4-dihydroxy-5-nitrophenyl)-6-methyl-2H-1,4-benzoxa-zin-2-one 3-(3,4-dipropionyloxy-5-nitrophenyl)-6- methyl-2H-1,4-benzoxazin-2-one with m.p. 158-160°C (from methylene chloride), c) from 6-chloro-3-(3,4-dihydroxy-5-nitrophenyl)-2H-1,4-benzoxa-zin-2-one 5-(6-chloro -2-oxo-2H-1,4-benzoxazin-3-yl)-3-nitro-o-phenylene-dipropionate with m.p. 148-150°C (from methylene chloride/ether), d) from 3-(3,4-dihydroxy-5-nitrophenyl)-7-nitro-2H-1,4-benzoxa-zin-2-one 3-nitro- 5-(7-nitro-2-oxo-2H-1,4-benzoxazin-3-yl)-o-phenylene dipropionate with m.p. 177-179°C (from methanol), e) from 3-(3,4-dihydroxy-5-nitrophenyl)-2-oxo-2H-1,4-benzoxazine-6-carboxylic acid 3-[3,4 -bis(propionyloxy)-5-nitrophenyl]-2-oxo-2H-1,4-benzoxazine-6-carboxylic acid with m.p. 192-194°C (from methylene chloride), f) from 3-nitro-5-(2-quinoxalinyl)pyrocatechol 3-nitro-5-(2-quinoxalinyl)-o-phenylene dipropionate with m.p. 152-154°C (from
metylenklorid/eter), methylene chloride/ether),
g) fra 5-(2-benzimidazolyl)-3-nitropyrokatekol 5-(2-benzimidazolyl) -3-nitro-o-fenylen-dipropionat med smp. 179-181°C (fra eter), h) fra 6,7-diklor-3-(3,4-dihydroksy-5-nitrofenyl)-2(1H)-kinoksalinon 5-(6,7-diklor-3,4-dihydro-3-okso-2-kinoksalinyl)-3-nitro-o-fenylen-dipropionat med smp. 260-262°C (fra metylenklorid) , g) from 5-(2-benzimidazolyl)-3-nitropyrocatechol 5-(2-benzimidazolyl)-3-nitro-o-phenylene dipropionate with m.p. 179-181°C (from ether), h) from 6,7-dichloro-3-(3,4-dihydroxy-5-nitrophenyl)-2(1H)-quinoxalinone 5-(6,7-dichloro-3, 4-dihydro-3-oxo-2-quinoxalinyl)-3-nitro-o-phenylene dipropionate with m.p. 260-262°C (from methylene chloride),
i) fra 5-brom-2-(3,4-dihydroksy-5-nitrobenzoyl)-3-metylindol 5-brom-2-(3,4-dipropionyloksy-5-nitrobenzoyl)-3-metylindol med smp. 196-198°C (fra eter) og i) from 5-bromo-2-(3,4-dihydroxy-5-nitrobenzoyl)-3-methylindole 5-bromo-2-(3,4-dipropionyloxy-5-nitrobenzoyl)-3-methylindole with m.p. 196-198°C (from ether) and
j) fra 6-(3,4-dihydroksy-5-nitrofenyl)-3-merkapto-l,2,4-triazin-5(4H)-on 3-nitro-5-(2,3,4,5-tetrahydro-5-okso-3-tiokso-as-triazin-6-yl)-o-fenylen-dipropionat med smp. 237-239°C (fra eter). j) from 6-(3,4-dihydroxy-5-nitrophenyl)-3-mercapto-1,2,4-triazin-5(4H)-one 3-nitro-5-(2,3,4,5- tetrahydro-5-oxo-3-thioxo-as-triazin-6-yl)-o-phenylene-dipropionate with m.p. 237-239°C (from ether).
Eksempel 3 3 Example 3 3
a) Man oppvarmer en løsning av 1,09 g 3,4-dihydroksy-5-nitrofe-nylglyoksylsyreetylester i 6 ml isosmørsyreanhydrid i nærvær av a) A solution of 1.09 g of 3,4-dihydroxy-5-nitro-nylglyoxylic acid ethyl ester in 6 ml of isobutyric anhydride is heated in the presence of
en katalytisk mengde kons. svovelsyre i 17 timer ved 110°C. Så blander man reaksjonsblandingen 10 ganger med 10 ml toluen hver gang, hvorunder man stadig inndamper ved 80°C og 18,7 mbar. Den oljeaktige resten destilleres i kulerør ved 175-180°C og 8,0 Pa. Man får 3,4-diisobutyryloksy-5-nitrofenylglyoksylsyreetylester. a catalytic amount of conc. sulfuric acid for 17 hours at 110°C. The reaction mixture is then mixed 10 times with 10 ml of toluene each time, during which the mixture is continuously evaporated at 80°C and 18.7 mbar. The oily residue is distilled in a bubble tube at 175-180°C and 8.0 Pa. 3,4-diisobutyryloxy-5-nitrophenylglyoxylic acid ethyl ester is obtained.
På analog måte får man: Analogously, you get:
b) Fra 3,5-dinitropyrokatekol i,2-diisobutyryloksy-3,5-dinitro-benzen med smp. 78-80°C (fra eter), c) fra 3-(3,4-dihydroksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksa-zin-2-on 3-(3,4-diisobutyryloksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksazin-2-on med smp. 142-144°C (fra eter), d) fra 2-(3,4-dihydroksy-5-nitrofenyl)kinoksalin 2-(3,4-diisobutyryloksy-5-nitrofenyl)kinoksalin med smp. 155-157°C (fra b) From 3,5-dinitropyrocatechol i,2-diisobutyryloxy-3,5-dinitro-benzene with m.p. 78-80°C (from ether), c) from 3-(3,4-dihydroxy-5-nitrophenyl)-6-methyl-2H-1,4-benzoxa-zin-2-one 3-(3,4 -diisobutyryloxy-5-nitrophenyl)-6-methyl-2H-1,4-benzoxazin-2-one with m.p. 142-144°C (from ether), d) from 2-(3,4-dihydroxy-5-nitrophenyl)quinoxaline 2-(3,4-diisobutyryloxy-5-nitrophenyl)quinoxaline with m.p. 155-157°C (from
eter) , ether),
e) fra l-metyl-3-(3,4-dihydroksy-5-nitrofenyl)-2(1H)-kinoksali-non l-metyl-3-(3,4-diisobutyryloksy-5-nitrofenyl)-2(1H)-kinoksa-linon med smp. 138-140°C (fra eter), f) fra 5-(imidazo[2,1-b]-1,3,4-tiadiazol-6-yl)-3-nitropyrokate-kol 5-(imidazo[2,l-b]-l,3,4-tiadiazol-6-yl)-3-nitro-o-fenylen-diisobutyrat med smp. 169-171°C (fra metylenklorid), g) fra 2-brom-3',4'-dihydroksy-5'-nitroacetofenon 5-(bromace-tyl)-3-nitro-o-fenylen-diisobutyrat med smp. 56-58°C (fra e) from l-methyl-3-(3,4-dihydroxy-5-nitrophenyl)-2(1H)-quinoxalinone l-methyl-3-(3,4-diisobutyryloxy-5-nitrophenyl)-2(1H )-quinoxa-linone with m.p. 138-140°C (from ether), f) from 5-(imidazo[2,1-b]-1,3,4-thiadiazol-6-yl)-3-nitropyrocatecol 5-(imidazo[2, 1-b]-1,3,4-thiadiazol-6-yl)-3-nitro-o-phenylene diisobutyrate with m.p. 169-171°C (from methylene chloride), g) from 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone 5-(bromoacetyl)-3-nitro-o-phenylene-diisobutyrate with m.p. 56-58°C (from
metylenklorid/heksan), methylene chloride/hexane),
h) fra 5-(2-amino-4-tiazolyl)-3-nitropyrokatekol-hydrobromid 3-nitro-5-(2-isobutyramido-4-tiazolyl)-o-fenylen-diisobutyrat med h) from 5-(2-amino-4-thiazolyl)-3-nitropyrocatechol hydrobromide 3-nitro-5-(2-isobutyramido-4-thiazolyl)-o-phenylene-diisobutyrate with
smp. 157-159°C (fra metylenklorid/eter), m.p. 157-159°C (from methylene chloride/ether),
i) fra 5-(2-amino-6H-l,3,4-tiadiazin-5-yl)-3-nitropyrokatekol-hydrobromid 3-nitro-5-(2-isobutyramido-4-isobutyryl-l,3,4-tiadiazin-5-yl)-o-fenylen-diisobutyrat med smp. 177-179°C (fra eter) , i) from 5-(2-amino-6H-1,3,4-thiadiazin-5-yl)-3-nitropyrocatechol hydrobromide 3-nitro-5-(2-isobutyramido-4-isobutyryl-1,3,4 -thiadiazin-5-yl)-o-phenylene-diisobutyrate with m.p. 177-179°C (from ether),
j) fra 3-(3,4-dihydroksy-5-nitrofenyl)-6-propyl-2H-l,4-ben-zoksazin-2-on 3-nitro-5-(2-okso-6-propyl-2H-l,4-benzoksazin-3-yl)-o-fenylen-diisobutyrat med smp. 131-133°C (fra metanol), j) from 3-(3,4-dihydroxy-5-nitrophenyl)-6-propyl-2H-1,4-benzoxazin-2-one 3-nitro-5-(2-oxo-6-propyl-2H -1,4-benzoxazin-3-yl)-o-phenylene-diisobutyrate with m.p. 131-133°C (from methanol),
k) fra 5-(imidazo[1,2-a]pyridin-3-yl)-3-nitropyrokatekol 5-(imidazo[1,2-a]pyridin-3-yl)-3-nitro-o-fenylen-diisobutyrat med smp. 137-139°C (fra eter), k) from 5-(imidazo[1,2-a]pyridin-3-yl)-3-nitropyrocatechol 5-(imidazo[1,2-a]pyridin-3-yl)-3-nitro-o-phenylene- diisobutyrate with m.p. 137-139°C (from ether),
1) fra 5-(imidazo[2,l-b]benzotiazol-2-yl)-3-nitropyrokatekol 5-(imidazo[2,l-b]benzotiazol-2-yl)-3-nitro-o-fenylen-diisobutyrat med smp. 197-199°C (fra metylenklorid/eter) og 1) from 5-(imidazo[2,1-b]benzothiazol-2-yl)-3-nitropyrocatechol 5-(imidazo[2,1-b]benzothiazol-2-yl)-3-nitro-o-phenylene diisobutyrate with m.p. 197-199°C (from methylene chloride/ether) and
m) fra 3,4-dihydroksy-5-nitrofenyl-2-pyridylketon-hydrobromid 3-nitro-5-(2-pyridylkarbonyl)-o-fenylen-diisobutyrat med smp. 83-85°C (fra eter/heksan). m) from 3,4-dihydroxy-5-nitrophenyl-2-pyridyl ketone hydrobromide 3-nitro-5-(2-pyridylcarbonyl)-o-phenylene diisobutyrate with m.p. 83-85°C (from ether/hexane).
Eksempel 34 Example 34
a) Man oppvarmer en løsning av 613,0 mg 3,4-dihydroksy-5-nitrofenylglyoksylsyreetylester i 4 ml pivaloylsyreanhydrid i a) A solution of 613.0 mg of 3,4-dihydroxy-5-nitrophenylglyoxylic acid ethyl ester in 4 ml of pivaloyl anhydride is heated in
nærvær av en katalytisk mengde kons. svovelsyre i 17 timer ved 100°C, fortynner den avkjølte løsning med eter, vasker med mettet natriumkloridløsning, tørker over natriumsulfat, filtrerer og inndamper. Resten blandes 10 ganger med 10 ml toluen hver gang, hvorunder man igjen inndamper stadig. Man får etter kulerørdes-tillasjon (luftbad) ved 175-180°C og 4,0 Pa 3,4-dipivaloyloksy-5-nitrofenylglyoksylsyreetylester. presence of a catalytic amount of conc. sulfuric acid for 17 hours at 100°C, dilute the cooled solution with ether, wash with saturated sodium chloride solution, dry over sodium sulfate, filter and evaporate. The residue is mixed 10 times with 10 ml of toluene each time, during which the mixture is again constantly evaporated. After ball-tube distillation (air bath) at 175-180°C and 4.0 Pa, 3,4-dipivaloyloxy-5-nitrophenylglyoxylic acid ethyl ester is obtained.
På analog måte får man: Analogously, you get:
b) Fra 3-(3,4-dihydroksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksa-zin-2-on 3-(3,4-dipivaloyloksy-5-nitrofenyl)-6-metyl-2H-l,4-benzoksazin-2-on med smp. 180-182°C (fra eter), c) fra 3,4-dihydroksy-5-nitrobenzofenon 3,4-dipivaloyloksy-5-nitrobenzofenon med smp. 101-103°C (fra t-butylmetyleter) og d) fra 2'-fluor-3,4-dihydroksy-5-nitrobenzofenon 3,4-dipiva-loyloksy-2'-fluorbenzofenon med smp. 74-76°C (fra petroleter b) From 3-(3,4-dihydroxy-5-nitrophenyl)-6-methyl-2H-1,4-benzoxa-zin-2-one 3-(3,4-dipivaloyloxy-5-nitrophenyl)-6- methyl-2H-1,4-benzoxazin-2-one with m.p. 180-182°C (from ether), c) from 3,4-dihydroxy-5-nitrobenzophenone 3,4-dipivaloyloxy-5-nitrobenzophenone with m.p. 101-103°C (from t-butyl methyl ether) and d) from 2'-fluoro-3,4-dihydroxy-5-nitrobenzophenone 3,4-dipiva-loyloxy-2'-fluorobenzophenone with m.p. 74-76°C (from petroleum ether
ts.) . ts.) .
Eksempel 3 5 Example 3 5
Man oppvarmer en løsning av 1,7 g 3-(3,4-dihydroksy-5-nitrofenyl)-2(1H)-kinoksalinon i 17 ml oenantsyreanhydrid i nærvær av en katalytisk mengde kons. svovelsyre i 17 timer ved 110°c, avdestillerer så overskuddet av anhydrid i høyvakuum, oppløser resten i metylenklorid, vasker den organiske løsningen med vann, tørker det over natriumsulfat, filtrerer og inndamper. Man får 5-(l,2-dihydro-2-okso-3-kinoksalinyl)-3-nitro-o-fenylen-diheptanoat med smp. 186-188°C (fra metylenklorid/eter). A solution of 1.7 g of 3-(3,4-dihydroxy-5-nitrophenyl)-2(1H)-quinoxalinone in 17 ml of enonic anhydride is heated in the presence of a catalytic amount of conc. sulfuric acid for 17 hours at 110°c, then distills off the excess of anhydride under high vacuum, dissolves the residue in methylene chloride, washes the organic solution with water, dries it over sodium sulfate, filters and evaporates. 5-(1,2-dihydro-2-oxo-3-quinoxalinyl)-3-nitro-o-phenylene diheptanoate is obtained with m.p. 186-188°C (from methylene chloride/ether).
Eksempel 3 6 Example 3 6
a) Til en løsning av 1,35 g 2-brom-3',4'-dihydroksy-5'-nitro-acetof enon i 25 ml alkohol setter man 1,26 g natriumacetat og a) To a solution of 1.35 g of 2-bromo-3',4'-dihydroxy-5'-nitro-acetophenone in 25 ml of alcohol, add 1.26 g of sodium acetate and
oppvarmer under tilbakeløp til kokepunktet. Etter 6 timer filtreres det utskilte natriumbromid fra reaksjonsblandingen og heats during reflux to the boiling point. After 6 hours, the separated sodium bromide is filtered from the reaction mixture and
inndampes. Resten oppløses i eddikester. Man vasker med mettet koksaltløsning, tørker over natriumsulfat, filtrerer og inndamper ved 50°C. Man får (3,4-dihydroksy-5-nitrobenzoyl)metylacetat med smp. 166-168°C (fra eddikester/eter). is evaporated. The rest is dissolved in vinegar. Wash with saturated sodium chloride solution, dry over sodium sulphate, filter and evaporate at 50°C. This gives (3,4-dihydroxy-5-nitrobenzoyl)methyl acetate with m.p. 166-168°C (from acetic acid/ether).
På analog måte får man: Analogously, you get:
b) Fra 2-brom-3',4'-dihydroksy-5'-nitroacetofenon og natrium-isobutyrat (3,4-dihydroksy-5-nitrobenzoyl)metylisobutyrat med b) From 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and sodium isobutyrate (3,4-dihydroxy-5-nitrobenzoyl)methyl isobutyrate with
smp. 120-122°C (fra eddikester/eter) og m.p. 120-122°C (from acetic acid/ether) and
c) fra 2-brom-3',4'-dihydroksy-5'-nitroacetofenon og 3,4-dihydroksy-5-nitrofenylglyoksylsyre-natriumsalt 3,4-dihydroksy-S-nitrofenacyl (3 ,4-dihydroksy-5-nitrobenzoyl) format med smp. 224-226°C (fra metanol/eddikester). c) from 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and 3,4-dihydroxy-5-nitrophenylglyoxylic acid sodium salt 3,4-dihydroxy-S-nitrophenacyl (3,4-dihydroxy-5-nitrobenzoyl ) format with m.p. 224-226°C (from methanol/acetic acid).
Eksempel 37 Example 37
Man blander en suspensjon av 2,91 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med 1,31 g tionikotinamid i 50 ml alkohol og oppvarmer i 2 timer under tilbakeløp ved kokepunktet. Etter avkjøling til romtemperatur filtrerer man krystallene fra og omkrystalliserer dem fra N,N-dimetylformamid/alkohol. Man får 3-nitro-5-[2-(3-pyridyl)-4-tiazolyl]pyrokatekol med smp. 279-281°C. A suspension of 2.91 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is mixed with 1.31 g of thionicotinamide in 50 ml of alcohol and heated for 2 hours under reflux at the boiling point. After cooling to room temperature, the crystals are filtered off and recrystallized from N,N-dimethylformamide/alcohol. 3-nitro-5-[2-(3-pyridyl)-4-thiazolyl]pyrocatechol with m.p. 279-281°C.
Eksempel 38 Example 38
En løsning av 5,52 g 2-brom-3',4'-dihydroksy-5'-nitroaceto-fenon og 2,7 g 2-aminoacetofenon i 100 ml tørt N,N-dimetylformamid røres ved 90°C i 24 timer. Man inndamper reaksjonsblandingen, oppløser resten i eddikester, vasker med vann, tørker over natriumsulfat, filtrerer og inndamper. Man får 2-(3,4-dihyd-roksy-5-nitrobenzoyl)-3-metylindol med smp. 212-214°C (fra n-butanol). A solution of 5.52 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and 2.7 g of 2-aminoacetophenone in 100 ml of dry N,N-dimethylformamide is stirred at 90°C for 24 hours . The reaction mixture is evaporated, the residue is dissolved in acetic acid, washed with water, dried over sodium sulphate, filtered and evaporated. 2-(3,4-dihydroxy-5-nitrobenzoyl)-3-methylindole is obtained with m.p. 212-214°C (from n-butanol).
Eksempel 3 9 Example 3 9
Man blander en suspensjon av 7,32 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med 4,06 g 1-(3-pyridinyl)-2-tiourea i 100 ml n-butanol og oppvarmer i 3 timer under tilbakeløp ved kokepunktet. Etter avkjøling til romtemperatur filtrerer man krystallene fra og omkrystalliserer dem fra n-butanol. Man får 3-nitro-5-[2-(3-pyridylamino)-4-tiazolyl]pyrokatekol-hydrobromid med smp. A suspension of 7.32 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is mixed with 4.06 g of 1-(3-pyridinyl)-2-thiourea in 100 ml of n-butanol and heated in 3 hours under reflux at the boiling point. After cooling to room temperature, the crystals are filtered off and recrystallized from n-butanol. 3-nitro-5-[2-(3-pyridylamino)-4-thiazolyl]pyrocatechol hydrobromide with m.p.
>300°C. >300°C.
Eksempel 4 0 Example 4 0
Man blander en suspensjon av 6,35 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med 4,68 g 1-(3-kinolinyl)-2-tiourea i 150 ml n-butanol og oppvarmer i 3 timer under tilbakeløp ved kokepunktet. Etter avkjøling til romtemperatur frafiltrerer man krystallene og omkrystalliserer dem fra n-butanol. Man får 3-nitro-5-[2-(3-kinolinylamino)-4-tiazolyl]pyrokatekol-hydrobromid med smp. >3 00°C. A suspension of 6.35 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is mixed with 4.68 g of 1-(3-quinolinyl)-2-thiourea in 150 ml of n-butanol and heated in 3 hours under reflux at the boiling point. After cooling to room temperature, the crystals are filtered off and recrystallized from n-butanol. 3-nitro-5-[2-(3-quinolinylamino)-4-thiazolyl]pyrocatechol hydrobromide with m.p. >300°C.
Eksempel 41 Example 41
Man blander en suspensjon av 8,28 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med 6,37 g rac-1-(2-ekso-bornyl)-2-tiourea i 100 ml n-butanol og oppvarmer i 3 timer under tilbakeløp ved kokepunktet. Etter avkjøling til romtemperatur filtrerer man krystallene fra og omkrystalliserer dem fra n-butnol. Man får rac-3-nitro-5-[2-(2-ekso-bornylamino)-4-tiazolyl]-pyrokatekol-hydrobromid med smp. 262-264°C. A suspension of 8.28 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is mixed with 6.37 g of rac-1-(2-exo-bornyl)-2-thiourea in 100 ml of n- butanol and heat for 3 hours under reflux at the boiling point. After cooling to room temperature, the crystals are filtered off and recrystallized from n-butnol. Rac-3-nitro-5-[2-(2-exo-bornylamino)-4-thiazolyl]-pyrocatechol hydrobromide is obtained with m.p. 262-264°C.
Eksempel 42 Example 42
Man blander 0,875 ml pyrrolidin i 35 ml tetrahydrofuran ved 5°C med 0,605 ml eddiksyre og så med 1,73 g 3,4-dihydroksy-5-nitrobenzaldehyd og 2,87 g 6-okso-4'-(trifluormetyl)heptanilid og rører i 56 timer under argon ved 2 3°C. Resten man får etter inndampning av reaksjonsblandingen fordeles mellom etylacetat og lN-natronlut. Man surgjør de samlede natronlutekstrakter med kons. saltsyre, ekstraherer med etylacetat, vasker de samlede etylacetatekstrakter med mettet koksaltløsning, tørker over natriumsulfat, inndamper og kromatograferer resten på 120 g kiselgel med metylenklorid/metanol (91:9). Etter omkrystallisering fra etylacetat/petroleter får man (E)-8-(3,4-dihydroksy-S-nitrofenyl) -6-okso-4 ' - (trif luormetyl) -7-octenanilid med smp. 194-197°C. 0.875 ml of pyrrolidine is mixed in 35 ml of tetrahydrofuran at 5°C with 0.605 ml of acetic acid and then with 1.73 g of 3,4-dihydroxy-5-nitrobenzaldehyde and 2.87 g of 6-oxo-4'-(trifluoromethyl)heptanilide and stirring for 56 hours under argon at 2 3°C. The residue obtained after evaporation of the reaction mixture is distributed between ethyl acetate and 1N caustic soda. The combined caustic soda extracts are acidified with conc. hydrochloric acid, extract with ethyl acetate, wash the combined ethyl acetate extracts with saturated sodium chloride solution, dry over sodium sulphate, evaporate and chromatograph the residue on 120 g silica gel with methylene chloride/methanol (91:9). After recrystallization from ethyl acetate/petroleum ether, (E)-8-(3,4-dihydroxy-S-nitrophenyl)-6-oxo-4'-(trifluoromethyl)-7-octenanilide is obtained with m.p. 194-197°C.
Eksempel 43 Example 43
a) 26,0 g 2-klor-3-hydroksy-p-anisaldehyd oppløses i 400 ml eddiksyreanhydrid og 5 ml pyridin. Man rører 8 timer ved 80°C, inndamper så reaksjonsblandingen, fordeler resten mellom isvann og metylenklorid, tørker den organiske fasen over natriumsulfat, inndamper og omkrystalliserer resten fra metylenklorid/petroleter. Man får 2-klor-3-formyl-6-metoksyfenyl-acetat med smp. 48-50°C. b) 38 g 2-klor-3-formyl-6-metoksyfenyl-acetat innføres ved -5°C til -10°C i løpet av 15 min. porsjonsvis i 150 ml 98% salpetersyre. Etter 30 min. røring ved -5°C helles reaksjonsblandingen på 1,5 1 isvann og ekstraheres 3 ganger med 500 ml metylenklorid. De samlede organiske faser vaskes med isvann, tørkes over natriumsulfat og inndampes. Resten krystalliseres fra eter. Man får 2-klor-3-formyl-6-metoksy-5-nitrofenyl-acetat med smp. 84-85°C. c) 35,8 g 2-klor-3-formyl-6-metoksy-5-nitrofenyl-acetat oppløses i 300 ml metanol. Etter tilsetning av 145 ml 1N-natronlut røres 1 time ved 23°C. Etter fordampning av metanolen fortynner man resten med isvann, surgjør med 2N-saltsyre og ekstraherer to ganger med 400 ml etylacetat hver gang. De organiske fasene vaskes med mettet koksaltløsning, tørkes over natriumsulfat og inndampes. Resten omkrystalliseres fra metylenklorid/petroleter. Man får 2-klor-3-hydroksy-5-nitro-p-anisalde-hyd med smp. 130°C. d) Man oppløser 1,3 g 2-klor-3-hydroksy-5-nitro-p-anisaldehyd i 80 ml metylenklorid, blander med 0,82 ml bortribromid, rører i 18 timer ved 23°C, blander reaksjonsblandingen under iskjøling med 5 ml metanol, inndamper, tørker resten i høyvakuum, gnir i vann, filtrerer og omkrystalliserer fra acetonitril. Man får 2-klor-3,4-dihydroksy-5-nitrobenzaldehyd med smp. 193-195°C. a) Dissolve 26.0 g of 2-chloro-3-hydroxy-p-anisaldehyde in 400 ml of acetic anhydride and 5 ml of pyridine. Stir for 8 hours at 80°C, then evaporate the reaction mixture, distribute the residue between ice water and methylene chloride, dry the organic phase over sodium sulfate, evaporate and recrystallize the residue from methylene chloride/petroleum ether. 2-Chloro-3-formyl-6-methoxyphenyl acetate is obtained with m.p. 48-50°C. b) 38 g of 2-chloro-3-formyl-6-methoxyphenyl-acetate are introduced at -5°C to -10°C during 15 minutes. portionwise in 150 ml 98% nitric acid. After 30 min. stirring at -5°C, the reaction mixture is poured into 1.5 l of ice water and extracted 3 times with 500 ml of methylene chloride. The combined organic phases are washed with ice water, dried over sodium sulphate and evaporated. The residue is crystallized from ether. 2-Chloro-3-formyl-6-methoxy-5-nitrophenyl acetate is obtained with m.p. 84-85°C. c) Dissolve 35.8 g of 2-chloro-3-formyl-6-methoxy-5-nitrophenyl acetate in 300 ml of methanol. After adding 145 ml of 1N caustic soda, stir for 1 hour at 23°C. After evaporation of the methanol, the residue is diluted with ice water, acidified with 2N hydrochloric acid and extracted twice with 400 ml of ethyl acetate each time. The organic phases are washed with saturated sodium chloride solution, dried over sodium sulphate and evaporated. The residue is recrystallized from methylene chloride/petroleum ether. This gives 2-chloro-3-hydroxy-5-nitro-p-anisalde-hyde with m.p. 130°C. d) Dissolve 1.3 g of 2-chloro-3-hydroxy-5-nitro-p-anisaldehyde in 80 ml of methylene chloride, mix with 0.82 ml of boron tribromide, stir for 18 hours at 23°C, mix the reaction mixture under ice cooling with 5 ml of methanol, evaporate, dry the residue in high vacuum, triturate in water, filter and recrystallize from acetonitrile. 2-Chloro-3,4-dihydroxy-5-nitrobenzaldehyde is obtained with m.p. 193-195°C.
Eksempel 44 Example 44
a) Man rører en blanding av 30 g 2-klor-3-hydroksy-p-anisalde-hyd og 230 ml etanol i nærvær av 12,3 g hydroksylaminhydroklorid a) A mixture of 30 g of 2-chloro-3-hydroxy-p-anisaldehyde and 230 ml of ethanol is stirred in the presence of 12.3 g of hydroxylamine hydrochloride
i 4 timer ved 70°C, inndamper så reaksjonsblandingen, tørker resten i høyvakuum og omkrystalliserer fra metanol/vann. Man får 2- klor-3-hydroksy-p-anisaldehyd-oksim med smp. 174-176°C. for 4 hours at 70°C, then evaporate the reaction mixture, dry the residue under high vacuum and recrystallize from methanol/water. 2-Chloro-3-hydroxy-p-anisaldehyde oxime is obtained with m.p. 174-176°C.
b) 21 g 2-klor-3-hydroksy-p-anisaldehyd-oksim oppvarmes med 400 ml eddiksyreanhydrid i 20 timer under tilbakeløp. Derpå b) 21 g of 2-chloro-3-hydroxy-p-anisaldehyde oxime is heated with 400 ml of acetic anhydride for 20 hours under reflux. Then
inndamper man reaksjonsblandingen, blander resten med 300 ml isvann, rører 1 time, dekanterer, fordeler den således erholdte rest mellom metylenklorid og vann, tørker den organiske fasen over natriumsuflat, inndamper, tørker resten i høyvakuum, kromatograferer denne på 2 00 g kiselgel med metylenklorid og omkrystalliserer fra metylenklorid/petroleter. Man får 2-klor-3- cyano-6-metoksyfenyl-acetat med smp. 97-99°C. c) Analogt med eksemplene 43b og 43c får man ut fra 2-klor-3-cyano-6-metoksyfenyl-acetat 2-klor-3-hydroksy-5-nitro-p-anisoni-tril med smp. 157-159°C (metylenklorid/heksan). d) Analogt med eksempel 4 3d får man ut fra 2-klor-3-hydroksy-5-nitro-p-anisonitril 2-klor-3,4-dihydroksy-5-nitrobenzonitril the reaction mixture is evaporated, the residue is mixed with 300 ml of ice water, stirred for 1 hour, decanted, the residue thus obtained is distributed between methylene chloride and water, the organic phase is dried over sodium sulfate, evaporated, the residue is dried in high vacuum, this is chromatographed on 200 g silica gel with methylene chloride and recrystallizes from methylene chloride/petroleum ether. 2-Chloro-3-cyano-6-methoxyphenyl acetate is obtained with m.p. 97-99°C. c) Analogous to examples 43b and 43c, 2-chloro-3-cyano-6-methoxyphenyl-acetate gives 2-chloro-3-hydroxy-5-nitro-p-anisonitrile with m.p. 157-159°C (methylene chloride/hexane). d) Analogous to example 4 3d, 2-chloro-3-hydroxy-5-nitro-p-anisonitrile yields 2-chloro-3,4-dihydroxy-5-nitrobenzonitrile
med smp. 180°C (acetonitril). with m.p. 180°C (acetonitrile).
Eksempel 45 Example 45
a) 5,5 g a-klor-2-fluor-3,4-dimetoksytoluen og 4,05 g kalium-acetat røres i 50 ml dimetylformamid i 25 timer ved 80°C. Så a) 5.5 g of α-chloro-2-fluoro-3,4-dimethoxytoluene and 4.05 g of potassium acetate are stirred in 50 ml of dimethylformamide for 25 hours at 80°C. So
helles reaksjonsblandingen på 150 ml isvann og ekstraheres med eter. Eterfåsene vaskes med koksaltløsning, tørkes over natriumsulfat og inndampes. Man får 2-fluor-3,4-dimetoksybenzyl-acetat som olje. b) 5,4 g 2-fluor-3,4-dimetoksybenzyl-acetat oppvarmes sammen med 50 ml metanol og 50 ml 1 N-natronlut i 1,5 timer ved 80°C. the reaction mixture is poured into 150 ml of ice water and extracted with ether. The ether layers are washed with sodium chloride solution, dried over sodium sulfate and evaporated. 2-fluoro-3,4-dimethoxybenzyl acetate is obtained as an oil. b) 5.4 g of 2-fluoro-3,4-dimethoxybenzyl acetate are heated together with 50 ml of methanol and 50 ml of 1N sodium hydroxide solution for 1.5 hours at 80°C.
Etter fordampning av metanolen ekstraheres resten med metylenklorid. De samlede ekstrakter vaskes med vann, tørkes over natriumsulfat og inndampes. Man kromatograferer resten på 80 g kiselgel med metylenklorid/metanol (95:5). Man får 2-fluor-3,4-dimetok-sybenzyl-alkohol som olje. c) 3,0 g 2-fluor-3,4-dimetoksybenzylalkohol og 5,0 g mangandioksyd oppvarmes sammen med 50 ml benzen 1 time under tilbake-løp. Så frafiltreres de uløselige deler under vasking med metylenklorid. Filtratet inndampes og resten omkrystalliseres fra metylenklorid/heksan. Man får 2-fluor-3,4-dimetoksybenzal-dehyd med smp. 52-54°C. d) 4,4 g 2-fluor-3,4-dimetoksybenzaldehyd og 1,83 g hydroksylaminhydroklorid oppvarmes sammen med 3 0 ml etanol 5 timer under tilbakeløp. Så inndampes reaksjonsblandingen og resten som er tørket i høyvakuum ved 23°C innføres i 40 ml fosforoksyklorid. Etter 2,5 timers røring ved 23°C inndamper man reaksjonsblandingen , behandler resten med isvann, filtrerer den derved dannede felling fra, vasker med vann, opptar i metylenklorid, tørker metylenkloridløsningen over natriumsulfat og inndamper. Ved omkrystallisering av resten fra metylenklorid/heksan får man 2-fluor-3,4-dimetoksybenzonitril med smp. 64-65°C. After evaporation of the methanol, the residue is extracted with methylene chloride. The combined extracts are washed with water, dried over sodium sulphate and evaporated. The residue is chromatographed on 80 g of silica gel with methylene chloride/methanol (95:5). 2-fluoro-3,4-dimethoxybenzyl alcohol is obtained as an oil. c) 3.0 g of 2-fluoro-3,4-dimethoxybenzyl alcohol and 5.0 g of manganese dioxide are heated together with 50 ml of benzene for 1 hour under reflux. The insoluble parts are then filtered off while washing with methylene chloride. The filtrate is evaporated and the residue is recrystallized from methylene chloride/hexane. 2-Fluoro-3,4-dimethoxybenzaldehyde is obtained with m.p. 52-54°C. d) 4.4 g of 2-fluoro-3,4-dimethoxybenzaldehyde and 1.83 g of hydroxylamine hydrochloride are heated together with 30 ml of ethanol for 5 hours under reflux. The reaction mixture is then evaporated and the residue, which has been dried in a high vacuum at 23°C, is introduced into 40 ml of phosphorus oxychloride. After stirring for 2.5 hours at 23°C, the reaction mixture is evaporated, the residue is treated with ice water, the resulting precipitate is filtered off, washed with water, taken up in methylene chloride, the methylene chloride solution is dried over sodium sulfate and evaporated. Recrystallization of the residue from methylene chloride/hexane yields 2-fluoro-3,4-dimethoxybenzonitrile with m.p. 64-65°C.
e) Man oppløser 2,0 g 2-fluor-3,4-dimetoksybenzonitril i 60 ml metylenklorid, vasker med 1,1 ml bortribromid, rører 1 time ved e) Dissolve 2.0 g of 2-fluoro-3,4-dimethoxybenzonitrile in 60 ml of methylene chloride, wash with 1.1 ml of boron tribromide, stir for 1 hour at
23°C, blander så med ytterligere 1,0 ml bortribromid og rører ytterligere 80 min. ved 23°C. Deretter helles reaksjonsblandin- 23°C, then mix with a further 1.0 ml of boron tribromide and stir for a further 80 min. at 23°C. The reaction mixture is then poured
gen på 100 ml iskald mettet natriumhydrogenkarbonatløsning, hvorpå man ekstraherer to ganger med 3 00 ml eter, vasker de samlede eterfaser to ganger med koksaltløsning, tørker over natriumsulfat, inndamper og kromatograferer resten på 50 g kiselgel med metylenklorid og metylenklorid/metanol (97:3). Man får 2-fluor-3-hydroksy-p-anisonitril med smp. 198-200°C. gen on 100 ml of ice-cold saturated sodium hydrogencarbonate solution, after which you extract twice with 300 ml of ether, wash the combined ether phases twice with sodium chloride solution, dry over sodium sulfate, evaporate and chromatograph the residue on 50 g of silica gel with methylene chloride and methylene chloride/methanol (97:3 ). 2-Fluoro-3-hydroxy-p-anisonitrile is obtained with m.p. 198-200°C.
f) 0,9 g 2-fluor-3-hydroksy-p-anisonitril oppløses i 10 ml eddiksyreanhydrid og 0,5 ml pyridin, hvoretter man rører 2 timer f) 0.9 g of 2-fluoro-3-hydroxy-p-anisonitrile is dissolved in 10 ml of acetic anhydride and 0.5 ml of pyridine, after which it is stirred for 2 hours
ved 120°C. Så inndampes reaksjonsblandingen og resten fordeles mellom isvann og metylenklorid. Den organiske fasen tørkes over natriumsulfat og inndampes, og resten omkrystalliseres fra metylenklorid/heksan. Man får 3-cyano-2-fluor-6-metoksyfenyl-acetat med smp. 90-91°C. at 120°C. The reaction mixture is then evaporated and the residue is distributed between ice water and methylene chloride. The organic phase is dried over sodium sulfate and evaporated, and the residue is recrystallized from methylene chloride/hexane. 3-cyano-2-fluoro-6-methoxyphenyl acetate is obtained with m.p. 90-91°C.
g) 0,8 g 3-cyano-2-fluor-6-metoksyfenyl-acetat innføres i tre porsjoner ved -15°C i 5 ml 96%-ig salpetersyre, hvorpå man rører g) 0.8 g of 3-cyano-2-fluoro-6-methoxyphenyl-acetate is introduced in three portions at -15°C in 5 ml of 96% nitric acid, after which stirring
1 time ved -10°C. Deretter helles reaksjonsblandingen på 50 g is. Man ekstraherer to ganger med hver gang 70 ml etylacetat. De samlede organiske faser vaskes med mettet natriumkloridløs-ning, tørkes over natriumsulfat og inndampes. Den således erholdte rest oppløses i 50 ml 1 N-natriumkarbonatløsning og 50 ml metanol, hvoretter man rører 1 time ved 23°C, og destillerer vekk metanolen. Den gjenværende vandige fase innstilles ved 0°C med kons. saltsyre på pH 2 og ekstraherer to ganger med 1 hour at -10°C. The reaction mixture is then poured onto 50 g of ice. The mixture is extracted twice with 70 ml of ethyl acetate each time. The combined organic phases are washed with saturated sodium chloride solution, dried over sodium sulfate and evaporated. The residue thus obtained is dissolved in 50 ml of 1 N sodium carbonate solution and 50 ml of methanol, after which it is stirred for 1 hour at 23°C, and the methanol is distilled off. The remaining aqueous phase is set at 0°C with conc. hydrochloric acid at pH 2 and extract twice with
100 ml etylacetat. De forenede organiske faser vaskes med mettet natriumkloridløsning, tørkes over natriumsulfat og inndampes, og resten kromatograferes på 45 g kiselgel med metylenklorid/metanol (97:3). Man får etter omkrystallisering fra eter/heksan 2-fluor-3-hydroksy-5-nitro-p-anisonitril med smp. 112-113°C. h) 550 mg 2-fluor-3-hydroksy-5-nitro-p-anisonitril oppløses i 30 ml metylenklorid, hvoretter man blander med 0,44 ml bortribromid. Etter 6 timers røring ved 23°C tilsettes ytterligere 0,1 ml bortribromid, hvorpå man rører 1,5 timer ved 23°C. Deretter tilsettes 3 ml etanol ved -15°C. Reaksjonsblandingen inndampes og resten tørkes ved 23°C i høyvakuum. Ved omkrystallisering fra eter/heksan får man 2-fluor-3,4-dihydroksy-5-nitrobenzonitril med smp. 154°C. 100 ml ethyl acetate. The combined organic phases are washed with saturated sodium chloride solution, dried over sodium sulfate and evaporated, and the residue is chromatographed on 45 g of silica gel with methylene chloride/methanol (97:3). After recrystallization from ether/hexane, 2-fluoro-3-hydroxy-5-nitro-p-anisonitrile with m.p. 112-113°C. h) 550 mg of 2-fluoro-3-hydroxy-5-nitro-p-anisonitrile is dissolved in 30 ml of methylene chloride, after which it is mixed with 0.44 ml of boron tribromide. After stirring for 6 hours at 23°C, a further 0.1 ml of boron tribromide is added, after which stirring is done for 1.5 hours at 23°C. 3 ml of ethanol are then added at -15°C. The reaction mixture is evaporated and the residue is dried at 23°C in a high vacuum. Recrystallization from ether/hexane yields 2-fluoro-3,4-dihydroxy-5-nitrobenzonitrile with m.p. 154°C.
Eksempel 4 6 Example 4 6
a) 9,5 g 3,4-dimetoksy-5-nitrobenzosyre oppslemmes i 95 ml tionylklorid. Man rører 1 time ved 80°C. Ved to gangers a) 9.5 g of 3,4-dimethoxy-5-nitrobenzoic acid are suspended in 95 ml of thionyl chloride. Stir for 1 hour at 80°C. At two times
inndampning under tilsetning av absolutt toluen får man 10 g 3,4-dimetoksy-5-nitrobenzosyreklorid, som oppløses i 100 ml tetrahydrofuran. Denne løsningen dryppes til 300 ml 28% vandig ammoniakk.- Så røres 2 timer ved 40°C og avkjøles til 5°C. Den krystallinske felling frafiltreres. Man får 3,4-dimetoksy-5-nitrobenzamid med smp. 182-185°C. evaporation with the addition of absolute toluene yields 10 g of 3,4-dimethoxy-5-nitrobenzoic acid chloride, which is dissolved in 100 ml of tetrahydrofuran. This solution is dripped into 300 ml of 28% aqueous ammonia. - Then stirred for 2 hours at 40°C and cooled to 5°C. The crystalline precipitate is filtered off. You get 3,4-dimethoxy-5-nitrobenzamide with m.p. 182-185°C.
b) Under iskjøling innføres 2,46 g klor i en blanding av 8,0 g natriumhydroksyd, 50 ml vann og 3 0 g is. Deretter tilsettes b) During ice cooling, 2.46 g of chlorine are introduced into a mixture of 8.0 g of sodium hydroxide, 50 ml of water and 30 g of ice. Then added
langsomt 6,5 g 3,4-dimetoksy-5-nitrobenzamid, oppslemmet i 5 ml tetrahydrofuran. Man oppvarmer reaksjonsblandingen i løpet av 30 min. til 70°C, rører 1 time ved 70°C, avkjøler til 5°C og filtrerer de utfelte krystaller fra. Man får 3,4-dimetoksy-5-nitroanilin med smp. 129-131°C. Ved ekstraksjon av filtratet med etylacetat, tørking av ekstraktene over natriumsulfat, inndampning og krystallisering av resten under tilsetning av eter kan en ytterligere porsjon 3,4-dimetoksy-5-nitroanilin oppnås. slowly 6.5 g of 3,4-dimethoxy-5-nitrobenzamide, suspended in 5 ml of tetrahydrofuran. The reaction mixture is heated for 30 min. to 70°C, stir for 1 hour at 70°C, cool to 5°C and filter off the precipitated crystals. 3,4-dimethoxy-5-nitroaniline is obtained with m.p. 129-131°C. By extracting the filtrate with ethyl acetate, drying the extracts over sodium sulfate, evaporating and crystallizing the residue while adding ether, a further portion of 3,4-dimethoxy-5-nitroaniline can be obtained.
c) 10 g finpulverisert 3,4-dimetoksy-5-nitroanilin oppslemmes i 15 ml 12 N-saltsyre og 4 0 ml vann, hvoretter man rører 1 time ved c) 10 g of finely powdered 3,4-dimethoxy-5-nitroaniline is suspended in 15 ml of 12 N-hydrochloric acid and 40 ml of water, after which it is stirred for 1 hour at
30°C. Deretter tildryppes ved -5°C 3,8 g natriumnitritt oppløst i 20 ml vann i løpet av 15 min.. Man rører 30 min. ved -5°C og tildrypper den kalde diazoniumsaltløsning i løpet av 45 min. til 100 ml pyridin på 40°C. Så røres 1 time ved 70°C. Reaksjonsblandingen inndampes og resten opptas i 300 ml etylacetat. Det ekstraheres tre ganger med 200 ml 2 N-saltsyre hver gang. Den sure vannfasen innstilles på pH 9 med kons. ammoniakk og ekstraheres med metylenklorid. De samlede metylenkloridekstrakter tørkes over natriumsulfat og inndampes, og resten kromatograferes på 250 g kiselgel med etylacetat. Man får etter krystallisering fra metylenklorid/heksan 2-(3,4-dimetoksy-5-nitrofenyl)pyridin med smp. 89-90°C. 30°C. Then, at -5°C, 3.8 g of sodium nitrite dissolved in 20 ml of water are added dropwise over the course of 15 min. The mixture is stirred for 30 min. at -5°C and drips the cold diazonium salt solution over the course of 45 min. to 100 ml of pyridine at 40°C. Then stir for 1 hour at 70°C. The reaction mixture is evaporated and the residue is taken up in 300 ml of ethyl acetate. It is extracted three times with 200 ml of 2 N hydrochloric acid each time. The acidic water phase is adjusted to pH 9 with conc. ammonia and extracted with methylene chloride. The combined methylene chloride extracts are dried over sodium sulphate and evaporated, and the residue is chromatographed on 250 g of silica gel with ethyl acetate. After crystallization from methylene chloride/hexane, 2-(3,4-dimethoxy-5-nitrophenyl)pyridine is obtained with m.p. 89-90°C.
d) 1,5 g 2-(3,4-dimetoksy-5-nitrofenyl)pyridin oppløses i 30 ml 48% vandig hydrogenbromid. Reaksjonsblandingen røres 16 timer ved 100°C og 18 timer ved 23°C. Den derved dannede felling frafiltreres og omkrystalliseres fra metanol/eter. Man får 3-nitro-5-(2-pyridyl)pyrokatekol-hydrobromid med smp. 239-240°C. d) 1.5 g of 2-(3,4-dimethoxy-5-nitrophenyl)pyridine is dissolved in 30 ml of 48% aqueous hydrogen bromide. The reaction mixture is stirred for 16 hours at 100°C and 18 hours at 23°C. The resulting precipitate is filtered off and recrystallized from methanol/ether. 3-nitro-5-(2-pyridyl)pyrocatechol hydrobromide with m.p. 239-240°C.
Eksempel 4 7 Example 4 7
a) 2,76 ml 2-brompyridin oppløst i 30 ml absolutt tetrahydrofuran blandes ved -60°C i løpet av 30 min. med 19,2 ml 1,6 M n-butyllitiumløsning (i heksan), hvoretter man rører 3 0 min. ved 60°C. Så tildryppes 6,0 g 3,4-dimetoksy-5-nitrobenzaldehyd oppløst i 50 ml tetrahydrofuran i løpet av 30 min. ved -40°C. Reaksjonsblandingen oppvarmes i løpet av 2 timer til 0°C, helles på isvann og ekstraheres med etylacetat. De samlede ekstrakter tørkes over natriumsulfat og inndampes, og resten kromatograferes på 200 g kiselgel med etylacetat. Man får a-(3,4-dimetoksy-5-nitrofenyl)-2-pyridinmetanol som brun olje. b) Til 4,0 g a-(3,4-dimetoksy-5-nitrofenyl)-2-pyridinmetanol oppløst i 100 ml aceton settes under stadig oppvarming og a) 2.76 ml of 2-bromopyridine dissolved in 30 ml of absolute tetrahydrofuran are mixed at -60°C during 30 min. with 19.2 ml of 1.6 M n-butyllithium solution (in hexane), after which it is stirred for 30 min. at 60°C. Then 6.0 g of 3,4-dimethoxy-5-nitrobenzaldehyde dissolved in 50 ml of tetrahydrofuran are added dropwise over the course of 30 minutes. at -40°C. The reaction mixture is heated to 0°C over 2 hours, poured onto ice water and extracted with ethyl acetate. The combined extracts are dried over sodium sulfate and evaporated, and the residue is chromatographed on 200 g of silica gel with ethyl acetate. α-(3,4-dimethoxy-5-nitrophenyl)-2-pyridinemethanol is obtained as a brown oil. b) Add 4.0 g of a-(3,4-dimethoxy-5-nitrophenyl)-2-pyridinemethanol dissolved in 100 ml of acetone under constant heating and
tilbakeløp over et tidsrom på 2,5 timer porsjonsvis 7 g mangandioksyd. Deretter oppvarmes videre 2 timer under tilbakeløp. Så frafiltreres mangansaltene og resten man får etter inndampning omkrystalliseres fra eter/heksan. Man får 3,4-dimetoksy-5-nitrofenyl-2-pyridylketon med smp. 113°C. reflux over a period of 2.5 hours portionwise 7 g of manganese dioxide. It is then heated under reflux for a further 2 hours. The manganese salts are then filtered off and the residue obtained after evaporation is recrystallized from ether/hexane. 3,4-dimethoxy-5-nitrophenyl-2-pyridyl ketone is obtained with m.p. 113°C.
c) 1,5 g 3,4-dimetoksy-5-nitrofenyl-2-pyridylketon oppløst i 30 ml 48% hydrogenbromid røres 18 timer ved 100°C. Deretter c) 1.5 g of 3,4-dimethoxy-5-nitrophenyl-2-pyridyl ketone dissolved in 30 ml of 48% hydrogen bromide is stirred for 18 hours at 100°C. Then
inndampes reaksjonsblandingen og resten omkrystalliseres fra acetonitril/metanol. Man får 3,4-dihydroksy-5-nitrofenyl-2-pyridylketon-hydrobromid med smp. 213°C. the reaction mixture is evaporated and the residue is recrystallized from acetonitrile/methanol. This gives 3,4-dihydroxy-5-nitrophenyl-2-pyridyl ketone hydrobromide with m.p. 213°C.
Eksmpel 4 8 Example 4 8
a) Til 2,25 g 3',4'-dimetoksy-5'-nitroacetofenon oppløst i 50 ml etanol settes 11,3 g tinndiklorid-dihydrat hvoretter man a) 11.3 g of tin dichloride dihydrate is added to 2.25 g of 3',4'-dimethoxy-5'-nitroacetophenone dissolved in 50 ml of ethanol, after which
rører 30 min. ved 75°C. Deretter helles reaksjonsblandingén på 100 g is, nøytraliseres med 300 ml mettet natriumhydrogenkarbo-natløsning og blandes med 150 ml metylenklorid. Man filtrerer og skiller metylenkloridfasen fra. Denne tørkes over natriumsulfat stirring 30 min. at 75°C. The reaction mixture is then poured onto 100 g of ice, neutralized with 300 ml of saturated sodium bicarbonate solution and mixed with 150 ml of methylene chloride. The methylene chloride phase is filtered and separated. This is dried over sodium sulfate
og inndampes, og resten omkrystalliseres fra eter/petroleter. Man får 5'-amino-3',4'-dimetoksyacetofenon med smp. 63-65°C. and evaporated, and the residue recrystallized from ether/petroleum ether. 5'-amino-3',4'-dimethoxyacetophenone is obtained with m.p. 63-65°C.
b) Til 14,0 g 5'-amino-3',4'-dimetoksyacetofenon opplost i b) To 14.0 g of 5'-amino-3',4'-dimethoxyacetophenone dissolved in
155 ml 1 N-saltsyre dryppes ved 0°C i løpet av 2 0 min. en løsning 155 ml of 1 N-hydrochloric acid is dripped at 0°C over 20 minutes. a solution
av 5,2 g natriumnitritt i 20 ml vann. Etter 30 min. røring ved - 2°C dryppes den kalde diazoniumsaltløsning i løpet av 30 min. ved 5-10°C til en løsning av 8,7 g kobber(I)cyanid og 5,45 g kaliumcyanid i 60 ml vann. Etter ferdig tilsetning tilsettes 200 ml of 5.2 g of sodium nitrite in 20 ml of water. After 30 min. stirring at - 2°C, the cold diazonium salt solution is dripped over the course of 30 min. at 5-10°C to a solution of 8.7 g of copper (I) cyanide and 5.45 g of potassium cyanide in 60 ml of water. After the addition is complete, add 200 ml
metylenklorid, og reaksjonsblandingen røres i 3 timer ved 23°C og filtreres deretter. Den organiske fasen skilles fra, vaskes med vann, tørkes over natriumsulfat og inndampes. Resten omkrystalliseres fra metylenklorid/petroleter. Man får 5'-cyano-3',4'-dimetoksyacetofenon med smp. 125-126°C. methylene chloride, and the reaction mixture is stirred for 3 hours at 23°C and then filtered. The organic phase is separated, washed with water, dried over sodium sulphate and evaporated. The residue is recrystallized from methylene chloride/petroleum ether. 5'-cyano-3',4'-dimethoxyacetophenone is obtained with m.p. 125-126°C.
c) 3,75 g aluminiumpulver og 28,5 g jod oppvarmes i 160 ml absolutt benzen i 2 timer under tilbakeløp. Ved 20°C tilsettes c) 3.75 g of aluminum powder and 28.5 g of iodine are heated in 160 ml of absolute benzene for 2 hours under reflux. At 20°C add
så 3,0 g 5'-cyano-3',4'-dimetoksyacetofenon og 0,5 g tetra-n-butylammoniumjodid, hvoretter man oppvarmer 1 time ved tilbake-løp. Deretter blandes ved 20°C med 50 g is og filtreres. Resten vaskes med etylacetat. Fasene adskilles, og den vandige fasen ekstraheres igjen to ganger med etylacetat. De samlede organiske faser vaskes med 20% natriumtiosulfatløsning, tørkes over natriumsulfat og inndampes. Der derved erholdte rest oppløses i 20 ml eddiksyreanhydrid og 0,5 ml pyridin og røres 6 timer ved 120°C. Så inndampes blandingen og resten fordeles mellom metylenklorid og isvann. Metylenkloridfasen tørkes over natriumsulfat og inndampes, og resten kromatograferes på 100 g kiselgel med metylenklorid. Man får etter omkrystallisering fra eter 5'-cyano-3',4'-diacetoksyacetofenon med smp. 76-79°C. then 3.0 g of 5'-cyano-3',4'-dimethoxyacetophenone and 0.5 g of tetra-n-butylammonium iodide, after which heating is done at reflux for 1 hour. Then mix at 20°C with 50 g of ice and filter. The residue is washed with ethyl acetate. The phases are separated, and the aqueous phase is again extracted twice with ethyl acetate. The combined organic phases are washed with 20% sodium thiosulphate solution, dried over sodium sulphate and evaporated. The resulting residue is dissolved in 20 ml of acetic anhydride and 0.5 ml of pyridine and stirred for 6 hours at 120°C. The mixture is then evaporated and the residue is distributed between methylene chloride and ice water. The methylene chloride phase is dried over sodium sulphate and evaporated, and the residue is chromatographed on 100 g of silica gel with methylene chloride. After recrystallization from ether, 5'-cyano-3',4'-diacetoxyacetophenone with m.p. 76-79°C.
Eksempel 49 Example 49
0,33 g 5'-cyano-3',4'-diacetoksyacetofenon oppløst i 3,3 ml metanol blandes med 2,7 ml 1,0 N natronlut, og reaksjonsblandingen røres 45 min. ved 23°C. Så surgjøres med 2N-saltsyre, fortynnes med 5 ml mettet koksaltløsning og ekstraheres to ganger med 30 ml etylacetat hver gang. De samlede etylacetatfaser tørkes over natriumsuflat og inndampes. Resten omkrystalliseres 0.33 g of 5'-cyano-3',4'-diacetoxyacetophenone dissolved in 3.3 ml of methanol is mixed with 2.7 ml of 1.0 N caustic soda, and the reaction mixture is stirred for 45 min. at 23°C. Then acidify with 2N hydrochloric acid, dilute with 5 ml of saturated sodium chloride solution and extract twice with 30 ml of ethyl acetate each time. The combined ethyl acetate phases are dried over sodium sulfate and evaporated. The rest is recrystallized
fra toluen/acetonitril. Man får 5'-cyano-3',4'-dihydorksyaceto-fenon som brunaktige krystaller som spaltes over 215°C. from toluene/acetonitrile. 5'-cyano-3',4'-dihydroxyacetophenone is obtained as brownish crystals which decompose above 215°C.
Eksempel 50 Example 50
a) Til 1,9 g 5'-cyano-3',4'-dimetoksyacetofenon oppløst i 30 ml tetrahydrofuran dryppes ved romtemperatur i løpet av 4 5 min. 3,48 g fenyltrimetylammoniumbromid-dibromid oppløst i 30 ml tetrahydrofuran, hvoretter man rører 30 min.. Deretter helles reaksjonsblandingen på 120 ml isvann og ekstraheres tre ganger med 70 ml metylenklorid. De samlede metylenkloridfasene vaskes med 2N-svovelsyre, tørkes over natriumsulfat og inndampes. Resten kromatograferes på 20 g kiselgel med metylenklorid. Man får etter omkrystallisering fra metylenklorid/heksan 5-(brom-acetyl)-2,3-dimetoksybenzonitril med smp. 138-141°C. b) 1,45 g 5-(bromacetyl)-2,3-dimetoksybenzonitril og 1,12 g selendioksyd røres i 10 ml n-heksanol 18 timer ved 120°C. Etter avkjøling til romtemperatur fortynnes med 2 0 ml metylenklorid og filtreres. Filtratet vaskes med vann, tørkes over natriumsulfat og inndampes. Resten kromatograferes på 70 g kiselgel med heksan/eter (2:1). Man får heksyl-(3-cyano-4,5-dimetoksyfenyl)-glyoksylat som olje. c) Til 4,0 g heksyl-(3-cyano-4,5-dimetoksyfenyl)glyoksylat oppløst i 100 ml metylenklorid dryppes under iskjøling i løpet av 20 min. 4,8 ml bortribromid oppløst i 20 ml metylenklorid, og reaksjonsblandingen røres i 18 timer ved romtemperatur. Så dryppes 40 ml metanol til ved -60°C, røres 1 time ved romtemperatur og inndampes. Resten tas opp i metanol. Det oppvarmes 10 min. under tilbakeløp, inndampes til tørrhet og tørkes i høyvakuum. Det således erholdte råprodukt omkrystalliseres fra acetonitril. Man får metyl-(3-cyano-4,5-dihydroksyfenyl)glyoksy-lat med smp. 252°C. a) To 1.9 g of 5'-cyano-3',4'-dimethoxyacetophenone dissolved in 30 ml of tetrahydrofuran is added dropwise at room temperature over 45 minutes. 3.48 g of phenyltrimethylammonium bromide-dibromide dissolved in 30 ml of tetrahydrofuran, after which it is stirred for 30 min. The reaction mixture is then poured into 120 ml of ice water and extracted three times with 70 ml of methylene chloride. The combined methylene chloride phases are washed with 2N sulfuric acid, dried over sodium sulphate and evaporated. The residue is chromatographed on 20 g of silica gel with methylene chloride. After recrystallization from methylene chloride/hexane, 5-(bromoacetyl)-2,3-dimethoxybenzonitrile with m.p. 138-141°C. b) 1.45 g of 5-(bromoacetyl)-2,3-dimethoxybenzonitrile and 1.12 g of selenium dioxide are stirred in 10 ml of n-hexanol for 18 hours at 120°C. After cooling to room temperature, dilute with 20 ml of methylene chloride and filter. The filtrate is washed with water, dried over sodium sulphate and evaporated. The residue is chromatographed on 70 g of silica gel with hexane/ether (2:1). Hexyl-(3-cyano-4,5-dimethoxyphenyl)-glyoxylate is obtained as an oil. c) To 4.0 g of hexyl-(3-cyano-4,5-dimethoxyphenyl)glyoxylate dissolved in 100 ml of methylene chloride is added dropwise under ice cooling during 20 min. 4.8 ml of boron tribromide dissolved in 20 ml of methylene chloride, and the reaction mixture is stirred for 18 hours at room temperature. Then 40 ml of methanol are added dropwise at -60°C, stirred for 1 hour at room temperature and evaporated. The rest is taken up in methanol. It is heated for 10 min. under reflux, evaporated to dryness and dried in high vacuum. The crude product thus obtained is recrystallized from acetonitrile. Methyl-(3-cyano-4,5-dihydroxyphenyl)glyoxylate with m.p. 252°C.
Eksmpel 51 Example 51
1,075 g metyl-(3-cyano-4,5-dihydroksyfenyl)glyoksylat og 0,60 g 2-amino-p-kresol røres 70 min. ved 12 0°C i 2 ml dimetylformamid. Så avkjøles til romtemperatur og fortynnes med 15 ml vann. Fellingen frafiltreres og tørkes 6 timer ved 80°C i vannstrålevakuum. Etter omkrystallisering fra acetonitril får man 2,3-dihydroksy-5-(6-metyl-2-okso-2H-l,4-benzoksazin-3-yl)benzonitril med smp. 278-280°C. 1.075 g of methyl-(3-cyano-4,5-dihydroxyphenyl)glyoxylate and 0.60 g of 2-amino-p-cresol are stirred for 70 minutes. at 120°C in 2 ml of dimethylformamide. Then cool to room temperature and dilute with 15 ml of water. The precipitate is filtered off and dried for 6 hours at 80°C in a water jet vacuum. After recrystallization from acetonitrile, 2,3-dihydroxy-5-(6-methyl-2-oxo-2H-1,4-benzoxazin-3-yl)benzonitrile is obtained with m.p. 278-280°C.
Eksmpel 52 Example 52
a) En løsning av 2,5 g (10,2 mmol) 3,4-dimetoksy-5-nitroben-zoylklorid i 10 ml absolutt tetrahydrofuran blandes med 1,1 ml a) A solution of 2.5 g (10.2 mmol) of 3,4-dimethoxy-5-nitrobenzoyl chloride in 10 ml of absolute tetrahydrofuran is mixed with 1.1 ml
isocyaneddiksyreetylester og deretter en løsning av 3,0 ml trietylamin i 10 ml tetrahydrofuran og røres i 48 timer ved romtemperatur. Etter avdestillering av løsningsmidlet ekstraheres med eddikester/vann. Det etter inndampning erholdte råprodukt kromatograferes på den 20-dobbelte mengde kiselgel med eddikester. Etter omkrystallisering fra eddikester/heksan får man etyl-5-(3,4-dimetoksy-5-nitrofenyl)-4-oksazolkarboksylat i form av gule krystaller med smp. 109-110°C. b) 1,0 g (3,1 mmol) etyl-5-(3,4-dimetoksy-5-nitrofenyl)-4-oksazolkarboksylat blandes med 10 ml konstantkokende hydrogenbromid og røres i 2 timer ved 140°C. Etter avdestillering av hydrogenbromidoverskuddet omløses den gule rest fra etanol/aceton. Man får 2-amino-3',4'-dihydroksy-5'-nitroacetofenon-hydrobromid i form av gule krystaller med smp. >250°C (spaltning) . isocyanoacetic acid ethyl ester and then a solution of 3.0 ml of triethylamine in 10 ml of tetrahydrofuran and stirred for 48 hours at room temperature. After distilling off the solvent, extract with vinegar/water. The crude product obtained after evaporation is chromatographed on the 20-fold amount of silica gel with acetic acid. After recrystallization from ethyl acetate/hexane, ethyl 5-(3,4-dimethoxy-5-nitrophenyl)-4-oxazole carboxylate is obtained in the form of yellow crystals with m.p. 109-110°C. b) 1.0 g (3.1 mmol) of ethyl 5-(3,4-dimethoxy-5-nitrophenyl)-4-oxazole carboxylate is mixed with 10 ml of constant boiling hydrogen bromide and stirred for 2 hours at 140°C. After distilling off the excess hydrogen bromide, the yellow residue is redissolved from ethanol/acetone. 2-amino-3',4'-dihydroxy-5'-nitroacetophenone hydrobromide is obtained in the form of yellow crystals with m.p. >250°C (decomposition) .
Eksempel 53 Example 53
a) 10 g (34 mmol) etyl-(3,4-dimetoksy-5-nitrobenzoyl)acetat oppslemmes i 100 ml etanol, blandes med 1,7 g (37 mmol) metylhyd-razin og oppvarmes i 16 timer under tilbakeløp. Etter avdestillering av ca. 50 ml etanol avkjøles til 0°C, og den utfelte felling frafiltreres. Etter omkrystallisering fra etanol får man 3-(3,4-dimetoksy-5-nitrofenyl)-l-metylpyrazol-5-ol i form av gule krystaller med smp. 200-202°C. b) 2,0 g (7,2 mmol) 3-(3,4-dimetoksy-5-nitrofenyl)-1-metylpyra-zol-5-ol oppslemmes i 100 ml metylenklorid. Etter avkjøling til -40°C tildryppes en løsning av 4,9 ml bortribromid i 60 ml metylenklorid i løpet av en time. så røres ved romtemperatur i 16 timer, avkjøles til -20°C og blandes med 100 ml etanol i løpet av 30 min.. Etter røring ved romtemperatur i en time avdestilleres løsningsmidlet i vannstrålevakuum ved 40°C. Resten blandes tre ganger med en blanding av 100 ml etanol/toluen hver gang, hvorunder man stadig avdestillerer løsningsmidlet. Resten omkrystalliseres ved etanol. Man får 5-(S-hydroksy-l-metylpyra-zol-S-yl) -3-nitropyrokatekol-hydrobromid i form av gule krystaller ved smp. >250°C. a) 10 g (34 mmol) of ethyl-(3,4-dimethoxy-5-nitrobenzoyl)acetate are suspended in 100 ml of ethanol, mixed with 1.7 g (37 mmol) of methylhydrazine and heated for 16 hours under reflux. After distilling approx. 50 ml of ethanol are cooled to 0°C, and the precipitate that has formed is filtered off. After recrystallization from ethanol, 3-(3,4-dimethoxy-5-nitrophenyl)-1-methylpyrazol-5-ol is obtained in the form of yellow crystals with m.p. 200-202°C. b) 2.0 g (7.2 mmol) of 3-(3,4-dimethoxy-5-nitrophenyl)-1-methylpyrazol-5-ol are suspended in 100 ml of methylene chloride. After cooling to -40°C, a solution of 4.9 ml of boron tribromide in 60 ml of methylene chloride is added dropwise over the course of one hour. then stirred at room temperature for 16 hours, cooled to -20°C and mixed with 100 ml of ethanol during 30 min. After stirring at room temperature for one hour, the solvent is distilled off in a water jet vacuum at 40°C. The residue is mixed three times with a mixture of 100 ml of ethanol/toluene each time, during which the solvent is constantly distilled off. The residue is recrystallized from ethanol. 5-(S-hydroxy-1-methylpyrazol-S-yl)-3-nitropyrocatechol hydrobromide is obtained in the form of yellow crystals at m.p. >250°C.
Eksempel 54 Example 54
a) 16,8 g (0,7 g-atom) magnesium blandes med 15 ml etanol og etter tilsetning av 2 ml karbontetraklorid oppstartes reaksjonen a) 16.8 g (0.7 g atom) of magnesium are mixed with 15 ml of ethanol and after the addition of 2 ml of carbon tetrachloride, the reaction is started
ved oppvarming. Under røring tildrypper man i løpet av 30 min. en løsning av 130,3 g tert.butyletylmalonat i 70 ml etanol og 600 ml absolutt eter slik at reaksjonen forløper ved tilbakeløps-temperatur. Deretter røres videre i 3 timer ved 50°C, og løsningsmidlet avdestilleres ved 4 0°C i vannstrålevakuum. Resten oppløses i 900 ml tetrahydrofuran. Til denne løsningen drypper man under røring ved 50°C en løsning av 170 g (0,7 mol) 3,4-dimetoksy-5-nitrobenzoylklorid i 700 ml absolutt tetrahydrofuran og rører i en time ved tilbakeløpstemperaturen. Løsningsmidlet avdestilleres ved 40°C i vannstrålevakuum. Resten blandes med 1 1 eter. Under røring og kjøling tilsetter man 260 ml 3N-svovelsyre og rører i 30 min.. Den vandige fasen ekstraheres to ganger med 600 ml eter hver gang. Den organiske fasen vaskes nøytral med vann, tørkes over natriumsulfat og inndampes. Den erholdte brune olje filtreres med toluen over 1 kg kiselgel. Den erholdte blanding som består av etyl-tert.butyl-(3,4-dimetoksy-5-nitrobenzoyl)malonat og etyl-(3,4-dimetoksy-5-nitrobenzoyl)ace-tet, oppløses i 600 ml metylenklorid og blandes under røring i løpet av ca. 30 min. med 193 ml trifluoreddiksyre. Så røres i 2 timer ved 40°C og deretter inndampes ved 40°C i vannstrålevakuum. Den oppnådde olje ekstraheres med eter/vann. Den organiske fasen tørkes over natriumsulfat og inndampes. Etter oppløsning i diisopropyleter/heksan og kjøling frafiltreres de utfelte krystaller og omkrystalliseres fra diisopropyleter. Man får etyl-(3,4-dimetoksy-5-nitrobenzoyl)acetat i form av svakt gulaktige krystaller med smp. 67-68°C. during heating. While stirring, drip over the course of 30 min. a solution of 130.3 g of tert.butyl ethyl malonate in 70 ml of ethanol and 600 ml of absolute ether so that the reaction proceeds at reflux temperature. The mixture is then stirred for 3 hours at 50°C, and the solvent is distilled off at 40°C in a water jet vacuum. The residue is dissolved in 900 ml of tetrahydrofuran. A solution of 170 g (0.7 mol) of 3,4-dimethoxy-5-nitrobenzoyl chloride in 700 ml of absolute tetrahydrofuran is added dropwise while stirring at 50°C and stirred for one hour at the reflux temperature. The solvent is distilled off at 40°C in a water jet vacuum. The residue is mixed with 1 1 ether. While stirring and cooling, 260 ml of 3N sulfuric acid is added and stirred for 30 min. The aqueous phase is extracted twice with 600 ml of ether each time. The organic phase is washed neutral with water, dried over sodium sulfate and evaporated. The brown oil obtained is filtered with toluene over 1 kg of silica gel. The mixture obtained, which consists of ethyl tert-butyl-(3,4-dimethoxy-5-nitrobenzoyl)malonate and ethyl-(3,4-dimethoxy-5-nitrobenzoyl)acetate, is dissolved in 600 ml of methylene chloride and mixed under stirring during approx. 30 min. with 193 ml of trifluoroacetic acid. Then stir for 2 hours at 40°C and then evaporate at 40°C in a water jet vacuum. The oil obtained is extracted with ether/water. The organic phase is dried over sodium sulfate and evaporated. After dissolution in diisopropyl ether/hexane and cooling, the precipitated crystals are filtered off and recrystallized from diisopropyl ether. Ethyl-(3,4-dimethoxy-5-nitrobenzoyl)acetate is obtained in the form of slightly yellowish crystals with m.p. 67-68°C.
b) 10,0 g (33,6 mmol) etyl-(3,4-dimetoksy-5-nitrobenzoyl)acetat omsettes analogt med eksempel 53a med 4,0 g (37 mmol) fenylhydra-zin. Etter omkrystallisering fra metylenklorid/etanol får man 3-(3,4-dimetoksy-5-nitrofenyl)-1-fenyl-2-pyrazolin-5-on i form av b) 10.0 g (33.6 mmol) of ethyl (3,4-dimethoxy-5-nitrobenzoyl)acetate is reacted analogously to example 53a with 4.0 g (37 mmol) of phenylhydrazine. After recrystallization from methylene chloride/ethanol, 3-(3,4-dimethoxy-5-nitrophenyl)-1-phenyl-2-pyrazolin-5-one is obtained in the form of
gule krystaller med smp. 190-192°C. yellow crystals with m.p. 190-192°C.
c) Analogt med eksempel 53b får man derav med bortribromid 5-(5-hydroksy-l-fenylpyrazol-3-yl)-3-nitropyrokatekol-hydrobromid i c) Analogous to example 53b, with boron tribromide 5-(5-hydroxy-1-phenylpyrazol-3-yl)-3-nitropyrocatechol hydrobromide is obtained in
form av gule krystaller med smp. >220°C (spaltning). form of yellow crystals with m.p. >220°C (decomposition).
Eksmpel 55 Example 55
20,1 g dietyl-(3,4-dimetoksy-5-nitrobenzoyl)malonat oppløses i 200 ml metylenklorid, hvoretter man avkjøler til -20°C og ved denne temperaturen under røring i løpet av 15 min. drypper til en løsning av 68,1 g bortribromid i 120 ml metylenklorid. Så røres natten over ved romtemperatur. Etter avkjøling til -20°C blandes med 300 ml etanol og røres i 30 min. ved romtemperatur. Løs-ningsmidlet avdestilleres i vannstrålevakuum ved 40°C. Resten blandes med 3 00 ml isvann og metylenklorid. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Det erholdte råprodukt kromatograferes på den 10-dobbelte mengde kiselgel med toluen. Etter omkrystallisering fra metylenklorid/- heksan får man etyl-(3,4-dihydroksy-5-nitrobenzoyl)acetat i form av gule krystaller med smp. 136-137°C. 20.1 g of diethyl-(3,4-dimethoxy-5-nitrobenzoyl)malonate are dissolved in 200 ml of methylene chloride, after which it is cooled to -20°C and at this temperature with stirring for 15 min. drops to a solution of 68.1 g of boron tribromide in 120 ml of methylene chloride. Then stir overnight at room temperature. After cooling to -20°C, mix with 300 ml of ethanol and stir for 30 min. at room temperature. The solvent is distilled off in a water jet vacuum at 40°C. The residue is mixed with 300 ml of ice water and methylene chloride. The organic phase is washed with water, dried over sodium sulphate and evaporated. The crude product obtained is chromatographed on the 10-fold amount of silica gel with toluene. After recrystallization from methylene chloride/hexane, ethyl-(3,4-dihydroxy-5-nitrobenzoyl)acetate is obtained in the form of yellow crystals with m.p. 136-137°C.
Eksempel 56 Example 56
2,0 g (7,4 mmol) etyl-(3,4-dihydroksy-5-nitrobenzoyl)acetat oppslemmes i 50 ml etanol. Etter blanding med 0,4 g hydrazinhyd-rat holder man temperaturen ved tilbakeløpstemperatur i 16 timer. Etter avdestillasjon av løsningsmidlet kokes resten sammen med 50 ml eddikester i 5 min.. Den utfelte felling frafiltreres, og filtratet inndampes til 10 ml. Krystallene som faller ut kaldt frafiltreres. Man får 5-(5-hydroksypyrazol-3-yl)-3-nitropyroka-tekol i form av orange krystaller med smp. 228°C (spaltning). 2.0 g (7.4 mmol) of ethyl-(3,4-dihydroxy-5-nitrobenzoyl)acetate are suspended in 50 ml of ethanol. After mixing with 0.4 g of hydrazine hydrate, the temperature is maintained at the reflux temperature for 16 hours. After the solvent has been distilled off, the residue is boiled together with 50 ml of acetic acid for 5 min. The precipitate that has formed is filtered off, and the filtrate is evaporated to 10 ml. The crystals that fall out cold are filtered off. 5-(5-Hydroxypyrazol-3-yl)-3-nitropyrocatechol is obtained in the form of orange crystals with m.p. 228°C (decomposition).
Eksempel 57 Example 57
7,3 g (36,66 mmol) 3,4-dihydroksy-5-nitrobenzosyre blandes med 30 ml eddiksyreanhydrid, hvoretter man varmer 8 timer ved tilbakeløpstemperatur. Reaksjonsblandingen helles på is. Den utfelte felling filtreres fra, vaskes med vann og tas opp i metylenklorid. Den organiske fasen tørkes over natriumsulfat og inndampes. Den erholdte rest omkrystalliseres fra metylenklorid/n-heksan kaldt. Man får 3,4-diacetoksy-5-nitrobenzosyre i form av fargeløse krystaller med smp. 126-127°C. 7.3 g (36.66 mmol) of 3,4-dihydroxy-5-nitrobenzoic acid are mixed with 30 ml of acetic anhydride, after which it is heated for 8 hours at reflux temperature. The reaction mixture is poured onto ice. The precipitate is filtered off, washed with water and taken up in methylene chloride. The organic phase is dried over sodium sulfate and evaporated. The residue obtained is recrystallized from cold methylene chloride/n-hexane. 3,4-diacetoxy-5-nitrobenzoic acid is obtained in the form of colorless crystals with m.p. 126-127°C.
Eksempel 58 Example 58
a) 9,7 g (32,2 mmol) 3,4-diacetoksy-5-nitrobenzosyre blandes med 12,5 ml tionylklorid, hvoretter man rører 1,5 timer ved a) 9.7 g (32.2 mmol) of 3,4-diacetoxy-5-nitrobenzoic acid are mixed with 12.5 ml of thionyl chloride, after which it is stirred for 1.5 hours at
100°C. Etter avdestillering av overskudd tionylklorid destilleres 5-(klorkarbonyl)-2-nitro-o-fenylendiacetat, kokepunkt 160°C (26,7 Pa). 100°C. After distillation of excess thionyl chloride, 5-(chlorocarbonyl)-2-nitro-o-phenylenediacetate, boiling point 160°C (26.7 Pa), is distilled.
b) 3,2 g (10,6 mmol) 5-(klorkarbonyl)-2-nitro-o-fenylendiacetat oppløses i 50 ml dimetylformamid. Den iskalde løsningen blandes b) 3.2 g (10.6 mmol) of 5-(chlorocarbonyl)-2-nitro-o-phenylene diacetate are dissolved in 50 ml of dimethylformamide. The ice-cold solution is mixed
under røring med en løsning av 2,2 ml dietylamin i 20 ml dimetylformamid. Så røres 1 time ved romtemperatur, hvoretter man avdestillerer løsningsmidlet i vannstrålevakuum ved 50°C. Den oppnådde rest blandes med vann og metylenklorid. Den organiske fasen tørkes over natriumsulfat og inndampes. Den erholdte gule harpiks krystalliserer fra metylenklorid/eter. Man får N,N-dietyl-3,4-dihydroksy-5-nitrobenzamid i form av gule krystaller med smp. 145-146°C. while stirring with a solution of 2.2 ml of diethylamine in 20 ml of dimethylformamide. The mixture is then stirred for 1 hour at room temperature, after which the solvent is distilled off in a water jet vacuum at 50°C. The obtained residue is mixed with water and methylene chloride. The organic phase is dried over sodium sulfate and evaporated. The yellow resin obtained crystallizes from methylene chloride/ether. N,N-diethyl-3,4-dihydroxy-5-nitrobenzamide is obtained in the form of yellow crystals with m.p. 145-146°C.
Eksempel 59 Example 59
3,2 g (10,6 mmol) 5-(klorkarbonyl)-2-nitro-o-fenylendiacetat oppløses i 50 ml dimetylformamid, hvoretter man ved 0-5°C under røring og i løpet av 40 min. blander med en løsning av 3,02 ml 2,2-dietylaminoetylamin i 20 ml dimetylformamid. Så røres i 30 min. ved romtemperatur. Løsningsmidlet avdestilleres ved 60°C i vannstrålevakuum. Resten ekstraheres to ganger med 20 ml etanol hver gang, oppløses i varm etanol og blandes med et overskudd av en etanolisk saltsyre, hvoretter man inndamper. Etter omkrystallisering fra etanol/eddikester får man N-[2-(dietylamino)etyl]- 3.2 g (10.6 mmol) of 5-(chlorocarbonyl)-2-nitro-o-phenylene diacetate are dissolved in 50 ml of dimethylformamide, after which at 0-5°C with stirring and during 40 min. mixing with a solution of 3.02 ml of 2,2-diethylaminoethylamine in 20 ml of dimethylformamide. Then stir for 30 min. at room temperature. The solvent is distilled off at 60°C in a water jet vacuum. The residue is extracted twice with 20 ml of ethanol each time, dissolved in hot ethanol and mixed with an excess of an ethanolic hydrochloric acid, after which it is evaporated. After recrystallization from ethanol/acetic acid, N-[2-(diethylamino)ethyl]-
3,4-dihydroksy-5-nitrobenzamid-hydroklorid i form1 av gule krystaller med smp. 139°C (spaltning). 3,4-dihydroxy-5-nitrobenzamide hydrochloride in form 1 of yellow crystals with m.p. 139°C (decomposition).
Eksempel 60 Example 60
a) 10,0 g (47,4 mmol) 2,3-dimetoksy-5-nitrobenzaldehyd blandes med 50 ml iseddik og 50 ml konstantkokende hydrogenbromid og a) 10.0 g (47.4 mmol) of 2,3-dimethoxy-5-nitrobenzaldehyde is mixed with 50 ml of glacial acetic acid and 50 ml of constant-boiling hydrogen bromide and
holdes 7 timer ved tilbakeløpstemperatur. Etter blanding med is frafiltreres den utfelte felling, vaskes med vann og opptas i eddikester. Den organiske fasen tørkes over natriumsulfat og inndampes. Det oppnådde råprodukt filtreres med eddikester gjennom kiselgel. Etter krystallisering fra eddikester/heksan får man 2,3-dihydroksy-5-nitrobenzaldehyd i form av brunaktige krystaller med smp. 226-228°C. kept for 7 hours at reflux temperature. After mixing with ice, the precipitate is filtered off, washed with water and absorbed in vinegar. The organic phase is dried over sodium sulfate and evaporated. The crude product obtained is filtered with vinegar through silica gel. After crystallization from ethyl acetate/hexane, 2,3-dihydroxy-5-nitrobenzaldehyde is obtained in the form of brownish crystals with m.p. 226-228°C.
b) 4,5 g 2,3-dihydroksy-5-nitrobenzaldehyd oppslemmes i 75 ml vann. Etter blanding med 4,2 g hydroksylamin-o-sulfonsyre røres b) 4.5 g of 2,3-dihydroxy-5-nitrobenzaldehyde is suspended in 75 ml of water. After mixing with 4.2 g of hydroxylamine-o-sulfonic acid, stir
i 16 timer ved 65°C. Etter avkjøling frafiltreres de utfelte krystaller og vaskes med vann. Filtratet ekstraheres med eddikester. Krystallene og den tørkede organiske fase forenes, hvorpå man inndamper og omkrystalliserer resten fra diisopropyleter. Man får 2,3-dihydroksy-5-nitrobenzonitril i form av gule krystaller med smp. 186-188°C. for 16 hours at 65°C. After cooling, the precipitated crystals are filtered off and washed with water. The filtrate is extracted with vinegar. The crystals and the dried organic phase are combined, after which the residue is evaporated and recrystallized from diisopropyl ether. 2,3-dihydroxy-5-nitrobenzonitrile is obtained in the form of yellow crystals with m.p. 186-188°C.
Eksempel 61 Example 61
a) 4,0 g (19,2 mmol) 3,4-dimetoksy-5-nitro-benzonitril oppløses i 50 ml dimetylformamid, hvoretter man blander med 1,66 g a) 4.0 g (19.2 mmol) of 3,4-dimethoxy-5-nitro-benzonitrile is dissolved in 50 ml of dimethylformamide, after which it is mixed with 1.66 g
ammoniumklorid og 2,02 g natriumazid og rører 31 timer ved 125°C. Etter hhv. 8 og 15 timer tilsettes enda en gang den samme mengde ammoniumklorid og natriumazid. Etter avkjøling helles på is. ammonium chloride and 2.02 g of sodium azide and stir for 31 hours at 125°C. After respectively 8 and 15 hours, the same amount of ammonium chloride and sodium azide is added once more. After cooling, pour over ice.
Den utfelte felling frafiltreres, vaskes med vann og tørkes. Man får 2-metoksy-6-nitro-4-(lH-tetrazol-5-yl)fenol i form av orange krystaller med smp. >240°C (spaltning). b) 4,0 g (16,9 mmol) 2-metoksy-6-nitro-4-(lH-tetrazol-5-yl)fenyl blandes med 4 0 ml konstantkokende hydrogenbromid, hvoretter man rører i 8 timer ved 140°C under nitrogenatmosfære. Etter avkjøling helles på is. Den utfelte felling frafiltreres og omkrystalliseres fra eter. Man får 3-nitro-5-(lH-tetrazol-5-yl)pyrokatekol i form av orange krystaller med smp. >240°C (spaltning). The precipitate is filtered off, washed with water and dried. 2-Methoxy-6-nitro-4-(1H-tetrazol-5-yl)phenol is obtained in the form of orange crystals with m.p. >240°C (decomposition). b) 4.0 g (16.9 mmol) of 2-methoxy-6-nitro-4-(1H-tetrazol-5-yl)phenyl is mixed with 40 ml of constant-boiling hydrogen bromide, after which it is stirred for 8 hours at 140°C under nitrogen atmosphere. After cooling, pour over ice. The precipitate is filtered off and recrystallized from ether. 3-nitro-5-(1H-tetrazol-5-yl)pyrocatechol is obtained in the form of orange crystals with m.p. >240°C (decomposition).
Eksempel 62 Example 62
Til 13 0 ml kons. svovelsyre innføres under røring i løpet av 10 min. porsjonsvis til sammen 7,2 g (40 mmol) 3,4-dihydroksy-5-nitrobenzonitril, hvoretter man rører i 4 timer ved 50°C. Reaksjonsblandingen helles på 800 ml isvann. Den utfelte felling frafiltreres, vaskes med vann og opptas i eddikester. Den organiske fasen tørkes over natriumsulfat og inndampes. Etter omkrystallisering fra aceton/eddikester får man 3,4-dihydroksy-5-nitrobenzamid i form av orange krystaller med smp. 235-236°C. To 13 0 ml conc. sulfuric acid is introduced while stirring during 10 min. in portions, a total of 7.2 g (40 mmol) of 3,4-dihydroxy-5-nitrobenzonitrile, after which it is stirred for 4 hours at 50°C. The reaction mixture is poured into 800 ml of ice water. The precipitate is filtered off, washed with water and taken up in vinegar. The organic phase is dried over sodium sulfate and evaporated. After recrystallization from acetone/acetic ester, 3,4-dihydroxy-5-nitrobenzamide is obtained in the form of orange crystals with m.p. 235-236°C.
Eksempel 63 Example 63
a) Til en suspensjon av 3,6 g (82,5 mmol) av en 55% natriumhyd-rid-dispersjon i 50 ml absolutt dimetylformamid drypper man under a) To a suspension of 3.6 g (82.5 mmol) of a 55% sodium hydride dispersion in 50 ml of absolute dimethylformamide, dropwise under
argonatmosfære i løpet av 15 min. en løsning av 11,25 g (82,6 mmol) 2-hydroksyacetofenon i 100 ml absolutt dimetylformamid og rører en time ved romtemperatur. Etter avkjøling til 0°C drypper man i løpet av 20 min. en løsning av 20,3 g (82,6 mmol) 3,4-dimetoksy-5-nitrobenzoylklorid i 100 ml absolutt dimetylformamid til dette og rører natten over ved romtemperatur. Reaksjonsblandingen helles på isvann, hvoretter man ekstraherer to ganger med 250 ml eddikester hver gang. Den organiske fasen vaskes to ganger med 100 ml koksaltløsning hver gang, tørkes over natriumsulfat og inndampes. Den oppnådde brune olje oppvarmes i 100 ml toluen. Den utfelte felling frafiltreres, og filtratet kromatograferes på den 3 0-dobbelte mengde kiselgel med toluen/eddikester (4:1). Etter omkrystallisering fra eddikester/heksan får man o-acetylfenyl-3,4-dimetoksy-5-nitrobenzoat i form av gulaktige krystaller med smp. 108-109°C. argon atmosphere within 15 min. a solution of 11.25 g (82.6 mmol) of 2-hydroxyacetophenone in 100 ml of absolute dimethylformamide and stir for one hour at room temperature. After cooling to 0°C, drip within 20 min. a solution of 20.3 g (82.6 mmol) of 3,4-dimethoxy-5-nitrobenzoyl chloride in 100 ml of absolute dimethylformamide to this and stir overnight at room temperature. The reaction mixture is poured onto ice water, after which it is extracted twice with 250 ml of acetic acid each time. The organic phase is washed twice with 100 ml of sodium chloride solution each time, dried over sodium sulfate and evaporated. The brown oil obtained is heated in 100 ml of toluene. The precipitate that precipitates is filtered off, and the filtrate is chromatographed on the 30-fold amount of silica gel with toluene/acetic ester (4:1). After recrystallization from ethyl acetate/hexane, o-acetylphenyl-3,4-dimethoxy-5-nitrobenzoate is obtained in the form of yellowish crystals with m.p. 108-109°C.
b) 10,0 g (29 mmol) o-acetylfenyl-3,4-dimetoksy-5-nitrobenzoat oppløses i 50 ml pyridin. Etter blanding med 8,12 g (144 mmol) b) Dissolve 10.0 g (29 mmol) of o-acetylphenyl-3,4-dimethoxy-5-nitrobenzoate in 50 ml of pyridine. After mixing with 8.12 g (144 mmol)
pulverisert og tørket kaliumhydroksyd røres i 5 min. ved 80°C. powdered and dried potassium hydroxide is stirred for 5 min. at 80°C.
Etter avkjøling heller man det hele på is. Den vandige løsning surgjøres ved blanding med 3N-saltsyre. Den utfelte felling filtreres fra. Etter omkrystallisering fra eddikester/heksan får man 1-(o-hydroksyfenyl)-3-(3,4-dimetoksy-5-nitrofenyl)-1,3-propandion i form av gulaktige krystaller med smp. 188-189°C. After cooling, the whole thing is poured over ice. The aqueous solution is acidified by mixing with 3N hydrochloric acid. The precipitate is filtered off. After recrystallization from ethyl acetate/hexane, 1-(o-hydroxyphenyl)-3-(3,4-dimethoxy-5-nitrophenyl)-1,3-propanedione is obtained in the form of yellowish crystals with m.p. 188-189°C.
c) Til en løsning av 500 mg (1,45 mmol) 1-(o-hydroksyfenyl)-3-(3,4-dimetoksy-5-nitrofenyl)-1,3-propandion i 50 ml metylenklorid c) To a solution of 500 mg (1.45 mmol) 1-(o-hydroxyphenyl)-3-(3,4-dimethoxy-5-nitrophenyl)-1,3-propanedione in 50 ml methylene chloride
dryppes under røring og argonatmosfære ved -20°C en løsning av 1,82 g (0,7 ml) bortribromid i 20 ml metylenklorid i løpet av ca. 20 min., hvoretter man rører natten over ved romtemperatur. Etter avkjøling til -20°C blandes dråpevis med 25 ml etanol og inndampes i vannstrålevakuum ved 40°C. Etter omløsning fra etanol får man l-(3,4-dihydroksy-5-nitrofenyl)-3-(o-hydroksyfe-nyl) -1 , 3 -propandion i form av gule krystaller med smp. 251-252°C. a solution of 1.82 g (0.7 ml) of boron tribromide in 20 ml of methylene chloride is added dropwise with stirring and an argon atmosphere at -20°C over approx. 20 min., after which it is stirred overnight at room temperature. After cooling to -20°C, mix dropwise with 25 ml of ethanol and evaporate in a water jet vacuum at 40°C. After redissolving from ethanol, 1-(3,4-dihydroxy-5-nitrophenyl)-3-(o-hydroxyphenyl)-1,3-propanedione is obtained in the form of yellow crystals with m.p. 251-252°C.
Eksempel 64 Example 64
a) En løsning av 2,0 g (5,79 mmol) o-acetylfenyl-3,4-dimetoksy-5-nitrobenzoat i 12,5 ml iseddik blandes med 0,94 g natriumacetat a) A solution of 2.0 g (5.79 mmol) of o-acetylphenyl-3,4-dimethoxy-5-nitrobenzoate in 12.5 ml of glacial acetic acid is mixed with 0.94 g of sodium acetate
og holdes ved tilbakeløpstemperatur i 4 timer. Etter avkjøling helles på isvann. De utfelte krystaller frafiltreres. Etter omkrystallisering fra eddikester/heksan får man 2-(3,4-dimetoksy-5-nitrofenyl)-4H-l-benzopyran-4-on i form av fargeløse krystaller med smp. 216-217°C. and kept at reflux temperature for 4 hours. After cooling, pour over ice water. The precipitated crystals are filtered off. After recrystallization from ethyl acetate/hexane, 2-(3,4-dimethoxy-5-nitrophenyl)-4H-1-benzopyran-4-one is obtained in the form of colorless crystals with m.p. 216-217°C.
b) Til en løsning av 1,0 g (2,9 mmol) 2-(3,4-dimetoksy-S-nitrof enyl ) -4H-l-benzopyran-4-on i 100 ml metylenklorid dryppes b) Add dropwise to a solution of 1.0 g (2.9 mmol) 2-(3,4-dimethoxy-S-nitrophenyl)-4H-1-benzopyran-4-one in 100 ml methylene chloride
ved -10°C under argonatmosfære en løsning av 10 ml bortribromid i 50 ml metylenklorid i løpet av 30 min., hvoretter man rører natten over ved romtemperatur. Etter avkjøling til -20°C tildryppes 20 ml etanol. Så inndampes ved 40°C i vannstrålevakuum. Den oppnådde gule rest ekstraheres med vann/eddikester. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Etter omkrystallisering fra etanol/eddikester får man 2-(3,4-dihydroksy-5-nitrofenyl)-4H-l-benzopyran 4-on i form av gule krystaller med smp. >240°C (spaltning). at -10°C under an argon atmosphere, a solution of 10 ml of boron tribromide in 50 ml of methylene chloride during 30 min., after which it is stirred overnight at room temperature. After cooling to -20°C, 20 ml of ethanol are added dropwise. Then evaporate at 40°C in a water jet vacuum. The resulting yellow residue is extracted with water/acetic acid. The organic phase is washed with water, dried over sodium sulphate and evaporated. After recrystallization from ethanol/acetic ester, 2-(3,4-dihydroxy-5-nitrophenyl)-4H-1-benzopyran 4-one is obtained in the form of yellow crystals with m.p. >240°C (decomposition).
Eksempel 65 Example 65
a) Til 33,0 g 4-brombenzotrifluorid (oppløst i 150 ml tetrahydrofuran) dryppes ved -70°C i løpet av 20 min. 92 ml n-butyl-litiumløsning (1,6 M i heksan). Etter 45 min. røring ved -70°C tildryppes 3 6 g 3-metoksy-4-benzyloksybenzaldehyd (oppløst i 100 ml tetrahydrofuran) mellom -70°C og -60°C. Reaksjonsblandingen røres i 2 timer ved -70°C og 1 time ved 0°C, helles på en blanding av is og 100 ml 2N-svovelsyre og ekstraheres to ganger med 500 ml eter. De sammenslåtte eterfaser vaskes med mettet koksaltløsning, tørkes over natriumsulfat og inndampes. Man får 4-(benzyloksy)-3-metoksy-4'-(trifluormetyl)benzhydrol som kan anvendes direkte i det etterfølgende reaksjonstrinn. a) To 33.0 g of 4-bromobenzotrifluoride (dissolved in 150 ml of tetrahydrofuran) is added dropwise at -70°C during 20 min. 92 ml of n-butyl lithium solution (1.6 M in hexane). After 45 min. stirring at -70°C, 3 6 g of 3-methoxy-4-benzyloxybenzaldehyde (dissolved in 100 ml of tetrahydrofuran) are added dropwise between -70°C and -60°C. The reaction mixture is stirred for 2 hours at -70°C and 1 hour at 0°C, poured onto a mixture of ice and 100 ml of 2N sulfuric acid and extracted twice with 500 ml of ether. The combined ether phases are washed with saturated sodium chloride solution, dried over sodium sulphate and evaporated. 4-(Benzyloxy)-3-methoxy-4'-(trifluoromethyl)benzhydrol is obtained, which can be used directly in the subsequent reaction step.
b) 52,6 g 4-(benzyloksy)-3-metoksy-4'-(trifluormetyl)benzhydrol (oppløst i 500 ml metylenklorid) blandes i løpet av 10 min. ved b) 52.6 g of 4-(benzyloxy)-3-methoxy-4'-(trifluoromethyl)benzhydrol (dissolved in 500 ml of methylene chloride) are mixed during 10 minutes. by
20°C med 30,6 g pyridiniumklorkromat og røres i 2 timer ved 20°C. Så frafiltreres den dannede felling og vaskes med metylenklorid. Filtratet inndampes, og resten kromatograferes på 150 g kiselgel med metylenklorid. Man får etter omkrystallisering fra metylenklorid/heksan 4-(benzyloksy)-3-metoksy-4'-(trifluormetyl)benzofe-non med smeltepunkt 101°C. 20°C with 30.6 g of pyridinium chlorochromate and stirred for 2 hours at 20°C. The formed precipitate is then filtered off and washed with methylene chloride. The filtrate is evaporated, and the residue is chromatographed on 150 g of silica gel with methylene chloride. After recrystallization from methylene chloride/hexane, 4-(benzyloxy)-3-methoxy-4'-(trifluoromethyl)benzophenone with a melting point of 101°C is obtained.
c) Til 20 g 4-(benzyloksy)-3-metoksy-4'-(trifluormetyl)benzofe-non (oppløst i 150 ml metyhlenklorid (settes ved 10°C 70 ml 33-% c) To 20 g of 4-(benzyloxy)-3-methoxy-4'-(trifluoromethyl)benzophenone (dissolved in 150 ml methylene chloride (put at 10°C 70 ml 33-%
hydrogenbromid i eddiksyre i løpet av 15 min.. Etter 1,5 timers røring ved 20°C helles reaksjonsblandingen på 600 ml isvann, metylenkloridfasen fraskilles og den vandige fasen ekstraheres enda to ganger med 100 ml metylenklorid. De samlede metylenklo-ridf aser vaskes med 600 ml vann, tørkes over natriumsulfat og hydrogen bromide in acetic acid during 15 min. After stirring for 1.5 hours at 20°C, the reaction mixture is poured into 600 ml of ice water, the methylene chloride phase is separated and the aqueous phase is extracted twice more with 100 ml of methylene chloride. The combined methylene chloride phases are washed with 600 ml of water, dried over sodium sulphate and
inndampes. Resten kromatograferes på 150 g kiselgel med metylenklorid. Man får etter omkrystallisering fra metylenklorid/heksan 4-hydroksy-3-metoksy-4'-(trifluormetyl)benzofenon med smeltepunkt 97°C. is evaporated. The residue is chromatographed on 150 g of silica gel with methylene chloride. After recrystallization from methylene chloride/hexane, 4-hydroxy-3-methoxy-4'-(trifluoromethyl)benzophenone with a melting point of 97°C is obtained.
d) Til 12,8 g 4-hydroksy-3-metoksy-4'-(trifluormetyl)benzofenon (oppløst i 160 ml eddiksyre) dryppes i løpet av 10 min. ved 20°C d) To 12.8 g of 4-hydroxy-3-methoxy-4'-(trifluoromethyl)benzophenone (dissolved in 160 ml of acetic acid) is added dropwise over the course of 10 min. at 20°C
3,2 ml 65% salpetersyre. Etter 1,5 timers røring helles reak-sj onsblandingen på 600 ml isvann, og den dannede felling frafiltreres, vaskes med vann og løses i metylenklorid. Metylenklorid-løsningen tørkes over natriumsulfat og inndampes, og resten omkrystalliseres fra metylenklorid/heksan. Man får 4-hydroksy- 3.2 ml of 65% nitric acid. After stirring for 1.5 hours, the reaction mixture is poured into 600 ml of ice water, and the precipitate formed is filtered off, washed with water and dissolved in methylene chloride. The methylene chloride solution is dried over sodium sulfate and evaporated, and the residue is recrystallized from methylene chloride/hexane. You get 4-hydroxy-
3-metoksy-5-nitro-4(trifluormetyl)benzofenon med smeltepunkt 172°C. 3-Methoxy-5-nitro-4(trifluoromethyl)benzophenone with melting point 172°C.
e) 2,0 g 4-hydroksy-3-metoksy-5-nitro-4'-(trifluormetyl)benzo-fenon (oppløst i 20 ml 33% hydrogenbromid i eddiksyre) røres i 18 e) 2.0 g of 4-hydroxy-3-methoxy-5-nitro-4'-(trifluoromethyl)benzo-phenone (dissolved in 20 ml of 33% hydrogen bromide in acetic acid) is stirred for 18
timer ved 90°C. Deretter tilsettes 20 ml 48% vandig hydrogenbromid, hvorpå man rører ytterligere 18 timer ved 110°C. Så inndampes reaksjonsblandingen under redusert trykk, og resten krystalliseres fra vann. Man får 3,4-dihydroksy-5-nitro-4'-(trifluormetyl) benzof enon med smp. 116-118°C. hours at 90°C. Then 20 ml of 48% aqueous hydrogen bromide is added, after which it is stirred for a further 18 hours at 110°C. The reaction mixture is then evaporated under reduced pressure, and the residue is crystallized from water. This gives 3,4-dihydroxy-5-nitro-4'-(trifluoromethyl)benzophenone with m.p. 116-118°C.
Eksempel 66 Example 66
a) 18,7 g 4-hydroksy-3-metoksy-5-nitro-4'-(trifluormetyl)benzo-fenon (oppløst i 2 50 ml tetrahydrofuran) blandes ved romtemperatur med 27,5 ml 2N-kaliumhydroksydløsning, hvoretter man inndamper. Resten blandes med 200 ml toluen, hvorpå man inndamper på nytt. Deretter oppvarmes med 400 ml toluen i 4 timer under vannutskilling og under tilbakeløp. 100 ml toluen avdestilleres på nytt og 10 ml dimetylformamid og 20 ml dimetylsulfat (nydes-tillert) tilsettes, hvorpå man oppvarmer 5 timer under tilbake-løp. Så tilsetes 300 ml lN-natronlut ved 20°C. Reaksjonsblandingen røres i 30 min. og blandes med 200 ml eter. Den organiske fasen fraskilles; den vandige fasen ekstraheres enda to ganger med 100 ml eter; de samlede eterfaser tørkes over natriumsulfat og inndampes, og resten kromatograferes på 70 g kiselgel med metylenklorid. Man får etter omkrystallisering fra metylenklorid/heksan 3,4-dimetoksy-5-nitro-4'-(trifluormetyl)benzofenon med smp. 115°C. b) Til 16,0 g 3,4-dimetoksy-5-nitro-4'-(trifluormetyl)benzofe-non (oppløst i 300 ml etanol) settes 49,5 g tinndiklorid-dihydrat, hvoretter man rører 30 min. ved 75°C. Deretter helles reaksjonsblandingen på 800 ml isvann. Den nøytraliseres med 28% natriumhydroksydløsning og ekstraheres tre ganger med 600 ml metylenklorid. De samlede metylenkloridfaser vaskes med vann, tørkes over natriumsulfat og inndampes. Man får etter omkrystallisering fra metylenklorid/heksan 5-amino-3,4-dimetoksy-4'-(trifluormetyl)benzofenon med smp. 95-96°C. c) 3,25 g 5-amino-3,4-dimetoksy-4'-(trifluormetyl)benzofenon (oppløst i 50 ml aceton) inndampes etter tilsetning av 15 ml 2N-svovelsyre under redusert trykk. Den således erholdte rest oppslemmes i 20 ml eddiksyre, fortynnes med 100 ml vann og blandes ved 5°C med en løsning av 700 mg natriumnitritt i 10 ml vann. Det røres 1 time ved 5°C. Deretter filtreres diazonium-saltløsningen, settes ved 5°C til en løsning av 2,0 g natriumcya-nid og 1,0 g kobber(I)cyanid i 20 ml vann og røres 1 time ved a) 18.7 g of 4-hydroxy-3-methoxy-5-nitro-4'-(trifluoromethyl)benzo-phenone (dissolved in 250 ml of tetrahydrofuran) is mixed at room temperature with 27.5 ml of 2N potassium hydroxide solution, after which it is evaporated . The residue is mixed with 200 ml of toluene, after which it is evaporated again. It is then heated with 400 ml of toluene for 4 hours under water separation and under reflux. 100 ml of toluene is distilled off again and 10 ml of dimethylformamide and 20 ml of dimethylsulphate (freshly distilled) are added, after which it is heated for 5 hours under reflux. Then 300 ml of 1N caustic soda is added at 20°C. The reaction mixture is stirred for 30 min. and mixed with 200 ml of ether. The organic phase is separated; the aqueous phase is extracted twice more with 100 ml of ether; the combined ether phases are dried over sodium sulfate and evaporated, and the residue is chromatographed on 70 g of silica gel with methylene chloride. After recrystallization from methylene chloride/hexane, 3,4-dimethoxy-5-nitro-4'-(trifluoromethyl)benzophenone with m.p. 115°C. b) 49.5 g of tin dichloride dihydrate is added to 16.0 g of 3,4-dimethoxy-5-nitro-4'-(trifluoromethyl)benzophenone (dissolved in 300 ml of ethanol), after which it is stirred for 30 min. at 75°C. The reaction mixture is then poured into 800 ml of ice water. It is neutralized with 28% sodium hydroxide solution and extracted three times with 600 ml of methylene chloride. The combined methylene chloride phases are washed with water, dried over sodium sulphate and evaporated. After recrystallization from methylene chloride/hexane, 5-amino-3,4-dimethoxy-4'-(trifluoromethyl)benzophenone with m.p. 95-96°C. c) 3.25 g of 5-amino-3,4-dimethoxy-4'-(trifluoromethyl)benzophenone (dissolved in 50 ml of acetone) is evaporated after adding 15 ml of 2N-sulfuric acid under reduced pressure. The residue thus obtained is suspended in 20 ml of acetic acid, diluted with 100 ml of water and mixed at 5°C with a solution of 700 mg of sodium nitrite in 10 ml of water. It is stirred for 1 hour at 5°C. The diazonium salt solution is then filtered, added at 5°C to a solution of 2.0 g of sodium cyanide and 1.0 g of copper (I) cyanide in 20 ml of water and stirred for 1 hour at
5°C. Deretter tilføres 200 ml metylenklorid. Uløselige andeler frafiltreres. Fasene skilles, den vandige fasen ekstraheres enda to ganger med 100 ml metylenklorid. De samlede metylenkloridfaser vaskes med vann, tørkes over natriumsulfat og inndampes. Resten kromatograferes på 30 g kiselgel med metylenklorid. Man får etter omkrystallisering fra metylenklorid/heksan 5-cyano-3,4-dimetoksy-4'-(trifluormetyl)benzofenon med smp. 130°C. 5°C. 200 ml of methylene chloride is then added. Insoluble parts are filtered out. The phases are separated, the aqueous phase is extracted twice more with 100 ml of methylene chloride. The combined methylene chloride phases are washed with water, dried over sodium sulphate and evaporated. The residue is chromatographed on 30 g of silica gel with methylene chloride. After recrystallization from methylene chloride/hexane, 5-cyano-3,4-dimethoxy-4'-(trifluoromethyl)benzophenone with m.p. 130°C.
d) 1,5 g 5-cyano-3,4-dimetoksy-4'-(trifluormetyl)benzofenon (oppløst i 75 ml metylenklorid) blandes ved 5°C med 2,18 ml d) 1.5 g of 5-cyano-3,4-dimethoxy-4'-(trifluoromethyl)benzophenone (dissolved in 75 ml of methylene chloride) is mixed at 5°C with 2.18 ml
bortribromid, hvoretter man rører 18 timer ved romtemperatur. Så fortynnes reaksjonsblandingen med 50 ml metylenklorid. Man oppvarmer ytterligere 4 timer under tilbakeløp, blander ved -70°C med 15 ml metanol, rører 2 timer ved romtemperatur, inndamper, tørker resten i vakuum og fordeler mellom etylacetat og isvann. Den vandige fasen ekstraheres enda to ganger med etylacetat. De samlede etylacetatfaser tørkes over natriumsulfat og inndampes. Det derved oppnådde materialet røres med 10 ml eddiksyreanhydrid og 1 ml pyridin i 6 timer ved 130°C. Det inndampes og resten fordeles mellom isvann <p>g metylenklorid. Metylenkloridfasen tørkes over natriumsulfat og inndampes, og resten kromatograferes på 30 g kiselgel med metylenklorid. Det derved oppnådde diacetat oppløses i 10 ml metanol. Det blandes med 4,2 ml lN-natronlut, røres 1 time ved 0°C, nøytraliseres med eddiksyre, inndampes og fordeles mellom etylacetat og mettet koksaltløsning. Etylacetat-fasene tørkes over natriumsulfat og inndampes, og resten omkrystalliseres fra metylenklorid. Man får 5-cyano-3,4-dihydroksy-4'-(trifluormetyl)benzofenon med smp. 204-206°C. boron tribromide, after which it is stirred for 18 hours at room temperature. The reaction mixture is then diluted with 50 ml of methylene chloride. It is heated for a further 4 hours under reflux, mixed at -70°C with 15 ml of methanol, stirred for 2 hours at room temperature, evaporated, the residue dried in a vacuum and distributed between ethyl acetate and ice water. The aqueous phase is extracted twice more with ethyl acetate. The combined ethyl acetate phases are dried over sodium sulphate and evaporated. The material thus obtained is stirred with 10 ml of acetic anhydride and 1 ml of pyridine for 6 hours at 130°C. It is evaporated and the residue is distributed between ice water <p>g methylene chloride. The methylene chloride phase is dried over sodium sulphate and evaporated, and the residue is chromatographed on 30 g of silica gel with methylene chloride. The diacetate thus obtained is dissolved in 10 ml of methanol. It is mixed with 4.2 ml of 1N caustic soda, stirred for 1 hour at 0°C, neutralized with acetic acid, evaporated and distributed between ethyl acetate and saturated sodium chloride solution. The ethyl acetate phases are dried over sodium sulfate and evaporated, and the residue is recrystallized from methylene chloride. 5-cyano-3,4-dihydroxy-4'-(trifluoromethyl)benzophenone is obtained with m.p. 204-206°C.
På analog måte får man: Analogously, you get:
al) Fra 2-fluor-4-hydroksy-3-meotksy-5-nitrobenzofenon 3,4-dimetoksy-2'-fluor-5-nitrobenzofenon med smp. 86-88°C (fra eter/petroleter, ts.), al) From 2-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone 3,4-dimethoxy-2'-fluoro-5-nitrobenzophenone with m.p. 86-88°C (from ether/petroleum ether, ts.),
bl) fra 3,4-dimetoksy-2'-fluor-5-nitrobenzofenon 5-amino-3,4-dimetoksy-2'-fluorbenzofenon med smp. 93-95°C (fra eter/petroleter , ts.), bl) from 3,4-dimethoxy-2'-fluoro-5-nitrobenzophenone 5-amino-3,4-dimethoxy-2'-fluorobenzophenone with m.p. 93-95°C (from ether/petroleum ether, ts.),
cl) fra 5-amino-3,4-dimetoksy-2'-fluorbenzofenon 5-benzoyl-2,3-dimetoksy-2'-fluorbenzonitril med smp. 132-134°c (fra metylenklorid/petroleter, ts) og cl) from 5-amino-3,4-dimethoxy-2'-fluorobenzophenone 5-benzoyl-2,3-dimethoxy-2'-fluorobenzonitrile with m.p. 132-134°c (from methylene chloride/petroleum ether, ts) and
dl) fra 5-benzoyl-2,3-dimetoksy-2'-fluorbenzonitril 5-benzoyl-2,3-dihydroksy-2'-fluorbenzonitril med smp. 228-230°C (fra eter/petroleter, ts.). dl) from 5-benzoyl-2,3-dimethoxy-2'-fluorobenzonitrile 5-benzoyl-2,3-dihydroxy-2'-fluorobenzonitrile with m.p. 228-230°C (from ether/petroleum ether, ts.).
På analog måte får man: Analogously, you get:
b2) Fra 3,4-dimetoksy-5-nitrobenzofenon 5-amino-3,4-dimetoksy-benzofenon som amorft faststoff, b2) From 3,4-dimethoxy-5-nitrobenzophenone 5-amino-3,4-dimethoxy-benzophenone as an amorphous solid,
c2) fra 5-amino-3,4-dimetoksybenzofenon 5-benzoyl-2,3-dimetoksy-benzonitril med smp. 98-100°C (fra eter/heksan) og c2) from 5-amino-3,4-dimethoxybenzophenone 5-benzoyl-2,3-dimethoxy-benzonitrile with m.p. 98-100°C (from ether/hexane) and
d2) fra 5-benzoyl-2,3-dimetoksybenzonitril 5-benzoyl-2,3-dihydroksybenzonitril med smp. 212-214°C (fra eddikester/eter). d2) from 5-benzoyl-2,3-dimethoxybenzonitrile 5-benzoyl-2,3-dihydroxybenzonitrile with m.p. 212-214°C (from acetic acid/ether).
Eksempel 67 Example 67
a) Til en løsning av 2,68 g (32,64 mmol) 1-metylimidazol og a) To a solution of 2.68 g (32.64 mmol) 1-methylimidazole and
6,6 g (65,14 mmol) trietylamin i 80 ml pyridin dryppes en løsning A solution of 6.6 g (65.14 mmol) triethylamine in 80 ml pyridine is added dropwise
av 16,0 g (65,14 mmol) 3,4-dimetoksy-5-nitrobenzoylklorid i 80 ml pyridin, hvoretter man rører i 3 timer ved 60°C. Etter blanding med 1,70 ml 3N-natronlut røres videre 1 time og deretter heller man på isvann. De utfelte grå krystaller frafiltreres og opptas i eddikester, hvoretter man tørker den organiske fasen over magnesiumsulfat og destillerer løsningsmidlet vekk. Etter of 16.0 g (65.14 mmol) of 3,4-dimethoxy-5-nitrobenzoyl chloride in 80 ml of pyridine, after which it is stirred for 3 hours at 60°C. After mixing with 1.70 ml of 3N caustic soda, it is stirred for a further 1 hour and then poured into ice water. The precipitated gray crystals are filtered off and taken up in vinegar, after which the organic phase is dried over magnesium sulphate and the solvent is distilled away. After
omkrystallisering fra eddikester/heksan får man 3,4-dimetoksy-5-nitrofenyl (l-metylimidazol-2-yl)keton i form av fargeløse krystaller med smp. 144-145°C. recrystallization from ethyl acetate/hexane gives 3,4-dimethoxy-5-nitrophenyl (1-methylimidazol-2-yl)ketone in the form of colorless crystals with m.p. 144-145°C.
b) 5,0 g (17,17 mmol) 3,4-dimetoksy-5-nitrofenyl (1-metylimidazol-2-yl)keton blandes med 50 ml hydrogenbromid (48%) , hvoretter b) 5.0 g (17.17 mmol) of 3,4-dimethoxy-5-nitrophenyl (1-methylimidazol-2-yl) ketone are mixed with 50 ml of hydrogen bromide (48%), after which
man rører i 2 timer ved tilbakeløpstemperatur. Etter avkjøling frafiltreres den utfelte felling, vaskes med isvann og omkrystalliseres fra etanol. Man får 3,4-dihydroksy-5-nitrofenyl (1-metylimidazol-2-yl)keton-hydrobromid i form av gule krystaller med spaltningspunkt >24 0°C. stirring for 2 hours at reflux temperature. After cooling, the precipitate is filtered off, washed with ice water and recrystallized from ethanol. 3,4-dihydroxy-5-nitrophenyl (1-methylimidazol-2-yl)ketone hydrobromide is obtained in the form of yellow crystals with a cleavage point >24 0°C.
Eksempel 68 Example 68
Analogt med eksempel 67 får man fra 3,4-dimetoksy-5-nitro-benzoylklorid og 1-benzylimidazol l-benzylimidazol-2-yl (3,4-dimetoksy-5-nitrofenyl)keton i form av fargeløse krystaller med smp. 134-135°C (fra metylenklorid/heksan) og derav med hydrogenbromid l-benzylimidazol-2-yl (3,4-dihydroksy-5-nitrofenyl)keton-hydrobromid som gule krystaller med smp. 218-219°C (spaltning). Analogous to example 67, from 3,4-dimethoxy-5-nitro-benzoyl chloride and 1-benzylimidazole, 1-benzylimidazol-2-yl (3,4-dimethoxy-5-nitrophenyl)ketone is obtained in the form of colorless crystals with m.p. 134-135°C (from methylene chloride/hexane) and thence with hydrogen bromide 1-benzylimidazol-2-yl (3,4-dihydroxy-5-nitrophenyl)ketone hydrobromide as yellow crystals with m.p. 218-219°C (decomposition).
Eksempel 69 Example 69
a) Til en løsning av 13,0 g (53,13 mmol) 3,4-dimetoksy-5-nitrobenzoylklorid og 5,4 g (53,13 mmol) trietylamin i 80 ml a) To a solution of 13.0 g (53.13 mmol) 3,4-dimethoxy-5-nitrobenzoyl chloride and 5.4 g (53.13 mmol) triethylamine in 80 ml
acetonitril dryppes i løpet av 10 min. en løsning av 10,0 g (53,13 mmol) 1-[(benzyloksy)metyl]imidazol i 50 ml acetonitril under iskjøling slik at temperaturen ikke overstiger 2 5°C. Så røres videre 3 timer, hvorpå man destillerer vekk løsningsmidlet. Etter blanding med vann ekstraheres med eddikester. Etter to gangers vask med vann tørkes den organiske fasen over natriumsulfat og inndampes. Den oppnådde olje kromatograferes på 600 g kiselgel med toluen/eddikester (95:5). Man får 1-[(benzyloksy)-metyl]imidazol-2-yl (3 ,4-dimetoksy-5-nitrofenyl)keton som gulaktig olje. b) Analogt med eksempel 67b) får man etter behandling med hydrogenbromid 3,4-dihydroksy-5-nitrofenyl (imidazol-2-yl)keton-hydrobromid som gule krystaller med smp. 247-248°C. acetonitrile is dripped over 10 min. a solution of 10.0 g (53.13 mmol) of 1-[(benzyloxy)methyl]imidazole in 50 ml of acetonitrile under ice-cooling so that the temperature does not exceed 25°C. It is then stirred for a further 3 hours, after which the solvent is distilled off. After mixing with water, extract with vinegar. After washing twice with water, the organic phase is dried over sodium sulphate and evaporated. The obtained oil is chromatographed on 600 g of silica gel with toluene/acetic ester (95:5). 1-[(benzyloxy)-methyl]imidazol-2-yl (3,4-dimethoxy-5-nitrophenyl)ketone is obtained as a yellowish oil. b) Analogous to example 67b), after treatment with hydrogen bromide 3,4-dihydroxy-5-nitrophenyl (imidazol-2-yl)ketone hydrobromide is obtained as yellow crystals with m.p. 247-248°C.
Eksempel 7 0 Example 7 0
a) En løsing av 25,0 g (120,16 mmol) 3-bromkinolin oppløses i 200 ml tørr eter og avkjøles til -60°C. Ved denne temperaturen a) A solution of 25.0 g (120.16 mmol) of 3-bromoquinoline is dissolved in 200 ml of dry ether and cooled to -60°C. At this temperature
tildryppes i løpet av 15 min. 75,1 ml (120,16 mmol) av en 1,6-molar løsning av n-butyllitium, hvoretter man rører i 10 min.. Til dette drypper man ved -60°C en løsning av 2 6,5 g (109,2 mmol) vanillinbenzyleter i 250 ml tørr eter, rører så i 3 timer ved romtemperatur, heller på ca. 1,5 1 isvann og ekstraherer tre ganger med 600 ml eddikester hver gang. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Den erholdte olje kromatograferes på 1 kg kiselgel med metylenklorid/ eddikester (1:1). Det erholdte krystallinske råprodukt omløses fra eddikester. Man får a-[4-(benzyloksy)-3-metoksyfe-nyl]-3-kinolinmetanol i form av fargeløse krystaller med smp. 124-125°C. is infused within 15 min. 75.1 ml (120.16 mmol) of a 1.6-molar solution of n-butyllithium, after which one stirs for 10 min. To this, at -60°C, a solution of 2 6.5 g (109 .2 mmol) vanillin benzyl ether in 250 ml of dry ether, then stir for 3 hours at room temperature, rather at approx. 1.5 1 ice water and extract three times with 600 ml of vinegar each time. The organic phase is washed with water, dried over sodium sulphate and evaporated. The oil obtained is chromatographed on 1 kg of silica gel with methylene chloride/acetic acid (1:1). The crystalline crude product obtained is redissolved from acetic acid. α-[4-(benzyloxy)-3-methoxyphenyl]-3-quinolinemethanol is obtained in the form of colorless crystals with m.p. 124-125°C.
b) En løsning av 6,2 g (16,7 mmol) a-[4-(benzyloksy)-3-metoksy-fenyl]-3-kinolinmetanol i 200 ml metylenklorid røres etter b) A solution of 6.2 g (16.7 mmol) of α-[4-(benzyloxy)-3-methoxy-phenyl]-3-quinoline methanol in 200 ml of methylene chloride is stirred after
blanding med 62 g mangandioksyd i 2 timer ved tilbakeløpstempera-tur. Etter avkjøling frafiltreres fellingen og vaskes med metylenklorid. Filtratet inndampes og den erholdte olje oppløses i varm eter, hvorpå man blander med litt pentan. De utfelte krystaller frafiltreres. Man får 4-(benzyloksy)-3-metoksyfenyl (3-kinolin)keton i form av fargeløse krystaller med smp. 110-111°C. mixture with 62 g of manganese dioxide for 2 hours at reflux temperature. After cooling, the precipitate is filtered off and washed with methylene chloride. The filtrate is evaporated and the oil obtained is dissolved in hot ether, after which it is mixed with a little pentane. The precipitated crystals are filtered off. 4-(Benzyloxy)-3-methoxyphenyl (3-quinoline)ketone is obtained in the form of colorless crystals with m.p. 110-111°C.
c) 11,0 g (29,78 mmol) 4-(benzyloksy)-3-metoksyfenyl (3-kinolin)keton blandes med 50 ml trifluoreddiksyre, hvoretter man c) 11.0 g (29.78 mmol) of 4-(benzyloxy)-3-methoxyphenyl (3-quinoline) ketone are mixed with 50 ml of trifluoroacetic acid, after which
rører i 2 timer ved romtemperatur. Etter avdestillering av trifluoreddiksyre blandes to ganger med 50 ml etanol hver gang og løsningsmidlet avdestilleres stadig. Den erholdte olje krystalliserer ved blanding med etanol. Etter omkrystallisering fra etanol får man 4-hydroksy-3-metoksyfenyl (3-kinolinyl)keton i form av gule krystaller med smp. 196-197°C. stir for 2 hours at room temperature. After the trifluoroacetic acid has been distilled off, it is mixed twice with 50 ml of ethanol each time and the solvent is constantly distilled off. The oil obtained crystallizes when mixed with ethanol. After recrystallization from ethanol, 4-hydroxy-3-methoxyphenyl (3-quinolinyl) ketone is obtained in the form of yellow crystals with m.p. 196-197°C.
d) Til en løsning av 5,5 g (19,69 mmol) 4-hydroksy-3-metoksyfe-nyl (3-kinolinyl)keton i 300 ml iseddik drypper man ved 15°C en d) To a solution of 5.5 g (19.69 mmol) of 4-hydroxy-3-methoxyphenyl (3-quinolinyl) ketone in 300 ml of glacial acetic acid, at 15°C a
løsning av 1,91 ml 65% salpetersyre i 20 ml iseddik og rører så solution of 1.91 ml of 65% nitric acid in 20 ml of glacial acetic acid and then stir
videre i 2 timer ved denne temperaturen. Det hele helles så på isvann og ekstraheres tre ganger med 3 00 ml eddikester hver gang. Den organiske fasen vaskes fem ganger med 100 ml vann hver gang, tørkes over natriumsulfat og inndampes. Etter blanding av resten med eddikester får man 4-hydroksy-3-metoksy-5-nitrofenyl (3-kinolinyl)keton i form av gule krystaller med smp. 220-221°C (spaltning). further for 2 hours at this temperature. The whole is then poured into ice water and extracted three times with 300 ml of vinegar each time. The organic phase is washed five times with 100 ml of water each time, dried over sodium sulphate and evaporated. After mixing the residue with ethyl acetate, 4-hydroxy-3-methoxy-5-nitrophenyl (3-quinolinyl) ketone is obtained in the form of yellow crystals with m.p. 220-221°C (decomposition).
e) 820 mg (2,53 mmol) 4-hydroksy-3-metoksy-5-nitrofenyl (3-kinolinyl)keton blandes med 50 ml 48% hydrogenbromid og holdes i 3 timer ved tilbakeløpstemperaturen. Etter avdestillering av hydrogenbromid ved 50°C blandes resten med 70 ml varmt vann, og den uløselige del frafiltreres. Man får 3,4-dihydroksy-5-nitrofenyl (3-kinolinyl)keton-hydrobromid i form av gule krystaller med smp. 270°C (spaltning). e) 820 mg (2.53 mmol) of 4-hydroxy-3-methoxy-5-nitrophenyl (3-quinolinyl) ketone are mixed with 50 ml of 48% hydrogen bromide and kept for 3 hours at the reflux temperature. After the hydrogen bromide has been distilled off at 50°C, the residue is mixed with 70 ml of hot water, and the insoluble part is filtered off. 3,4-dihydroxy-5-nitrophenyl (3-quinolinyl)ketone hydrobromide is obtained in the form of yellow crystals with m.p. 270°C (decomposition).
Eksempel 71 Example 71
Analogt med eksempel 70 får man a-[4-(benzyloksy)-3-metoksy-fenyl]-4-kinolinmetanol som fargeløse krystaller med smp. 117-118°C (eddikester), derav med mangandioksyd 4-(benzyloksy)-3-metoksyfenyl (4-isokinolinyl)keton som fargeløse krystaller med smp. 126,5-127,5°C, derav med trifluoreddiksyre 4-hydroksy-3-metoksyfenyl (4-isokinolinyl)keton som gule krystaller med smp. 197,5-198,5°C, og derav ved nitrering med salpetersyre i iseddik og etterfølgende behandling med hydrogenbromid 3,4-dihydroksy-5-nitrofenyl (4-isokinolinyl)keton-hydrobromid som gule krystaller med smp. 256°C (spaltning). Analogous to example 70, α-[4-(benzyloxy)-3-methoxy-phenyl]-4-quinolinemethanol is obtained as colorless crystals with m.p. 117-118°C (acetic ester), hence with manganese dioxide 4-(benzyloxy)-3-methoxyphenyl (4-isoquinolinyl)ketone as colorless crystals with m.p. 126.5-127.5°C, hence with trifluoroacetic acid 4-hydroxy-3-methoxyphenyl (4-isoquinolinyl)ketone as yellow crystals with m.p. 197.5-198.5°C, and hence by nitration with nitric acid in glacial acetic acid and subsequent treatment with hydrogen bromide 3,4-dihydroxy-5-nitrophenyl (4-isoquinolinyl)ketone hydrobromide as yellow crystals with m.p. 256°C (decomposition).
Eksempel 72 Example 72
Analogt med eksempel 70 får man a-[4-(benzyloksy)-3-metoksy-fenyl]-2-naftalinmetanol som fargeløse krystaller (eddikester/- heksan) med smp. 113-114°C, derav med mangandioksyd 4-(benzyl-oksy) -3 -metoksy f enyl (2-naftyl)keton som fargeløse krystaller (eddikester/heksan) med smp. 104-105°C, fra dette ved behandling med trifluoreddiksyre og nitrering med salpetersyre i iseddik 4-hydroksy-3-metoksy-5-nitrofenyl (2-naftyl)keton som gule krystaller med smp. 187-188°C, og derav ved behandling med hydrogenbromid 3,4-dihydroksy-5-nitrofenyl (2-naftyl)keton som gule krystaller med smp. 184-185°C. Analogous to example 70, α-[4-(benzyloxy)-3-methoxy-phenyl]-2-naphthalene methanol is obtained as colorless crystals (acetic ester/hexane) with m.p. 113-114°C, hence with manganese dioxide 4-(benzyl-oxy)-3-methoxyphenyl (2-naphthyl)ketone as colorless crystals (acetic ester/hexane) with m.p. 104-105°C, from this by treatment with trifluoroacetic acid and nitration with nitric acid in glacial acetic acid 4-hydroxy-3-methoxy-5-nitrophenyl (2-naphthyl) ketone as yellow crystals with m.p. 187-188°C, and hence on treatment with hydrogen bromide 3,4-dihydroxy-5-nitrophenyl (2-naphthyl)ketone as yellow crystals with m.p. 184-185°C.
Eksempel 7 3 Example 7 3
a) En løsning av 20,0 g (100,5 mmol) 3-fenylpropylbromid i 3 00 ml eter blandes ved -60°C under røring i løpet av 15 min. med a) A solution of 20.0 g (100.5 mmol) of 3-phenylpropyl bromide in 300 ml of ether is mixed at -60°C with stirring during 15 min. with
en løsning av 71,8 ml (100,5 mmol) tert.-butyllitium (1,4 molar) i pentan. Etter 10 min. tildryppes ved denne temperaturen en løsning av 22,14 g (91,36 mmol) vanillinbenzyleter i 200 ml eter i løpet av 15 min., hvorpå man rører videre i 2 timer. Satsen helles på 1 1 isvann og ekstraheres tre ganger med 500 ml eddikester hver gang. Den organiske fasen vaskes to ganger med 200 ml vann hver gang, tørkes over natriumsulfat og inndampes. Den erholdte olje kromatograferes på 1 kg kiselgel med metylenklorid. De erholdte krystaller omløses fra eter/pentan. Man får 4-(benzyloksy)-3-metoksy-cx-(3-fenylpropyl)benzylalkohol i form av fargeløse krystaller med smp. 71-73°C. a solution of 71.8 ml (100.5 mmol) of tert-butyllithium (1.4 molar) in pentane. After 10 min. at this temperature, a solution of 22.14 g (91.36 mmol) of vanillin benzyl ether in 200 ml of ether is added dropwise over the course of 15 min., after which stirring is continued for 2 hours. The batch is poured into 1 1 ice water and extracted three times with 500 ml of vinegar each time. The organic phase is washed twice with 200 ml of water each time, dried over sodium sulphate and evaporated. The oil obtained is chromatographed on 1 kg of silica gel with methylene chloride. The crystals obtained are redissolved from ether/pentane. 4-(Benzyloxy)-3-methoxy-c-(3-phenylpropyl)benzyl alcohol is obtained in the form of colorless crystals with m.p. 71-73°C.
b) En løsning av 9,0 g (24,83 mmol) 4-(benzyloksy)-3-metoksy-a-(3-fenylpropyl)benzylalkohol i 250 ml metylenklorid blandes med b) A solution of 9.0 g (24.83 mmol) of 4-(benzyloxy)-3-methoxy-α-(3-phenylpropyl)benzyl alcohol in 250 ml of methylene chloride is mixed with
90 g mangandioksyd og holdes i 2 timer ved tilbakeløpstemperatur. Etter avkjøling frafiltreres fellingen og vaskes med metylenklorid. Filtratet inndampes og resten omkrystalliseres fra eddikester/eter. Man får 4'-(benzyloksy)-3'-metoksy-4-fenylbutyrofenon i form av fargeløse krystaller med smp. 81-82°C. c) En løsning av 7,0 g (19,42 mmol) 4'-(benzyloksy)-3'-metoksy-4-fenylbutyrofenon i 40 ml 33% hydrogenbromid i iseddik røres i 5 timer ved romtemperatur og helles så på 500 ml isvann. Etter tilsetning av kons. ammoniakk innstilles pH på 6,0, og man ekstraherer tre ganger med 250 ml eddikester hver gang. Den organiske fasen vaskes tre ganger med 50 ml vann hver gang, tørkes over natriumsulfat og inndampes. Den erholdte olje oppløses i 20 ml eter, hvoretter man blander med heksan til blakking og lar utkrystallisere. Man får fargeløst 4'-hydroksy-3'-metoksy-4-fenylbutyrofenon med smp. 91-92°C. d) Til en løsning av 2,2 g (8,14 mmol) 4'-hydroksy-3'-metoksy-4-fenylbutyrofenon i 25 ml iseddik drypper man en løsning av 0,79 ml 65% salpetersyre i 25 ml iseddik og rører i 2 timer videre ved romtemperatur. Det hele helles på 150 ml isvann, og etter blanding med 20 ml 3N-saltsyre ekstraheres tre ganger med 75 ml eddikester hver gang. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Det oppnådde råprodukt opptas i eddikester og filtreres gjennom 75 g kiselgel. Etter omkrystallisering fra acetonitril får man 4'-hydroksy-3'-metoksy-5'-nitro-4-fenylbutyrofenon i form av gule krystaller med smp. 120-121°C. e) 1,0 g (3,2 mmol) 4'-hydroksy-3'-metoksy-5'-nitro-4-fenylbu-tyrof enon holdes med 8 g pyridin-hydroklorid på 2 00°C i 1 time. 90 g of manganese dioxide and kept for 2 hours at reflux temperature. After cooling, the precipitate is filtered off and washed with methylene chloride. The filtrate is evaporated and the residue is recrystallized from ethyl acetate/ether. 4'-(benzyloxy)-3'-methoxy-4-phenylbutyrophenone is obtained in the form of colorless crystals with m.p. 81-82°C. c) A solution of 7.0 g (19.42 mmol) 4'-(benzyloxy)-3'-methoxy-4-phenylbutyrophenone in 40 ml of 33% hydrogen bromide in glacial acetic acid is stirred for 5 hours at room temperature and then poured into 500 ml ice water. After adding conc. ammonia, the pH is set to 6.0, and extraction is carried out three times with 250 ml of acetic acid each time. The organic phase is washed three times with 50 ml of water each time, dried over sodium sulphate and evaporated. The oil obtained is dissolved in 20 ml of ether, after which it is mixed with hexane until clear and allowed to crystallize. Colorless 4'-hydroxy-3'-methoxy-4-phenylbutyrophenone is obtained with m.p. 91-92°C. d) To a solution of 2.2 g (8.14 mmol) 4'-hydroxy-3'-methoxy-4-phenylbutyrophenone in 25 ml of glacial acetic acid, a solution of 0.79 ml of 65% nitric acid in 25 ml of glacial acetic acid is added dropwise and stir for a further 2 hours at room temperature. The whole is poured into 150 ml of ice water, and after mixing with 20 ml of 3N hydrochloric acid, it is extracted three times with 75 ml of acetic acid each time. The organic phase is washed with water, dried over sodium sulphate and evaporated. The crude product obtained is taken up in vinegar and filtered through 75 g of silica gel. After recrystallization from acetonitrile, 4'-hydroxy-3'-methoxy-5'-nitro-4-phenylbutyrophenone is obtained in the form of yellow crystals with m.p. 120-121°C. e) 1.0 g (3.2 mmol) of 4'-hydroxy-3'-methoxy-5'-nitro-4-phenylbutyrophene is kept with 8 g of pyridine hydrochloride at 200°C for 1 hour.
Reaksjonsblandingen helles på isvann mens den enda er varm og ekstraheres med eddikester. Den organiske fasen vaskes med 1N-saltsyre og deretter med vann, tørkes over natriumsulfat og inndampes. Den oppnådde mørke rest kromatograferes på den 30 dobbelte mengde kiselgel med eddikester. Fra metylenklorid/heksan får man 3',4',dihydroksy-5'-nitro-4-fenylbutyrofenon i form av gule krystaller med smp. 118-119°C. The reaction mixture is poured onto ice water while it is still warm and extracted with vinegar. The organic phase is washed with 1N hydrochloric acid and then with water, dried over sodium sulphate and evaporated. The dark residue obtained is chromatographed on double the amount of silica gel with acetic acid. From methylene chloride/hexane, 3',4',dihydroxy-5'-nitro-4-phenylbutyrophenone is obtained in the form of yellow crystals with m.p. 118-119°C.
Eksempel 74 Example 74
a) Til en løsning av 10,0 g (47,4 mmol) 3,4-dimetoksy-5-nitrobenzaldehyd i 100 ml dioksan settes en løsning av 14,68 g a) To a solution of 10.0 g (47.4 mmol) of 3,4-dimethoxy-5-nitrobenzaldehyde in 100 ml of dioxane is added a solution of 14.68 g
(225,4 mmol) kaliumcyanid i 20 ml vann. Nå drypper man i løpet av 30 min. 18,81 ml (190,76 mmol) 37% saltsyre til dette under kraftig røring. Etter tilsetning av 120 ml eter drives overskudd av blåsyregass ut ved gjennomblåsning av argon. Reaksjonsblandingen filtreres over et filtreringshjelpemiddel av kiselgur, og den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Det dannede a-hydroksy-3,4-dimetoksyfenylacetoni-tril (gulaktig olje) oppløses i 200 ml eter, hvoretter man blander med 20 ml etanol, avkjøler til 0°C og innleder saltsyregass i 30 min.. Etter 3 timer ved røring filtreres den utfelte fargeløse felling fra og omløses fra etanol/eter. Man får etyl (3,4-dimetoksy-5-nitrofenyl)hydroksyacetimidat-hydroklorid. (225.4 mmol) of potassium cyanide in 20 ml of water. Now you drip within 30 minutes. 18.81 ml (190.76 mmol) of 37% hydrochloric acid to this with vigorous stirring. After adding 120 ml of ether, excess hydrocyanic acid gas is expelled by blowing through argon. The reaction mixture is filtered over a filter aid of kieselguhr, and the organic phase is washed with water, dried over sodium sulfate and evaporated. The formed α-hydroxy-3,4-dimethoxyphenylacetonitrile (yellowish oil) is dissolved in 200 ml of ether, after which it is mixed with 20 ml of ethanol, cooled to 0°C and hydrochloric acid gas is introduced for 30 min. After 3 hours of stirring, it is filtered the precipitated colorless precipitate from and redissolved from ethanol/ether. Ethyl (3,4-dimethoxy-5-nitrophenyl)hydroxyacetimidate hydrochloride is obtained.
b) 19,7 g (61,46 mmol) etyl (3,4-dimetoksy-5-nitrofenyl)hydrok-syacetimidat-hydroklorid oppløses i 500 ml etanol, hvoretter man b) Dissolve 19.7 g (61.46 mmol) of ethyl (3,4-dimethoxy-5-nitrophenyl)hydroxyacetimidate hydrochloride in 500 ml of ethanol, after which
etter tilsetning av 6,73 g (61,46 mmol) o-fenylendiamin rører i 2 timer ved romtemperatur og så holder tilbakeløpstemperatur natten over. Etter avdestillering av løsningsmidlet blandes med after adding 6.73 g (61.46 mmol) of o-phenylenediamine, stir for 2 hours at room temperature and then maintain the reflux temperature overnight. After distilling off the solvent, mix with
50 ml vann, innstilles alkalisk med sodaløsning og ekstraherer to ganger med 250 ml metylenklorid hver gang. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Den oppnådde orange rest kromatograferes på 400 g kiselgel med metylenklorid/eddikester (1:1). Fra eter/heksan får man a-(3,4-dimetoksy-5-nitrofenyl)-2-benzimidazolmetanol i form av gulaktige krystaller med smp. 50°C (spaltning). c) 13,2 g (40,1 mmol) a-(3,4-dimetoksy-5-nitrofenyl)-2-benzimi-dazolmetanol oppløses i 200 ml metylenklorid, hvorpå man etter blanding med 130 g mangandioksyd rører i 2 timer ved tilbakeløps-temperatur. Etter filtrering avdestilleres løsningsmidlet. Man får 2-benzimidazolyl (3,4-dimetoksy-5-nitrofenyl)keton i form av gulaktige krystaller med smp. 212-213°C. d) 1,0 g (3,05 mmol) 2-benzimidazolyl (3,4-dimetoksy-5-nitrofe-nyl)keton og 8,0 g pyridin-hydroklorid holdes ved 200°C i 60 min.. Den mørke løsningen helles på isvann mens den enda er varm og ekstraheres tre ganger med 100 ml eddikester hver gang. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Etter omkrystallisering fra eddikester/heksan får man 2-benzimidazolyl (3,4-dihydroksy-5-nitrofenyl)keton i form av gule krystaller med smp. 249-250°C. 50 ml of water, made alkaline with soda solution and extracted twice with 250 ml of methylene chloride each time. The organic phase is washed with water, dried over sodium sulphate and evaporated. The orange residue obtained is chromatographed on 400 g of silica gel with methylene chloride/acetic acid (1:1). From ether/hexane, α-(3,4-dimethoxy-5-nitrophenyl)-2-benzimidazole methanol is obtained in the form of yellowish crystals with m.p. 50°C (decomposition). c) 13.2 g (40.1 mmol) α-(3,4-dimethoxy-5-nitrophenyl)-2-benzimidazolemethanol is dissolved in 200 ml of methylene chloride, after which, after mixing with 130 g of manganese dioxide, it is stirred for 2 hours at return temperature. After filtration, the solvent is distilled off. 2-benzimidazolyl (3,4-dimethoxy-5-nitrophenyl)ketone is obtained in the form of yellowish crystals with m.p. 212-213°C. d) 1.0 g (3.05 mmol) of 2-benzimidazolyl (3,4-dimethoxy-5-nitro-nyl) ketone and 8.0 g of pyridine hydrochloride are kept at 200°C for 60 min. The dark solution poured onto ice water while it is still warm and extracted three times with 100 ml of vinegar each time. The organic phase is washed with water, dried over sodium sulphate and evaporated. After recrystallization from ethyl acetate/hexane, 2-benzimidazolyl (3,4-dihydroxy-5-nitrophenyl) ketone is obtained in the form of yellow crystals with m.p. 249-250°C.
Eksempel 75 Example 75
a) 30,0 g (132 mmol) 3,4-dimetoksy-5-nitrobenzosyre oppløses i 250 ml tetrahydrofuran, hvorpå man etter tilsetning av 21,85 g a) 30.0 g (132 mmol) of 3,4-dimethoxy-5-nitrobenzoic acid are dissolved in 250 ml of tetrahydrofuran, after which, after the addition of 21.85 g
(135 mmol) 1,1'-karbonyldiimidazol rører i 2 timer ved tilbake-løpstemperatur. Det hele helles på 300 ml isvann, og de utfelte krystaller frafiltreres etter 30 min. røring. Disse opptas i metylenklorid, hvoretter den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Etter krystallisering (135 mmol) of 1,1'-carbonyldiimidazole is stirred for 2 hours at reflux temperature. The whole is poured into 300 ml of ice water, and the precipitated crystals are filtered off after 30 min. stirring. These are taken up in methylene chloride, after which the organic phase is washed with water, dried over sodium sulphate and evaporated. After crystallization
fra metylenklorid/heksan får man 1-(3,4-dimetoksy-5-nitroben-zoyl)imidazol i form av fargeløse krystaller med smp. 136-137°C. from methylene chloride/hexane gives 1-(3,4-dimethoxy-5-nitrobenzoyl)imidazole in the form of colorless crystals with m.p. 136-137°C.
b) 10,0 g (36,1 mmol) 1-(3,4-dimetoksy-5-nitrobenzoyl)imidazol i 50 ml dimetylformamid blandes med 6,95 g (93,8 mmol) acetamid-oksim, hvoretter man rører i 1 time ved 70°C. Det hele helles b) 10.0 g (36.1 mmol) 1-(3,4-dimethoxy-5-nitrobenzoyl)imidazole in 50 ml dimethylformamide is mixed with 6.95 g (93.8 mmol) acetamide oxime, after which stirring is 1 hour at 70°C. It is all poured
etter avkjøling på 500 ml isvann og røres i 30 min.. De utfelte krystaller filtreres fra og vaskes med vann. Etter krystallisering fra eddikester får man N'-[(3,4-dimetoksy-5-nitrobenzoyl)-oksy]acetamidin i form av fargeløse krystaller med smp. 165-166°C. after cooling in 500 ml of ice water and stirred for 30 min. The precipitated crystals are filtered off and washed with water. After crystallization from acetic ester, N'-[(3,4-dimethoxy-5-nitrobenzoyl)-oxy]acetamidine is obtained in the form of colorless crystals with m.p. 165-166°C.
c) 2,0 g (7,2 mmol) N'-[(3,4-dimetoksy-5-nitrobenzoyl)oksy]-acetamidin holdes i 20 ml iseddik i 1 time ved tilbakeløpstempe-ratur. Etter avdestillering av iseddiken omløses den krystallinske rest fra eter/hekan. Man får 5-(3,4-dimetoksy-5-nitrofe-nyl)-3-metyl-l,2,4-oksadiazol] i form av fargeløse krystaller med smp. 111°C. d) 2,5 g (9,43 mmol) 5-(3,4-dimetoksy-5-nitrofenyl)-5-metyl-1,2,4-oksadiazol oppløses i 70 ml metylenklorid. Etter avkjøling til -60°C tildryppes i løpet av 20 min. under røring en løsning av 23,62 g (94,3 mmol) bortribromid i 50 ml metylenklorid, hvorpå man holder tilbakeløpstemperatur i 48 timer. Etter avkjøling til -60°C blandes med 60 ml etanol, og deretter rører man ved romtemperatur i 30 min.. Den gule løsningen inndampes til tørrhet, hvoretter resten blandes tre ganger med 100 ml toluen/- etanol (1:1), og løsningsmidlet avdestilleres hver gang. Etter krystallisering fra etanol får man 5-(3-metyl-l,2,4-oksadiazol-5-yl)-3-nitropyrokatekol i form av gule krystaller med smp. 201-202°C. c) 2.0 g (7.2 mmol) of N'-[(3,4-dimethoxy-5-nitrobenzoyl)oxy]-acetamidine is kept in 20 ml of glacial acetic acid for 1 hour at reflux temperature. After distilling off the glacial acetic acid, the crystalline residue is dissolved from ether/hexane. 5-(3,4-dimethoxy-5-nitro-nyl)-3-methyl-1,2,4-oxadiazole] is obtained in the form of colorless crystals with m.p. 111°C. d) 2.5 g (9.43 mmol) of 5-(3,4-dimethoxy-5-nitrophenyl)-5-methyl-1,2,4-oxadiazole are dissolved in 70 ml of methylene chloride. After cooling to -60°C, add drop by drop over the course of 20 min. with stirring, a solution of 23.62 g (94.3 mmol) of boron tribromide in 50 ml of methylene chloride, after which the reflux temperature is maintained for 48 hours. After cooling to -60°C, mix with 60 ml of ethanol, and then stir at room temperature for 30 min. The yellow solution is evaporated to dryness, after which the residue is mixed three times with 100 ml of toluene/ethanol (1:1), and the solvent is distilled off each time. After crystallization from ethanol, 5-(3-methyl-1,2,4-oxadiazol-5-yl)-3-nitropyrocatechol is obtained in the form of yellow crystals with m.p. 201-202°C.
Eksempel 76 Example 76
a) Til 35,0 g l-brom-2-fluorbenzen (oppløst i 600 ml tetrahydrofuran) dryppes ved -70°C i løpet av 30 min. 143,8 ml n-butyllitiumløsning (1,53 M i heksan). Etter 60 min. røring ved a) To 35.0 g of 1-bromo-2-fluorobenzene (dissolved in 600 ml of tetrahydrofuran) is added dropwise at -70°C during 30 min. 143.8 ml of n-butyl lithium solution (1.53 M in hexane). After 60 min. stirring wood
-70°c tildryppes 48,5 g 3-metoksy-4-benzyloksybenzaldehyd (oppløst i 450 ml tetrahydrofuran) i 30 min.. Reaksjonsblandin- -70°C, 48.5 g of 3-methoxy-4-benzyloxybenzaldehyde (dissolved in 450 ml of tetrahydrofuran) are added dropwise for 30 min.. Reaction mixture
gen røres 2 timer ved -70°C og 30 min. ved 0°C, helles på en blanding av is og 150 ml 2N-svovelsyre og ekstraheres tre ganger med 500 ml eter. De sammenslåtte eterfaser vaskes med mettet koksaltløsning, tørkes over natriumsulfat og inndampes. Man får 2-(benzyloksy)-2'-fluor-3-metoksybenzhydrol, som gulaktig olje, som kan anvendes direkte i det etterflølgende reaksjonstrinn. stir for 2 hours at -70°C and 30 min. at 0°C, poured onto a mixture of ice and 150 ml of 2N sulfuric acid and extracted three times with 500 ml of ether. The combined ether phases are washed with saturated sodium chloride solution, dried over sodium sulphate and evaporated. 2-(Benzyloxy)-2'-fluoro-3-methoxybenzhydrol is obtained as a yellowish oil, which can be used directly in the following reaction step.
På analog måte får man: Analogously, you get:
al) Fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-3-fluorben-zen 4-(benzyloksy)-3'-fluor-3-metoksybenzhydrol som en olje; al) From 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-3-fluorobenzene 4-(benzyloxy)-3'-fluoro-3-methoxybenzhydrol as an oil;
a2) fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-4-fluorben-zeh 4-(benzyloksy)-4'-fluor-3-metoksybenzhydrol som en olje; a2) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-4-fluorobenzeh 4-(benzyloxy)-4'-fluoro-3-methoxybenzhydrol as an oil;
a3) fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-2,6-difluor-benzen 4-(benzyloksy)-2',6'-difluor-3-metoksybenzhydrol som en olje; a3) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-2,6-difluoro-benzene 4-(benzyloxy)-2',6'-difluoro-3-methoxybenzhydrol as an oil;
a4) fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-2-klorbenzen 4-(benzyloksy)-2'-klor-3-metoksybenzhydrol som en olje; a4) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-2-chlorobenzene 4-(benzyloxy)-2'-chloro-3-methoxybenzhydrol as an oil;
a5) fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-3-klorbenzen 4-(benzyloksy)-3'-klor-3-metoksybenzhydrol som en olje; a5) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-3-chlorobenzene 4-(benzyloxy)-3'-chloro-3-methoxybenzhydrol as an oil;
a6) fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-4-klorbenzen 4-(benzyloksy)-4'-klor-3-metoksybenzhydrol som en olje; a6) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-4-chlorobenzene 4-(benzyloxy)-4'-chloro-3-methoxybenzhydrol as an oil;
a7) fra 4-benzyloksy-3-metoksybenzaldehyd og 2-bromtoluen 4-(benzyloksy)-3-metoksy-2'-metylbenzhydrol som en olje; a7) from 4-benzyloxy-3-methoxybenzaldehyde and 2-bromotoluene 4-(benzyloxy)-3-methoxy-2'-methylbenzhydrol as an oil;
a8) fra 3-metoksy-4-benzyloksybenzaldehyd og 4-bromtoluen 4-(benzyloksy)-3-metoksy-4'-metylbenzhydrol som en olje; a8) from 3-methoxy-4-benzyloxybenzaldehyde and 4-bromotoluene 4-(benzyloxy)-3-methoxy-4'-methylbenzhydrol as an oil;
a9) fra 3-metoksy-4-benzyloksybenzaldehyd og 1-brombenzonitril 4-(benzyloksy)-2'-cyano-3-metoksybenzhydrol som olje og a9) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromobenzonitrile 4-(benzyloxy)-2'-cyano-3-methoxybenzhydrol as oil and
alO) fra 3-metoksy-4-benzyloksybenzaldehyd og l-brom-2-trifluor-metylbenzen 4-(benzyloksy)-3-metoksy-2'-(trifluormetyl)benzhydrol som en olje. alO) from 3-methoxy-4-benzyloxybenzaldehyde and 1-bromo-2-trifluoromethylbenzene 4-(benzyloxy)-3-methoxy-2'-(trifluoromethyl)benzhydrol as an oil.
b) 69,8 g 4-(benzyloksy)-2'-fluor-3-metoksybenzhydrol (oppløst i 600 ml metylenklorid) blandes i løpet av 30 min. ved 20°C med b) 69.8 g of 4-(benzyloxy)-2'-fluoro-3-methoxybenzhydrol (dissolved in 600 ml of methylene chloride) are mixed during 30 min. at 20°C with
45,3 g pyridiniumklorkromat og røres 3 timer ved 20°C. Så frafiltreres den dannede felling og vaskes med metylenklorid. Filtratet inndampes, og resten filtreres på 100 g kiselgel med eter. Man får etter omkrystallisering fra eter 4-(benzyloksy)-2'-fluor-3-metoksybenzofenon med smp. 118-120°C. 45.3 g of pyridinium chlorochromate and stirred for 3 hours at 20°C. The formed precipitate is then filtered off and washed with methylene chloride. The filtrate is evaporated, and the residue is filtered on 100 g of silica gel with ether. After recrystallization from ether, 4-(benzyloxy)-2'-fluoro-3-methoxybenzophenone with m.p. 118-120°C.
På analog måte får man: Analogously, you get:
bl) Fra 4-(benzyloksy)-3'-fluor-3-metoksybenzhydrol 4-(benzyl-oksy) -3 ' -f luor-3-metoksybenzof enon som amorft faststoff; bl) From 4-(benzyloxy)-3'-fluoro-3-methoxybenzhydrol 4-(benzyloxy)-3'-fluoro-3-methoxybenzophenone as amorphous solid;
b2) fra 4-(benzyloksy)-4'-fluor-3-metoksybenzhydrol 4-(benzyl-oksy)-4'-fluor-3-metoksybenzofenon med smp. 99-101°C (fra eter/heksan); b2) from 4-(benzyloxy)-4'-fluoro-3-methoxybenzhydrol 4-(benzyloxy)-4'-fluoro-3-methoxybenzophenone with m.p. 99-101°C (from ether/hexane);
b3) fra 4-(benzyloksy)-2',6'-difluor-3-metoksybenzhydrol 4-(benzyloksy)-2',6'-difluor-3-metoksybenzofenon med smp. 139-141°C (fra metylenklorid/eter); b3) from 4-(benzyloxy)-2',6'-difluoro-3-methoxybenzhydrol 4-(benzyloxy)-2',6'-difluoro-3-methoxybenzophenone with m.p. 139-141°C (from methylene chloride/ether);
b4) fra 4-(benzyloksy)-2'-klor-3-metoksybenzhydrol 4-(benzyl-oksy) -2 ' -klor-3-metoksybenzof enon med smp. 128-130°C (fra eter); b4) from 4-(benzyloxy)-2'-chloro-3-methoxybenzhydrol 4-(benzyloxy)-2'-chloro-3-methoxybenzophenone with m.p. 128-130°C (from ether);
b5) fra 4-(benzyloksy)-3'-klor-3-metoksybenzhydrol 4-(benzyl-oksy) -3 ' -klor-3-metoksybenzof enon som amorft faststoff; b5) from 4-(benzyloxy)-3'-chloro-3-methoxybenzhydrol 4-(benzyloxy)-3'-chloro-3-methoxybenzophenone as amorphous solid;
b6) fra 4-(benzyloksy)-4'-klor-3-metoksybenzhydrol 4-(benzyl-oksy) -4 ' -klor-3-metoksybenzof enon med smp. 106-108°C (fra metylenklorid/heksan); b6) from 4-(benzyloxy)-4'-chloro-3-methoxybenzhydrol 4-(benzyloxy)-4'-chloro-3-methoxybenzophenone with m.p. 106-108°C (from methylene chloride/hexane);
b7) fra 4-(benzyloksy)-3-metoksy-2'-metylbenzhydrol 4-(benzyl-oksy) -3 -metoksy-2 ' -metylbenzof enon med smp. 86-88°C (fra isopropyleter) ; b7) from 4-(benzyloxy)-3-methoxy-2'-methylbenzhydrol 4-(benzyloxy)-3-methoxy-2'-methylbenzophenone with m.p. 86-88°C (from isopropyl ether);
b8) fra 4-(benzyloksy)-3-metoksy-4'-metylbenzhydrol 4-(benzyl-oksy) -3-metoksy-4 ' -metylbenzof enon med smp. 79-81°C (fra eter/heksan); b8) from 4-(benzyloxy)-3-methoxy-4'-methylbenzhydrol 4-(benzyloxy)-3-methoxy-4'-methylbenzophenone with m.p. 79-81°C (from ether/hexane);
b9) fra 4-(benzyloksy)-2'-cyano-3-metoksybenzhydrol 4-(benzyl-oksy) -2 '. -cyano-3 -metoksybenzof enon som amorft faststoff og b9) from 4-(benzyloxy)-2'-cyano-3-methoxybenzhydrol 4-(benzyloxy)-2'. -cyano-3-methoxybenzophenone as an amorphous solid and
blO) fra 4-(benzyloksy)-3-metoksy-2'-(trifluormetyl)benzhydrol 4-(benzyloksy)-3-metoksy-2'-(trifluormetyl)benzofenon med smp. 103-105°C (fra eter). blO) from 4-(benzyloxy)-3-methoxy-2'-(trifluoromethyl)benzhydrol 4-(benzyloxy)-3-methoxy-2'-(trifluoromethyl)benzophenone with m.p. 103-105°C (from ether).
c) Til 42,4 g 4-(benzyloksy)-2'-fluor-3-metoksybenzofenon (oppløst i 450 ml metylenklorid) settes ved 20-25°C 170 ml 33% c) To 42.4 g of 4-(benzyloxy)-2'-fluoro-3-methoxybenzophenone (dissolved in 450 ml of methylene chloride) is added at 20-25°C 170 ml of 33%
hydrogenbromid i iseddik i løpet av 20 min.. Etter 1,5 timer røring ved 20°C helles reaksjonsblandigen på 750 ml isvann; metylenkloridfasen skilles fra, og den vandige fasen ekstraheres enda to ganger med 200 ml metylenklorid. De samlede metylenklo-ridf aser vaskes med 1200 ml vann, tørkes over natriumsulfat og inndampes. For å fjerne det dannede benzylbromid blandes den oljeaktige resten med heksan og avdekanteres. Man får 2'-fluor-4-hydroksy-3-metoksybenzofenon som gulaktig olje, som kan anvendes direkte i det etterfølgende reaksjonstrinn. hydrogen bromide in glacial acetic acid during 20 min. After 1.5 hours of stirring at 20°C, the reaction mixture is poured into 750 ml of ice water; the methylene chloride phase is separated, and the aqueous phase is extracted twice more with 200 ml of methylene chloride. The combined methylene chloride phases are washed with 1200 ml of water, dried over sodium sulphate and evaporated. To remove the benzyl bromide formed, the oily residue is mixed with hexane and decanted. 2'-Fluoro-4-hydroxy-3-methoxybenzophenone is obtained as a yellowish oil, which can be used directly in the subsequent reaction step.
På analog måte får man: Analogously, you get:
cl) Fra 4-(benzyloksy)-3'-fluor-3-metoksybenzofenon 3'-fluor-4-hydroksy-3-metoksybenzofenon med smp. 133-135°C (fra metylenklorid/petroleter ts.); cl) From 4-(benzyloxy)-3'-fluoro-3-methoxybenzophenone 3'-fluoro-4-hydroxy-3-methoxybenzophenone with m.p. 133-135°C (from methylene chloride/petroleum ether ts.);
c2) fra 4-(benzyloksy)-4'-fluor-3-metoksybenzofenon 4'-fluor-4-hydroksy-3-metoksybenzofenon med smp. 139-141°C (fra eter); c2) from 4-(benzyloxy)-4'-fluoro-3-methoxybenzophenone 4'-fluoro-4-hydroxy-3-methoxybenzophenone with m.p. 139-141°C (from ether);
c3) fra 4-(benzyloksy)-2',6'-difluor-3-metoksybenzofenon 2',6'-difluor-4-hydroksy-3-metoksybenzofenon med smp. 130-132°C (fra metylenklorid/petroleter ts.); c3) from 4-(benzyloxy)-2',6'-difluoro-3-methoxybenzophenone 2',6'-difluoro-4-hydroxy-3-methoxybenzophenone with m.p. 130-132°C (from methylene chloride/petroleum ether ts.);
c4) fra 4-(benzyloksy)-2'-klor-3-metoksybenzofenon 2'-klor-4-hydroksy-3-metoksybenzofenon som amorft faststoff; c4) from 4-(benzyloxy)-2'-chloro-3-methoxybenzophenone 2'-chloro-4-hydroxy-3-methoxybenzophenone as amorphous solid;
c5) fra 4-(benzyloksy)-3'-klor-3-metoksybenzofenon 3'-klor-4-hydroksy-3-metoksybenzofenon med smp. 136-138°C (fra metylenklorid) ; c5) from 4-(benzyloxy)-3'-chloro-3-methoxybenzophenone 3'-chloro-4-hydroxy-3-methoxybenzophenone with m.p. 136-138°C (from methylene chloride);
c6) fra 4-(benzyloksy)-4'-klor-3-metoksybenzofenon 4'-klor-4-hydroksy-3-metoksybenzofenon med smp. 114-116°C (fra metylenklorid/petroleter ts.); c6) from 4-(benzyloxy)-4'-chloro-3-methoxybenzophenone 4'-chloro-4-hydroxy-3-methoxybenzophenone with m.p. 114-116°C (from methylene chloride/petroleum ether ts.);
cl) fra 4-(benzyloksy)-3-metoksy-2'-metylbenzofenon 4-hydroksy-3-metoksy-2'-metylbenzofenon med smp. 103-105°C (fra isopropyleter) ; cl) from 4-(benzyloxy)-3-methoxy-2'-methylbenzophenone 4-hydroxy-3-methoxy-2'-methylbenzophenone with m.p. 103-105°C (from isopropyl ether);
c8) fra 4-(benzyloksy)-3-metoksy-4'-metylbenzofenon 4-hydroksy-3-metoksy-4'-metylbenzofenon med smp. 103-105°C (fra eter/petroleter ts) ; c8) from 4-(benzyloxy)-3-methoxy-4'-methylbenzophenone 4-hydroxy-3-methoxy-4'-methylbenzophenone with m.p. 103-105°C (from ether/petroleum ether ts) ;
c9) fra 4-(benzyloksy)-2'-cyano-3-metoksybenzofenon 2'-cyano-4-hydroksy-3-metoksybenzofenon med smp. 124-126°C (fra eter/n-heksan) og c9) from 4-(benzyloxy)-2'-cyano-3-methoxybenzophenone 2'-cyano-4-hydroxy-3-methoxybenzophenone with m.p. 124-126°C (from ether/n-hexane) and
clO) fra 4-(benzyloksy)-3-metoksy-2'-(trifluormetyl)benzofenon 4-hydroksy-3-metoksy-2'-(trifluormetyl)benzofenon med smp. 115-117°C (fra eter). clO) from 4-(benzyloxy)-3-methoxy-2'-(trifluoromethyl)benzophenone 4-hydroxy-3-methoxy-2'-(trifluoromethyl)benzophenone with m.p. 115-117°C (from ether).
d) Til 29,4 g 2'-fluor-4-hydroksy-3-metoksybenzofenon (oppløst i 450 ml eddiksyre) dryppes i løpet av 20 min. ved 20°C 7,8 ml d) To 29.4 g of 2'-fluoro-4-hydroxy-3-methoxybenzophenone (dissolved in 450 ml of acetic acid) is added dropwise over the course of 20 min. at 20°C 7.8 ml
65%-ig salpetersyre. Etter 1,5 timers røring helles reaksjonsblandingen på 2 1 isvann, og den dannede felling frafiltreres, vaskes med vann og oppløses i metylenklorid. Metylenkloridløs-ningen vaskes med vann, tørkes over natriumsulfat og inndampes. Resten omkrystalliseres fra metanol. Man får 2'-fluor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 127-129°C. 65% nitric acid. After stirring for 1.5 hours, the reaction mixture is poured into 2 l of ice water, and the precipitate formed is filtered off, washed with water and dissolved in methylene chloride. The methylene chloride solution is washed with water, dried over sodium sulphate and evaporated. The residue is recrystallized from methanol. This gives 2'-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 127-129°C.
På analog måte får man: Analogously, you get:
dl) Fra 3'-fluor-4-hydroksy-3-metoksybenzofenon 3'-fluor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 168-170°C (fra metanol); d2) fra 4'-fluor-4-hydroksy-3-metoksybenzofenon 4'-fluor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 126-128°C (fra eter); d3) fra 2',6'-difluor-4-hydroksy-3-metoksybenzofenon 2',6'-difluor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 147-149°C (fra metanol); d4) fra 2'-klor-4-hydroksy-3-metoksybenzofenon 2'-klor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 123-125°C (fra eter); d5) fra 3'-klor-4-hydroksy-3-metoksybenzofenon 3'-klor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 152-154°C (fra metanol); d6) fra 4'-klor-4-hydroksy-3-metoksybenzofenon 4'-klor-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 129-131°C (fra metylenklorid/petroleter ts); d7) fra 4-hydroksy-3-metoksy-2'-metylbenzofenon 4-hydroksy-3-metoksy-2'-metyl-5-nitrobenzofenon med smp. 125-127°C (fra etanol); d8) fra 4-hydroksy-3-metoksy-4'-metylbenzofenon 4-hydroksy-3-metoksy-4-metyl-5-nitrobenzofenon med smp. 137-139°C (fra metylenklorid/eter); d9) fra 2'-cyano-4-hydroksy-3-metoksybenzofenon 2'-cyano-4-hydroksy-3-metoksy-5-nitrobenzofenon med smp. 163-164°C (fra metanol); dlO) fra 4-hydroksy-3-metoksy-2'-(trifluormetyl)benzofenon 4-hydroksy-3-metoksy-5-nitro-2'-(trifluormetyl)benzofenon med smp. 138-140°C (fra metylenklorid/petroleter ts); dll) fra 4-hydroksy-3,4'-dimetoksybenzofenon 4-hydroksy-3,4-dimetoksy-5-nitrobenzofenon med smp. 134-136°C (fra metanol) og dl2) fra 4-hydroksy-3,3',4'-trimetoksybenzofenon 4-hydroksy-5-nitro-3,3',4'-trimetoksybenzofenon med smp. 178-180°C (fra metanol). e) 24,8 g 2'-fluor-4-hydroksy-3-metoksy-5-nitrobenzofenon (oppløst i 120 ml iseddik, 100 ml 33% hydrogenbromid i iseddik og 68 ml 48% vandig hydrogenbromid) kokes 4 timer under tilbakeløp. Så inndampes reaksjonsblandingen under redusert trykk og avdestilleres med toluen. Resten oppløses i metylenklorid, vaskes med vann, tørkes over natriumsulfat, filtreres og inndampes. Produktet krystalliseres fra metylenklorid/petroleter ts. Man får 2'-fluor-3,4-dihydroksy-5-nitrobenzofenon med smp. 169-171°C. dl) From 3'-fluoro-4-hydroxy-3-methoxybenzophenone 3'-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 168-170°C (from methanol); d2) from 4'-fluoro-4-hydroxy-3-methoxybenzophenone 4'-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 126-128°C (from ether); d3) from 2',6'-difluoro-4-hydroxy-3-methoxybenzophenone 2',6'-difluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 147-149°C (from methanol); d4) from 2'-chloro-4-hydroxy-3-methoxybenzophenone 2'-chloro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 123-125°C (from ether); d5) from 3'-chloro-4-hydroxy-3-methoxybenzophenone 3'-chloro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 152-154°C (from methanol); d6) from 4'-chloro-4-hydroxy-3-methoxybenzophenone 4'-chloro-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 129-131°C (from methylene chloride/petroleum ether ts); d7) from 4-hydroxy-3-methoxy-2'-methylbenzophenone 4-hydroxy-3-methoxy-2'-methyl-5-nitrobenzophenone with m.p. 125-127°C (from ethanol); d8) from 4-hydroxy-3-methoxy-4'-methylbenzophenone 4-hydroxy-3-methoxy-4-methyl-5-nitrobenzophenone with m.p. 137-139°C (from methylene chloride/ether); d9) from 2'-cyano-4-hydroxy-3-methoxybenzophenone 2'-cyano-4-hydroxy-3-methoxy-5-nitrobenzophenone with m.p. 163-164°C (from methanol); dlO) from 4-hydroxy-3-methoxy-2'-(trifluoromethyl)benzophenone 4-hydroxy-3-methoxy-5-nitro-2'-(trifluoromethyl)benzophenone with m.p. 138-140°C (from methylene chloride/petroleum ether ts); dll) from 4-hydroxy-3,4'-dimethoxybenzophenone 4-hydroxy-3,4-dimethoxy-5-nitrobenzophenone with m.p. 134-136°C (from methanol) and dl2) from 4-hydroxy-3,3',4'-trimethoxybenzophenone 4-hydroxy-5-nitro-3,3',4'-trimethoxybenzophenone with m.p. 178-180°C (from methanol). e) 24.8 g of 2'-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone (dissolved in 120 ml of glacial acetic acid, 100 ml of 33% hydrogen bromide in glacial acetic acid and 68 ml of 48% aqueous hydrogen bromide) is boiled for 4 hours under reflux. The reaction mixture is then evaporated under reduced pressure and distilled off with toluene. The residue is dissolved in methylene chloride, washed with water, dried over sodium sulphate, filtered and evaporated. The product is crystallized from methylene chloride/petroleum ether ts. 2'-Fluoro-3,4-dihydroxy-5-nitrobenzophenone is obtained with m.p. 169-171°C.
På analog måte får man: Analogously, you get:
el) fra 3'-fluor-4-hydroksy-3-metoksy-5-nitrobenzofenon 3'-fluor-3,4-dihydroksy-5-nitrobenzofenon med smp. 124-126°C (fra metylenklorid); el) from 3'-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone 3'-fluoro-3,4-dihydroxy-5-nitrobenzophenone with m.p. 124-126°C (from methylene chloride);
e2) fra 4'-fluor-4-hydroksy-3-metoksy-5-nitrobenzofenon 4'-fluor-3,4-dihydroksy-5-nitrobenzofenon med smp. 171-173°C (fra metylenklorid); e2) from 4'-fluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone 4'-fluoro-3,4-dihydroxy-5-nitrobenzophenone with m.p. 171-173°C (from methylene chloride);
e3) fra 2',6'-difluor-4-hydroksy-3-metoksy-5-nitrobenzofenon 2',6'-difluor-3,4-dihydroksy-5-nitrobenzofenon med smp. 194-196°C (fra metanol); e3) from 2',6'-difluoro-4-hydroxy-3-methoxy-5-nitrobenzophenone 2',6'-difluoro-3,4-dihydroxy-5-nitrobenzophenone with m.p. 194-196°C (from methanol);
e4) fra 2'-klor-4-hydroksy-3-metoksy-5-nitrobenzofenon 2'-klor-3,4-dihydroksy-5-nitrobenzofenon med smp. 129-131°C (fra metylenklorid/petroleter ts) ; e4) from 2'-chloro-4-hydroxy-3-methoxy-5-nitrobenzophenone 2'-chloro-3,4-dihydroxy-5-nitrobenzophenone with m.p. 129-131°C (from methylene chloride/petroleum ether ts);
e5) fra 3'-klor-4-hydroksy-3-metoksy-5-nitrobenzofenon 3'-klor-3,4-dihydroksy-5-nitrobenzofenon med smp. 143-145°C (fra metylenklorid/petroleter ts) ; e5) from 3'-chloro-4-hydroxy-3-methoxy-5-nitrobenzophenone 3'-chloro-3,4-dihydroxy-5-nitrobenzophenone with m.p. 143-145°C (from methylene chloride/petroleum ether ts) ;
e6) fra 4'-klor-4-hydroksy-3-metoksybenzofenon 4'-klor-3,4-dihydroksybenzofenon med smp. 174-176°C (fra metylenklorid); e6) from 4'-chloro-4-hydroxy-3-methoxybenzophenone 4'-chloro-3,4-dihydroxybenzophenone with m.p. 174-176°C (from methylene chloride);
e7) fra 4-hydroksy-3-metoksy-2'-metyl-5-nitrobenzofenon 3,4-dihydroksy-2'-metyl-5-nitrobenzofenon med smp. 164-166°C (fra metylenklorid); e7) from 4-hydroxy-3-methoxy-2'-methyl-5-nitrobenzophenone 3,4-dihydroxy-2'-methyl-5-nitrobenzophenone with m.p. 164-166°C (from methylene chloride);
e8) fra 4-hydroksy-3-metoksy-4'-metyl-5-nitrobenzofenon 3,4-dihydroksy-4'-metyl-5-nitrobenzofenon med smp. 146-148°C (fra metylenklorid); e8) from 4-hydroxy-3-methoxy-4'-methyl-5-nitrobenzophenone 3,4-dihydroxy-4'-methyl-5-nitrobenzophenone with m.p. 146-148°C (from methylene chloride);
e9) fra 2'-cyano-4-hydroksy-3-metoksy-5-nitrobenzofenon 2'-cyano-3,4-dihydroksy-5-nitrobenzofenon med smp. 159-161°C (fra metanol); e9) from 2'-cyano-4-hydroxy-3-methoxy-5-nitrobenzophenone 2'-cyano-3,4-dihydroxy-5-nitrobenzophenone with m.p. 159-161°C (from methanol);
elO) fra 4-hydroksy-3-metoksy-5-nitro-2'-(trifluormetyl)benzofe-non 3,4-dihydroksy-5-nitro-2'-(trifluormetyl)benzofenon med smp. 146-148°C (fra metanol); elO) from 4-hydroxy-3-methoxy-5-nitro-2'-(trifluoromethyl)benzophenone 3,4-dihydroxy-5-nitro-2'-(trifluoromethyl)benzophenone with m.p. 146-148°C (from methanol);
ell) fra 4-hydroksy-3,4'-dimetoksy-5-nitrobenzofenon 5-nitro-3,4,4'-trihydroksybenzofenon med smp. 212-214°C (fra metanol/metylenklorid) og ell) from 4-hydroxy-3,4'-dimethoxy-5-nitrobenzophenone 5-nitro-3,4,4'-trihydroxybenzophenone with m.p. 212-214°C (from methanol/methylene chloride) and
el2) fra 4-hydroksy-5-nitro-3,3',4'-trimetoksybenzofenon 5-nitro-3,3',4,4'-tetrahydroksybenzofenon med smp. 222-224°C (fra eter). el2) from 4-hydroxy-5-nitro-3,3',4'-trimethoxybenzophenone 5-nitro-3,3',4,4'-tetrahydroxybenzophenone with m.p. 222-224°C (from ether).
Eksempel 77 Example 77
Man blander en suspensjon av 13,8 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med 9,0 g 1-(fenetyl)-2-tiourea i 150 ml n-butanol og oppvarmer ved kokepunktet 3 timer under tilbakeløp. Etter avkjøling til romtemperatur frafiltrerer man krystallene og omkrystalliserer dem fra n-butanol. Man får 3-nitro-5-[2-(fenetylamino)-4-tiazolyl]pyrokatekol-hydrobromid med smp. 249-251°C. A suspension of 13.8 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is mixed with 9.0 g of 1-(phenethyl)-2-thiourea in 150 ml of n-butanol and heated at boiling point 3 hours during reflux. After cooling to room temperature, the crystals are filtered off and recrystallized from n-butanol. 3-nitro-5-[2-(phenethylamino)-4-thiazolyl]pyrocatechol hydrobromide with m.p. 249-251°C.
Eksempel 7 8 Example 7 8
Analogt med eksempel 38 får man fra 2-brom-3',4'-dihydroksy-5'-nitroacetofenon og 2-amnobenzofenon 2-(3,4-dihydroksy-5-nitrobenzoyl)-3-fenylindol med smp. 196-198°C (fra isopropanol). Analogous to example 38, from 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone and 2-amnobenzophenone, 2-(3,4-dihydroxy-5-nitrobenzoyl)-3-phenylindole with m.p. 196-198°C (from isopropanol).
Eksempel 79 Example 79
Man blander en suspensjon av 8,3 g 2-brom-3',4'-dihydroksy-5'-nitroacetofenon med 1-(1-adamantyl)-2-tiourea i 90 ml n-butanol bg oppvarmer i 4 timer under tilbakeløp ved kokepunktet. Etter avkjøling til romtemperatur frafiltrerer man krystallene og omkrystalliserer dem fra n-butanol. Man får 5-[2-(1-adamantylamino)-5-tiazolyl]-3-nitropyrokatekol-hydrobromid med smp. 245-247°C. A suspension of 8.3 g of 2-bromo-3',4'-dihydroxy-5'-nitroacetophenone is mixed with 1-(1-adamantyl)-2-thiourea in 90 ml of n-butanol bg heating for 4 hours under reflux at the boiling point. After cooling to room temperature, the crystals are filtered off and recrystallized from n-butanol. 5-[2-(1-adamantylamino)-5-thiazolyl]-3-nitropyrocatechol hydrobromide with m.p. 245-247°C.
Eksempel 80 Example 80
En suspensjon av 2,6 g (3,4-dihydroksy-5-nitrobenzoyl)metyl-acetat i 20 ml etanol og 20 ml lN-saltsyre oppvarmes i 5 timer under tilbakeløp ved kokepunktet. Så inndamper man reaksjonsblandingen, destillerer igjen av med toluen og omkrystalliserer resten fra etanol. Man får 2,3',4'-trihydroksy-5'-nitroacetofe-non med smp. 208-210°C. A suspension of 2.6 g of (3,4-dihydroxy-5-nitrobenzoyl)methyl acetate in 20 ml of ethanol and 20 ml of 1N hydrochloric acid is heated for 5 hours under reflux at the boiling point. The reaction mixture is then evaporated, distilled again with toluene and the residue recrystallized from ethanol. 2,3',4'-trihydroxy-5'-nitroacetophenone is obtained with m.p. 208-210°C.
Eksempel 81 Example 81
En løsning av 4,0 g 3,4-dihydroksy-5-nitrofenylglyoksylsyre-n-heksylester og 1,5 g diaminomaleinsyrenitril i 35 ml etanol oppvarmes 24 timer under tilbakeløp ved kokepunktet. Så destillerer man alkoholen vekk, oppløser resten i eter, vasker med vann, tørker over natriumsulfat, filtrerer og inndamper. Man får 6-hydroksy-5-(3,4-dihydroksy-5-nitrofenyl)-2,3-pyrazindikar-bonitril med smp. >300°C (fra eter/metylenklorid). A solution of 4.0 g of 3,4-dihydroxy-5-nitrophenylglyoxylic acid-n-hexyl ester and 1.5 g of diaminomaleic acid nitrile in 35 ml of ethanol is heated for 24 hours under reflux at the boiling point. The alcohol is then distilled off, the residue dissolved in ether, washed with water, dried over sodium sulphate, filtered and evaporated. 6-Hydroxy-5-(3,4-dihydroxy-5-nitrophenyl)-2,3-pyrazine dicarbonitrile with m.p. >300°C (from ether/methylene chloride).
Eksempel 82 Example 82
a) Til 4,2 g 5-(bromacetyl)-2,3-dimetoksybenzonitril oppløst i 150 ml metylenklorid settes 8,9 ml bortribromid. Reaksjonsblandingen røres i 18 timer ved 20°C. Så helles dette på 220 ml mettet natriumhydrogenkarbonatløsning og 100 g is, pH innstilles på 6 med iseddik og man ekstraherer med eddikester. Den organiske fasen vaskes med vann, tørkes over natriumsulfat og inndampes. Man får 5-(bromacetyl)-2,3-dihydroksybenzonitril som amorft faststoff. a) To 4.2 g of 5-(bromoacetyl)-2,3-dimethoxybenzonitrile dissolved in 150 ml of methylene chloride, add 8.9 ml of boron tribromide. The reaction mixture is stirred for 18 hours at 20°C. This is then poured onto 220 ml of saturated sodium bicarbonate solution and 100 g of ice, the pH is adjusted to 6 with glacial acetic acid and extracted with acetic acid. The organic phase is washed with water, dried over sodium sulphate and evaporated. 5-(Bromoacetyl)-2,3-dihydroxybenzonitrile is obtained as an amorphous solid.
b) 3,8 g 5-(bromacetyl)-2,3-dihydroksybenzonitril, opplost i 25 ml N,N-dimetylformamid blandes med N-fenyltiourea og røres 5 b) 3.8 g of 5-(bromoacetyl)-2,3-dihydroxybenzonitrile, dissolved in 25 ml of N,N-dimethylformamide, are mixed with N-phenylthiourea and stirred for 5
timer ved 100°C. Deretter avdampes løsningsmidlet. Resten blandes, med 200 ml lN-natriumkarbonatløsning og ekstraheres tre ganger med 100 ml metylenklorid hver gang. De samlede organiske fasene vaskes med vann, tørkes over natriumsulfat og inndampes. Resten kromatograferes på 30 g kiselgel med eddikester. Det således oppnådde råprodukt blandes med 40 ml lN-saltsyre, inndampes og krystalliseres fra aceton. Man får 5-(2-anilino-4-tiazolyl)-2,3-dihydroksybenzonitril-hydroklorid med smp. 245-247°C. hours at 100°C. The solvent is then evaporated. The residue is mixed with 200 ml of 1N sodium carbonate solution and extracted three times with 100 ml of methylene chloride each time. The combined organic phases are washed with water, dried over sodium sulphate and evaporated. The residue is chromatographed on 30 g of silica gel with acetic acid. The crude product thus obtained is mixed with 40 ml of 1N hydrochloric acid, evaporated and crystallized from acetone. 5-(2-anilino-4-thiazolyl)-2,3-dihydroxybenzonitrile hydrochloride with m.p. 245-247°C.
Eksempel 83 Example 83
a) Til 10 g 4-(benzyloksy)-3-metoksy-brombenzen oppløst i 100 ml tetrahydrofuran dryppes ved -70°C i løpet av 10 min. 25 ml a) To 10 g of 4-(benzyloxy)-3-methoxy-bromobenzene dissolved in 100 ml of tetrahydrofuran is added dropwise at -70°C during 10 min. 25 ml
tert.-butyllitiumløsning (1.4M i heksan). Etter 1 time røring ved -70°C tildryppes 5 g kinolin-4-karbaldehyd oppløst i 50 ml tetrahydrofuran i løpet av 30 min.. Reaksjonsblandingen røres 1 time ved -40°C og 1 time ved -5°C, helles på 200 ml vann og pH innstilles på pH 4 med iseddik.. Det ekstraheres tre ganger med 50 ml eter hver gang. De sammenslåtte eterfaser vaskes med vann, tørkes over natriumsulfat og inndampes. Man får Q-[4-(benzyl-oksy) -3-metoksyf enyl] -4-kinolinmetanol som amorft faststoff. tert-butyllithium solution (1.4M in hexane). After 1 hour of stirring at -70°C, 5 g of quinoline-4-carbaldehyde dissolved in 50 ml of tetrahydrofuran are added dropwise over the course of 30 min. The reaction mixture is stirred for 1 hour at -40°C and 1 hour at -5°C, poured into 200 ml of water and the pH is adjusted to pH 4 with glacial acetic acid. It is extracted three times with 50 ml of ether each time. The combined ether phases are washed with water, dried over sodium sulphate and evaporated. Q-[4-(benzyloxy)-3-methoxyphenyl]-4-quinolinemethanol is obtained as an amorphous solid.
b) 9,4 g cx-[4-(benzyloksy) -3-metoksyf enyl ]-4-kinolinmetanol, oppløst i 200 ml metylenklorid, blandes med 6,5 g pyridiniumklorkromat, hvorpå man rører i 3 timer ved romtemperatur. Så frafiltreres de uløselige bestanddelene. Filtratet inndampes og resten kromatograferes på 150 g kiselgel med eddikester. Derved får man 4-(benzyloksy)-3-metoksyfenyl-4-kinolylketon som amorft faststoff. c) Til 7,5 g 4-(benzyloksy)-3-metoksyfenyl-4-kinolylketon, oppløst i 150 ml metylenklorid, tildryppes ved romtemperatur 15 ml 33% hydrogenbromid i iseddik i løpet av 5 min.. Etter 4,5 timer røring ved 20°C helles reaksjonsblandingen porsjonsvis på 250 ml mettet natriumbikarbonatløsning. Metylenkloridfasen skilles fra; den vandige fasen ekstraheres igjen to ganger med 100 ml metylenklorid hver gang. De samlede metylenkloridfaser tørkes over natriumsulfat og inndampes. Resten omkrystalliseres fra metylenklorid/heksan. Man får 4-hydroksy-3-metoksyfenyl-4-kinolylketon med smp. 190-192°C. d) 1,3 g 4-hydroksy-3-metoksyfenyl-4-kinolylketon, oppløst i 25 ml iseddik, tildryppes 0,37 ml 65% salpetersyre ved romtemperatur. Etter 3 timer røring helles reaksjonsblandingen på isvann, hvorpå man innstiller pH på 6 med kons. ammoniakk og frafiltrerer den dannede felling. Den således erholdte rest oppvarmes under tilbakeløp i 20 ml acetonitril, hvorved man frafiltrerer krystallene ved 0°C. Man får 4-hydroksy-3-metoksy-5-nitrofenyl-4-kinolylketon med smp. 246-248°C. e) lg 4-hydroksy-3-metoksy-5-nitrofenyl-4-kinolylketon oppløst i 30 ml 48% vandig hydrogenbromid røres i 18 timer ved 100°C. b) 9.4 g of cx-[4-(benzyloxy)-3-methoxyphenyl]-4-quinoline methanol, dissolved in 200 ml of methylene chloride, is mixed with 6.5 g of pyridinium chlorochromate, after which it is stirred for 3 hours at room temperature. The insoluble components are then filtered off. The filtrate is evaporated and the residue is chromatographed on 150 g of silica gel with acetic acid. This gives 4-(benzyloxy)-3-methoxyphenyl-4-quinolyl ketone as an amorphous solid. c) To 7.5 g of 4-(benzyloxy)-3-methoxyphenyl-4-quinolyl ketone, dissolved in 150 ml of methylene chloride, at room temperature 15 ml of 33% hydrogen bromide in glacial acetic acid are added dropwise over the course of 5 min. After 4.5 hours of stirring at 20°C, the reaction mixture is poured portionwise onto 250 ml of saturated sodium bicarbonate solution. The methylene chloride phase is separated; the aqueous phase is extracted again twice with 100 ml of methylene chloride each time. The combined methylene chloride phases are dried over sodium sulphate and evaporated. The residue is recrystallized from methylene chloride/hexane. 4-Hydroxy-3-methoxyphenyl-4-quinolyl ketone is obtained with m.p. 190-192°C. d) 1.3 g of 4-hydroxy-3-methoxyphenyl-4-quinolyl ketone, dissolved in 25 ml of glacial acetic acid, is added dropwise to 0.37 ml of 65% nitric acid at room temperature. After 3 hours of stirring, the reaction mixture is poured onto ice water, after which the pH is adjusted to 6 with conc. ammonia and filters off the formed precipitate. The residue thus obtained is heated under reflux in 20 ml of acetonitrile, whereby the crystals are filtered off at 0°C. 4-hydroxy-3-methoxy-5-nitrophenyl-4-quinolyl ketone is obtained with m.p. 246-248°C. e) lg 4-hydroxy-3-methoxy-5-nitrophenyl-4-quinolyl ketone dissolved in 30 ml of 48% aqueous hydrogen bromide is stirred for 18 hours at 100°C.
Etter avkjøling til romtemperatur fortynnes reaksjonsproduktet med 30 ml vann og fellingen frafiltreres. Man får 3,4-dihy-droksy-5-nitrofenyl-4-kinolylketon-hydrobromid med smp. 273-275°C (fra acetonitril). After cooling to room temperature, the reaction product is diluted with 30 ml of water and the precipitate is filtered off. This gives 3,4-dihydroxy-5-nitrophenyl-4-quinolyl ketone hydrobromide with m.p. 273-275°C (from acetonitrile).
Eksempel 84 Example 84
a) Til 4,03 g tiofen oppløst i 40 ml tetrahydrofuran dryppes ved -50°C i løpet av 10 min. 18,8 ml n-butyllitiumløsning (1,6M i a) To 4.03 g of thiophene dissolved in 40 ml of tetrahydrofuran is added dropwise at -50°C during 10 min. 18.8 ml of n-butyllithium solution (1.6M in
heksan). Etter 30 min. røring ved -50°C tildryppes 6,3 g 3,4-dimetoksy-5-nitrobenzaldehyd oppløst i 100 ml tetrahydrofuran i løpet av 30 min.. Reaksjonsblandingen røres 1 time ved -50°C og 3 0 min. ved 0°C og helles på 100 ml 2N-svovelsyre. Det ekstraheres tre ganger med 100 ml eter hver gang; og de sammenslåtte eterfaser vaskes med koksaltløsning, tørkes over natriumsulfat, filtreres og inndampes. Man får cx-(3,4-dimetoksy-5-nitrofenyl)-2-tiofenmetanol med smp. 79-81°C (fra metylenklorid/heksan). hexane). After 30 min. stirring at -50°C, 6.3 g of 3,4-dimethoxy-5-nitrobenzaldehyde dissolved in 100 ml of tetrahydrofuran are added dropwise over the course of 30 min. The reaction mixture is stirred for 1 hour at -50°C and 30 min. at 0°C and poured onto 100 ml of 2N sulfuric acid. It is extracted three times with 100 ml of ether each time; and the combined ether phases are washed with sodium chloride solution, dried over sodium sulphate, filtered and evaporated. One obtains c-(3,4-dimethoxy-5-nitrophenyl)-2-thiophene methanol with m.p. 79-81°C (from methylene chloride/hexane).
b) 9,9 g a-(3,4-dimetoksy-5-nitrofenyl)-2-tiofenmetanol, oppløst i 300 ml aceton, blandes med 90 g brunsten og oppvarmes i b) 9.9 g of α-(3,4-dimethoxy-5-nitrophenyl)-2-thiophene methanol, dissolved in 300 ml of acetone, is mixed with 90 g of brownstone and heated in
4 timer under tilbakeløp. Deretter frafiltreres brunstenet, og filtratet inndampes. Man får 3,4-dimetoksy-5-nitrofenyl-2-tienylketon med smp. 102-104°C (fra metylenklorid/heksan). 4 hours under reflux. The lignite is then filtered off, and the filtrate is evaporated. 3,4-dimethoxy-5-nitrophenyl-2-thienyl ketone is obtained with m.p. 102-104°C (from methylene chloride/hexane).
c) 2 g 3,4-dimetoksy-5-nitrofenyl-2-tienylketon røres i en blanding av 20 ml 30-33% hydrogenbromid i iseddik og 20 ml 48% c) 2 g of 3,4-dimethoxy-5-nitrophenyl-2-thienyl ketone are stirred in a mixture of 20 ml of 30-33% hydrogen bromide in glacial acetic acid and 20 ml of 48%
vandig hydrogenbromid i 8 timer ved 100°C. Så inndampes reak-sj onsblandingen til tørrhet. Resten opptas i eddikester, vaskes med vann, tørkes over natriumsuflat og filtreres, og filtratet inndampes. Etter omkrystallisering fra eddikester/heksan får man 3,4-dihydroksy-5-nitrofenyl-2-tienylketon med smp. 155-157°C. aqueous hydrogen bromide for 8 hours at 100°C. The reaction mixture is then evaporated to dryness. The residue is taken up in ethyl acetate, washed with water, dried over sodium sulfate and filtered, and the filtrate is evaporated. After recrystallization from ethyl acetate/hexane, 3,4-dihydroxy-5-nitrophenyl-2-thienyl ketone is obtained with m.p. 155-157°C.
Eksempel A Example A
Gelatin-stikk-kapslene med etterfølgende sammensetning kan fremstilles på i og for seg kjent måte: The gelatin stick capsules with the following composition can be produced in a manner known per se:
Claims (5)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH98086 | 1986-03-11 | ||
| CH6287 | 1987-01-09 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO870984D0 NO870984D0 (en) | 1987-03-10 |
| NO870984L NO870984L (en) | 1987-09-14 |
| NO165959B true NO165959B (en) | 1991-01-28 |
| NO165959C NO165959C (en) | 1991-05-08 |
Family
ID=25683401
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870984A NO165959C (en) | 1986-03-11 | 1987-03-10 | ANALOGY PROCEDURE FOR THE PREPARATION OF 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES. |
| NO1998006C NO1998006I1 (en) | 1986-03-11 | 1998-01-28 | Tolcapone |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO1998006C NO1998006I1 (en) | 1986-03-11 | 1998-01-28 | Tolcapone |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0237929B1 (en) |
| JP (1) | JPH0742254B2 (en) |
| AR (1) | AR245097A1 (en) |
| AT (1) | ATE90072T1 (en) |
| AU (1) | AU603788B2 (en) |
| CA (1) | CA1302418C (en) |
| CS (1) | CS402291A3 (en) |
| DE (1) | DE3786026D1 (en) |
| DK (1) | DK175069B1 (en) |
| ES (1) | ES2056792T3 (en) |
| FI (1) | FI91396C (en) |
| HK (1) | HK165896A (en) |
| HU (1) | HU201900B (en) |
| IE (1) | IE61316B1 (en) |
| IL (1) | IL81791A (en) |
| LU (1) | LU90219I2 (en) |
| LV (1) | LV5742B4 (en) |
| MC (1) | MC1807A1 (en) |
| NL (1) | NL970041I1 (en) |
| NO (2) | NO165959C (en) |
| NZ (1) | NZ219496A (en) |
| PT (1) | PT84449B (en) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU213587A (en) * | 1986-11-28 | 1989-06-30 | Orion Yhtymae Oy | Process for obtaining new pharmacologic active cateholic derivatives |
| FI864875A0 (en) * | 1986-11-28 | 1986-11-28 | Orion Yhtymae Oy | NYA FARMAKOLOGISKT AKTIVA FOERENINGAR, DESSA INNEHAOLLANDE KOMPOSITIONER SAMT FOERFARANDE OCH MELLANPRODUKTER FOER ANVAENDNING VID FRAMSTAELLNING AV DESSA. |
| US5283352A (en) * | 1986-11-28 | 1994-02-01 | Orion-Yhtyma Oy | Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
| US5489614A (en) * | 1987-11-27 | 1996-02-06 | Orion-Yhtyma Oy | Catechol derivatives, their physiologically acceptable salts, esters and use |
| MTP1031B (en) * | 1987-12-24 | 1990-10-04 | Orion Yhtymae Oy | New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters |
| GB9113431D0 (en) * | 1991-06-20 | 1991-08-07 | Orion Yhytma Oy | Method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde |
| GB9419274D0 (en) * | 1994-09-23 | 1994-11-09 | Orion Yhtymae Oy | New method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde |
| GB9626472D0 (en) | 1996-12-20 | 1997-02-05 | Aperia Anita C | New use of comt inhibitors |
| ID19540A (en) * | 1997-01-22 | 1998-07-23 | Hoffmann La Roche | METHOD OF MAKING BENZOFENON DECREASES |
| GB9819382D0 (en) | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
| GB2344819A (en) * | 1998-12-18 | 2000-06-21 | Portela & Ca Sa | 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones |
| DE19960105A1 (en) * | 1999-12-14 | 2001-06-21 | Haarmann & Reimer Gmbh | Catechol oximes and their use in cosmetic and dermatological preparations |
| FI20000635A0 (en) * | 2000-03-17 | 2000-03-17 | Orion Yhtymae Oyj | Use of COMT inhibitors as an analgesic |
| AU2001256765A1 (en) * | 2000-05-16 | 2001-11-26 | Nippon Soda Co., Ltd. | Phenyloxazole compounds and fungicides for agricultural and horticultural use |
| GB2363792A (en) * | 2000-06-21 | 2002-01-09 | Portela & Ca Sa | Nitrocatechols |
| GB0015228D0 (en) * | 2000-06-21 | 2000-08-16 | Portela & Ca Sa | Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders |
| FI20012242A0 (en) * | 2001-11-19 | 2001-11-19 | Orion Corp | New pharmaceutical compounds |
| US8158149B2 (en) | 2004-05-12 | 2012-04-17 | Chelsea Therapeutics, Inc. | Threo-DOPS controlled release formulation |
| WO2004100929A1 (en) | 2003-05-12 | 2004-11-25 | Synergia Pharma, Inc. | Threo-dops controlled release formulation |
| CA2563704A1 (en) | 2004-05-04 | 2005-11-24 | Children's Medical Center Corporation | Methods and compositions for treatment of preeclampsia |
| DE102004023332A1 (en) * | 2004-05-12 | 2006-01-19 | Bayer Cropscience Gmbh | Quinoxaline-2-one derivatives, crop protection agents containing them, and processes for their preparation and their use |
| WO2006051154A1 (en) | 2004-11-10 | 2006-05-18 | Orion Corporation | Treatment of restless legs syndrome |
| ES2545178T3 (en) | 2005-07-26 | 2015-09-09 | Bial-Portela & Ca, S.A. | Nitrocatechol derivatives as COMT inhibitors |
| EP1845097A1 (en) * | 2006-04-10 | 2007-10-17 | Portela & Ca., S.A. | Oxadiazole derivatives as COMT inhibitors |
| DK1948155T3 (en) | 2006-06-28 | 2012-07-02 | Chelsea Therapeutics Inc | Pharmaceutical compositions comprising droxidopa |
| EP2099933A4 (en) | 2006-11-21 | 2010-03-24 | Beth Israel Hospital | PROTEINS AND GENES ASSOCIATED WITH HYPOXIA AND FOR THE DIAGNOSIS AND TREATMENT OF PREGNANCY COMPLICATIONS |
| DK2481410T3 (en) | 2007-01-31 | 2016-10-24 | Bial - Portela & Ca S A | Nitrocatecholderivater as COMT inhibitors administered in a specific dosage regimen |
| JP2010520885A (en) | 2007-03-09 | 2010-06-17 | チェルシー・セラピューティクス,インコーポレイテッド | Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia |
| NZ581707A (en) | 2007-05-07 | 2011-05-27 | Chelsea Therapeutics Inc | Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders |
| JP2009126784A (en) * | 2007-11-19 | 2009-06-11 | Mitsubishi Gas Chem Co Inc | A method for producing 2-iodo-3,4-dimethoxybenzonitrile. |
| CN101965339B (en) * | 2007-12-25 | 2013-08-14 | 橘生药品工业株式会社 | Catechol derivative, pharmaceutical composition containing same, application of catechol derivative, and application of pharmaceutical composition |
| CL2009000628A1 (en) | 2008-03-17 | 2010-04-09 | Bial Portela & Companhia S A | Crystalline form of 5- [3- (2,5-dichloro-4,6-dimethyl-1-oxy-pyridin-3-yl) - [1,2,4] oxadiazol-5-yl] -3-nitrobenzene- 1,2-diol, a pharmaceutical composition that comprises it, a process to obtain it and its use to treat mood disorders, Parkinson's disease and Parkinsonian disorders, gastrointestinal disorders, among others. |
| WO2010001821A1 (en) | 2008-07-04 | 2010-01-07 | キッセイ薬品工業株式会社 | Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| KR20210009441A (en) | 2009-04-01 | 2021-01-26 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof |
| JP5529639B2 (en) * | 2009-06-18 | 2014-06-25 | キッセイ薬品工業株式会社 | Novel catechol-O-methyltransferase inhibitor |
| JP5707063B2 (en) * | 2009-06-18 | 2015-04-22 | キッセイ薬品工業株式会社 | Novel catechol derivatives, pharmaceutical compositions containing them, and uses thereof |
| CN102781424B (en) | 2010-03-04 | 2016-03-30 | 奥赖恩公司 | Levodopa, carbidopa and entacapone are used for the treatment of Parkinsonian application |
| US20140045900A1 (en) | 2011-02-11 | 2014-02-13 | Bial-Portela & Ca, S.A. | Administration regime for nitrocatechols |
| JP5880913B2 (en) | 2011-05-17 | 2016-03-09 | 三郎 佐古田 | Treatment for trunk symptoms (postural reflex abnormalities) in Parkinson's disease |
| EP2791134B1 (en) | 2011-12-13 | 2019-09-25 | BIAL - Portela & Cª S.A. | Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor |
| HK1200331A1 (en) | 2012-01-31 | 2015-08-07 | Lundbeck Na Ltd | Improving postural stability administering droxidopa |
| US9109005B2 (en) * | 2012-02-23 | 2015-08-18 | Boehringer Ingelheim International Gmbh | Method for manufacturing of ciclesonide |
| TWI638802B (en) * | 2012-05-24 | 2018-10-21 | 芬蘭商奧利安公司 | Catechol o-methyltransferase activity inhibiting compounds |
| WO2014147464A2 (en) * | 2013-03-20 | 2014-09-25 | Ra Chem Pharma Limited | Novel process for the preparation of tolcapone |
| WO2016083863A1 (en) | 2014-11-28 | 2016-06-02 | Bial - Portela & Ca, S.A. | Medicaments for slowing parkinson's disease |
| PT3394046T (en) | 2015-12-24 | 2022-04-05 | Univ California | CFTR REGULATORS AND THEIR METHODS OF USE |
| JP2020158391A (en) * | 2017-06-13 | 2020-10-01 | 株式会社富士薬品 | Novel nitrocatechol derivative |
| JP7532259B2 (en) * | 2018-04-05 | 2024-08-13 | プレックス ファーマスーティカルズ,インク | Eye disease treatment drugs |
| WO2022150962A1 (en) * | 2021-01-12 | 2022-07-21 | Westlake Pharmaceutical (Hangzhou) Co., Ltd. | Protease inhibitors, preparation, and uses thereof |
| CN114560771B (en) * | 2022-03-07 | 2023-10-27 | 中北大学 | Method for photocatalytic selective nitration of bromophenol |
| WO2025016521A1 (en) | 2023-07-18 | 2025-01-23 | Universitat Autonoma De Barcelona | Compound for the treatment of transthyretin amyloidosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54128542A (en) * | 1978-03-27 | 1979-10-05 | Ube Ind Ltd | Preparation of 3-cyanocatechol derivative |
| GB2038819B (en) * | 1978-12-21 | 1983-02-16 | Secr Defence | Initiatory explosives comprising a lead salt of 3,5-dinitro-catechol |
| EP0142283B1 (en) * | 1983-10-25 | 1991-01-30 | FISONS plc | Phenylethylamines, process for their preparation and compositions containing them |
| DE3406329A1 (en) * | 1984-02-22 | 1985-08-22 | Merck Patent Gmbh, 6100 Darmstadt | PYRIDONE |
| CA1339860C (en) * | 1985-06-17 | 1998-05-12 | Tsunehiko Soga | Derivatives of penem |
-
1987
- 1987-02-18 DK DK198700820A patent/DK175069B1/en not_active IP Right Cessation
- 1987-02-20 CA CA000530171A patent/CA1302418C/en not_active Expired - Lifetime
- 1987-03-04 NZ NZ219496A patent/NZ219496A/en unknown
- 1987-03-05 IL IL81791A patent/IL81791A/en not_active IP Right Cessation
- 1987-03-06 AU AU69764/87A patent/AU603788B2/en not_active Expired
- 1987-03-09 HU HU87989A patent/HU201900B/en unknown
- 1987-03-09 MC MC871876A patent/MC1807A1/en unknown
- 1987-03-09 AR AR87306966A patent/AR245097A1/en active
- 1987-03-10 IE IE60987A patent/IE61316B1/en not_active IP Right Cessation
- 1987-03-10 NO NO870984A patent/NO165959C/en not_active IP Right Cessation
- 1987-03-10 FI FI871041A patent/FI91396C/en not_active IP Right Cessation
- 1987-03-11 JP JP62056411A patent/JPH0742254B2/en not_active Expired - Lifetime
- 1987-03-11 ES ES87103469T patent/ES2056792T3/en not_active Expired - Lifetime
- 1987-03-11 EP EP87103469A patent/EP0237929B1/en not_active Expired - Lifetime
- 1987-03-11 PT PT84449A patent/PT84449B/en unknown
- 1987-03-11 DE DE8787103469T patent/DE3786026D1/en not_active Expired - Lifetime
- 1987-03-11 AT AT87103469T patent/ATE90072T1/en active
-
1991
- 1991-12-23 CS CS914022A patent/CS402291A3/en unknown
-
1996
- 1996-05-29 LV LV960162A patent/LV5742B4/en unknown
- 1996-09-05 HK HK165896A patent/HK165896A/en not_active IP Right Cessation
-
1997
- 1997-11-21 NL NL970041C patent/NL970041I1/en unknown
-
1998
- 1998-01-28 NO NO1998006C patent/NO1998006I1/en unknown
- 1998-02-25 LU LU90219C patent/LU90219I2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO165959B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF 3,5-DISUBSTITUTED PYROCATIC COLD DERIVATIVES. | |
| US5389653A (en) | Catechol derivatives | |
| Narayana et al. | Synthesis of some new 5-(2-substituted-1, 3-thiazol-5-yl)-2-hydroxy benzamides and their 2-alkoxy derivatives as possible antifungal agents | |
| Mao et al. | Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators | |
| FR2493320A1 (en) | NOVEL CARBOSTYRILE DERIVATIVES USEFUL AS CARDIOTONIC, PROCESSES FOR PREPARING THEM AND MEDICAMENTS CONTAINING SAME | |
| CA2686754A1 (en) | Hetarylanilines as modulators for amyloid beta | |
| US20100152192A1 (en) | Fused imidazole carboxamides as trpv3 modulators | |
| US20250042882A1 (en) | Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators | |
| Farghaly et al. | Synthesis and anticonvulsant activity of some new pyrazolo [3, 4-b] pyrazines and related heterocycles | |
| WO2023111144A1 (en) | Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators | |
| JP2003313176A (en) | Aminoazole derivative | |
| TWI399369B (en) | Anthraimidazole derivatives and the synthesis method thereof | |
| Jadhao et al. | Copper-mediated [3+ 2] oxidative cyclization of oxime acetate and its utility in the formal synthesis of fentiazac | |
| US20080076801A1 (en) | Indolylalkylpyridin-2-amines for the inhibition of beta-secretase | |
| US4933338A (en) | Benzimidazolesulfonamides and their application as drugs | |
| Bhat et al. | Synthesis, characterization and biological activity studies of 1, 3, 4-Oxadiazole analogs | |
| JPWO2004031180A1 (en) | Quinazolin-4-one derivatives | |
| KR930001337B1 (en) | 3,5-disubstituted pyrocatechole derivatives | |
| AU2020407604A1 (en) | 4-phenyl-n-(phenyl)thiazol-2-amine derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of e.g. angiogenesis implicated or inflammatory disorders | |
| BG60383B2 (en) | Catechol derivatives | |
| Nagasree et al. | Synthesis and in vitro studies of thiazolidine-4-carboxylic acid hydrazones as potential antitubercular agents | |
| DK151811B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF N- (5-TETRAZOLYL) -1-OXO-1H-THIAZOLOOE3,2-AAA-PYRIMIDIN-2-CARBOXAMIDES OR PHARMACEUTICALLY ACCEPTABLE COATAL SALTS THEREOF AND 1-OXO-2XO-OXO-2-OXO2 FOR USE AS THE INITIAL MATERIALS IN THE PROCEDURE | |
| KR960009162B1 (en) | 3,5-disubstituted pyrocatechole derivatives | |
| NZ206317A (en) | Acridanone derivatives and pharmaceutical compositions | |
| GB1569238A (en) | 2,5-dihdro-1,2-thiazino(5,6-b)indol-3-carboxamide-1,1-dioxide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |